data_2nlw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2nlw _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 6.7 p-10 . . . . . 0 C--O 1.207 -1.181 0 CA-C-O 121.066 0.46 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -110.92 16.85 21.03 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.106 0.479 . . . . 0.0 111.438 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.19 132.23 63.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.409 HD12 ' HD1' ' A' ' 73' ' ' HIS . 9.6 mm -97.63 135.12 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.27 116.66 53.19 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 173.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 10.3 t -113.34 122.97 68.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.449 0.468 . . . . 0.0 110.216 -175.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.1 t70 -91.87 136.25 33.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.931 0.77 . . . . 0.0 111.182 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.48 0.1 OUTLIER 41.5 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 128.043 2.537 . . . . 0.0 116.684 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.527 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 18.3 m -98.7 173.29 3.97 Favored Pre-proline 0 N--CA 1.427 -1.611 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.246 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.694 ' HA ' ' NE2' ' A' ' 90' ' ' HIS . 55.5 Cg_exo -41.16 127.58 2.9 Favored 'Trans proline' 0 C--O 1.266 1.903 0 C-N-CA 123.649 2.9 . . . . 0.0 114.223 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.84 -178.24 3.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.26 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 31' ' ' LEU . 6.6 p -111.93 134.23 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 118.885 -1.126 . . . . 0.0 113.325 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.78 157.08 15.28 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 104.263 -3.535 . . . . 0.0 104.263 166.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . 0.466 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 9.3 Cg_endo -52.23 123.16 12.0 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 121.557 2.678 . . . . 0.0 112.266 -172.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 50.74 25.74 2.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.432 1.493 . . . . 0.0 112.89 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 28' ' ' PRO . 70.7 mtt180 -107.08 -8.4 16.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 122.061 -0.4 . . . . 0.0 110.952 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.455 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.9 tm? -73.53 -19.72 60.84 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.39 -48.39 74.4 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.978 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -79.17 -22.29 45.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.412 0.625 . . . . 0.0 110.372 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.41 1.37 33.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 97.1 mttt -84.74 -43.23 14.47 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 48.9 t30 -75.71 -34.95 60.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.033 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.86 -32.78 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.656 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 mm -60.06 -59.01 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.539 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.06 -35.29 73.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.169 0.588 . . . . 0.0 110.542 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 29.9 mtpp -65.61 -39.91 92.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.794 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.3 -39.79 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.301 0.572 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.538 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 26.2 m-85 -76.22 -9.41 58.61 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -66.0 -19.31 65.81 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.636 0.732 . . . . 0.0 110.679 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -68.81 -21.16 64.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.951 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.85 -15.08 35.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.941 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.0 -152.74 24.86 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -96.11 125.72 40.84 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 mm -73.94 97.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -69.67 -54.37 14.2 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -135.84 135.19 39.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -134.14 126.98 31.12 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.87 0.843 . . . . 0.0 109.711 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -125.23 117.1 23.08 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.304 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.07 103.48 50.24 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -95.71 173.97 1.04 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.605 2.204 . . . . 0.0 111.101 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.408 ' HE3' HD11 ' A' ' 31' ' ' LEU . 16.5 pttp -69.95 139.99 52.96 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.35 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.47 16.55 6.25 Favored Glycine 0 C--N 1.288 -2.098 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.855 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 24.4 p90 -169.92 158.33 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.2 pt -147.48 174.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 124.383 1.073 . . . . 0.0 108.117 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.48 136.89 43.48 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.386 0.429 . . . . 0.0 109.875 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.538 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 3.1 mm? -127.92 123.43 34.91 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.19 129.8 56.18 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 9.5 m-85 -127.34 170.35 12.59 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.34 14.33 12.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.447 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 49.6 m -71.57 173.33 5.32 Favored Pre-proline 0 CA--C 1.594 2.636 0 CA-C-N 113.231 -1.804 . . . . 0.0 115.565 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 6.3 Cg_exo -36.64 6.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.521 3.105 1 C-N-CA 130.041 7.16 . . . . 0.0 121.015 175.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 84.56 63.31 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 124.464 2.078 . . . . 0.0 108.478 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.579 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 17.3 p80 -74.16 -36.93 64.13 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 110.125 -3.216 . . . . 0.0 111.065 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -76.98 -37.29 55.47 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.57 -42.83 95.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.52 -49.31 69.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.669 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.23 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.005 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 74' ' ' ALA . 27.8 m -60.06 -31.62 48.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -84.87 -31.02 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -104.8 -41.38 5.66 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.16 84.67 2.02 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.48 ' HB2' HG21 ' A' ' 94' ' ' VAL . 3.5 t70 -116.31 118.42 32.69 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.36 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.12 41.96 7.79 Favored Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.154 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . 0.251 39.6 p90 -88.48 120.58 29.99 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.033 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HG3' HG21 ' A' ' 91' ' ' THR . 0.8 OUTLIER -79.68 122.41 26.53 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.212 -176.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -87.08 -65.83 0.97 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.138 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -169.25 153.73 5.53 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 45.41 -91.47 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 C-N-CA 125.851 1.66 . . . . 0.0 114.705 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -111.49 -22.89 11.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.694 ' NE2' ' HA ' ' A' ' 24' ' ' PRO . 22.6 m170 -62.54 99.61 0.15 Allowed 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 122.814 0.446 . . . . 0.0 111.459 -171.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.45 HG21 ' HG3' ' A' ' 85' ' ' LYS . 7.5 m -134.45 103.0 5.52 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.8 100.25 10.19 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.888 -172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.476 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.2 mpt_? -83.12 138.55 33.63 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 82' ' ' ASP . 3.9 m -124.73 136.3 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 O-C-N 123.574 0.546 . . . . 0.0 110.344 -173.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.557 ' C ' HD21 ' A' ' 95' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.725 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 26.4 t70 . . . . . 0 C--O 1.186 -2.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.485 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 36.0 m -89.38 -3.16 58.56 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 88.3 t -127.55 122.57 59.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 14.0 mm -89.99 135.82 25.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 59.9 t -128.74 120.51 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.73 138.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.681 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.61 139.86 42.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.581 0.2 OUTLIER 46.58 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 127.253 2.221 . . . . 0.0 115.889 -169.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.525 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 29.9 m -107.25 179.04 0.95 Allowed Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.141 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.583 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 54.3 Cg_exo -42.41 131.74 5.04 Favored 'Trans proline' 0 C--O 1.269 2.04 0 C-N-CA 123.01 2.474 . . . . 0.0 114.831 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HA ' HG22 ' A' ' 60' ' ' THR . 9.1 pt20 -61.84 -165.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 128.06 2.544 . . . . 0.0 113.528 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.46 ' HB ' HD21 ' A' ' 31' ' ' LEU . 14.9 p -141.03 138.55 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-O 121.985 0.897 . . . . 0.0 110.691 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.93 141.85 15.38 Favored Glycine 0 C--N 1.275 -2.853 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 166.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.2 124.81 13.59 Favored 'Trans proline' 0 C--O 1.243 0.744 0 CA-C-N 121.274 2.537 . . . . 0.0 112.73 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 60.56 32.38 20.42 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.067 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.4 2.04 10.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.228 -0.92 . . . . 0.0 111.039 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.46 HD21 ' HB ' ' A' ' 26' ' ' VAL . 1.4 tm? -60.91 -27.01 67.88 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -174.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -57.7 -50.72 72.25 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.56 -23.53 61.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.661 0.743 . . . . 0.0 109.993 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.8 mt -81.2 -4.53 55.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.574 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 99.5 mttt -85.62 -37.46 19.49 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 168.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.494 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 4.4 m-20 -78.16 -33.89 50.04 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.921 -172.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.38 -32.5 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.944 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.47 -53.34 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.3 -31.68 67.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.842 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 52.9 mtpt -78.32 -41.6 33.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.5 mt -82.44 -41.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.708 0.765 . . . . 0.0 111.246 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.626 ' CD2' HD11 ' A' ' 66' ' ' LEU . 3.9 m-85 -78.57 -10.81 59.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 1.8 p -71.78 -10.02 59.15 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.733 0.778 . . . . 0.0 111.578 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -71.21 -22.03 62.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.318 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.69 -15.42 39.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.729 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 150.83 -171.47 30.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -83.73 127.08 33.52 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.1 mm -72.6 94.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.2 m -83.36 -37.25 23.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.097 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 39.5 t30 -154.04 145.57 23.19 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -146.64 151.25 36.95 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -135.99 106.14 6.34 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.783 0.677 . . . . 0.0 109.892 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.74 104.72 55.39 Favored Pre-proline 0 C--O 1.252 1.212 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.32 173.21 1.2 Allowed 'Trans proline' 0 N--CA 1.432 -2.128 0 C-N-CA 121.882 1.721 . . . . 0.0 110.898 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.286 -2.167 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 25' ' ' GLN . 98.7 m . . . . . 0 N--CA 1.429 -1.512 0 CA-C-O 121.165 0.507 . . . . 0.0 111.532 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -67.86 145.54 54.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.438 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -118.33 3.19 16.06 Favored Glycine 0 C--N 1.286 -2.225 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.932 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -168.19 150.06 5.26 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.12 167.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -132.69 136.06 46.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.626 HD11 ' CD2' ' A' ' 42' ' ' PHE . 47.1 mt -121.46 154.01 37.15 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 16' ' ' SER . 42.3 tt0 -135.95 122.58 20.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.54 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 11.8 m-30 -118.88 157.56 27.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.37 13.86 28.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.219 1.009 . . . . 0.0 108.82 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 20.8 m -73.57 161.63 78.01 Favored Pre-proline 0 CA--C 1.604 3.034 0 CA-C-N 114.16 -1.382 . . . . 0.0 114.605 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.2 Cg_endo -37.66 8.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.945 2 C-N-CA 130.622 7.548 . . . . 0.0 124.316 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.725 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.47 67.42 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 123.066 2.666 . . . . 0.0 106.153 -156.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.54 ' NE2' ' HB2' ' A' ' 68' ' ' TYR . 22.9 p-80 -93.94 -37.87 11.47 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 109.067 -3.697 . . . . 0.0 112.197 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.6 -23.42 53.43 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.354 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.3 p -65.11 -22.89 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.764 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.04 -46.71 12.51 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.05 -43.79 66.91 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.982 0.801 . . . . 0.0 111.964 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.49 -19.57 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.92 0.39 . . . . 0.0 111.872 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 7.5 ttpm? -85.27 -22.98 28.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.173 176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -71.91 0.14 Allowed 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.313 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -177.3 124.13 0.13 Allowed 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.642 0.588 . . . . 0.0 110.285 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.463 ' HB2' HG22 ' A' ' 94' ' ' VAL . 5.5 t70 -81.43 115.67 20.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.49 52.5 4.18 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.335 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -93.67 126.61 38.94 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.092 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -82.99 117.19 22.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.786 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.65 -58.78 2.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.8 0.809 . . . . 0.0 109.197 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -135.12 -164.79 1.58 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -36.2 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.744 1.617 . . . . 0.0 115.069 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -96.29 -1.15 48.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.726 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.583 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 42.1 m170 -81.43 93.29 6.59 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.2 m -133.95 108.38 8.36 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.681 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -82.83 101.07 10.72 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.261 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.56 136.73 34.14 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 82' ' ' ASP . 17.1 m -105.86 138.17 32.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 123.792 0.682 . . . . 0.0 110.594 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.438 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.052 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 . . . . . 0 N--CA 1.422 -1.828 0 CA-C-O 122.55 1.167 . . . . 0.0 107.992 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.501 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 44.9 m -96.48 7.18 47.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.265 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 38.7 t -127.93 126.53 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.981 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.5 mm -83.04 139.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.2 112.13 34.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.79 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.777 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 30.1 t70 -85.44 132.78 34.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.744 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.479 0.2 OUTLIER 45.7 97.92 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.9 m -86.63 167.94 20.55 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.656 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 48.9 Cg_exo -51.18 146.95 21.81 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.769 2.313 . . . . 0.0 116.098 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 25' ' ' GLN . 3.7 tt0 -61.06 145.3 51.32 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.19 -2.277 . . . . 0.0 109.503 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.87 151.0 25.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.715 0.769 . . . . 0.0 111.494 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.16 174.87 20.98 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.62 126.05 11.89 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.691 2.261 . . . . 0.0 113.642 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.9 t70 65.27 18.44 11.39 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.797 2.039 . . . . 0.0 112.9 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -100.89 -8.36 22.61 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.612 -1.305 . . . . 0.0 111.629 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.425 ' O ' HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -76.97 -21.9 54.02 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.63 -34.44 78.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.221 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -69.93 -36.96 75.74 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.563 ' O ' HG12 ' A' ' 38' ' ' ILE . 80.2 mt -73.59 -34.37 65.06 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.551 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -58.47 -31.61 67.97 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.98 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -80.96 -31.25 34.93 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.789 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 34' ' ' LEU . 3.8 p -75.25 -28.99 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.6 mm -62.12 -51.76 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -65.45 -17.56 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.257 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -88.07 -60.08 2.06 Favored 'General case' 0 N--CA 1.415 -2.21 0 O-C-N 122.15 -0.344 . . . . 0.0 110.784 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.12 -42.7 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.354 0.597 . . . . 0.0 111.303 -175.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.526 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 58.2 m-85 -79.4 -17.76 53.7 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 68.4 m -74.28 -3.71 31.73 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.388 0.613 . . . . 0.0 111.397 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.05 -3.39 58.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -113.16 9.64 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.319 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 126.62 -162.53 20.76 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -94.5 133.27 38.29 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.277 0.539 . . . . 0.0 111.619 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.44 95.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 68' ' ' TYR . 1.2 p -80.55 -34.64 35.27 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.379 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -152.19 147.22 26.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.991 -0.443 . . . . 0.0 110.177 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -136.65 107.2 6.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.413 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 2.4 m-85 -107.37 104.83 54.04 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.661 -1.236 . . . . 0.0 107.661 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.548 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 73.4 Cg_endo -83.89 159.19 13.87 Favored 'Trans proline' 0 N--CA 1.436 -1.882 0 C-N-CA 120.921 1.081 . . . . 0.0 110.19 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.458 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 20.1 pt-20 . . . . . 0 C--N 1.285 -2.204 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.252 1.189 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.548 ' HE3' ' O ' ' A' ' 54' ' ' PRO . 6.9 ptpp? -64.33 166.01 8.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 125.735 1.614 . . . . 0.0 110.072 170.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.04 14.66 4.88 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.229 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -170.66 152.46 3.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 pt -145.53 167.1 9.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -128.88 136.15 50.05 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.2 0.524 . . . . 0.0 109.682 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 3.6 mm? -115.67 118.26 32.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -103.52 122.08 44.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.526 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 m-85 -126.95 164.75 20.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.769 0.795 . . . . 0.0 111.952 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.66 13.58 26.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.605 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.485 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . 38.6 t -75.03 158.31 84.48 Favored Pre-proline 0 CA--C 1.585 2.319 0 C-N-CA 125.344 1.457 . . . . 0.0 113.469 -171.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -37.48 8.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.836 1 C-N-CA 130.31 7.34 . . . . 0.0 121.057 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.41 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . . . 84.84 62.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 125.026 2.346 . . . . 0.0 108.058 -166.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.515 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 14.3 p80 -72.41 -36.26 68.6 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 109.261 -3.608 . . . . 0.0 110.83 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.21 -33.33 63.36 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 84.4 t -64.73 -42.88 96.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.301 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.3 -41.85 80.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.768 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -50.47 73.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.437 0.695 . . . . 0.0 111.415 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -61.67 -32.39 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 123.536 0.734 . . . . 0.0 110.461 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -76.17 -38.11 57.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.209 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.86 -63.68 1.19 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -172.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.25 103.34 6.89 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.392 0.615 . . . . 0.0 111.926 -169.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.432 ' HB2' HG22 ' A' ' 94' ' ' VAL . 12.0 t0 -130.08 140.77 50.78 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.662 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.04 46.07 53.37 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -101.59 125.27 48.22 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 121.538 0.685 . . . . 0.0 110.418 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.91 129.0 45.23 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.198 -174.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.6 -59.83 2.16 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.495 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -162.6 151.4 14.87 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp 40.24 -95.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -110.43 3.46 19.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.858 -0.526 . . . . 0.0 110.842 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.656 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 12.1 m170 -80.7 89.16 5.74 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 m -133.23 115.31 14.82 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -85.54 116.18 23.69 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.56 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.428 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 3.5 mpt_? -91.42 121.63 33.3 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.7 m -103.5 148.85 7.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -175.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.462 ' C ' HD21 ' A' ' 95' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.287 -2.115 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.722 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 14.0 t70 . . . . . 0 C--O 1.195 -1.77 0 CA-C-O 121.861 0.838 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.659 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 30.3 t -92.34 -6.28 50.51 Favored 'General case' 0 C--N 1.275 -2.673 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.283 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.73 115.37 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.897 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 20.4 mm -93.59 143.41 11.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.649 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 98.0 t -121.0 123.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 79.7 t -119.15 139.88 44.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 20.2 t70 -107.21 145.9 32.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.043 0.537 . . . . 0.0 110.714 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.506 0.2 OUTLIER 31.68 104.76 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.985 2.587 . . . . 0.0 117.985 -174.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 27.1 m -107.98 177.22 1.34 Allowed Pre-proline 0 CA--C 1.562 1.418 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.739 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.652 ' HA ' ' CE1' ' A' ' 90' ' ' HIS . 5.0 Cg_exo -43.89 138.21 6.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.828 3.019 . . . . 0.0 112.725 170.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HA ' HG21 ' A' ' 60' ' ' THR . 0.1 OUTLIER -88.41 172.23 9.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.777 -175.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 31' ' ' LEU . 14.1 p -117.39 142.51 31.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.132 0.968 . . . . 0.0 111.747 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.77 155.52 16.23 Favored Glycine 0 N--CA 1.414 -2.804 1 N-CA-C 102.657 -4.177 . . . . 0.0 102.657 165.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.84 125.22 12.51 Favored 'Trans proline' 0 C--O 1.25 1.111 0 CA-C-N 121.224 2.512 . . . . 0.0 114.136 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.68 24.74 9.27 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.107 1.763 . . . . 0.0 111.879 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -98.46 -15.49 19.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 121.738 -0.601 . . . . 0.0 111.407 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -79.55 -18.2 52.32 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.855 -174.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.3 -42.72 82.31 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.24 -29.64 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.376 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 38' ' ' ILE . 94.8 mt -69.27 -27.01 65.05 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.339 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -59.57 -39.75 85.11 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.699 0.761 . . . . 0.0 110.216 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -84.08 -28.23 27.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 34' ' ' LEU . 7.3 p -70.56 -32.68 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.347 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 34' ' ' LEU . 43.2 mm -59.6 -53.1 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -53.61 -35.38 60.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.569 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.93 -42.22 24.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 37' ' ' VAL . 45.8 mm -64.77 -42.88 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.918 0.866 . . . . 0.0 109.68 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -76.88 -6.69 53.45 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.029 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 22.8 t -73.02 -6.76 47.66 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-O 121.271 0.557 . . . . 0.0 109.632 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -71.5 -28.15 63.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.273 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -85.71 -15.14 43.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.23 0.538 . . . . 0.0 111.058 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 155.18 -162.99 31.28 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -96.11 129.13 43.48 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.485 HD13 ' CE2' ' A' ' 68' ' ' TYR . 24.0 mm -73.03 109.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -81.88 -48.64 11.28 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 37.2 m-20 -134.75 144.21 47.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.464 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.6 p30 -137.04 132.72 34.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.557 0.694 . . . . 0.0 110.902 175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.31 97.77 5.35 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.233 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 2.5 m-85 -108.63 104.9 55.81 Favored Pre-proline 0 N--CA 1.416 -2.129 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.739 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 80.8 Cg_endo -83.88 170.8 11.01 Favored 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 120.932 1.088 . . . . 0.0 110.462 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 60' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.388 -3.575 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 175.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.476 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 11.3 t . . . . . 0 N--CA 1.413 -2.311 0 CA-C-O 122.741 1.258 . . . . 0.0 113.108 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.739 ' HD3' ' O ' ' A' ' 54' ' ' PRO 0.27 9.6 pttm -59.49 176.26 0.27 Allowed 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.478 167.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.64 20.91 4.82 Favored Glycine 0 C--N 1.288 -2.097 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 52.3 p90 -169.28 160.28 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 pt -147.09 171.98 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.92 136.94 44.59 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 123.952 0.783 . . . . 0.0 109.504 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 HD11 ' A' ' 48' ' ' ILE . 2.4 mm? -124.53 138.74 54.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 16' ' ' SER . 41.8 mt-10 -126.43 129.99 49.81 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.574 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 19.1 m-85 -125.98 170.78 11.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.32 14.24 12.89 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.424 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 39.4 m -73.27 168.02 29.03 Favored Pre-proline 0 CA--C 1.589 2.447 0 CA-C-N 113.493 -1.685 . . . . 0.0 114.633 -173.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 5.7 Cg_exo -35.52 9.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.358 2 C-N-CA 130.624 7.549 . . . . 0.0 123.08 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.722 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.11 65.2 0.01 OUTLIER 'General case' 0 CA--C 1.473 -2.016 0 CA-C-O 124.788 2.232 . . . . 0.0 106.867 -160.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.659 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 21.2 p-80 -82.17 -36.49 27.3 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 108.995 -3.729 . . . . 0.0 111.98 -171.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.1 -37.49 75.41 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.386 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.541 HG21 ' OD1' ' A' ' 15' ' ' ASP . 94.3 t -56.07 -48.42 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.489 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 3.1 t70 -65.7 -35.71 81.53 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.279 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.94 69.91 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.412 0.285 . . . . 0.0 110.888 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.1 -37.79 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 123.725 0.81 . . . . 0.0 109.706 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 76' ' ' ASP . 77.4 tttt -59.79 -36.46 76.76 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.414 1.485 . . . . 0.0 111.517 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -81.96 -77.31 0.23 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.32 113.01 3.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.084 -172.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.433 ' HB2' HG21 ' A' ' 94' ' ' VAL . 2.9 t70 -94.74 133.68 38.16 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.916 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 48.81 19.52 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.404 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -88.94 125.36 34.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.791 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.35 129.27 50.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.487 -172.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -86.28 -66.85 0.86 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -167.67 -173.81 2.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.23 -103.54 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -121.54 8.42 10.12 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.652 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 4.8 m-70 -87.28 91.74 8.83 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.359 -170.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 m -133.44 105.0 6.68 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -82.61 101.17 10.62 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.626 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.434 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -87.34 137.36 32.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 82' ' ' ASP . 5.4 m -105.01 134.55 46.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 O-C-N 123.944 0.778 . . . . 0.0 109.991 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.649 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.471 -2.064 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 12.2 t70 . . . . . 0 C--O 1.205 -1.259 0 CA-C-O 121.727 0.775 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.4 m -98.4 7.28 46.4 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.4 t -146.17 124.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.517 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 26.3 mm -86.13 136.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.684 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 89.4 t -129.9 103.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -96.74 120.47 46.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.572 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 25.5 t70 -79.72 140.16 37.07 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.917 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.405 HD21 ' C ' ' A' ' 21' ' ' ASP 0.427 0.1 OUTLIER 44.27 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 127.209 2.203 . . . . 0.0 114.552 -177.295 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 26.8 m -100.94 167.68 10.4 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.893 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -42.47 126.9 4.18 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.77 2.98 . . . . 0.0 114.692 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.502 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -91.02 149.0 22.01 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.459 -1.701 . . . . 0.0 108.337 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 27' ' ' GLY . 6.5 p -101.59 147.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -169.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.632 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -105.14 171.61 18.93 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 168.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.05 125.69 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 CA-C-N 121.101 2.45 . . . . 0.0 112.275 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 57.4 31.37 20.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.842 1.257 . . . . 0.0 113.792 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -109.73 1.02 19.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.22 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.14 -32.26 72.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -45.23 -49.34 12.43 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.029 1.332 . . . . 0.0 111.211 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -79.08 -31.85 44.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.531 -172.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -72.06 -35.22 69.24 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.194 -176.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -78.31 -20.83 50.67 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.109 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.514 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 49.6 t-20 -78.08 -37.8 45.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 34' ' ' LEU . 8.8 p -66.41 -31.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.435 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.9 mm -61.7 -49.88 82.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -63.04 -19.92 64.84 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.328 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.514 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 66.4 mttm -88.13 -60.01 2.08 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -63.19 -43.74 98.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.011 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -78.37 -14.75 59.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 m -75.76 -3.05 32.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.117 0.484 . . . . 0.0 111.308 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -79.32 -20.95 46.64 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -88.28 -15.03 36.88 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.639 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.82 -154.17 25.66 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.778 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.65 120.67 27.34 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 122.26 0.224 . . . . 0.0 110.602 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.6 mm -73.85 91.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.4 m -78.15 -52.66 8.37 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.321 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 85.9 m-20 -136.05 139.47 43.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -144.71 128.72 17.52 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.55 0.691 . . . . 0.0 109.671 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.75 116.01 19.56 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.258 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -107.9 105.18 55.72 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 96.5 Cg_endo -85.74 174.31 6.7 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 122.323 2.015 . . . . 0.0 110.72 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.3 pt-20 . . . . . 0 C--N 1.303 -1.429 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 3.4 t . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 120.649 0.261 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER 179.87 167.92 1.23 Allowed 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 124.915 1.286 . . . . 0.0 108.29 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.09 -6.32 2.52 Favored Glycine 0 C--N 1.297 -1.619 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -167.68 156.62 9.69 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.34 163.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -113.3 129.71 56.45 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 123.807 0.692 . . . . 0.0 110.264 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 18' ' ' ILE . 2.3 mm? -118.98 126.5 51.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 38.0 tt0 -121.69 119.31 31.43 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.601 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 87.6 m-85 -99.98 177.85 4.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.609 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.57 -15.82 56.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.3 m -119.51 167.31 12.41 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.46 -55.57 0.05 OUTLIER 'Trans proline' 0 C--O 1.176 -2.623 0 CA-C-N 123.887 2.424 . . . . 0.0 108.568 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.31 7.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 131.287 3.835 . . . . 0.0 121.307 142.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.601 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 31.1 p80 -125.28 -36.71 2.47 Favored 'General case' 1 C--N 1.241 -4.125 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.681 -165.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . . . -81.42 -22.82 37.97 Favored 'General case' 0 N--CA 1.383 -3.793 0 C-N-CA 119.251 -0.979 . . . . 0.0 108.644 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.5 -23.14 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.52 -33.88 25.41 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.4 63.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.337 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -32.49 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -67.49 -44.3 78.84 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.406 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -91.77 -52.4 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.2 104.74 3.83 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.305 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.405 ' HB2' HG23 ' A' ' 94' ' ' VAL . 2.6 p30 -114.44 136.41 53.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.0 51.03 61.36 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -96.76 124.17 40.67 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.733 0.778 . . . . 0.0 111.768 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.89 118.57 34.75 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.623 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.75 -52.92 5.23 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.4 ' HB2' ' ND1' ' A' ' 90' ' ' HIS . 16.1 m-20 -145.42 -168.62 3.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.172 -174.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -44.16 -69.81 0.12 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.925 1.29 . . . . 0.0 114.195 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.502 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -100.18 11.26 39.79 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.674 -176.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.4 ' ND1' ' HB2' ' A' ' 87' ' ' ASP . 14.8 m170 -102.45 86.97 2.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -135.29 94.09 3.07 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-O 120.708 0.29 . . . . 0.0 110.277 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.43 105.55 13.58 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.972 -168.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.1 mpt_? -83.45 141.96 31.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 82' ' ' ASP . 34.5 m -100.23 114.28 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.684 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.731 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 CA--C 1.5 -0.947 0 CA-C-O 122.28 1.038 . . . . 0.0 108.689 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 8.4 m -96.3 -11.88 25.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.229 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.5 t -122.15 132.5 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.554 -172.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 30.1 mm -87.3 145.13 7.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.48 121.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG2' HG12 ' A' ' 64' ' ' ILE . 27.4 m -118.41 157.76 19.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.236 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.76 133.42 55.93 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 42.57 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 28.7 m -91.21 167.04 16.76 Favored Pre-proline 0 N--CA 1.426 -1.637 0 CA-C-N 114.33 -1.305 . . . . 0.0 107.982 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 85.1 Cg_exo -42.44 138.94 3.14 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.985 3.124 . . . . 0.0 113.126 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 153.23 42.31 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.804 -173.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.26 132.91 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.476 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.89 -131.91 3.12 Favored Glycine 0 C--N 1.274 -2.868 0 N-CA-C 106.672 -2.571 . . . . 0.0 106.672 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.36 125.23 10.56 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 CA-C-N 119.459 1.629 . . . . 0.0 111.447 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 55.9 18.04 2.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.131 1.772 . . . . 0.0 114.373 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -79.1 -25.87 43.0 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.076 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.86 -33.89 64.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.38 -58.33 7.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.169 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -81.74 -15.68 53.55 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.599 ' O ' HG12 ' A' ' 38' ' ' ILE . 51.3 tp -63.3 -36.35 83.4 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -56.7 -36.9 70.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -84.09 -40.92 17.69 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.32 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.55 -31.88 55.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.356 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 34' ' ' LEU . 32.9 mm -67.33 -54.6 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -58.82 -36.09 73.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.39 -47.28 35.0 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.3 mm -70.15 -39.24 76.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.197 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.23 -7.79 59.63 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.1 p -67.38 -22.74 65.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.3 ptpt -61.74 -28.4 69.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.53 0.681 . . . . 0.0 111.755 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.533 ' CZ ' ' HB1' ' A' ' 81' ' ' ALA . 30.3 m-85 -85.46 -15.7 42.07 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.1 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.489 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.76 176.19 23.45 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -74.81 125.04 27.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -72.83 140.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 m -126.38 -61.22 1.22 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 55.0 m-80 -122.23 140.63 52.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.53 138.81 46.25 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.085 0.469 . . . . 0.0 110.446 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 89.2 m-85 -134.2 98.88 4.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -107.32 104.77 53.77 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -82.47 174.08 10.08 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.713 1.609 . . . . 0.0 109.823 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.62 ' HB3' ' NZ ' ' A' ' 61' ' ' LYS . 19.9 pt-20 . . . . . 0 CA--C 1.477 -1.845 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 83.4 m . . . . . 0 C--O 1.244 0.801 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.62 ' NZ ' ' HB3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -84.78 156.37 21.41 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.354 176.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.57 8.59 9.44 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.442 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -170.15 151.95 4.08 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.483 HG12 ' CG2' ' A' ' 20' ' ' VAL . 20.7 pt -142.06 166.29 16.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.3 m-85 -131.59 141.66 49.72 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.859 0.724 . . . . 0.0 109.048 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.3 mp -132.36 136.75 47.04 Favored 'General case' 0 C--O 1.198 -1.651 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.934 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 42.0 tt0 -122.05 136.97 54.97 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.15 0.5 . . . . 0.0 109.688 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.407 ' HE1' ' CG1' ' A' ' 18' ' ' ILE . 76.0 m-85 -104.83 177.53 4.82 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.367 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.33 -16.62 39.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.275 0.559 . . . . 0.0 111.369 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -135.35 144.97 51.87 Favored Pre-proline 0 C--N 1.294 -1.84 1 N-CA-C 99.34 -4.318 . . . . 0.0 99.34 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.6 Cg_exo -69.91 -54.12 0.23 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 CA-C-N 123.483 2.28 . . . . 0.0 109.57 -172.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.07 4.47 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 1 C-N-CA 132.374 4.27 . . . . 0.0 120.133 144.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.489 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 95.8 m-70 -128.43 -36.36 1.9 Allowed 'General case' 1 C--N 1.223 -4.923 0 CA-C-O 121.326 0.584 . . . . 0.0 109.624 -170.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -61.33 -32.1 71.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.517 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.76 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 123.315 0.384 . . . . 0.0 111.305 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.39 -32.49 37.56 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.242 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.27 -52.61 61.34 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.764 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 74' ' ' ALA . 31.2 m -63.13 -27.78 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -81.61 -21.81 38.08 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.9 0.88 . . . . 0.0 112.047 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -122.88 -23.96 4.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.533 ' HB1' ' CZ ' ' A' ' 45' ' ' PHE . . . -106.0 18.55 21.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.435 ' HB2' HG22 ' A' ' 94' ' ' VAL . 37.0 t70 -85.06 121.78 28.33 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 118.157 -1.417 . . . . 0.0 114.056 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.58 60.5 2.47 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.537 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 91' ' ' THR . 17.8 m-85 -103.27 105.51 15.81 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 102.69 7.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.204 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.7 mt -80.01 -41.46 25.79 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.91 -171.74 3.99 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -48.61 -58.32 4.89 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.594 1.558 . . . . 0.0 113.413 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -95.0 -4.55 46.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.203 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.53 101.42 10.76 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.765 -172.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 37.1 m -133.55 117.78 17.51 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.285 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -82.69 101.71 11.03 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.076 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 91' ' ' THR . 3.6 mpt_? -86.87 131.15 34.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 82' ' ' ASP . 25.6 m -117.75 149.11 20.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.942 -175.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.667 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.593 ' OD1' HG23 ' A' ' 75' ' ' VAL . 10.5 m-20 . . . . . 0 CA--C 1.444 -3.115 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.527 ' HB2' ' OE2' ' A' ' 67' ' ' GLU 0.251 69.6 p -118.25 -20.49 8.55 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 115.493 -2.483 . . . . 0.0 113.916 166.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 25.9 t -127.14 133.04 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.996 -171.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.52 HD11 ' HD1' ' A' ' 73' ' ' HIS . 25.9 mm -104.12 143.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.79 114.1 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.53 130.61 73.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.435 ' HB3' ' CG ' ' A' ' 93' ' ' ARG . 10.7 t70 -111.86 149.35 31.94 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.512 0.2 OUTLIER 44.57 85.65 0.02 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 127.057 2.143 . . . . 0.0 115.87 -176.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.497 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 26.8 m -97.77 -171.75 0.26 Allowed Pre-proline 0 N--CA 1.418 -2.029 0 CA-C-N 112.732 -2.031 . . . . 0.0 107.064 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.717 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 44.6 Cg_exo -54.05 143.82 60.32 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 121.686 1.591 . . . . 0.0 114.181 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.44 HE22 ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -89.37 164.33 14.93 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.879 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 27' ' ' GLY . 48.8 t -123.22 134.26 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 CA-C-O 121.675 0.75 . . . . 0.0 109.391 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 26' ' ' VAL . . . -108.7 -127.96 5.65 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 105.722 -2.951 . . . . 0.0 105.722 173.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.74 124.39 4.53 Favored 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-N 120.22 2.01 . . . . 0.0 110.721 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 50.73 33.57 8.58 Favored 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.353 1.461 . . . . 0.0 113.014 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -95.76 -0.7 51.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.771 -1.206 . . . . 0.0 112.105 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.0 -28.86 64.73 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.87 -51.03 69.84 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.76 0.314 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.14 -27.13 68.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.556 ' O ' HG12 ' A' ' 38' ' ' ILE . 6.0 tt -65.71 -43.91 87.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.32 -37.83 81.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 111.6 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -81.0 -33.77 33.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.705 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 34' ' ' LEU . 6.2 p -70.17 -30.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.763 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 34' ' ' LEU . 35.5 mm -63.79 -64.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.845 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -62.49 -25.37 67.98 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -64.33 -57.71 8.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.333 0.653 . . . . 0.0 110.522 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.453 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 82.0 mt -70.38 -38.84 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.286 0.565 . . . . 0.0 111.042 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.476 ' HB3' ' HH ' ' A' ' 68' ' ' TYR . 53.9 m-85 -73.86 -7.31 51.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 58.0 m -69.35 -6.37 29.35 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 41' ' ' ILE . 81.0 mttt -71.92 -31.93 66.86 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.113 0.959 . . . . 0.0 108.807 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -85.46 10.83 11.8 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.892 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 117.43 -167.88 12.8 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -89.91 145.24 25.28 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.23 110.44 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.4 m -75.48 -46.3 33.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 35.3 t-20 -152.76 152.69 31.94 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -144.48 136.75 26.37 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -126.64 113.0 16.14 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.06 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -107.67 106.59 58.82 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 63' ' ' TYR . 2.9 Cg_exo -68.66 174.73 8.08 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.525 1.483 . . . . 0.0 109.357 172.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 120.946 0.403 . . . . 0.0 110.466 -173.726 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 166.65 11.02 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.12 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 -0.73 9.44 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.91 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.492 ' O ' ' HD2' ' A' ' 54' ' ' PRO . 4.4 p90 -169.69 161.23 9.23 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -143.86 172.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 123.527 0.517 . . . . 0.0 110.35 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 94.6 m-85 -136.24 138.73 42.13 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 109.744 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.0 mm? -118.39 131.91 56.28 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.527 ' OE2' ' HB2' ' A' ' 16' ' ' SER . 12.9 tp10 -116.72 117.51 29.99 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.535 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 80.5 m-85 -127.46 172.53 10.6 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.241 0.543 . . . . 0.0 110.312 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.23 14.26 14.79 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.574 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 51.0 m -68.27 163.35 53.14 Favored Pre-proline 0 CA--C 1.597 2.78 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -171.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.1 Cg_exo -38.25 8.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.348 2 C-N-CA 130.435 7.423 . . . . 0.0 122.955 178.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.521 ' HA ' ' CG ' ' A' ' 15' ' ' ASP . . . 87.37 63.34 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 124.465 2.079 . . . . 0.0 106.997 -158.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.574 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 32.2 p80 -85.69 -36.99 19.89 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 110.148 -3.205 . . . . 0.0 109.282 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . . . -63.36 -35.94 82.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.059 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.593 HG23 ' OD1' ' A' ' 15' ' ' ASP . 82.0 t -59.39 -59.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.459 170.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.68 -35.77 73.14 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.145 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.0 -30.89 70.26 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.494 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.81 -29.34 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 8.4 mmpt? -72.02 -42.82 65.92 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.308 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -114.21 -29.87 6.81 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.2 -3.13 27.86 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -170.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.3 117.34 18.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.874 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.86 31.33 12.62 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -101.5 135.27 43.28 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.495 -1.282 . . . . 0.0 109.488 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -107.68 129.29 55.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.192 -172.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.44 -68.04 0.77 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.245 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -160.02 159.32 31.92 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.44 ' HD2' HE22 ' A' ' 25' ' ' GLN . 40.2 ttmt 47.04 -88.7 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.048 1.739 . . . . 0.0 114.297 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -121.43 -2.13 9.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.263 -0.273 . . . . 0.0 111.035 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.717 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m170 -79.72 92.65 5.43 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.31 0.576 . . . . 0.0 110.594 -171.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 m -133.17 109.04 9.18 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -82.21 105.62 13.44 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.917 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.435 ' CG ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -94.03 121.45 35.53 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.96 115.1 47.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.008 -166.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.404 -2.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 C--O 1.244 0.815 0 CA-C-O 121.452 0.644 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -114.39 -8.96 12.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.28 137.34 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 121.875 -0.516 . . . . 0.0 109.873 -175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 8.9 mm -101.0 133.12 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.66 106.5 15.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 16.6 m -96.36 154.94 3.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.203 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 22' ' ' ASN . 9.8 t70 -93.22 -178.29 4.72 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.443 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.417 ' H ' ' CG ' ' A' ' 21' ' ' ASP 0.279 0.2 OUTLIER -29.5 106.92 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -166.624 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.443 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 36.0 m -86.01 167.32 24.54 Favored Pre-proline 0 N--CA 1.421 -1.908 0 CA-C-N 113.052 -1.886 . . . . 0.0 108.198 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 86.7 Cg_exo -42.36 127.15 4.14 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.641 2.894 . . . . 0.0 113.351 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.78 151.12 47.36 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.915 -177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 60' ' ' THR . 52.6 t -125.91 139.77 50.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-O 122.028 0.918 . . . . 0.0 112.774 -173.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.45 -143.48 6.18 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.63 126.88 13.92 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 120.658 2.229 . . . . 0.0 111.416 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 63.32 17.69 10.44 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.127 1.371 . . . . 0.0 113.237 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -89.43 -15.86 32.21 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.079 -1.638 . . . . 0.0 111.305 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.94 -36.69 64.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 -177.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -64.95 -34.97 79.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.4 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -71.78 -40.53 69.19 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.8 tp -58.37 -44.0 88.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.818 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -54.51 -30.18 52.7 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.183 0.593 . . . . 0.0 112.512 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.433 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 55.6 t30 -84.49 -32.41 23.98 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.196 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 34' ' ' LEU . 8.6 p -78.07 -27.48 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.969 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 34' ' ' LEU . 39.3 mm -54.3 -51.79 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.642 0.734 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -68.21 -17.79 64.41 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.552 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.8 mmtp -85.28 -38.02 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.868 0.842 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mm -73.78 -53.89 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.74 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.607 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 61.7 m-85 -78.67 -16.93 56.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.9 p -65.73 -19.73 66.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.725 0.774 . . . . 0.0 110.829 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -73.22 -7.43 51.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.569 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.87 4.36 27.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.527 0.68 . . . . 0.0 110.279 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.89 -161.62 23.79 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.393 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -87.77 128.02 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.6 mm -75.35 89.73 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.935 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p -79.83 -52.37 7.99 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.496 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 17.7 m120 -126.33 138.86 53.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.0 0.429 . . . . 0.0 110.447 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -141.62 137.48 31.89 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.212 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -135.39 98.69 4.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.408 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -108.97 122.14 40.82 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.868 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.81 176.34 10.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.57 2.18 . . . . 0.0 109.972 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.199 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 26' ' ' VAL . 4.8 t . . . . . 0 N--CA 1.418 -2.025 0 CA-C-O 122.229 1.014 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -105.47 175.9 5.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.442 178.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.9 20.23 36.6 Favored Glycine 0 C--N 1.292 -1.874 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.115 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 7.0 p90 -170.74 151.73 3.55 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 122.293 0.237 . . . . 0.0 110.499 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.487 HG12 ' CG2' ' A' ' 20' ' ' VAL . 18.8 pt -146.03 163.33 10.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 70.8 m-85 -119.39 136.8 54.12 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.75 0.31 . . . . 0.0 110.673 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.7 mm? -123.08 124.58 43.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 7.1 tp10 -119.41 128.16 53.78 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.607 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 25.7 m-85 -127.06 -178.28 4.36 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.53 10.95 11.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.354 0.597 . . . . 0.0 109.541 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.2 p -81.67 163.43 54.0 Favored Pre-proline 0 CA--C 1.583 2.222 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -34.96 9.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.663 2 C-N-CA 130.556 7.504 . . . . 0.0 123.358 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.615 ' O ' HG13 ' A' ' 75' ' ' VAL . . . 86.18 65.59 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.731 0 CA-C-O 124.975 2.321 . . . . 0.0 108.557 -163.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 29.3 p-80 -79.49 -37.2 37.34 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 109.127 -3.67 . . . . 0.0 110.16 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.03 48.15 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.715 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 72' ' ' ALA . 3.0 p -65.5 -29.79 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.01 -45.95 13.45 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.83 71.06 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.728 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.2 t -65.1 -45.93 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-O 121.072 0.463 . . . . 0.0 111.748 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.39 -27.39 61.44 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -120.63 -45.47 2.41 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.481 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -88.27 -8.22 55.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -171.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.07 113.13 2.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.357 0.599 . . . . 0.0 112.366 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.01 47.89 3.75 Favored Glycine 0 N--CA 1.42 -2.426 0 CA-C-N 114.922 -1.035 . . . . 0.0 114.603 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.481 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 33.0 p90 -107.83 133.97 51.44 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.677 -1.209 . . . . 0.0 109.96 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.95 128.47 46.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.233 0.54 . . . . 0.0 112.342 -176.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.6 mt -84.79 -62.72 1.48 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.818 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -160.95 154.12 21.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.571 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 45.99 -107.19 0.14 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -103.86 -10.23 18.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.669 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m80 -68.27 93.79 0.49 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.128 -171.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 m -132.73 118.87 19.61 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -90.37 105.41 17.79 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.499 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.8 mmm180 -83.15 143.03 30.78 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.47 107.01 21.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.344 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 N--CA 1.403 -2.776 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.019 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.7 p -114.96 -14.36 11.87 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 60.2 t -139.16 137.17 41.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.963 -0.461 . . . . 0.0 110.762 -172.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 mm -97.25 135.14 32.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.1 105.92 19.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.82 122.89 62.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.156 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 21.7 t70 -92.73 138.03 31.84 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.613 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.47 0.1 OUTLIER 45.94 86.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 128.513 2.725 . . . . 0.0 115.66 -175.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 35.5 m -89.27 165.78 24.59 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.753 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.3 Cg_endo -45.92 150.19 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.474 2.783 . . . . 0.0 114.125 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -89.46 161.89 16.02 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.561 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 27' ' ' GLY . 60.9 t -129.15 138.89 53.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.517 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.496 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -102.34 -177.27 27.51 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.49 124.89 16.18 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 120.15 1.975 . . . . 0.0 112.067 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 53.76 23.44 3.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.187 1.795 . . . . 0.0 114.167 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -90.1 -2.61 58.12 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.183 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -63.17 -36.37 83.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 110.075 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -61.39 -47.42 85.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.542 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -74.83 -24.81 58.67 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.013 0.435 . . . . 0.0 110.135 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.617 ' O ' HG12 ' A' ' 38' ' ' ILE . 3.0 tm? -61.97 -49.39 76.29 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -55.51 -31.95 62.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.419 0.628 . . . . 0.0 111.123 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.45 -41.8 38.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.232 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.35 -30.71 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 34' ' ' LEU . 22.2 mm -62.59 -53.39 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -55.43 -36.74 66.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.955 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -69.13 -53.12 21.85 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.462 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 34.9 mm -56.16 -50.24 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.689 0.757 . . . . 0.0 110.484 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.524 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.4 m-85 -77.04 -0.67 25.48 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.6 m -69.96 -12.51 61.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.275 0.559 . . . . 0.0 110.204 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 29.5 mmmt -72.13 -16.5 62.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.057 0.456 . . . . 0.0 109.998 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.4 6.98 40.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.699 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.58 -156.4 19.96 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.18 128.48 42.05 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.441 HD13 HD12 ' A' ' 66' ' ' LEU . 32.0 mm -74.11 115.14 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 m -86.96 -41.92 13.55 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -154.77 160.92 41.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.903 0.881 . . . . 0.0 109.695 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 41.5 t0 -150.95 151.86 32.75 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -139.17 102.25 4.46 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.49 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -107.12 123.5 38.14 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 72.7 Cg_endo -82.21 177.57 7.08 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.061 2.507 . . . . 0.0 108.25 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.36 0 O-C-N 120.732 -1.23 . . . . 0.0 109.879 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 m . . . . . 0 N--CA 1.424 -1.742 0 CA-C-O 121.823 0.821 . . . . 0.0 112.872 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.49 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -112.37 173.49 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.399 174.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.28 27.27 9.1 Favored Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.949 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -169.07 147.84 3.94 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 pt -146.03 176.18 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.347 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 92.6 m-85 -140.18 114.73 9.36 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.019 0.827 . . . . 0.0 111.481 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.441 HD12 HD13 ' A' ' 48' ' ' ILE . 3.9 mm? -93.66 116.81 29.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.808 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.704 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 3.5 m-85 -127.54 171.14 11.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.49 12.66 22.87 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.456 ' HB3' ' ND1' ' A' ' 73' ' ' HIS . 48.0 t -73.26 155.89 89.59 Favored Pre-proline 0 CA--C 1.59 2.495 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.177 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HD2' ' OG ' ' A' ' 70' ' ' SER . 1.7 Cg_endo -36.4 8.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.529 3.593 1 C-N-CA 130.72 7.613 . . . . 0.0 122.27 -178.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 86.45 62.59 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 124.981 2.324 . . . . 0.0 107.97 -164.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.704 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 24.1 p-80 -77.65 -36.4 51.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 109.184 -3.644 . . . . 0.0 109.999 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.48 69.21 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.982 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.12 -26.72 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.31 -46.91 12.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.2 79.9 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.448 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.47 -33.33 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.968 0.413 . . . . 0.0 112.046 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -85.42 -29.08 24.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.641 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -109.9 -39.11 5.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.41 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -93.35 0.97 57.1 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.15 103.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.433 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.54 47.69 3.42 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.694 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.41 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 24.3 p90 -103.78 127.29 51.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.523 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.01 130.24 44.85 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.652 -173.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -85.96 -71.82 0.52 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -171.86 172.36 4.84 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 52.58 -95.93 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.099 1.76 . . . . 0.0 114.693 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -121.58 -1.12 9.6 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.089 0.471 . . . . 0.0 109.917 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.753 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 10.8 m170 -87.1 99.03 11.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.219 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.6 m -133.34 110.0 9.75 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -81.84 108.7 15.58 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.372 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -90.52 130.24 36.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.46 105.88 19.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.693 0.758 . . . . 0.0 110.585 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.291 -1.943 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.943 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.577 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 12.5 m -100.01 13.36 34.24 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -170.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.4 p -137.08 138.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.911 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.517 HD13 ' HD1' ' A' ' 73' ' ' HIS . 11.3 mm -111.62 137.91 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.413 ' HB ' HD21 ' A' ' 95' ' ' ASN . 60.4 t -125.59 113.87 36.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 173.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.49 ' CG2' HG12 ' A' ' 64' ' ' ILE . 14.3 m -110.14 137.67 41.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.306 0.574 . . . . 0.0 110.768 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.412 ' C ' HD21 ' A' ' 22' ' ' ASN . 20.7 t70 -97.74 139.73 33.19 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.757 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.412 HD21 ' C ' ' A' ' 21' ' ' ASP 0.423 0.1 OUTLIER 46.06 86.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.82 2.448 . . . . 0.0 115.536 -179.837 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.464 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.4 m -84.83 163.61 45.6 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.151 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.787 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.7 Cg_endo -42.73 145.43 1.07 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 124.509 3.473 . . . . 0.0 117.556 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.53 151.72 36.81 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 111.648 -2.523 . . . . 0.0 111.085 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 27' ' ' GLY . 8.1 p -132.01 146.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.326 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -95.37 171.48 29.48 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 169.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.37 125.62 18.49 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 CA-C-N 120.465 2.133 . . . . 0.0 112.286 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.02 22.49 12.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.599 1.16 . . . . 0.0 111.786 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -92.88 -2.5 55.81 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.697 -1.252 . . . . 0.0 111.102 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -62.1 -23.57 66.6 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.744 0.307 . . . . 0.0 110.703 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.48 -47.24 76.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.468 0.707 . . . . 0.0 109.194 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -69.7 -38.21 76.88 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.893 0.854 . . . . 0.0 109.502 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.09 -6.01 39.41 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.507 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 61.9 mttp -85.33 -31.41 23.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.576 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 22.6 t-20 -73.61 -44.61 56.68 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.158 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.46 -33.05 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.566 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.94 -62.54 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.185 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.576 ' CE1' ' HA ' ' A' ' 36' ' ' ASN . 4.9 p-80 -65.3 -20.13 66.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -70.55 -60.13 2.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.517 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 81.9 mt -67.67 -44.12 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.02 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -68.72 -9.68 51.95 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -67.75 -2.28 6.79 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 19.0 ptmt -70.56 -35.22 72.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.111 0.482 . . . . 0.0 110.584 171.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 44' ' ' LYS . 97.3 m-85 -80.08 -14.97 58.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.326 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 145.52 -161.3 28.2 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -91.5 138.74 31.33 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.04 89.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.99 -38.98 52.06 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 3.3 t-20 -148.64 139.85 23.23 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -144.27 153.91 42.52 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 73.5 m-85 -132.13 103.26 6.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -108.54 106.74 59.27 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.69 173.17 13.8 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 121.156 1.238 . . . . 0.0 111.902 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--N 1.298 -1.663 0 C-N-CA 123.631 0.772 . . . . 0.0 109.481 -178.835 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.422 ' HB ' ' CG1' ' A' ' 26' ' ' VAL . 5.8 t . . . . . 0 N--CA 1.422 -1.864 0 CA-C-O 122.881 1.325 . . . . 0.0 113.37 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -53.55 161.02 1.12 Allowed 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.748 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.69 18.23 13.13 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.002 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -169.96 155.34 5.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.49 HG12 ' CG2' ' A' ' 20' ' ' VAL . 22.4 pt -146.65 168.36 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 49.4 m-85 -131.84 133.04 44.23 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 2.1 mm? -114.13 132.81 55.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 1.6 tm-20 -126.41 115.7 20.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.575 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 81.5 m-85 -123.29 175.91 6.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.626 0.727 . . . . 0.0 111.185 -174.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.12 13.98 12.17 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.54 1.136 . . . . 0.0 108.425 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.579 ' OG ' ' HD2' ' A' ' 71' ' ' PRO . 23.1 t -75.61 161.17 77.34 Favored Pre-proline 0 CA--C 1.596 2.732 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.297 -172.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.579 ' HD2' ' OG ' ' A' ' 70' ' ' SER . 1.2 Cg_exo -36.1 8.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.967 1 C-N-CA 129.921 7.081 . . . . 0.0 121.931 177.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.496 ' HB1' ' CG2' ' A' ' 75' ' ' VAL . . . 85.93 62.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.987 2.327 . . . . 0.0 108.08 -164.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.577 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 17.5 p80 -73.43 -30.06 62.97 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 109.646 -3.434 . . . . 0.0 109.561 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.07 64.08 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.287 1.042 . . . . 0.0 108.582 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 78' ' ' VAL . 57.4 t -75.25 -30.22 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.254 176.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.65 -41.78 62.25 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.48 75.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.826 0.45 . . . . 0.0 111.218 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 75' ' ' VAL . 1.1 p -67.55 -26.73 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.381 0.61 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -33.82 67.01 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.206 1.003 . . . . 0.0 110.656 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.06 -76.55 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.658 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 177.32 106.54 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 123.954 0.784 . . . . 0.0 110.489 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.501 ' HA ' HG21 ' A' ' 94' ' ' VAL . 1.6 t70 -65.52 108.81 2.13 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 170.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.78 52.53 1.51 Allowed Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -97.72 133.13 42.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.199 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.84 129.57 48.09 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.987 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.21 -63.37 1.33 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.865 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -161.07 157.22 25.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.029 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 42.15 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.262 1.825 . . . . 0.0 114.187 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -119.5 8.78 11.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.524 0.602 . . . . 0.0 111.825 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.787 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 22.4 m170 -85.02 93.72 8.66 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -132.84 103.64 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.508 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.22 112.32 19.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -81.23 142.8 32.82 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 82' ' ' ASP . 14.6 m -120.1 128.94 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.878 -173.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.413 HD21 ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.367 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.48 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 35.6 t70 . . . . . 0 N--CA 1.424 -1.746 0 CA-C-O 122.88 1.324 . . . . 0.0 108.104 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.511 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 42.8 m -116.37 14.36 15.69 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.694 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.413 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 61.5 t -138.04 131.83 42.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.77 -0.581 . . . . 0.0 110.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 9.7 mm -88.93 135.32 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.97 121.46 62.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.858 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 92' ' ' PHE . 90.9 t -121.1 133.51 67.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.319 0.387 . . . . 0.0 111.816 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.9 t70 -101.1 137.51 39.36 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 109.52 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.424 0.2 OUTLIER 45.88 104.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 127.106 2.162 . . . . 0.0 116.397 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.513 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 17.1 m -109.61 172.17 3.84 Favored Pre-proline 0 C--N 1.289 -2.063 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.437 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 80.9 Cg_exo -42.4 133.14 4.97 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.292 2.661 . . . . 0.0 112.043 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.499 ' NE2' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -74.39 155.63 37.9 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.331 -177.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 31' ' ' LEU . 2.3 t -123.05 165.68 18.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.778 -167.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.26 -169.62 30.11 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.53 124.69 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.867 2.333 . . . . 0.0 111.99 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 58.62 17.87 5.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.3 1.84 . . . . 0.0 113.326 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -79.55 -26.98 41.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.022 -1.049 . . . . 0.0 109.814 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.58 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.5 tm? -69.65 -27.48 65.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.427 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.29 -40.55 94.57 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.928 0.394 . . . . 0.0 111.053 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -13.84 30.78 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.244 0.545 . . . . 0.0 111.569 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' HG12 ' A' ' 38' ' ' ILE . 7.2 tt -68.12 -37.61 81.3 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 91.5 mttt -57.8 -25.62 60.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 27.9 t-20 -81.71 -44.68 16.75 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.153 -171.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.68 -32.52 57.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.793 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.7 mm -67.63 -52.53 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.465 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -56.31 -38.46 71.32 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.583 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.0 mmmt -67.08 -48.02 69.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mm -66.78 -43.98 89.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.512 0.672 . . . . 0.0 110.573 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.49 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.2 m-85 -83.87 -9.86 58.43 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -171.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -72.4 -3.04 21.73 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.485 -0.759 . . . . 0.0 111.339 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.12 -21.72 42.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.174 0.511 . . . . 0.0 110.007 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -97.33 1.62 49.66 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.656 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.31 -151.79 22.04 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.88 128.01 52.92 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.469 HD11 ' CB ' ' A' ' 42' ' ' PHE . 47.3 mm -73.08 104.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -79.82 -41.33 26.62 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.177 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -156.14 161.14 40.38 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -142.66 144.69 32.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 117.977 0.353 . . . . 0.0 110.321 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.23 100.44 5.39 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.448 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -107.82 103.48 49.7 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.72 170.49 15.55 Favored 'Trans proline' 0 C--O 1.208 -0.979 0 C-N-CA 121.659 1.572 . . . . 0.0 109.95 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 14.6 pt-20 . . . . . 0 C--N 1.303 -1.447 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 48.2 m . . . . . 0 N--CA 1.438 -1.057 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 49.1 mttm -74.0 169.37 17.62 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.07 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.29 -8.62 6.4 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.94 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -169.54 159.66 8.56 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 pt -147.21 172.05 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.767 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.9 m-85 -136.26 137.09 40.4 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.665 0.603 . . . . 0.0 109.975 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.454 HD12 HD13 ' A' ' 48' ' ' ILE . 3.6 mm? -111.94 116.48 30.68 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -99.44 124.03 44.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.648 0.737 . . . . 0.0 110.668 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.49 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 6.2 m-85 -123.13 -176.42 3.42 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.74 7.65 11.06 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.867 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.65 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.6 m -79.66 154.57 76.06 Favored Pre-proline 0 CA--C 1.591 2.548 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -165.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -39.16 6.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.96 2 C-N-CA 130.76 7.64 . . . . 0.0 123.16 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.48 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.23 65.25 0.01 OUTLIER 'General case' 0 C--N 1.367 1.329 0 CA-C-N 122.238 2.29 . . . . 0.0 108.86 -158.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.65 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 29.6 p80 -95.63 -24.67 16.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 109.36 -3.564 . . . . 0.0 107.738 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -81.11 -33.86 32.99 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.42 -26.88 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.611 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.5 -38.06 77.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.76 94.0 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.291 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 74' ' ' ALA . 92.8 t -57.84 -46.76 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -84.89 -15.58 44.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -109.89 -68.38 0.93 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 75.41 0.94 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.559 0.695 . . . . 0.0 111.759 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.458 ' HB2' HG23 ' A' ' 94' ' ' VAL . 6.0 t70 -111.42 134.91 52.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.731 175.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.48 77.45 Favored Glycine 0 C--N 1.308 -0.993 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 91' ' ' THR . 31.0 p90 -92.33 130.97 37.88 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.097 0.475 . . . . 0.0 110.299 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.457 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.6 126.61 44.24 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.7 mt -87.29 -61.6 1.69 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -174.21 149.0 1.36 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.381 -174.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 58.92 -81.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.456 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 41.2 tt0 -122.27 -9.52 8.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.298 1.039 . . . . 0.0 110.148 -172.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.608 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 11.4 m170 -92.97 88.63 6.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.915 -167.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 6.4 m -132.95 98.19 4.22 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' HB3' HG13 ' A' ' 20' ' ' VAL . 53.2 m-85 -83.35 113.91 21.06 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.472 -169.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 2.9 mpt_? -89.05 136.85 32.79 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 82' ' ' ASP . 4.8 m -113.82 151.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-O 121.619 0.723 . . . . 0.0 110.808 -172.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.401 -2.921 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.664 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 5.6 t70 . . . . . 0 C--O 1.18 -2.585 0 CA-C-O 121.613 0.72 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.551 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 16.3 m -85.1 -1.49 56.93 Favored 'General case' 0 C--N 1.273 -2.751 0 O-C-N 120.585 -1.322 . . . . 0.0 113.72 -172.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 60.7 t -117.67 128.48 74.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.442 -175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 18.6 mm -94.85 136.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.01 119.34 23.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 15.5 m -125.09 133.33 69.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.87 135.5 39.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.33 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.483 0.2 OUTLIER 48.34 85.64 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.675 2.39 . . . . 0.0 116.983 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.425 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 16.8 m -81.93 169.76 17.43 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.467 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 2.0 Cg_endo -44.35 138.05 7.55 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 123.286 2.657 . . . . 0.0 112.312 173.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.559 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 3.8 pm0 -69.35 154.92 41.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.23 147.64 28.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.032 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.94 175.34 16.28 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.73 126.88 23.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.023 1.815 . . . . 0.0 111.928 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 68.17 17.41 9.39 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.002 1.321 . . . . 0.0 113.574 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -104.07 -6.18 21.37 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.163 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.461 HD21 ' HE2' ' A' ' 61' ' ' LYS . 1.2 tm? -66.87 -31.5 72.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.122 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.31 -40.03 92.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.44 -13.46 52.03 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.2 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.515 ' O ' HG11 ' A' ' 37' ' ' VAL . 8.6 tt -72.86 -28.35 62.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.21 -22.06 66.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 t-20 -79.78 -43.67 22.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.257 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.515 HG11 ' O ' ' A' ' 34' ' ' LEU . 9.0 p -63.9 -24.6 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.369 -174.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mm -55.61 -59.82 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.044 0.938 . . . . 0.0 110.408 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -73.08 -17.0 61.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 30.5 mmmt -71.39 -52.25 19.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.03 -52.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.127 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.554 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 22.7 m-85 -73.49 -6.43 46.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 p -71.82 -18.3 62.09 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.84 0.829 . . . . 0.0 110.455 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -84.8 -3.84 58.81 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.21 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -120.23 18.55 12.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.14 -174.89 21.93 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -101.6 138.59 38.39 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.9 mm -75.68 88.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.3 m -82.06 -55.37 4.61 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.879 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 19.7 m120 -137.08 145.73 44.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -137.26 135.75 37.46 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -128.19 110.7 12.67 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.414 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -106.05 106.29 56.44 Favored Pre-proline 0 N--CA 1.425 -1.685 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.59 173.67 12.0 Favored 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 122.182 1.922 . . . . 0.0 109.885 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 C--N 1.291 -1.977 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.271 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 121.404 0.621 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HE2' HD21 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -88.72 160.27 17.4 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.01 21.31 3.72 Favored Glycine 0 CA--C 1.489 -1.574 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.066 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 31.7 p90 -170.81 148.21 2.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.473 HG12 ' CG2' ' A' ' 20' ' ' VAL . 21.5 pt -141.41 166.16 18.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 76.8 m-85 -136.41 134.34 37.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.4 mp -120.6 145.32 47.49 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 9.3 tp10 -124.28 116.12 22.13 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.554 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 12.4 m-30 -118.31 171.6 8.02 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.78 14.26 13.37 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.619 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.3 m -75.74 160.15 79.64 Favored Pre-proline 0 CA--C 1.608 3.187 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -170.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -39.99 7.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.054 2 C-N-CA 129.972 7.115 . . . . 0.0 123.997 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.36 66.77 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 CA-C-N 122.46 2.391 . . . . 0.0 106.579 -155.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 26.6 p80 -97.02 -36.95 10.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.566 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -80.88 -20.84 41.37 Favored 'General case' 0 CA--C 1.474 -1.955 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.251 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 p -59.45 -30.07 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -83.53 -49.29 9.38 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.49 -42.58 74.62 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.395 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.88 -22.85 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 123.181 0.592 . . . . 0.0 111.556 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -85.72 -47.52 9.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.153 0.978 . . . . 0.0 109.805 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.52 -11.69 50.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 -167.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.42 13.25 13.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.188 0.518 . . . . 0.0 110.278 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -78.93 106.37 10.91 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.46 51.68 6.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 114.518 -1.219 . . . . 0.0 115.405 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.2 m-85 -101.5 106.18 17.25 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -77.41 99.64 5.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 173.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.57 -52.45 65.52 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.001 0.429 . . . . 0.0 110.544 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.519 ' OD2' ' HG2' ' A' ' 88' ' ' LYS . 27.4 t70 -151.54 -76.13 0.14 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.877 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.519 ' HG2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -100.86 -101.21 0.25 Allowed 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.376 0.607 . . . . 0.0 112.596 178.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.559 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -92.55 3.33 55.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 111.701 -175.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -86.99 96.54 10.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 39.5 m -133.41 123.98 26.31 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.88 101.85 13.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.476 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -93.92 126.42 39.11 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.3 150.62 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.31 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 N--CA 1.397 -3.108 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.658 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.5 -0.962 0 CA-C-O 121.152 0.501 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.548 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 21.4 m -107.28 6.2 28.31 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.3 t -139.27 135.72 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 9.6 mm -101.04 130.34 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.09 110.55 29.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.83 135.51 32.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 123.924 0.765 . . . . 0.0 111.763 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -107.1 132.11 53.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 47.79 100.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.846 2.058 . . . . 0.0 116.49 -178.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.526 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 22.5 m -91.57 173.77 5.01 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.668 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.696 ' HA ' ' CE1' ' A' ' 90' ' ' HIS . 98.8 Cg_exo -42.53 146.0 0.86 Allowed 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.195 2.596 . . . . 0.0 113.772 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.42 121.25 26.48 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.407 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 p -121.98 137.57 55.14 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.8 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.54 169.35 13.16 Favored Glycine 0 N--CA 1.405 -3.394 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.27 127.67 22.88 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.123 2.548 . . . . 0.0 112.775 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 73.66 21.15 2.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.998 1.319 . . . . 0.0 112.904 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -116.63 -1.58 12.12 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.095 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.53 -35.65 79.49 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 40.8 tt0 -63.27 -37.0 85.53 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -78.05 -32.58 50.94 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.543 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 38' ' ' ILE . 9.4 mp -71.7 -26.02 62.32 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.162 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 ptmm? -82.47 -18.22 42.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.628 0.728 . . . . 0.0 109.412 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -82.19 -37.79 25.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.201 -177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 41' ' ' ILE . 10.3 p -66.09 -32.12 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.941 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 34' ' ' LEU . 30.4 mm -58.36 -55.27 23.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.374 0.607 . . . . 0.0 109.465 173.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -55.14 -41.59 71.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.6 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -60.96 -57.44 12.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.599 0.76 . . . . 0.0 111.403 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 37' ' ' VAL . 41.2 mm -55.7 -51.06 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.656 0.741 . . . . 0.0 111.229 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.552 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 65.8 m-85 -74.57 -6.17 47.03 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -173.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -70.57 -11.91 61.23 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.66 -0.65 . . . . 0.0 111.428 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -74.79 -14.92 60.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.447 0.642 . . . . 0.0 110.58 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.07 0.63 32.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.746 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 137.27 -166.18 25.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.94 129.22 37.95 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.437 HD11 HD13 ' A' ' 66' ' ' LEU . 26.3 mm -74.75 103.69 2.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.4 m -71.55 -55.34 8.02 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -145.22 169.31 18.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 51.5 t0 -158.35 160.52 37.04 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 175.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.63 103.26 5.17 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -171.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.423 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 21.7 m-85 -108.2 105.07 55.78 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.591 -175.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.498 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 96.7 Cg_endo -89.26 164.13 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.402 1.402 . . . . 0.0 109.592 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--N 1.305 -1.347 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.675 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.419 -2.007 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 3.4 pttm -69.97 160.33 32.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.192 165.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.69 14.77 12.87 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.129 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -169.05 152.49 5.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 117.185 0.493 . . . . 0.0 110.986 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -147.37 174.87 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.262 1.736 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 86.6 m-85 -141.56 113.94 8.2 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.313 0.506 . . . . 0.0 110.447 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 3.7 mm? -89.62 108.89 19.94 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.32 123.54 45.58 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.552 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 22.2 m-85 -121.17 175.86 5.89 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 13.78 12.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.517 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 11.7 m -77.3 158.99 78.7 Favored Pre-proline 0 CA--C 1.581 2.159 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -170.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 4.7 Cg_endo -39.88 7.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.511 2.515 1 C-N-CA 129.866 7.044 . . . . 0.0 121.743 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 75' ' ' VAL . . . 84.41 65.45 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 124.706 2.193 . . . . 0.0 107.534 -160.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.548 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 27.2 p80 -82.6 -36.18 26.39 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 109.612 -3.449 . . . . 0.0 108.809 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.37 -28.44 63.01 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.501 -176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 72' ' ' ALA . 2.7 p -68.09 -24.41 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.571 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.478 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 26.8 t70 -83.78 -41.84 17.15 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.83 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.51 79.49 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.365 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.03 -21.56 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.439 0.638 . . . . 0.0 111.69 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 27.3 ttpp -79.31 -43.6 23.28 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.785 0.803 . . . . 0.0 110.73 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.64 -56.09 4.06 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.344 -171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.457 ' HB2' ' CE1' ' A' ' 84' ' ' TYR . . . -155.9 87.97 1.09 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.173 -1.011 . . . . 0.0 113.4 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.483 ' HB2' HG23 ' A' ' 94' ' ' VAL . 2.7 t70 -77.42 109.83 11.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 56.17 0.57 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 91' ' ' THR . 78.7 m-85 -67.59 99.33 0.76 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HD2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -85.01 100.0 11.38 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -78.15 -50.84 11.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -150.22 174.53 12.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -30.97 -61.98 0.18 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.767 2.027 . . . . 0.0 114.979 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -105.1 12.71 31.79 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.882 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.696 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 20.0 m-70 -117.05 100.67 7.89 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.249 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 9.0 m -133.02 101.1 5.1 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.005 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -82.39 106.47 14.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.522 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -78.88 137.4 37.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 173.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 82' ' ' ASP . 6.4 m -114.66 149.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 123.697 0.623 . . . . 0.0 109.681 -170.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 18.2 p-10 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.505 ' HA ' ' HB3' ' A' ' 71' ' ' PRO . 5.1 m -101.37 11.66 38.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -167.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.8 141.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.909 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 32.5 mm -100.29 132.93 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 67.9 t -135.88 109.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.433 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 m -112.51 123.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.532 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.45 144.61 27.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.345 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 62' ' ' GLY 0.533 0.3 OUTLIER 42.93 80.5 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 -176.694 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.486 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 19.4 m -91.57 168.09 14.09 Favored Pre-proline 0 N--CA 1.425 -1.719 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.284 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.743 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 73.3 Cg_exo -45.58 129.05 11.1 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.597 2.865 . . . . 0.0 113.502 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.45 153.46 41.38 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.244 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.438 HG13 ' OG1' ' A' ' 60' ' ' THR . 10.7 p -92.71 134.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 118.589 -1.245 . . . . 0.0 111.382 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.21 176.35 16.65 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 105.765 -2.934 . . . . 0.0 105.765 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -50.97 127.05 20.35 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.557 2.171 . . . . 0.0 112.14 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.31 23.42 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.122 1.369 . . . . 0.0 112.85 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -105.2 -10.99 16.75 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.36 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.35 -42.05 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.066 -175.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.59 -37.91 88.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.046 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -81.25 -17.7 48.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.658 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.552 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.6 tp -70.02 -39.7 75.65 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -39.61 84.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.163 0.982 . . . . 0.0 109.816 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.459 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 41.6 t-20 -78.35 -37.5 44.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.644 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 34' ' ' LEU . 5.1 p -65.28 -29.36 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 34' ' ' LEU . 36.5 mm -64.94 -50.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -63.48 -20.12 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.724 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 62.1 mttm -86.23 -60.1 2.1 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.412 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.587 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 77.9 mt -66.22 -42.22 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.594 ' CD2' HD12 ' A' ' 66' ' ' LEU . 3.3 m-85 -79.31 -23.57 43.41 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -170.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 67.3 m -64.43 -8.17 12.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 21.7 ptmt -68.35 -33.04 73.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -83.33 -17.19 43.3 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.595 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 153.16 -177.84 30.56 Favored Glycine 0 C--O 1.219 -0.81 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -76.86 131.93 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.09 103.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -82.02 -60.68 2.14 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.789 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 91.3 m-20 -126.91 122.97 36.11 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.74 133.68 53.13 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.47 102.9 8.76 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.08 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 12.6 m-30 -101.0 104.72 34.07 Favored Pre-proline 0 N--CA 1.428 -1.564 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 91.9 Cg_endo -87.81 173.92 4.95 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.008 1.805 . . . . 0.0 111.432 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--N 1.281 -2.371 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.209 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.438 ' OG1' HG13 ' A' ' 26' ' ' VAL . 13.5 t . . . . . 0 N--CA 1.43 -1.457 0 CA-C-O 121.381 0.61 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 13.6 pttm -79.35 163.94 24.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.493 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' ASN . . . -129.58 2.99 6.13 Favored Glycine 0 C--O 1.182 -3.133 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.046 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -154.99 156.04 35.27 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.933 -0.745 . . . . 0.0 109.833 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 pt -141.27 167.33 17.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.5 m-85 -131.92 141.07 49.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.594 HD12 ' CD2' ' A' ' 42' ' ' PHE . 26.9 mt -127.87 149.35 50.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 50' ' ' ASN . 44.2 mt-10 -128.04 153.35 46.88 Favored 'General case' 0 C--O 1.255 1.388 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.37 159.89 29.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.26 73.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.521 1.128 . . . . 0.0 111.212 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.444 ' O ' ' HD2' ' A' ' 73' ' ' HIS . 28.5 t -123.72 128.25 25.22 Favored Pre-proline 0 CA--C 1.461 -2.472 1 N-CA-C 97.14 -5.133 . . . . 0.0 97.14 173.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.505 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 23.2 Cg_exo -62.49 -52.0 2.86 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 CA-C-N 121.813 1.683 . . . . 0.0 110.647 -165.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 26.52 5.79 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.807 0 C-N-CA 131.551 3.94 . . . . 0.0 119.657 144.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.444 ' HD2' ' O ' ' A' ' 70' ' ' SER . 88.4 m-70 -127.24 -28.95 2.78 Favored 'General case' 1 C--N 1.225 -4.81 0 CA-C-O 121.214 0.53 . . . . 0.0 109.884 -170.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -69.25 -26.77 64.95 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.048 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.65 -24.86 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.07 -45.1 28.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.14 82.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.911 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.38 -18.0 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.109 0.48 . . . . 0.0 111.599 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -84.2 -24.59 30.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.42 -84.18 0.05 Allowed 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.89 109.45 3.21 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.253 0.549 . . . . 0.0 112.024 -173.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 94' ' ' VAL . 1.2 t70 -95.46 120.22 35.33 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.86 173.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.05 53.8 2.29 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.576 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -106.42 119.14 38.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.196 -0.591 . . . . 0.0 110.369 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 130.47 35.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.873 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.36 -63.3 1.34 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -172.15 169.63 5.44 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HG2' ' OE1' ' A' ' 89' ' ' GLN . 24.3 ttmm 51.79 -104.04 0.17 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.651 1.18 . . . . 0.0 112.44 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.453 ' OE1' ' HG2' ' A' ' 88' ' ' LYS . 5.7 pm0 -121.61 11.93 10.63 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.959 0.885 . . . . 0.0 109.217 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.743 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 7.4 m170 -90.33 88.48 7.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.9 m -133.49 114.82 14.04 Favored 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.452 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -82.53 100.64 10.23 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.79 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.74 122.59 31.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.6 m -107.65 126.12 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.543 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.027 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.96 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 120.256 0.074 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.5 m -106.48 -7.53 17.5 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -172.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -134.92 135.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.231 -175.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -92.66 134.82 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.4 t -123.89 112.9 34.71 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.8 m -121.98 118.42 55.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.446 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.77 148.81 22.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.263 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.442 0.1 OUTLIER 47.41 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 128.204 2.602 . . . . 0.0 114.776 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 32.3 m -90.77 163.63 29.32 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.043 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 0.9 OUTLIER -42.7 142.54 1.99 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 124.531 3.487 . . . . 0.0 114.987 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.478 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -80.52 159.38 25.53 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.323 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 27' ' ' GLY . 14.0 p -128.53 136.93 58.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.957 -177.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -101.51 168.09 19.42 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.96 126.87 19.85 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.834 2.356 . . . . 0.0 113.19 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.15 24.08 10.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.096 1.359 . . . . 0.0 112.996 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.405 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 20.0 mtp180 -107.3 -3.78 19.34 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.487 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -68.51 -33.92 74.98 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.54 -45.68 63.07 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.094 1.358 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HZ3' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -85.08 -29.17 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.022 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.596 ' O ' HG12 ' A' ' 38' ' ' ILE . 78.2 mt -64.51 -39.48 93.86 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.56 -21.26 61.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.479 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.7 t-20 -84.38 -38.18 20.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.246 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 34' ' ' LEU . 8.8 p -67.05 -26.28 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 34' ' ' LEU . 44.0 mm -57.69 -51.32 71.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.059 175.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -62.88 -31.16 72.15 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 34.4 mmtp -65.69 -47.8 74.18 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.66 -47.86 78.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.63 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.53 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 68.4 m-85 -83.98 -11.76 56.32 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.5 p -69.31 -16.54 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 121.555 -0.715 . . . . 0.0 110.827 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.6 mmpt? -64.73 -24.75 67.66 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.347 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.23 -8.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.758 0.313 . . . . 0.0 111.39 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.95 -149.12 21.23 Favored Glycine 0 N--CA 1.428 -1.87 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.35 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -103.18 118.29 36.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . 0.435 HD12 ' CZ ' ' A' ' 68' ' ' TYR . 23.0 mm -73.82 103.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.9 p -88.5 -23.74 23.14 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.007 0.432 . . . . 0.0 111.411 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -158.23 139.03 12.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.401 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 4.5 p30 -130.53 142.35 50.47 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.843 -0.536 . . . . 0.0 110.982 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . 0.438 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 97.4 m-85 -128.23 98.97 5.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 7.4 m-30 -108.12 104.66 54.41 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.35 163.07 19.67 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.153 1.235 . . . . 0.0 109.863 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.425 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 8.3 pt-20 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 42.2 mttm -57.38 168.39 0.79 Allowed 'General case' 0 C--O 1.245 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 110.883 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.51 -13.93 7.18 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.669 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -170.47 159.45 6.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.7 pt -146.9 166.28 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.438 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 63.7 m-85 -132.43 134.26 44.89 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.407 HD12 HD13 ' A' ' 48' ' ' ILE . 3.1 mm? -112.87 117.63 32.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -107.15 130.81 54.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . 0.587 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -127.38 177.62 6.6 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.72 13.51 14.21 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.435 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . 29.6 m -79.11 151.0 75.37 Favored Pre-proline 0 CA--C 1.574 1.867 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.59 8.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.04 2 C-N-CA 130.593 7.529 . . . . 0.0 122.751 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.513 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 85.33 64.64 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 124.576 2.131 . . . . 0.0 106.928 -160.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 53.4 p-80 -90.34 -36.35 14.7 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 109.129 -3.669 . . . . 0.0 107.662 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.67 -31.02 69.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.311 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 72' ' ' ALA . 4.0 p -65.92 -28.55 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.153 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -81.5 -40.0 23.89 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.854 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.43 75.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.626 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.58 -38.74 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 C-N-CA 124.439 1.096 . . . . 0.0 111.198 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.06 -20.91 60.87 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.422 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -93.59 -56.52 2.88 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.694 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.62 97.85 3.66 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.445 ' CG ' HG23 ' A' ' 94' ' ' VAL . 5.5 t0 -112.0 122.69 48.45 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.47 42.39 9.25 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.988 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' THR . 16.9 p90 -94.65 139.13 31.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.736 0.303 . . . . 0.0 110.939 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -103.36 123.84 47.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.09 -50.59 6.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.812 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.18 -167.19 2.48 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -27.6 -75.41 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.932 2.093 . . . . 0.0 115.541 -170.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.478 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 5.1 pm0 -111.12 12.62 21.92 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.27 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 3.7 m-70 -88.46 88.88 7.77 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 5.1 m -133.49 102.07 5.38 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.39 118.54 22.76 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -167.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -88.34 125.19 34.57 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.445 HG23 ' CG ' ' A' ' 82' ' ' ASP . 4.1 m -94.56 147.78 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.067 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.692 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 t70 . . . . . 0 C--O 1.193 -1.911 0 CA-C-O 121.967 0.889 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 t -109.04 -6.12 15.77 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 111.108 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 48.7 t -111.84 118.47 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 35.5 mm -84.11 139.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 49.9 t -130.71 113.09 23.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.103 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 64' ' ' ILE . 12.0 m -120.24 131.93 71.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.22 142.88 29.34 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.994 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.484 0.2 OUTLIER 44.17 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.127 2.171 . . . . 0.0 115.815 -174.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.0 160.42 73.83 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.546 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HA ' ' ND1' ' A' ' 90' ' ' HIS . 5.6 Cg_endo -46.64 132.94 16.78 Favored 'Trans proline' 0 CA--C 1.501 -1.138 0 C-N-CA 123.465 2.777 . . . . 0.0 114.28 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.7 138.05 42.69 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.311 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.11 138.42 27.47 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.205 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.4 -178.14 25.08 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.6 125.79 18.83 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.203 1.935 . . . . 0.0 112.299 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 51.71 22.53 1.68 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.519 1.928 . . . . 0.0 112.44 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -86.91 -17.92 32.08 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.354 -0.841 . . . . 0.0 111.253 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.17 -45.08 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -56.9 -56.95 15.06 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.465 0.478 . . . . 0.0 110.99 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -68.38 -24.19 64.75 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.522 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.6 ' O ' HG12 ' A' ' 38' ' ' ILE . 8.0 tt -70.69 -44.91 66.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -73.57 -18.07 61.11 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.324 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . 0.493 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 11.3 m120 -78.86 -41.73 29.17 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.591 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 34' ' ' LEU . 9.8 p -68.08 -32.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.989 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 34' ' ' LEU . 26.5 mm -61.09 -53.87 43.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 122.968 0.507 . . . . 0.0 109.661 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -53.34 -38.48 63.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.355 0.662 . . . . 0.0 109.916 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 28.0 mtpp -73.92 -48.87 27.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.082 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.526 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 88.4 mt -62.01 -40.74 88.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.135 0.493 . . . . 0.0 110.326 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.434 ' CE1' HG22 ' A' ' 38' ' ' ILE . 2.4 m-30 -74.26 -11.99 60.43 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.31 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 -16.43 63.32 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.8 ptpt -67.32 -33.39 75.16 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 110.523 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 81' ' ' ALA . 27.8 m-85 -79.79 -16.05 56.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.448 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.18 179.88 26.35 Favored Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.663 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -67.38 114.36 6.01 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.301 1.04 . . . . 0.0 110.816 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.3 mm -74.43 108.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.3 m -80.16 -45.2 18.52 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -154.03 153.15 31.41 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -131.62 150.69 52.06 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.037 0.535 . . . . 0.0 110.055 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.01 101.22 4.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . 0.48 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 34.8 m-85 -108.89 107.05 59.77 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.194 177.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.435 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 83.4 Cg_endo -95.44 173.22 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.864 1.709 . . . . 0.0 111.216 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 C-N-CA 125.7 1.6 . . . . 0.0 106.725 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 1.4 pttm -62.55 164.55 7.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.296 168.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.01 18.83 6.16 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.993 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -169.35 149.16 4.01 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ILE . . . . . 0.482 HG12 ' CG2' ' A' ' 20' ' ' VAL . 19.8 pt -142.84 168.18 13.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.4 m-85 -135.71 152.91 51.63 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.5 mp -135.0 154.48 51.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -130.24 128.17 41.09 Favored 'General case' 0 C--O 1.253 1.284 0 O-C-N 124.05 0.844 . . . . 0.0 109.273 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -104.75 176.59 5.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.98 -37.39 26.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.343 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 t -127.78 145.52 55.3 Favored Pre-proline 0 CA--C 1.466 -2.254 1 N-CA-C 99.534 -4.247 . . . . 0.0 99.534 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 73' ' ' HIS . 39.2 Cg_exo -63.64 -54.64 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.791 0 CA-C-N 122.193 1.819 . . . . 0.0 110.562 -171.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.8 4.07 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.654 1 C-N-CA 132.077 4.151 . . . . 0.0 119.824 148.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . 0.459 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 94.6 m-70 -129.32 -36.95 1.67 Allowed 'General case' 1 C--N 1.227 -4.754 0 C-N-CA 123.291 0.636 . . . . 0.0 110.045 -170.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.86 64.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.521 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.65 -31.9 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.256 0.551 . . . . 0.0 110.45 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -40.16 19.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.195 0.522 . . . . 0.0 109.759 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.8 86.05 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.639 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.59 -22.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.678 0.751 . . . . 0.0 111.16 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -83.8 -38.3 21.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -110.06 -25.91 9.98 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ALA . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . . . -101.47 7.11 42.62 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 122.018 -0.427 . . . . 0.0 111.793 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.446 ' HB2' ' CG2' ' A' ' 94' ' ' VAL . 14.4 t0 -76.63 103.35 6.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.59 8.41 Favored Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.585 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -105.3 136.38 44.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.101 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.483 ' N ' ' HD3' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -106.72 129.33 54.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.5 mt -79.46 -62.45 1.69 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.891 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -155.48 133.81 11.67 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 53.1 -93.74 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 125.647 1.579 . . . . 0.0 114.792 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -107.33 -4.1 18.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 120.661 0.267 . . . . 0.0 110.819 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.506 ' ND1' ' HA ' ' A' ' 24' ' ' PRO . 6.9 m-70 -79.3 91.46 5.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.6 m -132.84 120.48 21.6 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.86 104.6 14.08 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.114 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.06 109.08 20.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.448 HG11 HG11 ' A' ' 20' ' ' VAL . 17.2 m -93.62 143.53 11.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.263 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.066 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.565 0 N-CA-C 112.726 -0.15 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.5 135.32 33.67 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 117.354 0.577 . . . . 0.0 110.506 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.73 109.22 22.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.0 mt -101.57 -36.09 8.9 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -73.23 -46.94 47.36 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-O 121.506 0.669 . . . . 0.0 109.775 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.2 96.84 10.86 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -84.54 126.3 69.33 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.879 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.87 148.33 35.76 Favored 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 122.096 1.864 . . . . 0.0 110.766 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -106.02 157.38 17.56 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -74.9 -21.74 59.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.351 0.596 . . . . 0.0 109.807 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.07 134.62 34.66 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.985 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -164.96 137.43 4.47 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.48 -113.66 5.46 Favored Glycine 0 N--CA 1.443 -0.847 0 O-C-N 123.6 0.563 . . . . 0.0 113.33 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 tp -90.93 95.2 5.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 122.704 1.24 . . . . 0.0 111.182 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.456 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 6.7 p-10 -108.31 21.63 17.07 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.592 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -110.92 16.85 21.03 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.106 0.479 . . . . 0.0 111.438 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.19 132.23 63.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.409 HD12 ' HD1' ' A' ' 73' ' ' HIS . 9.6 mm -97.63 135.12 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.27 116.66 53.19 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 173.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 10.3 t -113.34 122.97 68.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.449 0.468 . . . . 0.0 110.216 -175.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.1 t70 -91.87 136.25 33.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.931 0.77 . . . . 0.0 111.182 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.48 0.1 OUTLIER 41.5 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 128.043 2.537 . . . . 0.0 116.684 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.527 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 18.3 m -98.7 173.29 3.97 Favored Pre-proline 0 N--CA 1.427 -1.611 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.246 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.694 ' HA ' ' NE2' ' A' ' 90' ' ' HIS . 55.5 Cg_exo -41.16 127.58 2.9 Favored 'Trans proline' 0 C--O 1.266 1.903 0 C-N-CA 123.649 2.9 . . . . 0.0 114.223 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.84 -178.24 3.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.26 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.427 ' CG2' ' HB2' ' A' ' 31' ' ' LEU . 6.6 p -111.93 134.23 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 118.885 -1.126 . . . . 0.0 113.325 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.78 157.08 15.28 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 104.263 -3.535 . . . . 0.0 104.263 166.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.466 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 9.3 Cg_endo -52.23 123.16 12.0 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 121.557 2.678 . . . . 0.0 112.266 -172.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 50.74 25.74 2.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.432 1.493 . . . . 0.0 112.89 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.466 ' HG3' ' O ' ' A' ' 28' ' ' PRO . 70.7 mtt180 -107.08 -8.4 16.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 122.061 -0.4 . . . . 0.0 110.952 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.455 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.9 tm? -73.53 -19.72 60.84 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.39 -48.39 74.4 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.978 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -79.17 -22.29 45.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.412 0.625 . . . . 0.0 110.372 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 97.7 mt -81.41 1.37 33.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 97.1 mttt -84.74 -43.23 14.47 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.451 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 48.9 t30 -75.71 -34.95 60.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.033 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.86 -32.78 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.656 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 mm -60.06 -59.01 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.539 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.06 -35.29 73.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.169 0.588 . . . . 0.0 110.542 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 29.9 mtpp -65.61 -39.91 92.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.794 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.3 -39.79 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.301 0.572 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.538 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 26.2 m-85 -76.22 -9.41 58.61 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -66.0 -19.31 65.81 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.636 0.732 . . . . 0.0 110.679 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -68.81 -21.16 64.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.951 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.85 -15.08 35.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.941 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.0 -152.74 24.86 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -96.11 125.72 40.84 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 mm -73.94 97.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -69.67 -54.37 14.2 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -135.84 135.19 39.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -134.14 126.98 31.12 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.87 0.843 . . . . 0.0 109.711 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -125.23 117.1 23.08 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.304 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.07 103.48 50.24 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -95.71 173.97 1.04 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.605 2.204 . . . . 0.0 111.101 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -105.66 -176.22 3.02 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 174.642 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -136.12 114.1 11.3 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.7 t0 62.87 27.99 16.21 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 122.054 0.93 . . . . 0.0 110.33 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.07 13.12 83.52 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.189 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 48.6 mtmt -128.44 -175.54 3.55 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 124.115 0.966 . . . . 0.0 109.923 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 m -34.66 129.19 0.43 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.53 1.932 . . . . 0.0 112.667 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.408 ' HE3' HD11 ' A' ' 31' ' ' LEU . 16.5 pttp -69.95 139.99 52.96 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.35 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.47 16.55 6.25 Favored Glycine 0 C--N 1.288 -2.098 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.855 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.496 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 24.4 p90 -169.92 158.33 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.2 pt -147.48 174.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 124.383 1.073 . . . . 0.0 108.117 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.48 136.89 43.48 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.386 0.429 . . . . 0.0 109.875 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.538 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 3.1 mm? -127.92 123.43 34.91 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.19 129.8 56.18 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.579 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 9.5 m-85 -127.34 170.35 12.59 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.34 14.33 12.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.447 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 49.6 m -71.57 173.33 5.32 Favored Pre-proline 0 CA--C 1.594 2.636 0 CA-C-N 113.231 -1.804 . . . . 0.0 115.565 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.447 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 6.3 Cg_exo -36.64 6.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.521 3.105 1 C-N-CA 130.041 7.16 . . . . 0.0 121.015 175.344 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 84.56 63.31 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 124.464 2.078 . . . . 0.0 108.478 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.579 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 17.3 p80 -74.16 -36.93 64.13 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 110.125 -3.216 . . . . 0.0 111.065 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -76.98 -37.29 55.47 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.57 -42.83 95.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.52 -49.31 69.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.669 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.23 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.005 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.428 HG21 ' O ' ' A' ' 74' ' ' ALA . 27.8 m -60.06 -31.62 48.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -84.87 -31.02 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -104.8 -41.38 5.66 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.16 84.67 2.02 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.48 ' HB2' HG21 ' A' ' 94' ' ' VAL . 3.5 t70 -116.31 118.42 32.69 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.36 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.12 41.96 7.79 Favored Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.154 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . 0.251 39.6 p90 -88.48 120.58 29.99 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.033 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.45 ' HG3' HG21 ' A' ' 91' ' ' THR . 0.8 OUTLIER -79.68 122.41 26.53 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.212 -176.142 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -87.08 -65.83 0.97 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.138 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -169.25 153.73 5.53 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 45.41 -91.47 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 C-N-CA 125.851 1.66 . . . . 0.0 114.705 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -111.49 -22.89 11.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.694 ' NE2' ' HA ' ' A' ' 24' ' ' PRO . 22.6 m170 -62.54 99.61 0.15 Allowed 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 122.814 0.446 . . . . 0.0 111.459 -171.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.45 HG21 ' HG3' ' A' ' 85' ' ' LYS . 7.5 m -134.45 103.0 5.52 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.8 100.25 10.19 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.888 -172.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.476 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.2 mpt_? -83.12 138.55 33.63 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.48 HG21 ' HB2' ' A' ' 82' ' ' ASP . 3.9 m -124.73 136.3 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 O-C-N 123.574 0.546 . . . . 0.0 110.344 -173.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.557 ' C ' HD21 ' A' ' 95' ' ' ASN . 0.2 OUTLIER -158.1 -179.34 8.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.205 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.468 ' HG ' ' OG1' ' A' ' 98' ' ' THR . 0.5 OUTLIER -102.76 -166.56 1.29 Allowed 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.56 0.537 . . . . 0.0 111.424 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -83.59 11.73 6.76 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.511 -174.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.468 ' OG1' ' HG ' ' A' ' 96' ' ' LEU . 8.6 p -72.0 65.02 0.54 Allowed 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 122.556 1.17 . . . . 0.0 111.065 171.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.95 -12.55 35.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.888 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -71.92 140.61 49.29 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.053 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.56 -32.96 15.33 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.71 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -60.62 134.81 57.45 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -171.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -104.94 141.59 36.27 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 49.7 ttm -70.07 99.33 1.44 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.382 0.611 . . . . 0.0 111.57 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.001 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.272 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -95.63 151.09 19.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.928 0.364 . . . . 0.0 111.377 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.448 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 4.1 p 63.02 6.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 127.256 2.222 . . . . 0.0 113.761 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -106.84 -53.78 2.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.416 0.627 . . . . 0.0 110.63 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -76.05 -40.58 53.04 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -114.93 113.2 23.83 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.448 ' HG2' ' O ' ' A' ' 3' ' ' VAL . 78.1 mtp180 -119.88 138.19 26.6 Favored Pre-proline 0 C--N 1.285 -2.237 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.063 -174.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.1 128.24 17.28 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 105.495 -2.54 . . . . 0.0 105.495 164.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.481 ' HG3' ' H ' ' A' ' 11' ' ' ALA . 47.4 tp60 -85.95 149.76 24.97 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.61 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -74.82 -9.67 58.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.761 0.791 . . . . 0.0 109.984 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.481 ' H ' ' HG3' ' A' ' 9' ' ' GLN . . . -87.26 100.97 13.09 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.613 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -154.07 174.43 14.71 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.76 -7.25 35.98 Favored Glycine 0 CA--C 1.494 -1.277 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.5 tp -154.07 125.53 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.725 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 26.4 t70 -110.93 -24.53 10.34 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.051 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.485 ' HA ' ' CE1' ' A' ' 73' ' ' HIS . 36.0 m -89.38 -3.16 58.56 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.433 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 88.3 t -127.55 122.57 59.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.415 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 14.0 mm -89.99 135.82 25.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.438 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 59.9 t -128.74 120.51 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.73 138.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.681 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.61 139.86 42.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.581 0.2 OUTLIER 46.58 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 127.253 2.221 . . . . 0.0 115.889 -169.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.525 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 29.9 m -107.25 179.04 0.95 Allowed Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.141 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.583 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 54.3 Cg_exo -42.41 131.74 5.04 Favored 'Trans proline' 0 C--O 1.269 2.04 0 C-N-CA 123.01 2.474 . . . . 0.0 114.831 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HA ' HG22 ' A' ' 60' ' ' THR . 9.1 pt20 -61.84 -165.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 128.06 2.544 . . . . 0.0 113.528 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.46 ' HB ' HD21 ' A' ' 31' ' ' LEU . 14.9 p -141.03 138.55 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-O 121.985 0.897 . . . . 0.0 110.691 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.93 141.85 15.38 Favored Glycine 0 C--N 1.275 -2.853 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 166.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.2 124.81 13.59 Favored 'Trans proline' 0 C--O 1.243 0.744 0 CA-C-N 121.274 2.537 . . . . 0.0 112.73 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 60.56 32.38 20.42 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.067 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.4 2.04 10.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.228 -0.92 . . . . 0.0 111.039 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.46 HD21 ' HB ' ' A' ' 26' ' ' VAL . 1.4 tm? -60.91 -27.01 67.88 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -174.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -57.7 -50.72 72.25 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.56 -23.53 61.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.661 0.743 . . . . 0.0 109.993 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.8 mt -81.2 -4.53 55.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.574 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 99.5 mttt -85.62 -37.46 19.49 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 168.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.494 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 4.4 m-20 -78.16 -33.89 50.04 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.921 -172.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.38 -32.5 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.944 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.47 -53.34 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.3 -31.68 67.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.842 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 52.9 mtpt -78.32 -41.6 33.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.5 mt -82.44 -41.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.708 0.765 . . . . 0.0 111.246 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.626 ' CD2' HD11 ' A' ' 66' ' ' LEU . 3.9 m-85 -78.57 -10.81 59.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 1.8 p -71.78 -10.02 59.15 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.733 0.778 . . . . 0.0 111.578 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -71.21 -22.03 62.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.318 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.69 -15.42 39.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.729 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 150.83 -171.47 30.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -83.73 127.08 33.52 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 20.1 mm -72.6 94.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 176.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.2 m -83.36 -37.25 23.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.097 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 39.5 t30 -154.04 145.57 23.19 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -146.64 151.25 36.95 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -135.99 106.14 6.34 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.783 0.677 . . . . 0.0 109.892 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.74 104.72 55.39 Favored Pre-proline 0 C--O 1.252 1.212 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.32 173.21 1.2 Allowed 'Trans proline' 0 N--CA 1.432 -2.128 0 C-N-CA 121.882 1.721 . . . . 0.0 110.898 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.15 175.88 9.54 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 174.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.778 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 39.7 mt-10 -137.5 117.53 13.38 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 56.29 26.22 10.26 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 123.58 0.752 . . . . 0.0 111.208 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.77 15.84 65.05 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 116.167 -0.47 . . . . 0.0 113.195 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.778 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 56.3 pttt -101.77 -176.83 3.25 Favored 'General case' 0 C--O 1.246 0.885 0 O-C-N 121.904 -0.763 . . . . 0.0 109.163 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.472 HG22 ' HA ' ' A' ' 25' ' ' GLN . 98.7 m -53.64 119.01 4.37 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 123.649 0.78 . . . . 0.0 111.532 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -67.86 145.54 54.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.438 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -118.33 3.19 16.06 Favored Glycine 0 C--N 1.286 -2.225 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.932 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -168.19 150.06 5.26 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.12 167.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -132.69 136.06 46.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.626 HD11 ' CD2' ' A' ' 42' ' ' PHE . 47.1 mt -121.46 154.01 37.15 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 16' ' ' SER . 42.3 tt0 -135.95 122.58 20.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.54 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 11.8 m-30 -118.88 157.56 27.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.37 13.86 28.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.219 1.009 . . . . 0.0 108.82 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 20.8 m -73.57 161.63 78.01 Favored Pre-proline 0 CA--C 1.604 3.034 0 CA-C-N 114.16 -1.382 . . . . 0.0 114.605 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.2 Cg_endo -37.66 8.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.945 2 C-N-CA 130.622 7.548 . . . . 0.0 124.316 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.725 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.47 67.42 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 123.066 2.666 . . . . 0.0 106.153 -156.112 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.54 ' NE2' ' HB2' ' A' ' 68' ' ' TYR . 22.9 p-80 -93.94 -37.87 11.47 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 109.067 -3.697 . . . . 0.0 112.197 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.6 -23.42 53.43 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.354 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.3 p -65.11 -22.89 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.764 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.04 -46.71 12.51 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.05 -43.79 66.91 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.982 0.801 . . . . 0.0 111.964 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.49 -19.57 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.92 0.39 . . . . 0.0 111.872 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.471 ' HZ2' ' HB3' ' A' ' 79' ' ' LYS . 7.5 ttpm? -85.27 -22.98 28.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.173 176.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -71.91 0.14 Allowed 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.313 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -177.3 124.13 0.13 Allowed 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.642 0.588 . . . . 0.0 110.285 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.463 ' HB2' HG22 ' A' ' 94' ' ' VAL . 5.5 t70 -81.43 115.67 20.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.49 52.5 4.18 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.335 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -93.67 126.61 38.94 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.092 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -82.99 117.19 22.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.786 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.65 -58.78 2.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.8 0.809 . . . . 0.0 109.197 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -135.12 -164.79 1.58 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -36.2 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.744 1.617 . . . . 0.0 115.069 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -96.29 -1.15 48.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.726 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.583 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 42.1 m170 -81.43 93.29 6.59 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 21.2 m -133.95 108.38 8.36 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.681 -178.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -82.83 101.07 10.72 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.261 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.56 136.73 34.14 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.463 HG22 ' HB2' ' A' ' 82' ' ' ASP . 17.1 m -105.86 138.17 32.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 123.792 0.682 . . . . 0.0 110.594 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.438 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -156.14 170.61 21.8 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -86.41 -174.14 4.88 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.718 0.77 . . . . 0.0 112.298 -176.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.427 ' C ' ' H ' ' A' ' 99' ' ' ASP . 81.7 t80 -106.71 -35.8 6.89 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.435 -175.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.29 28.19 0.05 Allowed 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.445 1.498 . . . . 0.0 112.04 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 97' ' ' PHE . 17.7 t70 -124.97 -43.26 1.98 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.262 0.553 . . . . 0.0 109.601 -178.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -92.35 35.06 1.01 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.652 0.739 . . . . 0.0 112.379 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.81 62.12 0.93 Allowed 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 176.93 5.94 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.918 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -93.09 138.25 31.7 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 56.0 ttp -92.35 100.63 13.17 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.423 0.63 . . . . 0.0 110.566 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.42 -1.934 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 179.724 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.283 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -85.49 150.29 24.79 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 117.14 0.47 . . . . 0.0 111.147 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.28 -10.94 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.23 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.7 mt -69.0 -16.78 63.81 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 123.736 0.814 . . . . 0.0 111.521 178.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.407 ' HB3' ' HZ3' ' A' ' 5' ' ' LYS . 2.1 mmmp? -82.18 -20.65 37.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.063 0.458 . . . . 0.0 110.091 174.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -89.46 -53.38 4.57 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.526 ' NH2' ' HB2' ' A' ' 10' ' ' GLU . 11.2 ptm180 -119.47 139.31 27.59 Favored Pre-proline 0 N--CA 1.415 -2.203 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.622 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.29 158.9 53.38 Favored 'Trans proline' 0 C--O 1.268 1.977 0 C-N-CA 121.451 1.434 . . . . 0.0 109.335 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.419 ' HG3' ' H ' ' A' ' 11' ' ' ALA . 60.4 tp60 -66.57 135.06 53.6 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.526 ' HB2' ' NH2' ' A' ' 7' ' ' ARG . 20.5 tt0 -79.42 -6.78 57.6 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.682 0.753 . . . . 0.0 111.511 -171.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' H ' ' HG3' ' A' ' 9' ' ' GLN . . . -95.85 97.94 10.04 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.396 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -159.92 129.56 5.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.525 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.45 -66.83 0.53 Allowed Glycine 0 C--N 1.298 -1.578 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.6 tp -150.11 92.14 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.02 0 CA-C-O 122.234 1.016 . . . . 0.0 110.94 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.534 ' OD1' ' HB2' ' A' ' 96' ' ' LEU . 23.5 m-20 -131.03 54.16 1.93 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 122.55 1.167 . . . . 0.0 107.992 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.501 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 44.9 m -96.48 7.18 47.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.265 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 38.7 t -127.93 126.53 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.981 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 30.5 mm -83.04 139.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.2 112.13 34.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.79 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.777 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 30.1 t70 -85.44 132.78 34.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.744 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.479 0.2 OUTLIER 45.7 97.92 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.428 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.9 m -86.63 167.94 20.55 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.656 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 48.9 Cg_exo -51.18 146.95 21.81 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.769 2.313 . . . . 0.0 116.098 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.471 HE21 ' HB3' ' A' ' 25' ' ' GLN . 3.7 tt0 -61.06 145.3 51.32 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.19 -2.277 . . . . 0.0 109.503 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 7.3 p -137.87 151.0 25.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.715 0.769 . . . . 0.0 111.494 -176.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.16 174.87 20.98 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.62 126.05 11.89 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.691 2.261 . . . . 0.0 113.642 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.9 t70 65.27 18.44 11.39 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.797 2.039 . . . . 0.0 112.9 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -100.89 -8.36 22.61 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.612 -1.305 . . . . 0.0 111.629 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.425 ' O ' HD11 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -76.97 -21.9 54.02 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.63 -34.44 78.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.221 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -69.93 -36.96 75.74 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.563 ' O ' HG12 ' A' ' 38' ' ' ILE . 80.2 mt -73.59 -34.37 65.06 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.551 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -58.47 -31.61 67.97 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.98 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -80.96 -31.25 34.93 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.789 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.56 HG12 ' O ' ' A' ' 34' ' ' LEU . 3.8 p -75.25 -28.99 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.6 mm -62.12 -51.76 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -65.45 -17.56 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.257 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -88.07 -60.08 2.06 Favored 'General case' 0 N--CA 1.415 -2.21 0 O-C-N 122.15 -0.344 . . . . 0.0 110.784 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.12 -42.7 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.354 0.597 . . . . 0.0 111.303 -175.362 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.526 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 58.2 m-85 -79.4 -17.76 53.7 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 68.4 m -74.28 -3.71 31.73 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.388 0.613 . . . . 0.0 111.397 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.05 -3.39 58.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -113.16 9.64 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.319 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 126.62 -162.53 20.76 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -94.5 133.27 38.29 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.277 0.539 . . . . 0.0 111.619 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.44 95.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.422 ' OG1' ' HA ' ' A' ' 68' ' ' TYR . 1.2 p -80.55 -34.64 35.27 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.379 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -152.19 147.22 26.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.991 -0.443 . . . . 0.0 110.177 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -136.65 107.2 6.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.413 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 2.4 m-85 -107.37 104.83 54.04 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.661 -1.236 . . . . 0.0 107.661 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.548 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 73.4 Cg_endo -83.89 159.19 13.87 Favored 'Trans proline' 0 N--CA 1.436 -1.882 0 C-N-CA 120.921 1.081 . . . . 0.0 110.19 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.458 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 20.1 pt-20 -173.98 -176.78 1.24 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.716 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 41.7 mt-10 -138.76 133.59 32.37 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 172.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 54.6 25.28 6.17 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.778 0.831 . . . . 0.0 112.259 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.7 23.07 54.85 Favored Glycine 0 CA--C 1.549 2.181 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.297 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.716 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 56.6 pttt -97.37 -177.05 3.69 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 117.667 0.733 . . . . 0.0 110.618 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 m -56.95 92.26 0.01 OUTLIER 'General case' 0 C--O 1.252 1.189 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.548 ' HE3' ' O ' ' A' ' 54' ' ' PRO . 6.9 ptpp? -64.33 166.01 8.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 125.735 1.614 . . . . 0.0 110.072 170.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.04 14.66 4.88 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.229 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -170.66 152.46 3.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 pt -145.53 167.1 9.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -128.88 136.15 50.05 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.2 0.524 . . . . 0.0 109.682 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 3.6 mm? -115.67 118.26 32.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -103.52 122.08 44.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.526 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 m-85 -126.95 164.75 20.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.769 0.795 . . . . 0.0 111.952 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.66 13.58 26.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.605 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.485 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . 38.6 t -75.03 158.31 84.48 Favored Pre-proline 0 CA--C 1.585 2.319 0 C-N-CA 125.344 1.457 . . . . 0.0 113.469 -171.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -37.48 8.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.836 1 C-N-CA 130.31 7.34 . . . . 0.0 121.057 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.41 ' HB2' ' CG2' ' A' ' 75' ' ' VAL . . . 84.84 62.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 125.026 2.346 . . . . 0.0 108.058 -166.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.515 ' H ' ' CD2' ' A' ' 73' ' ' HIS . 14.3 p80 -72.41 -36.26 68.6 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 109.261 -3.608 . . . . 0.0 110.83 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.21 -33.33 63.36 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.41 ' CG2' ' HB2' ' A' ' 72' ' ' ALA . 84.4 t -64.73 -42.88 96.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.301 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.3 -41.85 80.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.768 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -50.47 73.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.437 0.695 . . . . 0.0 111.415 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -61.67 -32.39 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 123.536 0.734 . . . . 0.0 110.461 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -76.17 -38.11 57.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.209 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.86 -63.68 1.19 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -172.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.25 103.34 6.89 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.392 0.615 . . . . 0.0 111.926 -169.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.432 ' HB2' HG22 ' A' ' 94' ' ' VAL . 12.0 t0 -130.08 140.77 50.78 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.662 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.04 46.07 53.37 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -101.59 125.27 48.22 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 121.538 0.685 . . . . 0.0 110.418 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.91 129.0 45.23 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.198 -174.658 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.6 -59.83 2.16 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.495 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -162.6 151.4 14.87 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp 40.24 -95.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -110.43 3.46 19.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.858 -0.526 . . . . 0.0 110.842 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.656 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 12.1 m170 -80.7 89.16 5.74 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 m -133.23 115.31 14.82 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -85.54 116.18 23.69 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.56 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.428 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 3.5 mpt_? -91.42 121.63 33.3 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.7 m -103.5 148.85 7.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -175.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.462 ' C ' HD21 ' A' ' 95' ' ' ASN . 0.1 OUTLIER -149.19 178.34 8.83 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.534 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 1.5 pt? -87.87 -173.02 4.1 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 123.437 0.46 . . . . 0.0 112.211 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -119.04 -20.13 8.19 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.45 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.8 m -73.65 68.78 1.24 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.287 1.041 . . . . 0.0 110.889 175.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.55 -18.41 24.14 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.11 143.35 48.95 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.145 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -81.8 81.07 7.94 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.148 0.975 . . . . 0.0 108.627 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -50.42 146.89 4.87 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.136 174.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -80.18 122.3 26.66 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' MET . . . . . 0.401 ' C ' ' HG1' ' A' ' 105' ' ' THR . 0.7 OUTLIER -82.42 126.5 32.27 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.083 0.468 . . . . 0.0 109.793 -175.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.401 ' HG1' ' C ' ' A' ' 104' ' ' MET . 29.7 m . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.699 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.421 ' C ' ' H ' ' A' ' 4' ' ' LEU . 3.5 t70 -96.12 154.35 17.29 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.91 29.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.421 ' H ' ' C ' ' A' ' 2' ' ' ASP . 6.2 mp -100.62 -48.98 4.33 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -96.4 -3.23 43.98 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . 3.9 p-10 -78.37 28.62 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.817 0.818 . . . . 0.0 112.568 -171.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -111.08 164.99 13.58 Favored Pre-proline 0 C--N 1.285 -2.196 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.61 128.23 21.77 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 N-CA-C 106.98 -1.969 . . . . 0.0 106.98 169.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.419 ' C ' ' H ' ' A' ' 11' ' ' ALA . 0.0 OUTLIER -120.79 159.4 25.52 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.119 -1.032 . . . . 0.0 113.353 -169.465 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.45 19.8 2.24 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.029 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 9' ' ' GLN . . . -57.49 120.96 9.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.185 -172.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.89 121.85 18.86 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.431 ' HA2' HG21 ' A' ' 98' ' ' THR . . . -62.41 94.43 0.1 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 116.714 1.445 . . . . 0.0 116.714 -171.574 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.8 tp -97.06 89.35 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-O 122.807 1.289 . . . . 0.0 107.766 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.722 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 14.0 t70 -92.85 -2.51 55.82 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.611 -173.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.659 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 30.3 t -92.34 -6.28 50.51 Favored 'General case' 0 C--N 1.275 -2.673 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.283 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.73 115.37 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.897 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 20.4 mm -93.59 143.41 11.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.649 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 98.0 t -121.0 123.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 79.7 t -119.15 139.88 44.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.434 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 20.2 t70 -107.21 145.9 32.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.043 0.537 . . . . 0.0 110.714 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.506 0.2 OUTLIER 31.68 104.76 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.985 2.587 . . . . 0.0 117.985 -174.931 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 27.1 m -107.98 177.22 1.34 Allowed Pre-proline 0 CA--C 1.562 1.418 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.739 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.652 ' HA ' ' CE1' ' A' ' 90' ' ' HIS . 5.0 Cg_exo -43.89 138.21 6.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.828 3.019 . . . . 0.0 112.725 170.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.432 ' HA ' HG21 ' A' ' 60' ' ' THR . 0.1 OUTLIER -88.41 172.23 9.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.777 -175.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.41 HG21 ' HB2' ' A' ' 31' ' ' LEU . 14.1 p -117.39 142.51 31.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.132 0.968 . . . . 0.0 111.747 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.77 155.52 16.23 Favored Glycine 0 N--CA 1.414 -2.804 1 N-CA-C 102.657 -4.177 . . . . 0.0 102.657 165.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.84 125.22 12.51 Favored 'Trans proline' 0 C--O 1.25 1.111 0 CA-C-N 121.224 2.512 . . . . 0.0 114.136 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.68 24.74 9.27 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.107 1.763 . . . . 0.0 111.879 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -98.46 -15.49 19.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 121.738 -0.601 . . . . 0.0 111.407 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.447 ' O ' HD12 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -79.55 -18.2 52.32 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.855 -174.08 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.3 -42.72 82.31 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.24 -29.64 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.376 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.587 ' O ' HG12 ' A' ' 38' ' ' ILE . 94.8 mt -69.27 -27.01 65.05 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.339 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -59.57 -39.75 85.11 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.699 0.761 . . . . 0.0 110.216 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -84.08 -28.23 27.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.433 HG11 ' O ' ' A' ' 34' ' ' LEU . 7.3 p -70.56 -32.68 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.347 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.587 HG12 ' O ' ' A' ' 34' ' ' LEU . 43.2 mm -59.6 -53.1 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -53.61 -35.38 60.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.569 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.93 -42.22 24.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 37' ' ' VAL . 45.8 mm -64.77 -42.88 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.918 0.866 . . . . 0.0 109.68 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -76.88 -6.69 53.45 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.029 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.402 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 22.8 t -73.02 -6.76 47.66 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-O 121.271 0.557 . . . . 0.0 109.632 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -71.5 -28.15 63.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.273 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -85.71 -15.14 43.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.23 0.538 . . . . 0.0 111.058 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 155.18 -162.99 31.28 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -96.11 129.13 43.48 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.485 HD13 ' CE2' ' A' ' 68' ' ' TYR . 24.0 mm -73.03 109.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -81.88 -48.64 11.28 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.463 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 37.2 m-20 -134.75 144.21 47.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.464 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.6 p30 -137.04 132.72 34.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.557 0.694 . . . . 0.0 110.902 175.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.31 97.77 5.35 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.233 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.464 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 2.5 m-85 -108.63 104.9 55.81 Favored Pre-proline 0 N--CA 1.416 -2.129 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.739 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 80.8 Cg_endo -83.88 170.8 11.01 Favored 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 120.932 1.088 . . . . 0.0 110.462 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' OE2' ' HA ' ' A' ' 60' ' ' THR . 1.0 OUTLIER -139.22 162.54 34.72 Favored 'General case' 0 N--CA 1.388 -3.575 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 175.842 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 40.2 mt-10 -134.04 103.56 5.85 Favored 'General case' 0 C--N 1.28 -2.437 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.566 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 62.9 27.6 16.04 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.785 0.802 . . . . 0.0 111.998 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.32 -4.83 85.92 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.352 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 62.2 pttt -103.26 171.51 7.33 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.476 ' HA ' ' OE2' ' A' ' 55' ' ' GLU . 11.3 t -79.25 141.54 37.0 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-O 122.741 1.258 . . . . 0.0 113.108 -173.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.739 ' HD3' ' O ' ' A' ' 54' ' ' PRO 0.27 9.6 pttm -59.49 176.26 0.27 Allowed 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.478 167.06 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.64 20.91 4.82 Favored Glycine 0 C--N 1.288 -2.097 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 52.3 p90 -169.28 160.28 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 pt -147.09 171.98 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.92 136.94 44.59 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 123.952 0.783 . . . . 0.0 109.504 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 HD11 ' A' ' 48' ' ' ILE . 2.4 mm? -124.53 138.74 54.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.634 ' HA ' ' O ' ' A' ' 16' ' ' SER . 41.8 mt-10 -126.43 129.99 49.81 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.574 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 19.1 m-85 -125.98 170.78 11.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.32 14.24 12.89 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.424 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 39.4 m -73.27 168.02 29.03 Favored Pre-proline 0 CA--C 1.589 2.447 0 CA-C-N 113.493 -1.685 . . . . 0.0 114.633 -173.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 5.7 Cg_exo -35.52 9.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.358 2 C-N-CA 130.624 7.549 . . . . 0.0 123.08 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.722 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.11 65.2 0.01 OUTLIER 'General case' 0 CA--C 1.473 -2.016 0 CA-C-O 124.788 2.232 . . . . 0.0 106.867 -160.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.659 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 21.2 p-80 -82.17 -36.49 27.3 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 108.995 -3.729 . . . . 0.0 111.98 -171.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.1 -37.49 75.41 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.386 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.541 HG21 ' OD1' ' A' ' 15' ' ' ASP . 94.3 t -56.07 -48.42 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.489 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 3.1 t70 -65.7 -35.71 81.53 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.279 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.94 69.91 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.412 0.285 . . . . 0.0 110.888 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.1 -37.79 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 123.725 0.81 . . . . 0.0 109.706 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.41 ' HD3' ' HA ' ' A' ' 76' ' ' ASP . 77.4 tttt -59.79 -36.46 76.76 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.414 1.485 . . . . 0.0 111.517 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -81.96 -77.31 0.23 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.32 113.01 3.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.084 -172.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.433 ' HB2' HG21 ' A' ' 94' ' ' VAL . 2.9 t70 -94.74 133.68 38.16 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.916 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 48.81 19.52 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.404 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -88.94 125.36 34.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.791 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -103.35 129.27 50.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.487 -172.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -86.28 -66.85 0.86 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -167.67 -173.81 2.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.23 -103.54 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -121.54 8.42 10.12 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.652 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 4.8 m-70 -87.28 91.74 8.83 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.359 -170.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 m -133.44 105.0 6.68 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -82.61 101.17 10.62 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.626 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.434 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -87.34 137.36 32.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.433 HG21 ' HB2' ' A' ' 82' ' ' ASP . 5.4 m -105.01 134.55 46.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 O-C-N 123.944 0.778 . . . . 0.0 109.991 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.649 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -148.06 144.12 27.67 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 3.6 mp -109.96 -178.89 3.64 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 173.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -81.99 -44.77 16.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 171.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.431 HG21 ' HA2' ' A' ' 13' ' ' GLY . 17.9 m -94.66 73.49 3.68 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 168.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.64 -28.46 26.44 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.378 1.085 . . . . 0.0 109.046 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 6' ' ' ASP . 89.2 m-85 -92.77 88.35 6.2 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.743 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.42 -24.31 62.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.834 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.414 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -68.89 135.26 50.79 Favored 'General case' 0 N--CA 1.406 -2.634 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.556 173.413 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -129.3 169.96 14.2 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.617 -170.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.6 tpt -61.39 101.43 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.436 1.085 . . . . 0.0 108.279 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.424 -1.731 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.017 -174.831 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.742 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -96.28 150.41 20.58 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.346 0.593 . . . . 0.0 109.956 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 13.0 p -146.94 12.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.857 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.888 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.76 -53.41 3.3 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.752 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -92.5 -38.19 12.08 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.459 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 22.4 t70 -86.02 76.85 9.76 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -121.34 163.4 30.52 Favored Pre-proline 0 C--N 1.288 -2.088 0 CA-C-N 114.09 -1.414 . . . . 0.0 112.249 -167.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.99 169.22 16.53 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.074 1.85 . . . . 0.0 108.656 167.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.499 ' NE2' ' H ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -77.54 151.03 34.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.499 ' H ' ' NE2' ' A' ' 9' ' ' GLN . 2.4 mp0 -74.8 -20.7 59.68 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.726 0.298 . . . . 0.0 111.625 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.24 91.39 3.77 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.506 0.67 . . . . 0.0 109.307 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -142.11 116.72 9.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.786 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.35 -53.22 0.22 Allowed Glycine 0 C--N 1.274 -2.908 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.0 tp -145.37 123.7 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.495 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 12.2 t70 -128.45 -17.43 4.18 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.8 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.4 m -98.4 7.28 46.4 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.4 t -146.17 124.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.517 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 26.3 mm -86.13 136.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.684 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 89.4 t -129.9 103.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.0 m -96.74 120.47 46.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.572 178.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.44 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 25.5 t70 -79.72 140.16 37.07 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.917 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.405 HD21 ' C ' ' A' ' 21' ' ' ASP 0.427 0.1 OUTLIER 44.27 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 127.209 2.203 . . . . 0.0 114.552 -177.295 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 26.8 m -100.94 167.68 10.4 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.893 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.443 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -42.47 126.9 4.18 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.77 2.98 . . . . 0.0 114.692 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.502 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -91.02 149.0 22.01 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.459 -1.701 . . . . 0.0 108.337 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.632 HG21 ' O ' ' A' ' 27' ' ' GLY . 6.5 p -101.59 147.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -169.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.632 ' O ' HG21 ' A' ' 26' ' ' VAL . . . -105.14 171.61 18.93 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 168.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.05 125.69 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 CA-C-N 121.101 2.45 . . . . 0.0 112.275 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 57.4 31.37 20.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.842 1.257 . . . . 0.0 113.792 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -109.73 1.02 19.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.22 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.14 -32.26 72.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -45.23 -49.34 12.43 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.029 1.332 . . . . 0.0 111.211 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -79.08 -31.85 44.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.531 -172.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' O ' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -72.06 -35.22 69.24 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.194 -176.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -78.31 -20.83 50.67 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.109 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.514 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 49.6 t-20 -78.08 -37.8 45.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.45 HG13 ' O ' ' A' ' 34' ' ' LEU . 8.8 p -66.41 -31.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.435 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.9 mm -61.7 -49.88 82.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -63.04 -19.92 64.84 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.328 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.514 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 66.4 mttm -88.13 -60.01 2.08 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -63.19 -43.74 98.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.011 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -78.37 -14.75 59.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 m -75.76 -3.05 32.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.117 0.484 . . . . 0.0 111.308 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -79.32 -20.95 46.64 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -88.28 -15.03 36.88 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.639 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.82 -154.17 25.66 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.778 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.65 120.67 27.34 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 122.26 0.224 . . . . 0.0 110.602 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.6 mm -73.85 91.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.4 m -78.15 -52.66 8.37 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.321 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.404 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 85.9 m-20 -136.05 139.47 43.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -144.71 128.72 17.52 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.55 0.691 . . . . 0.0 109.671 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.75 116.01 19.56 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.258 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -107.9 105.18 55.72 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.469 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 96.5 Cg_endo -85.74 174.31 6.7 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 122.323 2.015 . . . . 0.0 110.72 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.3 pt-20 -102.08 177.75 4.8 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -162.2 114.85 1.73 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.154 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 60.19 28.48 18.07 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.859 1.264 . . . . 0.0 112.768 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.87 1.96 72.6 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.896 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -96.55 165.88 11.95 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.454 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 3.4 t -53.64 -54.55 36.12 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 124.885 1.366 . . . . 0.0 111.677 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER 179.87 167.92 1.23 Allowed 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 124.915 1.286 . . . . 0.0 108.29 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.09 -6.32 2.52 Favored Glycine 0 C--N 1.297 -1.619 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -167.68 156.62 9.69 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -176.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.34 163.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -113.3 129.71 56.45 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 123.807 0.692 . . . . 0.0 110.264 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' HB2' ' CG1' ' A' ' 18' ' ' ILE . 2.3 mm? -118.98 126.5 51.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.404 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 38.0 tt0 -121.69 119.31 31.43 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.601 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 87.6 m-85 -99.98 177.85 4.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.609 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.57 -15.82 56.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.3 m -119.51 167.31 12.41 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -77.46 -55.57 0.05 OUTLIER 'Trans proline' 0 C--O 1.176 -2.623 0 CA-C-N 123.887 2.424 . . . . 0.0 108.568 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.31 7.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 131.287 3.835 . . . . 0.0 121.307 142.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.601 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 31.1 p80 -125.28 -36.71 2.47 Favored 'General case' 1 C--N 1.241 -4.125 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.681 -165.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.495 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . . . -81.42 -22.82 37.97 Favored 'General case' 0 N--CA 1.383 -3.793 0 C-N-CA 119.251 -0.979 . . . . 0.0 108.644 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.5 -23.14 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.52 -33.88 25.41 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.4 63.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.337 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -32.49 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -67.49 -44.3 78.84 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.406 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -91.77 -52.4 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.2 104.74 3.83 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.305 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.405 ' HB2' HG23 ' A' ' 94' ' ' VAL . 2.6 p30 -114.44 136.41 53.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.0 51.03 61.36 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -96.76 124.17 40.67 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.733 0.778 . . . . 0.0 111.768 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.89 118.57 34.75 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.623 -176.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.75 -52.92 5.23 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.4 ' HB2' ' ND1' ' A' ' 90' ' ' HIS . 16.1 m-20 -145.42 -168.62 3.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.172 -174.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -44.16 -69.81 0.12 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.925 1.29 . . . . 0.0 114.195 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.502 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -100.18 11.26 39.79 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.674 -176.538 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.4 ' ND1' ' HB2' ' A' ' 87' ' ' ASP . 14.8 m170 -102.45 86.97 2.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -135.29 94.09 3.07 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-O 120.708 0.29 . . . . 0.0 110.277 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.43 105.55 13.58 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.972 -168.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.44 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.1 mpt_? -83.45 141.96 31.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 82' ' ' ASP . 34.5 m -100.23 114.28 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.684 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -154.78 -165.58 2.09 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -104.29 -173.04 2.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.005 0.431 . . . . 0.0 112.046 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.405 ' CE2' HG21 ' A' ' 98' ' ' THR . 20.0 p90 -121.89 -22.98 5.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.429 0.633 . . . . 0.0 111.8 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.405 HG21 ' CE2' ' A' ' 97' ' ' PHE . 2.2 p -91.94 -161.51 0.83 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.121 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -91.46 -15.73 28.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.143 179.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -59.14 66.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -174.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.82 75.25 1.33 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -87.95 -28.12 21.69 Favored 'General case' 0 CA--C 1.484 -1.574 0 CA-C-N 113.858 -1.519 . . . . 0.0 114.161 -172.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -80.26 86.75 5.61 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 122.096 0.951 . . . . 0.0 112.505 -175.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.2 ttm -120.72 91.31 3.5 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 C--N 1.296 -1.73 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.602 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.689 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 3' ' ' VAL . 5.5 p-10 -56.66 151.35 14.06 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.397 1.079 . . . . 0.0 111.353 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 2' ' ' ASP 0.286 5.4 m 67.23 -33.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 127.54 2.336 . . . . 0.0 114.355 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.04 -50.38 7.08 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -96.05 20.53 10.01 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.262 0.625 . . . . 0.0 110.506 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -71.88 95.09 1.5 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.275 0.56 . . . . 0.0 109.688 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -148.03 152.86 40.95 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.163 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.37 144.82 81.53 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 121.814 1.676 . . . . 0.0 109.156 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.574 ' NE2' ' H ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -108.38 164.81 12.0 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.574 ' H ' ' NE2' ' A' ' 9' ' ' GLN . 29.7 mm-40 -74.61 20.12 0.13 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.798 0.839 . . . . 0.0 112.436 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.444 ' H ' ' C ' ' A' ' 9' ' ' GLN . . . -77.79 97.42 5.21 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.874 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -148.02 163.9 35.47 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.02 -81.28 1.75 Allowed Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 tp -115.3 88.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-O 123.018 1.389 . . . . 0.0 108.867 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -118.74 31.21 6.77 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.689 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 8.4 m -96.3 -11.88 25.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.229 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.5 t -122.15 132.5 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.554 -172.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 30.1 mm -87.3 145.13 7.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.48 121.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.483 ' CG2' HG12 ' A' ' 64' ' ' ILE . 27.4 m -118.41 157.76 19.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.236 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.76 133.42 55.93 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 42.57 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 28.7 m -91.21 167.04 16.76 Favored Pre-proline 0 N--CA 1.426 -1.637 0 CA-C-N 114.33 -1.305 . . . . 0.0 107.982 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.447 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 85.1 Cg_exo -42.44 138.94 3.14 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.985 3.124 . . . . 0.0 113.126 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.56 153.23 42.31 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.804 -173.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.7 t -119.26 132.91 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.476 -176.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.89 -131.91 3.12 Favored Glycine 0 C--N 1.274 -2.868 0 N-CA-C 106.672 -2.571 . . . . 0.0 106.672 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.36 125.23 10.56 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 CA-C-N 119.459 1.629 . . . . 0.0 111.447 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 55.9 18.04 2.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.131 1.772 . . . . 0.0 114.373 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.2 mmt180 -79.1 -25.87 43.0 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.076 -178.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.86 -33.89 64.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.38 -58.33 7.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.169 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -81.74 -15.68 53.55 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.599 ' O ' HG12 ' A' ' 38' ' ' ILE . 51.3 tp -63.3 -36.35 83.4 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -56.7 -36.9 70.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -84.09 -40.92 17.69 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.32 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.4 p -65.55 -31.88 55.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.356 -175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 34' ' ' LEU . 32.9 mm -67.33 -54.6 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -58.82 -36.09 73.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.39 -47.28 35.0 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.602 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.3 mm -70.15 -39.24 76.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.197 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.23 -7.79 59.63 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.1 p -67.38 -22.74 65.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.3 ptpt -61.74 -28.4 69.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.53 0.681 . . . . 0.0 111.755 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.533 ' CZ ' ' HB1' ' A' ' 81' ' ' ALA . 30.3 m-85 -85.46 -15.7 42.07 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.1 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.489 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.76 176.19 23.45 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -74.81 125.04 27.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -72.83 140.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 m -126.38 -61.22 1.22 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.467 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 55.0 m-80 -122.23 140.63 52.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.53 138.81 46.25 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.085 0.469 . . . . 0.0 110.446 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.408 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 89.2 m-85 -134.2 98.88 4.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -107.32 104.77 53.77 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -82.47 174.08 10.08 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.713 1.609 . . . . 0.0 109.823 177.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.62 ' HB3' ' NZ ' ' A' ' 61' ' ' LYS . 19.9 pt-20 -160.48 179.26 8.76 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.704 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 6.2 tp10 -121.12 108.79 14.23 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 59.4 27.2 16.26 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 121.932 0.872 . . . . 0.0 111.83 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.71 8.03 88.03 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.293 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.704 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 26.7 pttt -121.82 -176.8 3.41 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 122.108 -0.642 . . . . 0.0 109.617 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 83.4 m -28.79 108.0 0.04 OUTLIER 'General case' 0 C--O 1.244 0.801 0 C-N-CA 126.199 1.8 . . . . 0.0 115.386 -175.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.62 ' NZ ' ' HB3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -84.78 156.37 21.41 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.354 176.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.57 8.59 9.44 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.442 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -170.15 151.95 4.08 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.483 HG12 ' CG2' ' A' ' 20' ' ' VAL . 20.7 pt -142.06 166.29 16.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.3 m-85 -131.59 141.66 49.72 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.859 0.724 . . . . 0.0 109.048 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.626 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.3 mp -132.36 136.75 47.04 Favored 'General case' 0 C--O 1.198 -1.651 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.934 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.467 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 42.0 tt0 -122.05 136.97 54.97 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.15 0.5 . . . . 0.0 109.688 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.407 ' HE1' ' CG1' ' A' ' 18' ' ' ILE . 76.0 m-85 -104.83 177.53 4.82 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.367 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.33 -16.62 39.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.275 0.559 . . . . 0.0 111.369 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -135.35 144.97 51.87 Favored Pre-proline 0 C--N 1.294 -1.84 1 N-CA-C 99.34 -4.318 . . . . 0.0 99.34 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.6 Cg_exo -69.91 -54.12 0.23 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 CA-C-N 123.483 2.28 . . . . 0.0 109.57 -172.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.07 4.47 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 1 C-N-CA 132.374 4.27 . . . . 0.0 120.133 144.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.489 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 95.8 m-70 -128.43 -36.36 1.9 Allowed 'General case' 1 C--N 1.223 -4.923 0 CA-C-O 121.326 0.584 . . . . 0.0 109.624 -170.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.53 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -61.33 -32.1 71.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.517 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.76 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 123.315 0.384 . . . . 0.0 111.305 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.39 -32.49 37.56 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.242 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.27 -52.61 61.34 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.764 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.53 HG23 ' O ' ' A' ' 74' ' ' ALA . 31.2 m -63.13 -27.78 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -81.61 -21.81 38.08 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.9 0.88 . . . . 0.0 112.047 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -122.88 -23.96 4.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.533 ' HB1' ' CZ ' ' A' ' 45' ' ' PHE . . . -106.0 18.55 21.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.435 ' HB2' HG22 ' A' ' 94' ' ' VAL . 37.0 t70 -85.06 121.78 28.33 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 118.157 -1.417 . . . . 0.0 114.056 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.58 60.5 2.47 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.537 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.593 ' O ' ' HA ' ' A' ' 91' ' ' THR . 17.8 m-85 -103.27 105.51 15.81 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.33 102.69 7.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.204 177.32 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.7 mt -80.01 -41.46 25.79 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.91 -171.74 3.99 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -48.61 -58.32 4.89 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.594 1.558 . . . . 0.0 113.413 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -95.0 -4.55 46.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.203 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.53 101.42 10.76 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.765 -172.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.593 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 37.1 m -133.55 117.78 17.51 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.285 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -82.69 101.71 11.03 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.076 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.409 ' HD2' ' O ' ' A' ' 91' ' ' THR . 3.6 mpt_? -86.87 131.15 34.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 82' ' ' ASP . 25.6 m -117.75 149.11 20.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.942 -175.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.72 -171.12 3.3 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.431 ' HB2' ' H ' ' A' ' 97' ' ' PHE . 0.5 OUTLIER -72.07 -175.4 1.47 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 179.138 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.431 ' H ' ' HB2' ' A' ' 96' ' ' LEU . 48.9 t80 -108.14 58.45 0.61 Allowed 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -47.69 78.8 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 111.264 -2.698 . . . . 0.0 111.226 170.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -141.06 -45.7 0.39 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -101.21 20.6 15.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 122.188 0.994 . . . . 0.0 109.589 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -105.47 74.11 1.07 Allowed 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 105.898 -1.889 . . . . 0.0 105.898 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -105.17 169.63 8.33 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.331 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -140.41 -69.04 0.4 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.947 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 16.1 tpt -112.99 -27.16 8.17 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.401 -2.9 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.686 177.311 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 112.288 -0.325 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 14.0 t70 -74.66 152.8 39.13 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 m -80.68 -37.36 16.49 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.71 -54.05 2.54 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.459 ' N ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -79.16 -1.61 36.93 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -171.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.428 ' HB2' ' HB3' ' A' ' 2' ' ' ASP . 10.9 t70 -93.76 98.84 11.37 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -91.23 128.1 48.62 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.92 137.77 45.95 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.285 1.99 . . . . 0.0 111.172 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -135.79 121.83 20.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.938 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -123.96 -24.96 4.31 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.613 171.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.32 102.43 14.17 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -80.11 104.97 11.04 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.36 96.32 0.08 OUTLIER Glycine 0 C--N 1.281 -2.488 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -167.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.64 91.74 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 163.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.593 ' OD1' HG23 ' A' ' 75' ' ' VAL . 10.5 m-20 -93.13 44.76 1.15 Allowed 'General case' 0 CA--C 1.444 -3.115 0 CA-C-N 113.809 -1.542 . . . . 0.0 113.569 -169.005 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.527 ' HB2' ' OE2' ' A' ' 67' ' ' GLU 0.251 69.6 p -118.25 -20.49 8.55 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 115.493 -2.483 . . . . 0.0 113.916 166.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 25.9 t -127.14 133.04 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.996 -171.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.52 HD11 ' HD1' ' A' ' 73' ' ' HIS . 25.9 mm -104.12 143.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.79 114.1 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.53 130.61 73.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.435 ' HB3' ' CG ' ' A' ' 93' ' ' ARG . 10.7 t70 -111.86 149.35 31.94 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.512 0.2 OUTLIER 44.57 85.65 0.02 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 127.057 2.143 . . . . 0.0 115.87 -176.155 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.497 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 26.8 m -97.77 -171.75 0.26 Allowed Pre-proline 0 N--CA 1.418 -2.029 0 CA-C-N 112.732 -2.031 . . . . 0.0 107.064 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.717 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 44.6 Cg_exo -54.05 143.82 60.32 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 121.686 1.591 . . . . 0.0 114.181 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.44 HE22 ' HD2' ' A' ' 88' ' ' LYS . 0.0 OUTLIER -89.37 164.33 14.93 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.879 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.402 HG11 ' O ' ' A' ' 27' ' ' GLY . 48.8 t -123.22 134.26 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 CA-C-O 121.675 0.75 . . . . 0.0 109.391 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.402 ' O ' HG11 ' A' ' 26' ' ' VAL . . . -108.7 -127.96 5.65 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 105.722 -2.951 . . . . 0.0 105.722 173.454 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.74 124.39 4.53 Favored 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-N 120.22 2.01 . . . . 0.0 110.721 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 50.73 33.57 8.58 Favored 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.353 1.461 . . . . 0.0 113.014 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -95.76 -0.7 51.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.771 -1.206 . . . . 0.0 112.105 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -71.0 -28.86 64.73 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.87 -51.03 69.84 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.76 0.314 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.14 -27.13 68.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.556 ' O ' HG12 ' A' ' 38' ' ' ILE . 6.0 tt -65.71 -43.91 87.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.32 -37.83 81.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 111.6 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -81.0 -33.77 33.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.705 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.409 HG13 ' O ' ' A' ' 34' ' ' LEU . 6.2 p -70.17 -30.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.763 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.556 HG12 ' O ' ' A' ' 34' ' ' LEU . 35.5 mm -63.79 -64.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.845 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -62.49 -25.37 67.98 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -64.33 -57.71 8.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.333 0.653 . . . . 0.0 110.522 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.453 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 82.0 mt -70.38 -38.84 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.286 0.565 . . . . 0.0 111.042 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.476 ' HB3' ' HH ' ' A' ' 68' ' ' TYR . 53.9 m-85 -73.86 -7.31 51.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 58.0 m -69.35 -6.37 29.35 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.453 ' HG3' ' O ' ' A' ' 41' ' ' ILE . 81.0 mttt -71.92 -31.93 66.86 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.113 0.959 . . . . 0.0 108.807 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -85.46 10.83 11.8 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.892 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.408 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 117.43 -167.88 12.8 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -89.91 145.24 25.28 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 32.4 mm -73.23 110.44 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.4 m -75.48 -46.3 33.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.437 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 35.3 t-20 -152.76 152.69 31.94 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -144.48 136.75 26.37 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -126.64 113.0 16.14 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.06 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -107.67 106.59 58.82 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 63' ' ' TYR . 2.9 Cg_exo -68.66 174.73 8.08 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.525 1.483 . . . . 0.0 109.357 172.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -173.34 -175.3 1.14 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.946 0.403 . . . . 0.0 110.466 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -136.74 102.36 4.88 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 56.71 27.37 12.57 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.513 1.125 . . . . 0.0 112.715 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.92 0.06 85.96 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.361 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -100.03 -176.45 3.24 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 123.436 0.695 . . . . 0.0 110.04 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.9 m -34.03 124.13 0.47 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 126.5 1.92 . . . . 0.0 114.38 -177.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 166.65 11.02 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.12 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 -0.73 9.44 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.91 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.492 ' O ' ' HD2' ' A' ' 54' ' ' PRO . 4.4 p90 -169.69 161.23 9.23 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -143.86 172.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 123.527 0.517 . . . . 0.0 110.35 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 94.6 m-85 -136.24 138.73 42.13 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 109.744 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.0 mm? -118.39 131.91 56.28 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.527 ' OE2' ' HB2' ' A' ' 16' ' ' SER . 12.9 tp10 -116.72 117.51 29.99 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.535 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 80.5 m-85 -127.46 172.53 10.6 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.241 0.543 . . . . 0.0 110.312 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.23 14.26 14.79 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.574 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 51.0 m -68.27 163.35 53.14 Favored Pre-proline 0 CA--C 1.597 2.78 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -171.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.43 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.1 Cg_exo -38.25 8.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.348 2 C-N-CA 130.435 7.423 . . . . 0.0 122.955 178.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.521 ' HA ' ' CG ' ' A' ' 15' ' ' ASP . . . 87.37 63.34 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 124.465 2.079 . . . . 0.0 106.997 -158.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.574 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 32.2 p80 -85.69 -36.99 19.89 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 110.148 -3.205 . . . . 0.0 109.282 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . . . -63.36 -35.94 82.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.059 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.593 HG23 ' OD1' ' A' ' 15' ' ' ASP . 82.0 t -59.39 -59.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.459 170.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.68 -35.77 73.14 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.145 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.0 -30.89 70.26 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.494 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.81 -29.34 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.417 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 8.4 mmpt? -72.02 -42.82 65.92 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.308 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -114.21 -29.87 6.81 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.2 -3.13 27.86 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -170.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.3 117.34 18.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.874 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.86 31.33 12.62 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -101.5 135.27 43.28 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.495 -1.282 . . . . 0.0 109.488 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -107.68 129.29 55.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.192 -172.365 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.44 -68.04 0.77 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.245 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -160.02 159.32 31.92 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.44 ' HD2' HE22 ' A' ' 25' ' ' GLN . 40.2 ttmt 47.04 -88.7 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.048 1.739 . . . . 0.0 114.297 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -121.43 -2.13 9.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.263 -0.273 . . . . 0.0 111.035 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.717 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m170 -79.72 92.65 5.43 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.31 0.576 . . . . 0.0 110.594 -171.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 m -133.17 109.04 9.18 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -82.21 105.62 13.44 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.917 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.435 ' CG ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -94.03 121.45 35.53 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.96 115.1 47.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.008 -166.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.99 158.18 29.69 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -87.32 -172.12 3.79 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.27 0.557 . . . . 0.0 112.378 -177.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.418 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 31.8 t80 -84.47 5.19 28.38 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.184 0.516 . . . . 0.0 110.539 -173.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 p -69.21 76.13 0.35 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -86.99 -24.17 24.77 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 167.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -52.4 134.98 34.11 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.595 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.33 76.02 5.9 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 121.894 0.854 . . . . 0.0 108.975 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -48.26 -46.61 35.86 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.046 -1.888 . . . . 0.0 112.342 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -67.89 126.39 29.3 Favored 'General case' 0 C--N 1.256 -3.466 0 CA-C-N 112.961 -1.927 . . . . 0.0 109.334 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.57 105.81 3.78 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.419 -1.982 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.83 -175.09 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.76 150.48 46.85 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 120.695 0.283 . . . . 0.0 111.269 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.427 HG21 ' H ' ' A' ' 4' ' ' LEU . 16.5 m -33.92 -76.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -168.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.427 ' H ' HG21 ' A' ' 3' ' ' VAL . 84.8 mt -74.35 -26.96 60.45 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -169.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.33 6.71 47.87 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.714 0.769 . . . . 0.0 111.215 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.05 -35.92 6.47 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.564 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -74.81 146.03 82.37 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.203 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.01 127.89 24.76 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 121.784 1.656 . . . . 0.0 109.304 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.414 ' HG3' ' H ' ' A' ' 11' ' ' ALA . 19.6 tp60 -104.11 157.59 17.02 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 96' ' ' LEU . 30.4 mp0 -74.21 -22.85 59.2 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.347 0.594 . . . . 0.0 109.729 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.414 ' H ' ' HG3' ' A' ' 9' ' ' GLN . . . -96.67 74.73 2.75 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -151.17 110.02 3.87 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.82 -64.54 3.39 Favored Glycine 0 C--N 1.277 -2.742 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.452 HG12 ' HB3' ' A' ' 97' ' ' PHE . 8.2 tp -101.93 126.55 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.323 0.582 . . . . 0.0 109.714 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -141.84 28.17 1.78 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.325 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -114.39 -8.96 12.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.28 137.34 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 121.875 -0.516 . . . . 0.0 109.873 -175.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 8.9 mm -101.0 133.12 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.66 106.5 15.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 16.6 m -96.36 154.94 3.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.203 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.417 ' CG ' ' H ' ' A' ' 22' ' ' ASN . 9.8 t70 -93.22 -178.29 4.72 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.443 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.417 ' H ' ' CG ' ' A' ' 21' ' ' ASP 0.279 0.2 OUTLIER -29.5 106.92 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -166.624 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.443 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 36.0 m -86.01 167.32 24.54 Favored Pre-proline 0 N--CA 1.421 -1.908 0 CA-C-N 113.052 -1.886 . . . . 0.0 108.198 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 86.7 Cg_exo -42.36 127.15 4.14 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.641 2.894 . . . . 0.0 113.351 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.78 151.12 47.36 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.915 -177.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 60' ' ' THR . 52.6 t -125.91 139.77 50.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-O 122.028 0.918 . . . . 0.0 112.774 -173.698 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.45 -143.48 6.18 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.63 126.88 13.92 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 120.658 2.229 . . . . 0.0 111.416 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 63.32 17.69 10.44 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.127 1.371 . . . . 0.0 113.237 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -89.43 -15.86 32.21 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.079 -1.638 . . . . 0.0 111.305 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.94 -36.69 64.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 -177.679 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -64.95 -34.97 79.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.4 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -71.78 -40.53 69.19 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.54 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.8 tp -58.37 -44.0 88.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.818 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -54.51 -30.18 52.7 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.183 0.593 . . . . 0.0 112.512 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.433 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 55.6 t30 -84.49 -32.41 23.98 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.196 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.442 HG13 ' O ' ' A' ' 34' ' ' LEU . 8.6 p -78.07 -27.48 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.969 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.54 HG12 ' O ' ' A' ' 34' ' ' LEU . 39.3 mm -54.3 -51.79 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.642 0.734 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -68.21 -17.79 64.41 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.552 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.8 mmtp -85.28 -38.02 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.868 0.842 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mm -73.78 -53.89 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.74 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.607 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 61.7 m-85 -78.67 -16.93 56.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.9 p -65.73 -19.73 66.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.725 0.774 . . . . 0.0 110.829 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -73.22 -7.43 51.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.569 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.87 4.36 27.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.527 0.68 . . . . 0.0 110.279 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.89 -161.62 23.79 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.393 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -87.77 128.02 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.6 mm -75.35 89.73 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.935 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p -79.83 -52.37 7.99 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.496 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.41 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 17.7 m120 -126.33 138.86 53.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.0 0.429 . . . . 0.0 110.447 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -141.62 137.48 31.89 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.212 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -135.39 98.69 4.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.408 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -108.97 122.14 40.82 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.868 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.81 176.34 10.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.57 2.18 . . . . 0.0 109.972 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.8 164.46 25.97 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.625 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 35.9 tt0 -141.66 103.33 4.35 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.1 t70 58.08 27.46 14.96 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.401 1.096 . . . . 0.0 111.984 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.77 -1.75 87.57 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.021 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.625 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 20.5 pttp -107.41 -176.08 2.97 Favored 'General case' 0 C--O 1.259 1.576 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.536 ' HB ' ' CG2' ' A' ' 26' ' ' VAL . 4.8 t -78.41 167.39 21.39 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 122.229 1.014 . . . . 0.0 111.822 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.408 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -105.47 175.9 5.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.442 178.158 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.9 20.23 36.6 Favored Glycine 0 C--N 1.292 -1.874 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.115 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.446 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 7.0 p90 -170.74 151.73 3.55 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 122.293 0.237 . . . . 0.0 110.499 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.487 HG12 ' CG2' ' A' ' 20' ' ' VAL . 18.8 pt -146.03 163.33 10.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.437 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 70.8 m-85 -119.39 136.8 54.12 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.75 0.31 . . . . 0.0 110.673 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.427 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.7 mm? -123.08 124.58 43.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.41 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 7.1 tp10 -119.41 128.16 53.78 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.607 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 25.7 m-85 -127.06 -178.28 4.36 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.53 10.95 11.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.354 0.597 . . . . 0.0 109.541 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.2 p -81.67 163.43 54.0 Favored Pre-proline 0 CA--C 1.583 2.222 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -34.96 9.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.663 2 C-N-CA 130.556 7.504 . . . . 0.0 123.358 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.615 ' O ' HG13 ' A' ' 75' ' ' VAL . . . 86.18 65.59 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.731 0 CA-C-O 124.975 2.321 . . . . 0.0 108.557 -163.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.469 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 29.3 p-80 -79.49 -37.2 37.34 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 109.127 -3.67 . . . . 0.0 110.16 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.03 48.15 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.715 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 72' ' ' ALA . 3.0 p -65.5 -29.79 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.01 -45.95 13.45 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.83 71.06 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.728 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.407 ' CG1' ' HB2' ' A' ' 10' ' ' GLU . 47.2 t -65.1 -45.93 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-O 121.072 0.463 . . . . 0.0 111.748 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.39 -27.39 61.44 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -120.63 -45.47 2.41 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.481 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -88.27 -8.22 55.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -171.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -61.07 113.13 2.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.357 0.599 . . . . 0.0 112.366 176.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.01 47.89 3.75 Favored Glycine 0 N--CA 1.42 -2.426 0 CA-C-N 114.922 -1.035 . . . . 0.0 114.603 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.481 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 33.0 p90 -107.83 133.97 51.44 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.677 -1.209 . . . . 0.0 109.96 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.95 128.47 46.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.233 0.54 . . . . 0.0 112.342 -176.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.6 mt -84.79 -62.72 1.48 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.818 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -160.95 154.12 21.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.571 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 45.99 -107.19 0.14 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 14.3 pm0 -103.86 -10.23 18.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -178.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.669 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m80 -68.27 93.79 0.49 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.128 -171.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.4 m -132.73 118.87 19.61 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -90.37 105.41 17.79 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.499 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.59 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.8 mmm180 -83.15 143.03 30.78 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 58.5 t -106.47 107.01 21.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.344 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.407 ' HA ' ' HG2' ' A' ' 10' ' ' GLU . 2.6 t30 -100.84 162.44 12.9 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.417 ' HB3' ' HA ' ' A' ' 10' ' ' GLU . 1.0 OUTLIER -79.31 -166.06 0.88 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 124.27 1.028 . . . . 0.0 111.473 -176.151 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.452 ' HB3' HG12 ' A' ' 14' ' ' ILE . 73.3 t80 -139.06 -13.55 1.2 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.798 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 12.7 t -80.78 158.22 25.53 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.07 -44.08 93.49 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -173.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -108.24 132.29 53.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -85.57 68.28 10.37 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.082 1.42 . . . . 0.0 110.349 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.63 172.49 13.71 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.676 -1.602 . . . . 0.0 114.365 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -118.63 170.02 9.31 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.583 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -66.92 105.79 1.72 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.792 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.512 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.54 140.23 39.7 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.454 0.645 . . . . 0.0 110.131 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.3 19.01 2.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.022 0.915 . . . . 0.0 109.349 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.14 -40.52 82.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 5.57 50.37 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.294 -176.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.56 99.64 4.32 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -169.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -130.54 151.59 78.91 Favored Pre-proline 0 C--N 1.285 -2.238 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.29 153.29 61.68 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 121.38 1.386 . . . . 0.0 111.522 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -84.8 125.29 32.45 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -74.9 -6.07 47.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.58 95.39 1.82 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.59 136.63 57.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.67 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.51 81.79 0.83 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.408 ' HA ' ' HE3' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -65.74 133.73 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.438 ' OD1' ' HE2' ' A' ' 102' ' ' LYS . 8.6 p-10 -112.13 -5.54 14.23 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -169.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.7 p -114.96 -14.36 11.87 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.438 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 60.2 t -139.16 137.17 41.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.963 -0.461 . . . . 0.0 110.762 -172.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 mm -97.25 135.14 32.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 54.4 t -116.1 105.92 19.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.7 m -107.82 122.89 62.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.156 -176.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.436 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 21.7 t70 -92.73 138.03 31.84 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.613 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.47 0.1 OUTLIER 45.94 86.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 128.513 2.725 . . . . 0.0 115.66 -175.452 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 35.5 m -89.27 165.78 24.59 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.753 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.3 Cg_endo -45.92 150.19 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.474 2.783 . . . . 0.0 114.125 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -89.46 161.89 16.02 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.561 -173.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.496 HG13 ' O ' ' A' ' 27' ' ' GLY . 60.9 t -129.15 138.89 53.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.517 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.496 ' O ' HG13 ' A' ' 26' ' ' VAL . . . -102.34 -177.27 27.51 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.49 124.89 16.18 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 120.15 1.975 . . . . 0.0 112.067 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 53.76 23.44 3.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.187 1.795 . . . . 0.0 114.167 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 13.8 mtm180 -90.1 -2.61 58.12 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.183 177.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -63.17 -36.37 83.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 110.075 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -61.39 -47.42 85.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.542 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -74.83 -24.81 58.67 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.013 0.435 . . . . 0.0 110.135 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.617 ' O ' HG12 ' A' ' 38' ' ' ILE . 3.0 tm? -61.97 -49.39 76.29 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -55.51 -31.95 62.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.419 0.628 . . . . 0.0 111.123 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.45 -41.8 38.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.232 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.35 -30.71 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.617 HG12 ' O ' ' A' ' 34' ' ' LEU . 22.2 mm -62.59 -53.39 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -55.43 -36.74 66.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.955 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 tptt -69.13 -53.12 21.85 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.462 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 34.9 mm -56.16 -50.24 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.689 0.757 . . . . 0.0 110.484 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.524 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.4 m-85 -77.04 -0.67 25.48 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.6 m -69.96 -12.51 61.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.275 0.559 . . . . 0.0 110.204 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 29.5 mmmt -72.13 -16.5 62.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.057 0.456 . . . . 0.0 109.998 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.4 6.98 40.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.699 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.58 -156.4 19.96 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.18 128.48 42.05 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.441 HD13 HD12 ' A' ' 66' ' ' LEU . 32.0 mm -74.11 115.14 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 m -86.96 -41.92 13.55 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 68.6 m-20 -154.77 160.92 41.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.903 0.881 . . . . 0.0 109.695 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 41.5 t0 -150.95 151.86 32.75 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -139.17 102.25 4.46 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.49 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -107.12 123.5 38.14 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.926 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.443 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 72.7 Cg_endo -82.21 177.57 7.08 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.061 2.507 . . . . 0.0 108.25 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.71 177.23 11.62 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 120.732 -1.23 . . . . 0.0 109.879 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -135.25 102.48 5.19 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.7 t70 54.75 26.09 7.23 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-O 122.561 1.172 . . . . 0.0 111.487 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.33 5.65 59.12 Favored Glycine 0 C--O 1.222 -0.602 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.248 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.61 -177.62 3.54 Favored 'General case' 0 C--O 1.258 1.542 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.3 m -68.23 142.65 55.57 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.872 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.49 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -112.37 173.49 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.399 174.642 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.28 27.27 9.1 Favored Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.949 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -169.07 147.84 3.94 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 pt -146.03 176.18 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.347 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.546 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 92.6 m-85 -140.18 114.73 9.36 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.019 0.827 . . . . 0.0 111.481 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.441 HD12 HD13 ' A' ' 48' ' ' ILE . 3.9 mm? -93.66 116.81 29.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.808 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.704 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 3.5 m-85 -127.54 171.14 11.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.49 12.66 22.87 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.456 ' HB3' ' ND1' ' A' ' 73' ' ' HIS . 48.0 t -73.26 155.89 89.59 Favored Pre-proline 0 CA--C 1.59 2.495 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.177 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.408 ' HD2' ' OG ' ' A' ' 70' ' ' SER . 1.7 Cg_endo -36.4 8.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.529 3.593 1 C-N-CA 130.72 7.613 . . . . 0.0 122.27 -178.583 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 86.45 62.59 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 124.981 2.324 . . . . 0.0 107.97 -164.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.704 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 24.1 p-80 -77.65 -36.4 51.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 109.184 -3.644 . . . . 0.0 109.999 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.48 69.21 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.982 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.12 -26.72 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.31 -46.91 12.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.2 79.9 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.448 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.47 -33.33 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.968 0.413 . . . . 0.0 112.046 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -85.42 -29.08 24.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.641 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -109.9 -39.11 5.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.41 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -93.35 0.97 57.1 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.15 103.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.433 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.54 47.69 3.42 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.694 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.41 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 24.3 p90 -103.78 127.29 51.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.523 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -98.01 130.24 44.85 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.652 -173.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -85.96 -71.82 0.52 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -171.86 172.36 4.84 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 52.58 -95.93 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.099 1.76 . . . . 0.0 114.693 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -121.58 -1.12 9.6 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.089 0.471 . . . . 0.0 109.917 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.753 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 10.8 m170 -87.1 99.03 11.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.219 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.6 m -133.34 110.0 9.75 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -81.84 108.7 15.58 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.372 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -90.52 130.24 36.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.7 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.46 105.88 19.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.693 0.758 . . . . 0.0 110.585 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -108.15 166.48 10.71 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.943 -179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -75.25 -174.26 2.3 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.303 0.573 . . . . 0.0 111.162 -177.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.511 ' C ' ' H ' ' A' ' 99' ' ' ASP . 33.7 t80 -91.18 -16.35 27.84 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.0 m 66.53 -21.39 0.1 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.358 1.463 . . . . 0.0 113.659 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 97' ' ' PHE . 30.4 t70 -88.94 -34.49 16.88 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.261 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . 0.343 20.1 p90 37.31 89.75 0.01 OUTLIER 'General case' 0 C--N 1.348 0.502 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -86.34 71.09 10.53 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.434 1.111 . . . . 0.0 110.219 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . 0.438 ' HE2' ' OD1' ' A' ' 15' ' ' ASP . 1.6 mptm? -106.52 163.01 13.22 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.799 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -107.0 167.16 10.08 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -46.85 -45.76 20.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.044 0.938 . . . . 0.0 111.501 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.425 -1.714 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.002 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.144 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.16 144.98 26.6 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 121.192 0.52 . . . . 0.0 111.574 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.12 26.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.517 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.0 mt -84.29 -42.37 15.9 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.491 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -72.94 -48.47 36.57 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 120.838 0.351 . . . . 0.0 111.231 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -106.97 107.41 18.41 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . 0.401 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.9 mtp180 -100.01 141.24 22.39 Favored Pre-proline 0 C--N 1.277 -2.579 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 -174.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 12.7 Cg_exo -70.59 128.98 15.99 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.872 1.714 . . . . 0.0 110.668 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -142.57 163.85 31.7 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' O ' HD23 ' A' ' 96' ' ' LEU . 4.4 mm-40 -78.01 15.77 0.84 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 124.292 1.037 . . . . 0.0 111.337 -174.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.74 79.99 7.29 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.071 0.463 . . . . 0.0 111.999 -174.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -167.47 158.31 11.39 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.27 -115.85 4.8 Favored Glycine 0 C--N 1.309 -0.917 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.387 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 tp -83.79 97.1 4.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 122.649 1.214 . . . . 0.0 112.032 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -78.41 -7.95 57.94 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.365 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.577 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 12.5 m -100.01 13.36 34.24 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -170.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.4 p -137.08 138.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.911 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.517 HD13 ' HD1' ' A' ' 73' ' ' HIS . 11.3 mm -111.62 137.91 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.413 ' HB ' HD21 ' A' ' 95' ' ' ASN . 60.4 t -125.59 113.87 36.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 173.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.49 ' CG2' HG12 ' A' ' 64' ' ' ILE . 14.3 m -110.14 137.67 41.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.306 0.574 . . . . 0.0 110.768 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.412 ' C ' HD21 ' A' ' 22' ' ' ASN . 20.7 t70 -97.74 139.73 33.19 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.757 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.412 HD21 ' C ' ' A' ' 21' ' ' ASP 0.423 0.1 OUTLIER 46.06 86.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.82 2.448 . . . . 0.0 115.536 -179.837 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.4 m -84.83 163.61 45.6 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.151 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.787 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.7 Cg_endo -42.73 145.43 1.07 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 124.509 3.473 . . . . 0.0 117.556 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.53 151.72 36.81 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 111.648 -2.523 . . . . 0.0 111.085 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 27' ' ' GLY . 8.1 p -132.01 146.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.326 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.566 ' O ' HG23 ' A' ' 26' ' ' VAL . . . -95.37 171.48 29.48 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 169.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.37 125.62 18.49 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 CA-C-N 120.465 2.133 . . . . 0.0 112.286 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.02 22.49 12.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.599 1.16 . . . . 0.0 111.786 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -92.88 -2.5 55.81 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.697 -1.252 . . . . 0.0 111.102 175.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.52 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -62.1 -23.57 66.6 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.744 0.307 . . . . 0.0 110.703 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.48 -47.24 76.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.468 0.707 . . . . 0.0 109.194 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -69.7 -38.21 76.88 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.893 0.854 . . . . 0.0 109.502 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -72.09 -6.01 39.41 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.507 -178.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.52 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 61.9 mttp -85.33 -31.41 23.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.162 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.576 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 22.6 t-20 -73.61 -44.61 56.68 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.158 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.46 -33.05 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.566 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.94 -62.54 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.185 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.576 ' CE1' ' HA ' ' A' ' 36' ' ' ASN . 4.9 p-80 -65.3 -20.13 66.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -70.55 -60.13 2.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.517 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 81.9 mt -67.67 -44.12 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.02 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -68.72 -9.68 51.95 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.427 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -67.75 -2.28 6.79 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 19.0 ptmt -70.56 -35.22 72.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.111 0.482 . . . . 0.0 110.584 171.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.437 ' CD2' ' HG3' ' A' ' 44' ' ' LYS . 97.3 m-85 -80.08 -14.97 58.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.326 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 145.52 -161.3 28.2 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -91.5 138.74 31.33 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.04 89.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.99 -38.98 52.06 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.477 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 3.3 t-20 -148.64 139.85 23.23 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -144.27 153.91 42.52 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 73.5 m-85 -132.13 103.26 6.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -108.54 106.74 59.27 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.69 173.17 13.8 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 121.156 1.238 . . . . 0.0 111.902 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -154.99 165.65 36.05 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.631 0.772 . . . . 0.0 109.481 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.59 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -149.4 101.44 3.11 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 173.551 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.78 27.36 1.54 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.283 1.833 . . . . 0.0 114.032 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.57 9.45 56.52 Favored Glycine 0 C--N 1.309 -0.941 0 O-C-N 121.395 -0.815 . . . . 0.0 112.366 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.59 ' HE3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -103.54 170.9 7.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.422 ' HB ' ' CG1' ' A' ' 26' ' ' VAL . 5.8 t -92.75 128.73 38.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 122.881 1.325 . . . . 0.0 113.37 -172.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.6 pttp -53.55 161.02 1.12 Allowed 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.748 166.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.69 18.23 13.13 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.002 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -169.96 155.34 5.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.49 HG12 ' CG2' ' A' ' 20' ' ' VAL . 22.4 pt -146.65 168.36 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.414 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 49.4 m-85 -131.84 133.04 44.23 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.522 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 2.1 mm? -114.13 132.81 55.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 1.6 tm-20 -126.41 115.7 20.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.575 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 81.5 m-85 -123.29 175.91 6.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.626 0.727 . . . . 0.0 111.185 -174.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.12 13.98 12.17 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.54 1.136 . . . . 0.0 108.425 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.579 ' OG ' ' HD2' ' A' ' 71' ' ' PRO . 23.1 t -75.61 161.17 77.34 Favored Pre-proline 0 CA--C 1.596 2.732 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.297 -172.001 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.579 ' HD2' ' OG ' ' A' ' 70' ' ' SER . 1.2 Cg_exo -36.1 8.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.967 1 C-N-CA 129.921 7.081 . . . . 0.0 121.931 177.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.496 ' HB1' ' CG2' ' A' ' 75' ' ' VAL . . . 85.93 62.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.987 2.327 . . . . 0.0 108.08 -164.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.577 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 17.5 p80 -73.43 -30.06 62.97 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 109.646 -3.434 . . . . 0.0 109.561 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.07 64.08 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.287 1.042 . . . . 0.0 108.582 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.522 ' O ' HG12 ' A' ' 78' ' ' VAL . 57.4 t -75.25 -30.22 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.254 176.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.65 -41.78 62.25 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.48 75.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.826 0.45 . . . . 0.0 111.218 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.522 HG12 ' O ' ' A' ' 75' ' ' VAL . 1.1 p -67.55 -26.73 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.381 0.61 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -33.82 67.01 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.206 1.003 . . . . 0.0 110.656 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.06 -76.55 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.658 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . 177.32 106.54 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 123.954 0.784 . . . . 0.0 110.489 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.501 ' HA ' HG21 ' A' ' 94' ' ' VAL . 1.6 t70 -65.52 108.81 2.13 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 170.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.78 52.53 1.51 Allowed Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -97.72 133.13 42.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.199 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -101.84 129.57 48.09 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.987 -172.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.21 -63.37 1.33 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.865 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -161.07 157.22 25.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.029 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 42.15 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.262 1.825 . . . . 0.0 114.187 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -119.5 8.78 11.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.524 0.602 . . . . 0.0 111.825 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.787 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 22.4 m170 -85.02 93.72 8.66 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -132.84 103.64 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.508 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.22 112.32 19.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.5 mpt_? -81.23 142.8 32.82 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 82' ' ' ASP . 14.6 m -120.1 128.94 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.878 -173.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.413 HD21 ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -151.61 167.8 26.97 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 170.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.418 HD23 ' O ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -108.64 -163.1 0.85 Allowed 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 123.27 0.628 . . . . 0.0 111.216 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -91.75 6.31 46.46 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.336 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.603 ' HA ' ' CE1' ' A' ' 100' ' ' PHE . 83.5 m -78.64 67.46 4.39 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.94 1.353 . . . . 0.0 110.162 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -101.43 -9.96 20.63 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.566 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.603 ' CE1' ' HA ' ' A' ' 98' ' ' THR 0.264 8.7 p90 -59.49 151.34 24.38 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 177.326 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -49.72 -54.46 18.7 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.511 1.524 . . . . 0.0 114.889 -170.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -102.86 147.2 27.19 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.318 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -168.84 163.03 11.67 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 125.108 1.363 . . . . 0.0 107.513 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.0 tpt -72.22 121.91 20.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.382 0.61 . . . . 0.0 110.216 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.413 -2.29 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.506 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.585 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.51 150.4 26.01 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.7 m -93.14 2.14 9.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -175.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 mp -96.53 -61.53 1.41 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.997 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -103.46 -34.38 8.73 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.205 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.6 t70 57.7 65.79 1.26 Allowed 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 124.532 1.145 . . . . 0.0 108.998 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -146.75 159.27 44.31 Favored Pre-proline 0 C--N 1.304 -1.392 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.681 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.45 169.55 12.42 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.193 1.929 . . . . 0.0 107.73 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -58.16 120.93 9.51 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.809 0.814 . . . . 0.0 109.584 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -74.16 -16.72 60.98 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 126.125 1.77 . . . . 0.0 113.943 -169.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.86 135.03 46.44 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -151.81 114.74 4.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.551 0.691 . . . . 0.0 110.22 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.22 -71.82 2.91 Favored Glycine 0 C--N 1.286 -2.209 0 CA-C-N 115.034 -0.985 . . . . 0.0 113.334 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 tp -126.08 124.51 66.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.331 0.586 . . . . 0.0 111.377 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.591 ' OD1' ' HB2' ' A' ' 96' ' ' LEU . 35.6 t70 -151.22 62.37 0.9 Allowed 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.88 1.324 . . . . 0.0 108.104 172.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.511 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 42.8 m -116.37 14.36 15.69 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.694 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.527 ' HB ' ' CD1' ' A' ' 97' ' ' PHE . 61.5 t -138.04 131.83 42.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.77 -0.581 . . . . 0.0 110.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 9.7 mm -88.93 135.32 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.97 121.46 62.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.858 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.4 HG13 ' HB3' ' A' ' 92' ' ' PHE . 90.9 t -121.1 133.51 67.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.319 0.387 . . . . 0.0 111.816 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.9 t70 -101.1 137.51 39.36 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 109.52 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.424 0.2 OUTLIER 45.88 104.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 127.106 2.162 . . . . 0.0 116.397 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.513 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 17.1 m -109.61 172.17 3.84 Favored Pre-proline 0 C--N 1.289 -2.063 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.437 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.608 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 80.9 Cg_exo -42.4 133.14 4.97 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.292 2.661 . . . . 0.0 112.043 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.499 ' NE2' ' H ' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -74.39 155.63 37.9 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.331 -177.449 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.4 HG11 ' HB2' ' A' ' 31' ' ' LEU . 2.3 t -123.05 165.68 18.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.778 -167.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.26 -169.62 30.11 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.53 124.69 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.867 2.333 . . . . 0.0 111.99 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 58.62 17.87 5.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.3 1.84 . . . . 0.0 113.326 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -79.55 -26.98 41.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.022 -1.049 . . . . 0.0 109.814 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.58 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.5 tm? -69.65 -27.48 65.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.427 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.29 -40.55 94.57 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.928 0.394 . . . . 0.0 111.053 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.81 -13.84 30.78 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.244 0.545 . . . . 0.0 111.569 179.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.592 ' O ' HG12 ' A' ' 38' ' ' ILE . 7.2 tt -68.12 -37.61 81.3 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.58 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 91.5 mttt -57.8 -25.62 60.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.528 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 27.9 t-20 -81.71 -44.68 16.75 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.153 -171.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.7 p -67.68 -32.52 57.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.793 -177.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.7 mm -67.63 -52.53 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.465 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -56.31 -38.46 71.32 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.583 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.528 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.0 mmmt -67.08 -48.02 69.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.3 mm -66.78 -43.98 89.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.512 0.672 . . . . 0.0 110.573 -179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.49 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.2 m-85 -83.87 -9.86 58.43 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -171.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -72.4 -3.04 21.73 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.485 -0.759 . . . . 0.0 111.339 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.12 -21.72 42.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.174 0.511 . . . . 0.0 110.007 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -97.33 1.62 49.66 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.656 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.31 -151.79 22.04 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.88 128.01 52.92 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.469 HD11 ' CB ' ' A' ' 42' ' ' PHE . 47.3 mm -73.08 104.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -79.82 -41.33 26.62 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.177 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -156.14 161.14 40.38 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -142.66 144.69 32.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 117.977 0.353 . . . . 0.0 110.321 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.23 100.44 5.39 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.448 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -107.82 103.48 49.7 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.72 170.49 15.55 Favored 'Trans proline' 0 C--O 1.208 -0.979 0 C-N-CA 121.659 1.572 . . . . 0.0 109.95 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.464 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 14.6 pt-20 -173.8 -175.87 1.14 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.695 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 5.9 mm-40 -144.21 135.42 25.49 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 50.73 26.69 2.65 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.638 1.175 . . . . 0.0 113.734 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.76 27.54 70.18 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.566 -0.349 . . . . 0.0 112.805 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.695 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 62.7 pttt -117.35 -176.57 3.03 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 48.2 m -43.8 119.29 1.66 Allowed 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 49.1 mttm -74.0 169.37 17.62 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.07 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.29 -8.62 6.4 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.94 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -169.54 159.66 8.56 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 pt -147.21 172.05 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.767 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.478 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.9 m-85 -136.26 137.09 40.4 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.665 0.603 . . . . 0.0 109.975 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.454 HD12 HD13 ' A' ' 48' ' ' ILE . 3.6 mm? -111.94 116.48 30.68 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -99.44 124.03 44.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.648 0.737 . . . . 0.0 110.668 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.49 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 6.2 m-85 -123.13 -176.42 3.42 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.74 7.65 11.06 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.867 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.65 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.6 m -79.66 154.57 76.06 Favored Pre-proline 0 CA--C 1.591 2.548 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -165.461 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -39.16 6.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.96 2 C-N-CA 130.76 7.64 . . . . 0.0 123.16 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.48 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.23 65.25 0.01 OUTLIER 'General case' 0 C--N 1.367 1.329 0 CA-C-N 122.238 2.29 . . . . 0.0 108.86 -158.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.65 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 29.6 p80 -95.63 -24.67 16.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 109.36 -3.564 . . . . 0.0 107.738 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -81.11 -33.86 32.99 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 2.7 p -66.42 -26.88 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.611 175.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -69.5 -38.06 77.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.76 94.0 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.291 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 74' ' ' ALA . 92.8 t -57.84 -46.76 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -84.89 -15.58 44.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -109.89 -68.38 0.93 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 75.41 0.94 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.559 0.695 . . . . 0.0 111.759 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.458 ' HB2' HG23 ' A' ' 94' ' ' VAL . 6.0 t70 -111.42 134.91 52.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.731 175.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.48 77.45 Favored Glycine 0 C--N 1.308 -0.993 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 91' ' ' THR . 31.0 p90 -92.33 130.97 37.88 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.097 0.475 . . . . 0.0 110.299 -178.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.457 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.6 126.61 44.24 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.518 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.7 mt -87.29 -61.6 1.69 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -174.21 149.0 1.36 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.381 -174.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 58.92 -81.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.456 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 41.2 tt0 -122.27 -9.52 8.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.298 1.039 . . . . 0.0 110.148 -172.714 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.608 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 11.4 m170 -92.97 88.63 6.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.915 -167.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.405 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 6.4 m -132.95 98.19 4.22 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.046 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' HB3' HG13 ' A' ' 20' ' ' VAL . 53.2 m-85 -83.35 113.91 21.06 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.472 -169.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 2.9 mpt_? -89.05 136.85 32.79 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.458 HG23 ' HB2' ' A' ' 82' ' ' ASP . 4.8 m -113.82 151.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-O 121.619 0.723 . . . . 0.0 110.808 -172.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.9 152.73 43.85 Favored 'General case' 0 N--CA 1.401 -2.921 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.591 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 1.1 pt? -84.78 -172.11 4.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.942 0.776 . . . . 0.0 111.581 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . 0.527 ' CD1' ' HB ' ' A' ' 17' ' ' VAL . 6.2 t80 -108.97 2.64 21.48 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 117.14 -1.824 . . . . 0.0 112.287 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.0 m -78.39 82.48 4.67 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -77.61 -26.84 50.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.673 -176.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -84.66 110.21 18.58 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -101.71 79.61 1.95 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 122.057 0.932 . . . . 0.0 109.801 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 152.8 35.09 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.46 174.16 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -105.96 125.14 50.64 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.2 ttt -106.91 99.2 8.78 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.105 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.835 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.788 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 6' ' ' ASP . 3.4 m-20 -85.5 150.29 24.79 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.757 0.313 . . . . 0.0 110.338 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.3 m -106.02 -25.43 3.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.263 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.98 -45.56 4.71 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.396 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -71.32 -37.61 71.76 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.073 0.463 . . . . 0.0 111.632 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.445 ' HB3' ' O ' ' A' ' 2' ' ' ASP . 26.8 t70 -85.33 105.62 16.12 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -142.25 138.73 16.91 Favored Pre-proline 0 C--N 1.278 -2.513 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.338 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.75 128.15 10.7 Favored 'Trans proline' 0 N--CA 1.436 -1.873 0 N-CA-C 104.69 -2.85 . . . . 0.0 104.69 162.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -102.45 157.04 17.2 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 117.419 -1.712 . . . . 0.0 111.959 -172.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.87 19.6 0.14 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.102 1.361 . . . . 0.0 113.291 -172.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.54 93.99 3.65 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -118.93 119.68 35.04 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.775 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.25 -49.82 4.27 Favored Glycine 0 C--N 1.294 -1.786 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.931 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 8.1 tp -127.84 124.87 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.103 0.477 . . . . 0.0 111.295 -176.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.664 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 5.6 t70 -108.03 -17.19 14.11 Favored 'General case' 0 C--O 1.18 -2.585 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.437 175.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.551 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 16.3 m -85.1 -1.49 56.93 Favored 'General case' 0 C--N 1.273 -2.751 0 O-C-N 120.585 -1.322 . . . . 0.0 113.72 -172.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 60.7 t -117.67 128.48 74.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.442 -175.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 18.6 mm -94.85 136.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.01 119.34 23.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.478 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 15.5 m -125.09 133.33 69.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.87 135.5 39.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.33 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.483 0.2 OUTLIER 48.34 85.64 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.675 2.39 . . . . 0.0 116.983 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.425 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 16.8 m -81.93 169.76 17.43 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.467 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 2.0 Cg_endo -44.35 138.05 7.55 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 123.286 2.657 . . . . 0.0 112.312 173.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.559 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 3.8 pm0 -69.35 154.92 41.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.23 147.64 28.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.032 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.94 175.34 16.28 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.73 126.88 23.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.023 1.815 . . . . 0.0 111.928 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 68.17 17.41 9.39 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.002 1.321 . . . . 0.0 113.574 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -104.07 -6.18 21.37 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.163 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.461 HD21 ' HE2' ' A' ' 61' ' ' LYS . 1.2 tm? -66.87 -31.5 72.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.122 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.31 -40.03 92.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.44 -13.46 52.03 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.2 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.515 ' O ' HG11 ' A' ' 37' ' ' VAL . 8.6 tt -72.86 -28.35 62.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.21 -22.06 66.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 t-20 -79.78 -43.67 22.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.257 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.515 HG11 ' O ' ' A' ' 34' ' ' LEU . 9.0 p -63.9 -24.6 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.369 -174.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mm -55.61 -59.82 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.044 0.938 . . . . 0.0 110.408 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -73.08 -17.0 61.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 30.5 mmmt -71.39 -52.25 19.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.03 -52.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.127 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.554 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 22.7 m-85 -73.49 -6.43 46.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 p -71.82 -18.3 62.09 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.84 0.829 . . . . 0.0 110.455 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.499 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -84.8 -3.84 58.81 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.21 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -120.23 18.55 12.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -178.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.14 -174.89 21.93 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -101.6 138.59 38.39 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.9 mm -75.68 88.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.3 m -82.06 -55.37 4.61 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.879 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.495 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 19.7 m120 -137.08 145.73 44.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -137.26 135.75 37.46 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -128.19 110.7 12.67 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.414 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -106.05 106.29 56.44 Favored Pre-proline 0 N--CA 1.425 -1.685 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.59 173.67 12.0 Favored 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 122.182 1.922 . . . . 0.0 109.885 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.45 170.01 18.97 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -120.67 99.76 6.72 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.6 t70 39.66 56.21 2.35 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.028 1.331 . . . . 0.0 111.553 -177.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.3 -3.12 41.59 Favored Glycine 0 N--CA 1.466 0.68 0 CA-C-N 113.466 -1.697 . . . . 0.0 115.197 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -100.0 -177.46 3.55 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 122.337 -0.508 . . . . 0.0 111.056 -176.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.1 m -45.66 129.19 8.89 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.027 1.731 . . . . 0.0 111.611 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.461 ' HE2' HD21 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -88.72 160.27 17.4 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.431 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.01 21.31 3.72 Favored Glycine 0 CA--C 1.489 -1.574 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.066 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.478 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 31.7 p90 -170.81 148.21 2.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.473 HG12 ' CG2' ' A' ' 20' ' ' VAL . 21.5 pt -141.41 166.16 18.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.477 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 76.8 m-85 -136.41 134.34 37.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.496 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.4 mp -120.6 145.32 47.49 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 9.3 tp10 -124.28 116.12 22.13 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.554 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 12.4 m-30 -118.31 171.6 8.02 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.78 14.26 13.37 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.619 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.3 m -75.74 160.15 79.64 Favored Pre-proline 0 CA--C 1.608 3.187 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -170.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -39.99 7.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.054 2 C-N-CA 129.972 7.115 . . . . 0.0 123.997 -179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.664 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.36 66.77 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 CA-C-N 122.46 2.391 . . . . 0.0 106.579 -155.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.619 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 26.6 p80 -97.02 -36.95 10.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.566 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -80.88 -20.84 41.37 Favored 'General case' 0 CA--C 1.474 -1.955 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.251 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 p -59.45 -30.07 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -83.53 -49.29 9.38 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.49 -42.58 74.62 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.395 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 42.7 t -66.88 -22.85 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 123.181 0.592 . . . . 0.0 111.556 -177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -85.72 -47.52 9.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.153 0.978 . . . . 0.0 109.805 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.52 -11.69 50.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 -167.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.42 13.25 13.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.188 0.518 . . . . 0.0 110.278 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -78.93 106.37 10.91 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.46 51.68 6.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 114.518 -1.219 . . . . 0.0 115.405 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.597 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.2 m-85 -101.5 106.18 17.25 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 2.8 mptt -77.41 99.64 5.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 173.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.57 -52.45 65.52 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.001 0.429 . . . . 0.0 110.544 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.519 ' OD2' ' HG2' ' A' ' 88' ' ' LYS . 27.4 t70 -151.54 -76.13 0.14 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.877 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.519 ' HG2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -100.86 -101.21 0.25 Allowed 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.376 0.607 . . . . 0.0 112.596 178.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.559 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -92.55 3.33 55.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 111.701 -175.911 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -86.99 96.54 10.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 39.5 m -133.41 123.98 26.31 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.88 101.85 13.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.476 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -93.92 126.42 39.11 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.3 150.62 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.31 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -155.81 175.05 14.44 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.99 177.28 1.77 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 84.8 t80 -131.56 -27.69 1.91 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 112.961 -1.927 . . . . 0.0 109.43 177.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -25.37 60.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.75 0.786 . . . . 0.0 112.25 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -109.73 -19.53 13.13 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.17 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -113.22 153.45 28.33 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -173.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.2 t70 166.69 125.47 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 129.474 3.11 . . . . 0.0 103.002 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.16 145.23 3.29 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.752 0.787 . . . . 0.0 113.097 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . 0.43 ' CE2' ' HB ' ' A' ' 105' ' ' THR . 41.4 t80 -90.57 97.87 11.44 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.986 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.6 tmm? -109.62 97.67 7.18 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.43 ' HB ' ' CE2' ' A' ' 103' ' ' TYR . 38.2 m . . . . . 0 C--N 1.294 -1.845 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.831 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -92.38 146.29 23.81 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -111.23 96.03 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.883 0.849 . . . . 0.0 111.995 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 59.5 tp -84.19 -42.99 15.39 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.033 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.06 16.07 22.09 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.404 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.6 t70 72.32 -49.18 0.69 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.236 1.414 . . . . 0.0 112.09 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -69.47 124.71 91.07 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.32 128.38 25.32 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.343 2.695 . . . . 0.0 112.809 -177.237 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -76.44 131.89 39.33 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.813 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -123.46 -21.58 5.26 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.189 168.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 98.41 0.24 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.325 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -90.72 126.93 36.14 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.22 146.99 18.42 Favored Glycine 0 C--N 1.29 -1.975 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.917 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.4 tp -84.04 87.08 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 123.096 1.427 . . . . 0.0 109.429 175.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -103.75 40.49 1.42 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.739 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.548 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 21.4 m -107.28 6.2 28.31 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.474 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.3 t -139.27 135.72 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 9.6 mm -101.04 130.34 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.09 110.55 29.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.6 t -97.83 135.51 32.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 123.924 0.765 . . . . 0.0 111.763 -175.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -107.1 132.11 53.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 47.79 100.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.846 2.058 . . . . 0.0 116.49 -178.536 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.526 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 22.5 m -91.57 173.77 5.01 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.668 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.696 ' HA ' ' CE1' ' A' ' 90' ' ' HIS . 98.8 Cg_exo -42.53 146.0 0.86 Allowed 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.195 2.596 . . . . 0.0 113.772 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.42 121.25 26.48 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.407 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 5.2 p -121.98 137.57 55.14 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.8 -173.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.54 169.35 13.16 Favored Glycine 0 N--CA 1.405 -3.394 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.27 127.67 22.88 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.123 2.548 . . . . 0.0 112.775 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 73.66 21.15 2.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.998 1.319 . . . . 0.0 112.904 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -116.63 -1.58 12.12 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.095 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -67.53 -35.65 79.49 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -173.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.425 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 40.8 tt0 -63.27 -37.0 85.53 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -78.05 -32.58 50.94 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.543 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 38' ' ' ILE . 9.4 mp -71.7 -26.02 62.32 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.162 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.425 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 ptmm? -82.47 -18.22 42.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.628 0.728 . . . . 0.0 109.412 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -82.19 -37.79 25.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.201 -177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.417 ' O ' HG12 ' A' ' 41' ' ' ILE . 10.3 p -66.09 -32.12 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.941 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.524 HG12 ' O ' ' A' ' 34' ' ' LEU . 30.4 mm -58.36 -55.27 23.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.374 0.607 . . . . 0.0 109.465 173.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -55.14 -41.59 71.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.6 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -60.96 -57.44 12.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.599 0.76 . . . . 0.0 111.403 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 37' ' ' VAL . 41.2 mm -55.7 -51.06 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.656 0.741 . . . . 0.0 111.229 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.552 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 65.8 m-85 -74.57 -6.17 47.03 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -173.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -70.57 -11.91 61.23 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.66 -0.65 . . . . 0.0 111.428 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -74.79 -14.92 60.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.447 0.642 . . . . 0.0 110.58 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.07 0.63 32.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.746 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 137.27 -166.18 25.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.94 129.22 37.95 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.437 HD11 HD13 ' A' ' 66' ' ' LEU . 26.3 mm -74.75 103.69 2.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.4 m -71.55 -55.34 8.02 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -145.22 169.31 18.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.569 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 51.5 t0 -158.35 160.52 37.04 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 175.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.63 103.26 5.17 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -171.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.423 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 21.7 m-85 -108.2 105.07 55.78 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.591 -175.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.498 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 96.7 Cg_endo -89.26 164.13 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.402 1.402 . . . . 0.0 109.592 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -176.37 -175.51 0.68 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.708 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 1.9 tm-20 -154.98 114.55 3.71 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.0 t70 64.89 26.47 12.84 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.932 1.293 . . . . 0.0 110.292 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.61 24.42 69.55 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.074 -0.966 . . . . 0.0 114.702 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 15.4 pttm -92.47 -177.95 4.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 117.565 0.682 . . . . 0.0 110.278 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.7 m -71.61 108.09 4.8 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -171.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.498 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 3.4 pttm -69.97 160.33 32.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.192 165.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.69 14.77 12.87 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.129 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -169.05 152.49 5.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 117.185 0.493 . . . . 0.0 110.986 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -147.37 174.87 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.262 1.736 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.569 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 86.6 m-85 -141.56 113.94 8.2 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.313 0.506 . . . . 0.0 110.447 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.474 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 3.7 mm? -89.62 108.89 19.94 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.32 123.54 45.58 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.552 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 22.2 m-85 -121.17 175.86 5.89 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 13.78 12.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.517 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 11.7 m -77.3 158.99 78.7 Favored Pre-proline 0 CA--C 1.581 2.159 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -170.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 4.7 Cg_endo -39.88 7.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.511 2.515 1 C-N-CA 129.866 7.044 . . . . 0.0 121.743 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 75' ' ' VAL . . . 84.41 65.45 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 124.706 2.193 . . . . 0.0 107.534 -160.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.548 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 27.2 p80 -82.6 -36.18 26.39 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 109.612 -3.449 . . . . 0.0 108.809 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.37 -28.44 63.01 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.501 -176.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.585 HG13 ' O ' ' A' ' 72' ' ' ALA . 2.7 p -68.09 -24.41 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.571 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.478 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 26.8 t70 -83.78 -41.84 17.15 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.83 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.51 79.49 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.365 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.4 m -66.03 -21.56 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.439 0.638 . . . . 0.0 111.69 -179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.478 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 27.3 ttpp -79.31 -43.6 23.28 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.785 0.803 . . . . 0.0 110.73 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.64 -56.09 4.06 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.344 -171.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.457 ' HB2' ' CE1' ' A' ' 84' ' ' TYR . . . -155.9 87.97 1.09 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.173 -1.011 . . . . 0.0 113.4 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.483 ' HB2' HG23 ' A' ' 94' ' ' VAL . 2.7 t70 -77.42 109.83 11.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.273 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 56.17 0.57 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.49 ' O ' ' HA ' ' A' ' 91' ' ' THR . 78.7 m-85 -67.59 99.33 0.76 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HD2' ' H ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -85.01 100.0 11.38 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -78.15 -50.84 11.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -150.22 174.53 12.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -30.97 -61.98 0.18 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.767 2.027 . . . . 0.0 114.979 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -105.1 12.71 31.79 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.882 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.696 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 20.0 m-70 -117.05 100.67 7.89 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.249 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.49 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 9.0 m -133.02 101.1 5.1 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.005 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -82.39 106.47 14.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.522 -171.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -78.88 137.4 37.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 173.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.483 HG23 ' HB2' ' A' ' 82' ' ' ASP . 6.4 m -114.66 149.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 123.697 0.623 . . . . 0.0 109.681 -170.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.69 159.54 33.09 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.421 ' HG ' ' H ' ' A' ' 98' ' ' THR . 1.8 pt? -79.42 -167.54 1.24 Allowed 'General case' 0 C--N 1.31 -1.128 0 O-C-N 124.116 0.885 . . . . 0.0 111.294 -177.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -82.93 -16.03 49.0 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.784 -176.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.421 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 4.5 m -86.09 70.05 10.55 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.77 -21.45 59.33 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.418 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.13 26.55 2.81 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.82 0.819 . . . . 0.0 112.069 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -117.64 77.52 1.15 Allowed 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -94.9 167.33 11.48 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.765 -1.561 . . . . 0.0 108.523 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -118.06 76.36 1.07 Allowed 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 122.152 0.977 . . . . 0.0 109.203 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -95.57 -40.89 9.2 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 63.9 m . . . . . 0 N--CA 1.426 -1.669 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.939 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.423 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . 0.559 ' O ' HG21 ' A' ' 3' ' ' VAL . 4.8 m-20 -91.33 111.61 23.17 Favored 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.339 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.559 HG21 ' O ' ' A' ' 2' ' ' ASP . 15.3 t 178.66 128.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 C-N-CA 130.466 3.506 . . . . 0.0 104.257 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.86 -26.07 66.72 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.153 0.501 . . . . 0.0 112.219 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.419 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -85.62 -10.97 55.04 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.893 178.206 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -99.88 79.01 2.17 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.961 0.886 . . . . 0.0 108.692 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -112.94 161.74 25.16 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.878 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.47 149.39 87.91 Favored 'Trans proline' 0 C--O 1.246 0.903 0 C-N-CA 121.929 1.752 . . . . 0.0 109.706 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -73.63 133.29 43.43 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 122.609 1.195 . . . . 0.0 109.635 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.69 -21.72 34.8 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 112.127 -2.306 . . . . 0.0 110.936 -171.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.07 153.09 36.62 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -102.8 174.06 6.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 101' ' ' ASP . . . -170.53 -139.75 2.83 Favored Glycine 0 CA--C 1.472 -2.633 0 C-N-CA 119.634 -1.27 . . . . 0.0 113.645 -173.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.507 HD13 ' C ' ' A' ' 14' ' ' ILE . 1.4 pp -74.0 -172.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 CA-C-O 122.899 1.333 . . . . 0.0 113.242 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 18.2 p-10 -122.41 13.57 10.25 Favored 'General case' 0 C--N 1.26 -3.285 0 CA-C-N 112.905 -1.952 . . . . 0.0 107.889 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.505 ' HA ' ' HB3' ' A' ' 71' ' ' PRO . 5.1 m -101.37 11.66 38.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -167.502 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.8 141.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.909 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.458 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 32.5 mm -100.29 132.93 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.543 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 67.9 t -135.88 109.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.433 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 m -112.51 123.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.532 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.45 144.61 27.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.345 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 62' ' ' GLY 0.533 0.3 OUTLIER 42.93 80.5 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 -176.694 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.486 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 19.4 m -91.57 168.09 14.09 Favored Pre-proline 0 N--CA 1.425 -1.719 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.284 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.743 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 73.3 Cg_exo -45.58 129.05 11.1 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.597 2.865 . . . . 0.0 113.502 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.45 153.46 41.38 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.244 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.438 HG13 ' OG1' ' A' ' 60' ' ' THR . 10.7 p -92.71 134.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 118.589 -1.245 . . . . 0.0 111.382 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -123.21 176.35 16.65 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 105.765 -2.934 . . . . 0.0 105.765 171.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -50.97 127.05 20.35 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.557 2.171 . . . . 0.0 112.14 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.31 23.42 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.122 1.369 . . . . 0.0 112.85 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.9 mtp180 -105.2 -10.99 16.75 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.36 179.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -73.35 -42.05 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.066 -175.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.59 -37.91 88.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.046 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -81.25 -17.7 48.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.658 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.552 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.6 tp -70.02 -39.7 75.65 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -39.61 84.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.163 0.982 . . . . 0.0 109.816 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.459 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 41.6 t-20 -78.35 -37.5 44.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.644 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.477 HG11 ' O ' ' A' ' 34' ' ' LEU . 5.1 p -65.28 -29.36 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.552 HG12 ' O ' ' A' ' 34' ' ' LEU . 36.5 mm -64.94 -50.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -63.48 -20.12 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.724 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.459 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 62.1 mttm -86.23 -60.1 2.1 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.412 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.587 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 77.9 mt -66.22 -42.22 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.594 ' CD2' HD12 ' A' ' 66' ' ' LEU . 3.3 m-85 -79.31 -23.57 43.41 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -170.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 67.3 m -64.43 -8.17 12.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.587 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 21.7 ptmt -68.35 -33.04 73.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -83.33 -17.19 43.3 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.595 -176.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.549 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 153.16 -177.84 30.56 Favored Glycine 0 C--O 1.219 -0.81 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -76.86 131.93 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.09 103.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -82.02 -60.68 2.14 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.789 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.43 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 91.3 m-20 -126.91 122.97 36.11 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.74 133.68 53.13 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.47 102.9 8.76 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.08 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 12.6 m-30 -101.0 104.72 34.07 Favored Pre-proline 0 N--CA 1.428 -1.564 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.463 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 91.9 Cg_endo -87.81 173.92 4.95 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.008 1.805 . . . . 0.0 111.432 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.19 -175.66 4.79 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 37.6 tt0 -148.29 103.21 3.42 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 56.02 27.65 11.61 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.09 7.31 73.9 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.541 0.576 . . . . 0.0 114.541 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 15.6 ptpt -92.74 175.29 6.86 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 118.157 0.978 . . . . 0.0 108.866 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.438 ' OG1' HG13 ' A' ' 26' ' ' VAL . 13.5 t -72.16 137.56 47.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.381 0.61 . . . . 0.0 110.153 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 13.6 pttm -79.35 163.94 24.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.493 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' ASN . . . -129.58 2.99 6.13 Favored Glycine 0 C--O 1.182 -3.133 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.046 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -154.99 156.04 35.27 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.933 -0.745 . . . . 0.0 109.833 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 pt -141.27 167.33 17.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.5 m-85 -131.92 141.07 49.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.594 HD12 ' CD2' ' A' ' 42' ' ' PHE . 26.9 mt -127.87 149.35 50.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . 0.43 ' HB2' ' HB2' ' A' ' 50' ' ' ASN . 44.2 mt-10 -128.04 153.35 46.88 Favored 'General case' 0 C--O 1.255 1.388 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.37 159.89 29.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.26 73.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.521 1.128 . . . . 0.0 111.212 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.444 ' O ' ' HD2' ' A' ' 73' ' ' HIS . 28.5 t -123.72 128.25 25.22 Favored Pre-proline 0 CA--C 1.461 -2.472 1 N-CA-C 97.14 -5.133 . . . . 0.0 97.14 173.101 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.505 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 23.2 Cg_exo -62.49 -52.0 2.86 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 CA-C-N 121.813 1.683 . . . . 0.0 110.647 -165.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 26.52 5.79 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.807 0 C-N-CA 131.551 3.94 . . . . 0.0 119.657 144.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.444 ' HD2' ' O ' ' A' ' 70' ' ' SER . 88.4 m-70 -127.24 -28.95 2.78 Favored 'General case' 1 C--N 1.225 -4.81 0 CA-C-O 121.214 0.53 . . . . 0.0 109.884 -170.22 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.438 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -69.25 -26.77 64.95 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.048 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.65 -24.86 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.07 -45.1 28.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.4 -47.14 82.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.911 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.38 -18.0 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.109 0.48 . . . . 0.0 111.599 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -84.2 -24.59 30.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.42 -84.18 0.05 Allowed 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.89 109.45 3.21 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.253 0.549 . . . . 0.0 112.024 -173.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.459 ' HB2' HG22 ' A' ' 94' ' ' VAL . 1.2 t70 -95.46 120.22 35.33 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.86 173.347 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.05 53.8 2.29 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.576 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -106.42 119.14 38.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.196 -0.591 . . . . 0.0 110.369 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.56 130.47 35.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.873 -175.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.36 -63.3 1.34 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -172.15 169.63 5.44 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.453 ' HG2' ' OE1' ' A' ' 89' ' ' GLN . 24.3 ttmm 51.79 -104.04 0.17 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.651 1.18 . . . . 0.0 112.44 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.453 ' OE1' ' HG2' ' A' ' 88' ' ' LYS . 5.7 pm0 -121.61 11.93 10.63 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.959 0.885 . . . . 0.0 109.217 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.743 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 7.4 m170 -90.33 88.48 7.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 61.9 m -133.49 114.82 14.04 Favored 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.452 -178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -82.53 100.64 10.23 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.79 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.74 122.59 31.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.459 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.6 m -107.65 126.12 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.543 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -159.11 176.22 12.51 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.96 179.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 pp -109.76 -173.78 2.34 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 123.2 0.6 . . . . 0.0 109.406 171.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -123.43 -13.72 7.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.5 m -60.76 154.22 22.29 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 124.971 1.309 . . . . 0.0 111.189 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.19 -42.96 18.3 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -133.09 164.31 27.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.436 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 5.7 p-10 -90.08 -0.13 57.43 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.807 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.27 18.2 mmmt -66.06 127.51 32.39 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.876 -172.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -134.31 161.43 34.97 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 112.945 -1.934 . . . . 0.0 106.246 -169.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.6 tpt -71.02 102.97 2.56 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.413 -2.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.632 -178.447 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.577 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -78.56 150.13 32.89 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.23 0.538 . . . . 0.0 111.428 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -91.46 3.96 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.493 0.664 . . . . 0.0 110.086 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.23 -20.1 64.8 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.765 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -75.84 -18.07 59.59 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.825 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -92.01 82.12 5.1 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.084 0.469 . . . . 0.0 109.916 176.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -138.32 142.44 35.13 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.365 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -73.99 128.54 12.4 Favored 'Trans proline' 0 N--CA 1.435 -1.919 0 N-CA-C 104.866 -2.782 . . . . 0.0 104.866 167.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -67.09 119.5 12.13 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.644 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.3 -20.36 60.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.515 0.674 . . . . 0.0 110.197 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.41 86.82 3.96 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 173.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -127.8 161.3 29.32 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.53 -49.4 4.22 Favored Glycine 0 C--N 1.312 -0.793 0 O-C-N 123.317 0.385 . . . . 0.0 112.297 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.4 tp -75.03 132.52 33.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.124 0.488 . . . . 0.0 109.884 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -129.2 -13.14 4.5 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.844 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 38.5 m -106.48 -7.53 17.5 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -172.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -134.92 135.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.231 -175.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -92.66 134.82 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.4 t -123.89 112.9 34.71 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.8 m -121.98 118.42 55.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.446 -178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.77 148.81 22.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.263 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.442 0.1 OUTLIER 47.41 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 128.204 2.602 . . . . 0.0 114.776 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.436 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 32.3 m -90.77 163.63 29.32 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.043 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 0.9 OUTLIER -42.7 142.54 1.99 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 124.531 3.487 . . . . 0.0 114.987 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.478 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -80.52 159.38 25.53 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.323 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 27' ' ' GLY . 14.0 p -128.53 136.93 58.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.957 -177.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -101.51 168.09 19.42 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.96 126.87 19.85 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.834 2.356 . . . . 0.0 113.19 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.15 24.08 10.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.096 1.359 . . . . 0.0 112.996 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.405 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 20.0 mtp180 -107.3 -3.78 19.34 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.487 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -68.51 -33.92 74.98 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.54 -45.68 63.07 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.094 1.358 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.473 ' HZ3' ' HB3' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -85.08 -29.17 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.022 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.596 ' O ' HG12 ' A' ' 38' ' ' ILE . 78.2 mt -64.51 -39.48 93.86 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.56 -21.26 61.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.479 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.4 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.7 t-20 -84.38 -38.18 20.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.246 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 34' ' ' LEU . 8.8 p -67.05 -26.28 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.596 HG12 ' O ' ' A' ' 34' ' ' LEU . 44.0 mm -57.69 -51.32 71.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.059 175.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -62.88 -31.16 72.15 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.4 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 34.4 mmtp -65.69 -47.8 74.18 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.66 -47.86 78.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.63 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.53 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 68.4 m-85 -83.98 -11.76 56.32 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.5 p -69.31 -16.54 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 121.555 -0.715 . . . . 0.0 110.827 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.6 mmpt? -64.73 -24.75 67.66 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.347 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.23 -8.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.758 0.313 . . . . 0.0 111.39 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.95 -149.12 21.23 Favored Glycine 0 N--CA 1.428 -1.87 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.35 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -103.18 118.29 36.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . 0.435 HD12 ' CZ ' ' A' ' 68' ' ' TYR . 23.0 mm -73.82 103.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.9 p -88.5 -23.74 23.14 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.007 0.432 . . . . 0.0 111.411 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -158.23 139.03 12.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.401 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 4.5 p30 -130.53 142.35 50.47 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.843 -0.536 . . . . 0.0 110.982 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . 0.438 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 97.4 m-85 -128.23 98.97 5.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.401 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 7.4 m-30 -108.12 104.66 54.41 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.35 163.07 19.67 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.153 1.235 . . . . 0.0 109.863 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.431 ' OE1' ' HA2' ' A' ' 58' ' ' GLY . 8.3 pt-20 -174.31 177.73 2.18 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -128.77 105.19 8.08 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 58.12 27.57 15.19 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.958 0.903 . . . . 0.0 111.979 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.431 ' HA2' ' OE1' ' A' ' 55' ' ' GLU . . . 79.1 15.2 80.86 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.104 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -92.03 -178.74 5.08 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 122.537 -0.39 . . . . 0.0 110.521 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 7.0 t -57.15 106.16 0.29 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -174.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.425 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 42.2 mttm -57.38 168.39 0.79 Allowed 'General case' 0 C--O 1.245 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 110.883 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.51 -13.93 7.18 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.669 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -170.47 159.45 6.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.7 pt -146.9 166.28 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.438 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 63.7 m-85 -132.43 134.26 44.89 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.407 HD12 HD13 ' A' ' 48' ' ' ILE . 3.1 mm? -112.87 117.63 32.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -107.15 130.81 54.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . 0.587 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -127.38 177.62 6.6 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.72 13.51 14.21 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.435 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . 29.6 m -79.11 151.0 75.37 Favored Pre-proline 0 CA--C 1.574 1.867 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.59 8.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.04 2 C-N-CA 130.593 7.529 . . . . 0.0 122.751 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.513 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 85.33 64.64 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 124.576 2.131 . . . . 0.0 106.928 -160.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 53.4 p-80 -90.34 -36.35 14.7 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 109.129 -3.669 . . . . 0.0 107.662 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.67 -31.02 69.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.311 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 72' ' ' ALA . 4.0 p -65.92 -28.55 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.153 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -81.5 -40.0 23.89 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.854 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.43 75.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.626 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.58 -38.74 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 C-N-CA 124.439 1.096 . . . . 0.0 111.198 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -73.06 -20.91 60.87 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.422 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -93.59 -56.52 2.88 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.694 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.62 97.85 3.66 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.445 ' CG ' HG23 ' A' ' 94' ' ' VAL . 5.5 t0 -112.0 122.69 48.45 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.47 42.39 9.25 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.988 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' THR . 16.9 p90 -94.65 139.13 31.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.736 0.303 . . . . 0.0 110.939 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.414 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -103.36 123.84 47.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.09 -50.59 6.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.812 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.18 -167.19 2.48 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -27.6 -75.41 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.932 2.093 . . . . 0.0 115.541 -170.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.478 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 5.1 pm0 -111.12 12.62 21.92 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.27 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.42 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 3.7 m-70 -88.46 88.88 7.77 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 5.1 m -133.49 102.07 5.38 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.39 118.54 22.76 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -167.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -88.34 125.19 34.57 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.445 HG23 ' CG ' ' A' ' 82' ' ' ASP . 4.1 m -94.56 147.78 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.067 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.14 167.94 28.93 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.48 -175.45 0.83 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.424 1.106 . . . . 0.0 112.554 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -123.21 -40.15 2.41 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.299 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 p -87.5 83.29 7.29 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.629 0.728 . . . . 0.0 111.162 -178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.08 -32.82 71.09 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.572 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -112.39 84.96 2.06 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.739 174.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -98.06 -7.69 29.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 122.408 1.099 . . . . 0.0 108.559 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -73.02 164.03 27.3 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.162 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -139.11 155.16 48.1 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.8 ttt -94.75 94.39 8.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.9 m . . . . . 0 C--N 1.29 -1.99 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 177.77 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.998 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.47 150.72 21.1 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.576 0.703 . . . . 0.0 110.161 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 p -134.34 8.71 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.695 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.09 -24.79 24.45 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -76.05 -2.28 29.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.566 175.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -95.6 104.62 16.54 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -139.26 147.38 52.82 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.79 144.11 82.47 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 121.56 1.507 . . . . 0.0 109.107 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.16 109.45 6.7 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.197 0.999 . . . . 0.0 113.301 -174.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -125.78 -22.13 4.27 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.4 -1.727 . . . . 0.0 107.229 167.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.46 103.0 13.23 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.935 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.617 ' OD2' ' HB2' ' A' ' 96' ' ' LEU . 11.9 t70 -167.3 150.04 6.15 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.68 -6.46 40.71 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.734 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.2 tp -134.33 97.39 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 122.55 1.167 . . . . 0.0 112.096 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -96.02 18.34 13.62 Favored 'General case' 0 C--O 1.193 -1.911 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.376 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 t -109.04 -6.12 15.77 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 111.108 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 48.7 t -111.84 118.47 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.51 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 35.5 mm -84.11 139.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 49.9 t -130.71 113.09 23.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.103 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.482 ' CG2' HG12 ' A' ' 64' ' ' ILE . 12.0 m -120.24 131.93 71.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.22 142.88 29.34 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.994 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.484 0.2 OUTLIER 44.17 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.127 2.171 . . . . 0.0 115.815 -174.421 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.0 160.42 73.83 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.546 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.506 ' HA ' ' ND1' ' A' ' 90' ' ' HIS . 5.6 Cg_endo -46.64 132.94 16.78 Favored 'Trans proline' 0 CA--C 1.501 -1.138 0 C-N-CA 123.465 2.777 . . . . 0.0 114.28 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.7 138.05 42.69 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.311 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.11 138.42 27.47 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.205 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.4 -178.14 25.08 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.6 125.79 18.83 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.203 1.935 . . . . 0.0 112.299 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 51.71 22.53 1.68 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.519 1.928 . . . . 0.0 112.44 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -86.91 -17.92 32.08 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.354 -0.841 . . . . 0.0 111.253 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.17 -45.08 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -56.9 -56.95 15.06 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.465 0.478 . . . . 0.0 110.99 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -68.38 -24.19 64.75 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.522 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.6 ' O ' HG12 ' A' ' 38' ' ' ILE . 8.0 tt -70.69 -44.91 66.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -73.57 -18.07 61.11 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.324 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . 0.493 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 11.3 m120 -78.86 -41.73 29.17 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.591 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG12 ' O ' ' A' ' 34' ' ' LEU . 9.8 p -68.08 -32.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.989 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.6 HG12 ' O ' ' A' ' 34' ' ' LEU . 26.5 mm -61.09 -53.87 43.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 122.968 0.507 . . . . 0.0 109.661 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -53.34 -38.48 63.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.355 0.662 . . . . 0.0 109.916 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 28.0 mtpp -73.92 -48.87 27.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.082 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.526 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 88.4 mt -62.01 -40.74 88.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.135 0.493 . . . . 0.0 110.326 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.434 ' CE1' HG22 ' A' ' 38' ' ' ILE . 2.4 m-30 -74.26 -11.99 60.43 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.31 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 -16.43 63.32 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.8 ptpt -67.32 -33.39 75.16 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 110.523 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.46 ' CZ ' ' HB3' ' A' ' 81' ' ' ALA . 27.8 m-85 -79.79 -16.05 56.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.448 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.459 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.18 179.88 26.35 Favored Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.663 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -67.38 114.36 6.01 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.301 1.04 . . . . 0.0 110.816 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.3 mm -74.43 108.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.3 m -80.16 -45.2 18.52 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -154.03 153.15 31.41 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -131.62 150.69 52.06 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.037 0.535 . . . . 0.0 110.055 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.01 101.22 4.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . 0.48 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 34.8 m-85 -108.89 107.05 59.77 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.194 177.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.435 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 83.4 Cg_endo -95.44 173.22 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.864 1.709 . . . . 0.0 111.216 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -175.05 -175.49 0.86 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 125.7 1.6 . . . . 0.0 106.725 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 7.6 pt-20 -128.41 128.36 44.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 54.5 26.95 7.72 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.905 1.282 . . . . 0.0 111.282 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.53 21.38 76.15 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.047 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 14.9 ptpt -92.75 -177.77 4.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.082 0.941 . . . . 0.0 109.198 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.7 m -66.86 106.03 1.77 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.48 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 1.4 pttm -62.55 164.55 7.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.296 168.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.01 18.83 6.16 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.993 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -169.35 149.16 4.01 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ILE . . . . . 0.482 HG12 ' CG2' ' A' ' 20' ' ' VAL . 19.8 pt -142.84 168.18 13.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.51 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.4 m-85 -135.71 152.91 51.63 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.555 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.5 mp -135.0 154.48 51.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -130.24 128.17 41.09 Favored 'General case' 0 C--O 1.253 1.284 0 O-C-N 124.05 0.844 . . . . 0.0 109.273 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -104.75 176.59 5.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.98 -37.39 26.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.343 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 t -127.78 145.52 55.3 Favored Pre-proline 0 CA--C 1.466 -2.254 1 N-CA-C 99.534 -4.247 . . . . 0.0 99.534 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.414 ' C ' ' H ' ' A' ' 73' ' ' HIS . 39.2 Cg_exo -63.64 -54.64 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.791 0 CA-C-N 122.193 1.819 . . . . 0.0 110.562 -171.162 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.8 4.07 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.654 1 C-N-CA 132.077 4.151 . . . . 0.0 119.824 148.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . 0.459 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 94.6 m-70 -129.32 -36.95 1.67 Allowed 'General case' 1 C--N 1.227 -4.754 0 C-N-CA 123.291 0.636 . . . . 0.0 110.045 -170.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.86 64.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.521 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.65 -31.9 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.256 0.551 . . . . 0.0 110.45 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -40.16 19.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.195 0.522 . . . . 0.0 109.759 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.8 86.05 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.639 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.59 -22.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.678 0.751 . . . . 0.0 111.16 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -83.8 -38.3 21.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -110.06 -25.91 9.98 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ALA . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 45' ' ' PHE . . . -101.47 7.11 42.62 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 122.018 -0.427 . . . . 0.0 111.793 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.446 ' HB2' ' CG2' ' A' ' 94' ' ' VAL . 14.4 t0 -76.63 103.35 6.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.59 8.41 Favored Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.585 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -105.3 136.38 44.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.101 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.483 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -106.72 129.33 54.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.662 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.5 mt -79.46 -62.45 1.69 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.891 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -155.48 133.81 11.67 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 53.1 -93.74 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 125.647 1.579 . . . . 0.0 114.792 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -107.33 -4.1 18.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 120.661 0.267 . . . . 0.0 110.819 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.506 ' ND1' ' HA ' ' A' ' 24' ' ' PRO . 6.9 m-70 -79.3 91.46 5.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.6 m -132.84 120.48 21.6 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.86 104.6 14.08 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.114 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.06 109.08 20.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.448 HG11 HG11 ' A' ' 20' ' ' VAL . 17.2 m -93.62 143.53 11.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.08 -172.0 3.73 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.066 176.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.617 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 2.0 pp -66.77 176.94 1.8 Allowed 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 124.913 1.285 . . . . 0.0 112.181 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -124.96 -14.03 6.73 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.042 -175.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.9 p -71.61 78.0 0.81 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.623 1.201 . . . . 0.0 112.825 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.11 -13.89 60.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.054 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -64.33 154.87 34.04 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.684 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -87.44 79.68 8.33 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.936 0.874 . . . . 0.0 110.929 -174.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 151.37 37.69 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 168.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -64.35 103.5 0.65 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.9 ttm -69.95 107.34 3.54 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.527 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 6.1 m . . . . . 0 N--CA 1.414 -2.27 0 CA-C-O 117.953 -1.022 . . . . 0.0 108.889 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 6.7 p-10 . . . . . 0 C--O 1.207 -1.181 0 CA-C-O 121.066 0.46 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -110.92 16.85 21.03 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.106 0.479 . . . . 0.0 111.438 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.19 132.23 63.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 9.6 mm -97.63 135.12 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.27 116.66 53.19 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 173.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 10.3 t -113.34 122.97 68.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.449 0.468 . . . . 0.0 110.216 -175.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.1 t70 -91.87 136.25 33.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.931 0.77 . . . . 0.0 111.182 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.48 29.9 p-10 41.5 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 128.043 2.537 . . . . 0.0 116.684 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.573 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 18.3 m -98.7 173.29 3.97 Favored Pre-proline 0 N--CA 1.427 -1.611 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.246 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.712 ' HA ' ' NE2' ' A' ' 90' ' ' HIS . 55.5 Cg_exo -41.16 127.58 2.9 Favored 'Trans proline' 0 C--O 1.266 1.903 0 C-N-CA 123.649 2.9 . . . . 0.0 114.223 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.84 -178.24 3.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.26 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 31' ' ' LEU . 6.6 p -111.93 134.23 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 118.885 -1.126 . . . . 0.0 113.325 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.78 157.08 15.28 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 104.263 -3.535 . . . . 0.0 104.263 166.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 9.3 Cg_endo -52.23 123.16 12.0 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 121.557 2.678 . . . . 0.0 112.266 -172.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 50.74 25.74 2.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.432 1.493 . . . . 0.0 112.89 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 28' ' ' PRO . 70.7 mtt180 -107.08 -8.4 16.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 122.061 -0.4 . . . . 0.0 110.952 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.608 ' HB2' HG23 ' A' ' 26' ' ' VAL . 2.9 tm? -73.53 -19.72 60.84 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.39 -48.39 74.4 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.978 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -79.17 -22.29 45.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.412 0.625 . . . . 0.0 110.372 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB2' HD22 ' A' ' 31' ' ' LEU . 97.7 mt -81.41 1.37 33.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 97.1 mttt -84.74 -43.23 14.47 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 48.9 t30 -75.71 -34.95 60.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.033 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.86 -32.78 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.656 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 mm -60.06 -59.01 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.539 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.06 -35.29 73.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.169 0.588 . . . . 0.0 110.542 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 29.9 mtpp -65.61 -39.91 92.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.794 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.3 -39.79 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.301 0.572 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.536 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 26.2 m-85 -76.22 -9.41 58.61 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -66.0 -19.31 65.81 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.636 0.732 . . . . 0.0 110.679 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -68.81 -21.16 64.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.951 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.85 -15.08 35.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.941 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.0 -152.74 24.86 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -96.11 125.72 40.84 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 mm -73.94 97.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -69.67 -54.37 14.2 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -135.84 135.19 39.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -134.14 126.98 31.12 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.87 0.843 . . . . 0.0 109.711 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -125.23 117.1 23.08 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.304 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.07 103.48 50.24 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -95.71 173.97 1.04 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.605 2.204 . . . . 0.0 111.101 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE3' HD11 ' A' ' 31' ' ' LEU . 16.5 pttp -69.95 139.99 52.96 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.35 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.47 16.55 6.25 Favored Glycine 0 C--N 1.288 -2.098 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.855 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 24.4 p90 -169.92 158.33 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.2 pt -147.48 174.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 124.383 1.073 . . . . 0.0 108.117 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.48 136.89 43.48 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.386 0.429 . . . . 0.0 109.875 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.536 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 3.1 mm? -127.92 123.43 34.91 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.19 129.8 56.18 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 9.5 m-85 -127.34 170.35 12.59 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.34 14.33 12.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.513 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 49.6 m -71.57 173.33 5.32 Favored Pre-proline 0 CA--C 1.594 2.636 0 CA-C-N 113.231 -1.804 . . . . 0.0 115.565 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 6.3 Cg_exo -36.64 6.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.521 3.105 1 C-N-CA 130.041 7.16 . . . . 0.0 121.015 175.344 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 84.56 63.31 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 124.464 2.078 . . . . 0.0 108.478 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.591 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 17.3 p80 -74.16 -36.93 64.13 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 110.125 -3.216 . . . . 0.0 111.065 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -76.98 -37.29 55.47 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.57 -42.83 95.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.52 -49.31 69.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.669 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.23 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.005 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 74' ' ' ALA . 27.8 m -60.06 -31.62 48.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -84.87 -31.02 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -104.8 -41.38 5.66 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.16 84.67 2.02 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 94' ' ' VAL . 3.5 t70 -116.31 118.42 32.69 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.36 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.12 41.96 7.79 Favored Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.154 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . 0.251 39.6 p90 -88.48 120.58 29.99 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.033 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.57 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.8 OUTLIER -79.68 122.41 26.53 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.212 -176.142 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -87.08 -65.83 0.97 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.138 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -169.25 153.73 5.53 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 45.41 -91.47 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 C-N-CA 125.851 1.66 . . . . 0.0 114.705 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -111.49 -22.89 11.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.712 ' NE2' ' HA ' ' A' ' 24' ' ' PRO . 22.6 m170 -62.54 99.61 0.15 Allowed 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 122.814 0.446 . . . . 0.0 111.459 -171.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.57 HG23 ' HG3' ' A' ' 85' ' ' LYS . 7.5 m -134.45 103.0 5.52 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.8 100.25 10.19 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.888 -172.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.587 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.2 mpt_? -83.12 138.55 33.63 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 82' ' ' ASP . 3.9 m -124.73 136.3 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 O-C-N 123.574 0.546 . . . . 0.0 110.344 -173.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.1 p30 . . . . . 0 C--N 1.302 -1.488 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.205 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.69 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 26.4 t70 . . . . . 0 C--O 1.186 -2.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.501 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 36.0 m -89.38 -3.16 58.56 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 88.3 t -127.55 122.57 59.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 14.0 mm -89.99 135.82 25.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 59.9 t -128.74 120.51 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.73 138.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.681 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.61 139.86 42.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.581 0.2 OUTLIER 46.58 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 127.253 2.221 . . . . 0.0 115.889 -169.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.585 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 29.9 m -107.25 179.04 0.95 Allowed Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.141 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.6 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 54.3 Cg_exo -42.41 131.74 5.04 Favored 'Trans proline' 0 C--O 1.269 2.04 0 C-N-CA 123.01 2.474 . . . . 0.0 114.831 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.658 ' HA ' HG23 ' A' ' 60' ' ' THR . 9.1 pt20 -61.84 -165.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 128.06 2.544 . . . . 0.0 113.528 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.601 ' HB ' HD23 ' A' ' 31' ' ' LEU . 14.9 p -141.03 138.55 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-O 121.985 0.897 . . . . 0.0 110.691 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.93 141.85 15.38 Favored Glycine 0 C--N 1.275 -2.853 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 166.39 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.2 124.81 13.59 Favored 'Trans proline' 0 C--O 1.243 0.744 0 CA-C-N 121.274 2.537 . . . . 0.0 112.73 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 60.56 32.38 20.42 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.067 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.4 2.04 10.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.228 -0.92 . . . . 0.0 111.039 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.601 HD23 ' HB ' ' A' ' 26' ' ' VAL . 1.4 tm? -60.91 -27.01 67.88 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -174.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -57.7 -50.72 72.25 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.56 -23.53 61.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.661 0.743 . . . . 0.0 109.993 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.8 mt -81.2 -4.53 55.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.574 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 99.5 mttt -85.62 -37.46 19.49 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 168.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.49 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 4.4 m-20 -78.16 -33.89 50.04 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.921 -172.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.38 -32.5 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.944 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.47 -53.34 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.3 -31.68 67.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.842 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 52.9 mtpt -78.32 -41.6 33.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.5 mt -82.44 -41.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.708 0.765 . . . . 0.0 111.246 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 66' ' ' LEU . 3.9 m-85 -78.57 -10.81 59.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 1.8 p -71.78 -10.02 59.15 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.733 0.778 . . . . 0.0 111.578 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -71.21 -22.03 62.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.318 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.69 -15.42 39.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.729 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 150.83 -171.47 30.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -83.73 127.08 33.52 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 68' ' ' TYR . 20.1 mm -72.6 94.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.2 m -83.36 -37.25 23.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.097 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 39.5 t30 -154.04 145.57 23.19 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -146.64 151.25 36.95 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -135.99 106.14 6.34 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.783 0.677 . . . . 0.0 109.892 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.74 104.72 55.39 Favored Pre-proline 0 C--O 1.252 1.212 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.32 173.21 1.2 Allowed 'Trans proline' 0 N--CA 1.432 -2.128 0 C-N-CA 121.882 1.721 . . . . 0.0 110.898 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.286 -2.167 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.658 HG23 ' HA ' ' A' ' 25' ' ' GLN . 98.7 m . . . . . 0 N--CA 1.429 -1.512 0 CA-C-O 121.165 0.507 . . . . 0.0 111.532 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -67.86 145.54 54.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.438 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -118.33 3.19 16.06 Favored Glycine 0 C--N 1.286 -2.225 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.932 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -168.19 150.06 5.26 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.12 167.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -132.69 136.06 46.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.693 HD11 ' CD2' ' A' ' 42' ' ' PHE . 47.1 mt -121.46 154.01 37.15 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 42.3 tt0 -135.95 122.58 20.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.544 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 11.8 m-30 -118.88 157.56 27.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.37 13.86 28.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.219 1.009 . . . . 0.0 108.82 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 20.8 m -73.57 161.63 78.01 Favored Pre-proline 0 CA--C 1.604 3.034 0 CA-C-N 114.16 -1.382 . . . . 0.0 114.605 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.2 Cg_endo -37.66 8.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.945 2 C-N-CA 130.622 7.548 . . . . 0.0 124.316 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.69 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.47 67.42 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 123.066 2.666 . . . . 0.0 106.153 -156.112 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.544 ' NE2' ' HB2' ' A' ' 68' ' ' TYR . 22.9 p-80 -93.94 -37.87 11.47 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 109.067 -3.697 . . . . 0.0 112.197 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.6 -23.42 53.43 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.354 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.3 p -65.11 -22.89 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.764 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.04 -46.71 12.51 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.05 -43.79 66.91 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.982 0.801 . . . . 0.0 111.964 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.49 -19.57 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.92 0.39 . . . . 0.0 111.872 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -85.27 -22.98 28.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.173 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -71.91 0.14 Allowed 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.313 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -177.3 124.13 0.13 Allowed 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.642 0.588 . . . . 0.0 110.285 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 94' ' ' VAL . 5.5 t70 -81.43 115.67 20.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.49 52.5 4.18 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.335 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -93.67 126.61 38.94 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.092 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -82.99 117.19 22.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.786 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.65 -58.78 2.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.8 0.809 . . . . 0.0 109.197 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -135.12 -164.79 1.58 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -36.2 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.744 1.617 . . . . 0.0 115.069 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -96.29 -1.15 48.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.726 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.6 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 42.1 m170 -81.43 93.29 6.59 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' ' 85' ' ' LYS . 21.2 m -133.95 108.38 8.36 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.681 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -82.83 101.07 10.72 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.261 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.56 136.73 34.14 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 82' ' ' ASP . 17.1 m -105.86 138.17 32.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 123.792 0.682 . . . . 0.0 110.594 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.458 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.289 -2.052 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 23.5 m-20 . . . . . 0 N--CA 1.422 -1.828 0 CA-C-O 122.55 1.167 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.626 ' HA ' ' HE2' ' A' ' 73' ' ' HIS . 44.9 m -96.48 7.18 47.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.265 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 38.7 t -127.93 126.53 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.981 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 30.5 mm -83.04 139.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.2 112.13 34.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.79 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.777 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 30.1 t70 -85.44 132.78 34.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.744 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.479 0.2 OUTLIER 45.7 97.92 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.9 m -86.63 167.94 20.55 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.617 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 48.9 Cg_exo -51.18 146.95 21.81 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.769 2.313 . . . . 0.0 116.098 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -61.06 145.3 51.32 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.19 -2.277 . . . . 0.0 109.503 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 ' HB2' ' A' ' 31' ' ' LEU . 7.3 p -137.87 151.0 25.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.715 0.769 . . . . 0.0 111.494 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.16 174.87 20.98 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.62 126.05 11.89 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.691 2.261 . . . . 0.0 113.642 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.9 t70 65.27 18.44 11.39 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.797 2.039 . . . . 0.0 112.9 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -100.89 -8.36 22.61 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.612 -1.305 . . . . 0.0 111.629 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HB2' HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -76.97 -21.9 54.02 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.63 -34.44 78.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.221 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -69.93 -36.96 75.74 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.581 ' O ' HG12 ' A' ' 38' ' ' ILE . 80.2 mt -73.59 -34.37 65.06 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.551 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HE3' HD12 ' A' ' 31' ' ' LEU . 98.5 mttt -58.47 -31.61 67.97 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.98 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -80.96 -31.25 34.93 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.789 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 34' ' ' LEU . 3.8 p -75.25 -28.99 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.6 mm -62.12 -51.76 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -65.45 -17.56 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.257 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -88.07 -60.08 2.06 Favored 'General case' 0 N--CA 1.415 -2.21 0 O-C-N 122.15 -0.344 . . . . 0.0 110.784 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.12 -42.7 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.354 0.597 . . . . 0.0 111.303 -175.362 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.536 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 58.2 m-85 -79.4 -17.76 53.7 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 68.4 m -74.28 -3.71 31.73 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.388 0.613 . . . . 0.0 111.397 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.05 -3.39 58.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -113.16 9.64 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.319 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 126.62 -162.53 20.76 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -94.5 133.27 38.29 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.277 0.539 . . . . 0.0 111.619 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.44 95.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.426 ' OG1' ' HA ' ' A' ' 68' ' ' TYR . 1.2 p -80.55 -34.64 35.27 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.379 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 63.3 t30 -152.19 147.22 26.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.991 -0.443 . . . . 0.0 110.177 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 81.2 m-85 -136.65 107.2 6.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.464 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 2.4 m-85 -107.37 104.83 54.04 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.661 -1.236 . . . . 0.0 107.661 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.55 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 73.4 Cg_endo -83.89 159.19 13.87 Favored 'Trans proline' 0 N--CA 1.436 -1.882 0 C-N-CA 120.921 1.081 . . . . 0.0 110.19 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.502 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 20.1 pt-20 . . . . . 0 C--N 1.285 -2.204 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.252 1.189 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 54' ' ' PRO . 6.9 ptpp? -64.33 166.01 8.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 125.735 1.614 . . . . 0.0 110.072 170.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.04 14.66 4.88 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.229 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -170.66 152.46 3.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 pt -145.53 167.1 9.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 80.8 m-85 -128.88 136.15 50.05 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.2 0.524 . . . . 0.0 109.682 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 3.6 mm? -115.67 118.26 32.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 13.4 tp10 -103.52 122.08 44.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.536 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 m-85 -126.95 164.75 20.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.769 0.795 . . . . 0.0 111.952 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.66 13.58 26.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.605 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.493 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . 38.6 t -75.03 158.31 84.48 Favored Pre-proline 0 CA--C 1.585 2.319 0 C-N-CA 125.344 1.457 . . . . 0.0 113.469 -171.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -37.48 8.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.836 1 C-N-CA 130.31 7.34 . . . . 0.0 121.057 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.418 ' HB1' ' CG2' ' A' ' 75' ' ' VAL . . . 84.84 62.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 125.026 2.346 . . . . 0.0 108.058 -166.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.626 ' HE2' ' HA ' ' A' ' 16' ' ' SER . 14.3 p80 -72.41 -36.26 68.6 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 109.261 -3.608 . . . . 0.0 110.83 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -74.21 -33.33 63.36 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.418 ' CG2' ' HB1' ' A' ' 72' ' ' ALA . 84.4 t -64.73 -42.88 96.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.301 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.3 -41.85 80.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.768 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -50.47 73.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.437 0.695 . . . . 0.0 111.415 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -61.67 -32.39 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 123.536 0.734 . . . . 0.0 110.461 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -76.17 -38.11 57.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.209 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -92.86 -63.68 1.19 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -172.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.25 103.34 6.89 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.392 0.615 . . . . 0.0 111.926 -169.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.54 ' HB2' HG22 ' A' ' 94' ' ' VAL . 12.0 t0 -130.08 140.77 50.78 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.662 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.04 46.07 53.37 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -101.59 125.27 48.22 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 121.538 0.685 . . . . 0.0 110.418 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.91 129.0 45.23 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.198 -174.658 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.6 -59.83 2.16 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.495 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -162.6 151.4 14.87 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp 40.24 -95.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -110.43 3.46 19.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.858 -0.526 . . . . 0.0 110.842 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.617 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 12.1 m170 -80.7 89.16 5.74 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 m -133.23 115.31 14.82 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -85.54 116.18 23.69 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.56 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 3.5 mpt_? -91.42 121.63 33.3 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.7 m -103.5 148.85 7.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -175.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.6 p30 . . . . . 0 C--N 1.287 -2.115 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.914 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.679 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 14.0 t70 . . . . . 0 C--O 1.195 -1.77 0 CA-C-O 121.861 0.838 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.686 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 30.3 t -92.34 -6.28 50.51 Favored 'General case' 0 C--N 1.275 -2.673 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.283 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.73 115.37 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.897 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 20.4 mm -93.59 143.41 11.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 98.0 t -121.0 123.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 79.7 t -119.15 139.88 44.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 20.2 t70 -107.21 145.9 32.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.043 0.537 . . . . 0.0 110.714 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.506 0.2 OUTLIER 31.68 104.76 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.985 2.587 . . . . 0.0 117.985 -174.931 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.523 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 27.1 m -107.98 177.22 1.34 Allowed Pre-proline 0 CA--C 1.562 1.418 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.739 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HA ' ' CE1' ' A' ' 90' ' ' HIS . 5.0 Cg_exo -43.89 138.21 6.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.828 3.019 . . . . 0.0 112.725 170.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HA ' HG21 ' A' ' 60' ' ' THR . 0.1 OUTLIER -88.41 172.23 9.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.777 -175.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 31' ' ' LEU . 14.1 p -117.39 142.51 31.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.132 0.968 . . . . 0.0 111.747 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.77 155.52 16.23 Favored Glycine 0 N--CA 1.414 -2.804 1 N-CA-C 102.657 -4.177 . . . . 0.0 102.657 165.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.84 125.22 12.51 Favored 'Trans proline' 0 C--O 1.25 1.111 0 CA-C-N 121.224 2.512 . . . . 0.0 114.136 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.68 24.74 9.27 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.107 1.763 . . . . 0.0 111.879 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -98.46 -15.49 19.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 121.738 -0.601 . . . . 0.0 111.407 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' HB2' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -79.55 -18.2 52.32 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.855 -174.08 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.3 -42.72 82.31 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.24 -29.64 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.376 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 38' ' ' ILE . 94.8 mt -69.27 -27.01 65.05 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.339 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -59.57 -39.75 85.11 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.699 0.761 . . . . 0.0 110.216 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -84.08 -28.23 27.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 34' ' ' LEU . 7.3 p -70.56 -32.68 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.347 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 34' ' ' LEU . 43.2 mm -59.6 -53.1 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -53.61 -35.38 60.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.569 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.93 -42.22 24.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 37' ' ' VAL . 45.8 mm -64.77 -42.88 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.918 0.866 . . . . 0.0 109.68 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -76.88 -6.69 53.45 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.029 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 22.8 t -73.02 -6.76 47.66 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-O 121.271 0.557 . . . . 0.0 109.632 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -71.5 -28.15 63.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.273 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -85.71 -15.14 43.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.23 0.538 . . . . 0.0 111.058 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 155.18 -162.99 31.28 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -96.11 129.13 43.48 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.489 HD13 ' CE2' ' A' ' 68' ' ' TYR . 24.0 mm -73.03 109.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -81.88 -48.64 11.28 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 37.2 m-20 -134.75 144.21 47.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.477 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.6 p30 -137.04 132.72 34.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.557 0.694 . . . . 0.0 110.902 175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.31 97.77 5.35 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.233 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 2.5 m-85 -108.63 104.9 55.81 Favored Pre-proline 0 N--CA 1.416 -2.129 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.747 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 80.8 Cg_endo -83.88 170.8 11.01 Favored 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 120.932 1.088 . . . . 0.0 110.462 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' OE2' ' HA ' ' A' ' 60' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.388 -3.575 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 175.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 25' ' ' GLN . 11.3 t . . . . . 0 N--CA 1.413 -2.311 0 CA-C-O 122.741 1.258 . . . . 0.0 113.108 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.747 ' HD3' ' O ' ' A' ' 54' ' ' PRO 0.27 9.6 pttm -59.49 176.26 0.27 Allowed 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.478 167.06 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.64 20.91 4.82 Favored Glycine 0 C--N 1.288 -2.097 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 52.3 p90 -169.28 160.28 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 pt -147.09 171.98 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.92 136.94 44.59 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 123.952 0.783 . . . . 0.0 109.504 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 48' ' ' ILE . 2.4 mm? -124.53 138.74 54.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 16' ' ' SER . 41.8 mt-10 -126.43 129.99 49.81 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.567 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 19.1 m-85 -125.98 170.78 11.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.32 14.24 12.89 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 39.4 m -73.27 168.02 29.03 Favored Pre-proline 0 CA--C 1.589 2.447 0 CA-C-N 113.493 -1.685 . . . . 0.0 114.633 -173.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 5.7 Cg_exo -35.52 9.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.358 2 C-N-CA 130.624 7.549 . . . . 0.0 123.08 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.679 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.11 65.2 0.01 OUTLIER 'General case' 0 CA--C 1.473 -2.016 0 CA-C-O 124.788 2.232 . . . . 0.0 106.867 -160.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.686 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 21.2 p-80 -82.17 -36.49 27.3 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 108.995 -3.729 . . . . 0.0 111.98 -171.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.1 -37.49 75.41 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.386 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.586 HG23 ' OD1' ' A' ' 15' ' ' ASP . 94.3 t -56.07 -48.42 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.489 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 3.1 t70 -65.7 -35.71 81.53 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.279 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.94 69.91 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.412 0.285 . . . . 0.0 110.888 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.1 -37.79 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 123.725 0.81 . . . . 0.0 109.706 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 76' ' ' ASP . 77.4 tttt -59.79 -36.46 76.76 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.414 1.485 . . . . 0.0 111.517 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -81.96 -77.31 0.23 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.32 113.01 3.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.084 -172.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' A' ' 94' ' ' VAL . 2.9 t70 -94.74 133.68 38.16 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.916 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 48.81 19.52 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.404 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -88.94 125.36 34.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.791 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.512 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -103.35 129.27 50.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.487 -172.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -86.28 -66.85 0.86 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -167.67 -173.81 2.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.23 -103.54 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -121.54 8.42 10.12 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.669 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 4.8 m-70 -87.28 91.74 8.83 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.359 -170.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 85' ' ' LYS . 5.9 m -133.44 105.0 6.68 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -82.61 101.17 10.62 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.626 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -87.34 137.36 32.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 82' ' ' ASP . 5.4 m -105.01 134.55 46.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 O-C-N 123.944 0.778 . . . . 0.0 109.991 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.66 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER . . . . . 0 CA--C 1.471 -2.064 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.523 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 12.2 t70 . . . . . 0 C--O 1.205 -1.259 0 CA-C-O 121.727 0.775 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.4 m -98.4 7.28 46.4 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.4 t -146.17 124.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 26.3 mm -86.13 136.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.695 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 89.4 t -129.9 103.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 3.0 m -96.74 120.47 46.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.572 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 25.5 t70 -79.72 140.16 37.07 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.917 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.427 21.1 p-10 44.27 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 127.209 2.203 . . . . 0.0 114.552 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.488 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 26.8 m -100.94 167.68 10.4 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.893 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -42.47 126.9 4.18 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.77 2.98 . . . . 0.0 114.692 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.508 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -91.02 149.0 22.01 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.459 -1.701 . . . . 0.0 108.337 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 27' ' ' GLY . 6.5 p -101.59 147.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -169.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -105.14 171.61 18.93 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 168.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.05 125.69 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 CA-C-N 121.101 2.45 . . . . 0.0 112.275 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 57.4 31.37 20.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.842 1.257 . . . . 0.0 113.792 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -109.73 1.02 19.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.22 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.14 -32.26 72.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -45.23 -49.34 12.43 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.029 1.332 . . . . 0.0 111.211 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -79.08 -31.85 44.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.531 -172.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -72.06 -35.22 69.24 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.194 -176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -78.31 -20.83 50.67 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.109 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 49.6 t-20 -78.08 -37.8 45.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 34' ' ' LEU . 8.8 p -66.41 -31.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.435 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.9 mm -61.7 -49.88 82.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -63.04 -19.92 64.84 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.328 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 66.4 mttm -88.13 -60.01 2.08 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -63.19 -43.74 98.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.011 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -78.37 -14.75 59.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 m -75.76 -3.05 32.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.117 0.484 . . . . 0.0 111.308 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -79.32 -20.95 46.64 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -88.28 -15.03 36.88 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.639 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.82 -154.17 25.66 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.778 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.65 120.67 27.34 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 122.26 0.224 . . . . 0.0 110.602 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.6 mm -73.85 91.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.4 m -78.15 -52.66 8.37 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.321 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 85.9 m-20 -136.05 139.47 43.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -144.71 128.72 17.52 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.55 0.691 . . . . 0.0 109.671 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.75 116.01 19.56 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.258 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -107.9 105.18 55.72 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 96.5 Cg_endo -85.74 174.31 6.7 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 122.323 2.015 . . . . 0.0 110.72 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.3 pt-20 . . . . . 0 C--N 1.303 -1.429 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 3.4 t . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 120.649 0.261 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER 179.87 167.92 1.23 Allowed 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 124.915 1.286 . . . . 0.0 108.29 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.09 -6.32 2.52 Favored Glycine 0 C--N 1.297 -1.619 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 20.3 p90 -167.68 156.62 9.69 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.34 163.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -113.3 129.71 56.45 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 123.807 0.692 . . . . 0.0 110.264 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 2.3 mm? -118.98 126.5 51.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 38.0 tt0 -121.69 119.31 31.43 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.604 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 87.6 m-85 -99.98 177.85 4.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.609 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.57 -15.82 56.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.3 m -119.51 167.31 12.41 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 73' ' ' HIS . 4.9 Cg_exo -77.46 -55.57 0.05 OUTLIER 'Trans proline' 0 C--O 1.176 -2.623 0 CA-C-N 123.887 2.424 . . . . 0.0 108.568 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.31 7.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 131.287 3.835 . . . . 0.0 121.307 142.128 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.604 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 31.1 p80 -125.28 -36.71 2.47 Favored 'General case' 1 C--N 1.241 -4.125 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.681 -165.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . . . -81.42 -22.82 37.97 Favored 'General case' 0 N--CA 1.383 -3.793 0 C-N-CA 119.251 -0.979 . . . . 0.0 108.644 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.5 -23.14 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.52 -33.88 25.41 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.4 63.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.337 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -32.49 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -67.49 -44.3 78.84 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.406 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -91.77 -52.4 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.2 104.74 3.83 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.305 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' HB2' HG22 ' A' ' 94' ' ' VAL . 2.6 p30 -114.44 136.41 53.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.0 51.03 61.36 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -96.76 124.17 40.67 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.733 0.778 . . . . 0.0 111.768 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -97.89 118.57 34.75 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.623 -176.7 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.75 -52.92 5.23 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.414 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 16.1 m-20 -145.42 -168.62 3.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.172 -174.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -44.16 -69.81 0.12 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.925 1.29 . . . . 0.0 114.195 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -100.18 11.26 39.79 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.674 -176.538 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.414 ' HB2' ' H ' ' A' ' 87' ' ' ASP . 14.8 m170 -102.45 86.97 2.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -135.29 94.09 3.07 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-O 120.708 0.29 . . . . 0.0 110.277 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.43 105.55 13.58 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.972 -168.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.522 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.1 mpt_? -83.45 141.96 31.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 82' ' ' ASP . 34.5 m -100.23 114.28 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.695 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 4.6 p-10 . . . . . 0 C--O 1.215 -0.731 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 CA--C 1.5 -0.947 0 CA-C-O 122.28 1.038 . . . . 0.0 108.689 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 8.4 m -96.3 -11.88 25.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.229 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.5 t -122.15 132.5 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.554 -172.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 30.1 mm -87.3 145.13 7.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.48 121.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 64' ' ' ILE . 27.4 m -118.41 157.76 19.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.236 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.76 133.42 55.93 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 42.57 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 28.7 m -91.21 167.04 16.76 Favored Pre-proline 0 N--CA 1.426 -1.637 0 CA-C-N 114.33 -1.305 . . . . 0.0 107.982 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 85.1 Cg_exo -42.44 138.94 3.14 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.985 3.124 . . . . 0.0 113.126 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HA ' HG23 ' A' ' 60' ' ' THR . 2.6 pm0 -71.56 153.23 42.31 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.804 -173.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 30' ' ' ARG . 16.7 t -119.26 132.91 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.476 -176.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.89 -131.91 3.12 Favored Glycine 0 C--N 1.274 -2.868 0 N-CA-C 106.672 -2.571 . . . . 0.0 106.672 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.36 125.23 10.56 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 CA-C-N 119.459 1.629 . . . . 0.0 111.447 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 55.9 18.04 2.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.131 1.772 . . . . 0.0 114.373 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.503 ' HB2' HG13 ' A' ' 26' ' ' VAL . 35.2 mmt180 -79.1 -25.87 43.0 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.076 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -73.86 -33.89 64.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.38 -58.33 7.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.169 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -81.74 -15.68 53.55 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.612 ' O ' HG12 ' A' ' 38' ' ' ILE . 51.3 tp -63.3 -36.35 83.4 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -56.7 -36.9 70.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -84.09 -40.92 17.69 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.32 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' LEU . 7.4 p -65.55 -31.88 55.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.356 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 34' ' ' LEU . 32.9 mm -67.33 -54.6 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -58.82 -36.09 73.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.39 -47.28 35.0 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.3 mm -70.15 -39.24 76.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.197 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.23 -7.79 59.63 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.1 p -67.38 -22.74 65.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.3 ptpt -61.74 -28.4 69.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.53 0.681 . . . . 0.0 111.755 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 30.3 m-85 -85.46 -15.7 42.07 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.1 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.76 176.19 23.45 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -74.81 125.04 27.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -72.83 140.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 m -126.38 -61.22 1.22 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 55.0 m-80 -122.23 140.63 52.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.53 138.81 46.25 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.085 0.469 . . . . 0.0 110.446 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 89.2 m-85 -134.2 98.88 4.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -107.32 104.77 53.77 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 64' ' ' ILE . 51.1 Cg_endo -82.47 174.08 10.08 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.713 1.609 . . . . 0.0 109.823 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.634 ' HB3' ' NZ ' ' A' ' 61' ' ' LYS . 19.9 pt-20 . . . . . 0 CA--C 1.477 -1.845 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 25' ' ' GLN . 83.4 m . . . . . 0 C--O 1.244 0.801 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.634 ' NZ ' ' HB3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -84.78 156.37 21.41 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.354 176.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.57 8.59 9.44 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.442 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -170.15 151.95 4.08 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 20' ' ' VAL . 20.7 pt -142.06 166.29 16.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.3 m-85 -131.59 141.66 49.72 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.859 0.724 . . . . 0.0 109.048 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.3 mp -132.36 136.75 47.04 Favored 'General case' 0 C--O 1.198 -1.651 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.934 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 42.0 tt0 -122.05 136.97 54.97 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.15 0.5 . . . . 0.0 109.688 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.41 ' HE1' ' CG1' ' A' ' 18' ' ' ILE . 76.0 m-85 -104.83 177.53 4.82 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.367 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.33 -16.62 39.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.275 0.559 . . . . 0.0 111.369 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -135.35 144.97 51.87 Favored Pre-proline 0 C--N 1.294 -1.84 1 N-CA-C 99.34 -4.318 . . . . 0.0 99.34 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.6 Cg_exo -69.91 -54.12 0.23 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 CA-C-N 123.483 2.28 . . . . 0.0 109.57 -172.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.07 4.47 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 1 C-N-CA 132.374 4.27 . . . . 0.0 120.133 144.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.508 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 95.8 m-70 -128.43 -36.36 1.9 Allowed 'General case' 1 C--N 1.223 -4.923 0 CA-C-O 121.326 0.584 . . . . 0.0 109.624 -170.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -61.33 -32.1 71.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.517 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.76 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 123.315 0.384 . . . . 0.0 111.305 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.39 -32.49 37.56 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.242 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.27 -52.61 61.34 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.764 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 74' ' ' ALA . 31.2 m -63.13 -27.78 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -81.61 -21.81 38.08 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.9 0.88 . . . . 0.0 112.047 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -122.88 -23.96 4.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . . . -106.0 18.55 21.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 94' ' ' VAL . 37.0 t70 -85.06 121.78 28.33 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 118.157 -1.417 . . . . 0.0 114.056 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.58 60.5 2.47 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.537 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 91' ' ' THR . 17.8 m-85 -103.27 105.51 15.81 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.33 102.69 7.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.204 177.32 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.7 mt -80.01 -41.46 25.79 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.91 -171.74 3.99 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -48.61 -58.32 4.89 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.594 1.558 . . . . 0.0 113.413 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -95.0 -4.55 46.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.203 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.53 101.42 10.76 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.765 -172.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 37.1 m -133.55 117.78 17.51 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.285 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -82.69 101.71 11.03 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.076 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 91' ' ' THR . 3.6 mpt_? -86.87 131.15 34.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 82' ' ' ASP . 25.6 m -117.75 149.11 20.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.942 -175.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.667 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 10.5 m-20 . . . . . 0 CA--C 1.444 -3.115 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.525 ' HB2' ' OE2' ' A' ' 67' ' ' GLU 0.251 69.6 p -118.25 -20.49 8.55 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 115.493 -2.483 . . . . 0.0 113.916 166.519 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 25.9 t -127.14 133.04 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.996 -171.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.586 HD11 ' HD1' ' A' ' 73' ' ' HIS . 25.9 mm -104.12 143.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.79 114.1 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.53 130.61 73.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB3' ' CG ' ' A' ' 93' ' ' ARG . 10.7 t70 -111.86 149.35 31.94 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.512 0.2 OUTLIER 44.57 85.65 0.02 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 127.057 2.143 . . . . 0.0 115.87 -176.155 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 26.8 m -97.77 -171.75 0.26 Allowed Pre-proline 0 N--CA 1.418 -2.029 0 CA-C-N 112.732 -2.031 . . . . 0.0 107.064 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.749 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 44.6 Cg_exo -54.05 143.82 60.32 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 121.686 1.591 . . . . 0.0 114.181 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HA ' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -89.37 164.33 14.93 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.879 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 31' ' ' LEU . 48.8 t -123.22 134.26 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 CA-C-O 121.675 0.75 . . . . 0.0 109.391 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.7 -127.96 5.65 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 105.722 -2.951 . . . . 0.0 105.722 173.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.74 124.39 4.53 Favored 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-N 120.22 2.01 . . . . 0.0 110.721 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 50.73 33.57 8.58 Favored 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.353 1.461 . . . . 0.0 113.014 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -95.76 -0.7 51.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.771 -1.206 . . . . 0.0 112.105 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 26' ' ' VAL . 3.2 tm? -71.0 -28.86 64.73 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.87 -51.03 69.84 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.76 0.314 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.14 -27.13 68.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.564 ' O ' HG12 ' A' ' 38' ' ' ILE . 6.0 tt -65.71 -43.91 87.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.32 -37.83 81.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 111.6 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -81.0 -33.77 33.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.705 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 34' ' ' LEU . 6.2 p -70.17 -30.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.763 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 34' ' ' LEU . 35.5 mm -63.79 -64.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.845 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -62.49 -25.37 67.98 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -64.33 -57.71 8.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.333 0.653 . . . . 0.0 110.522 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 82.0 mt -70.38 -38.84 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.286 0.565 . . . . 0.0 111.042 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.453 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 53.9 m-85 -73.86 -7.31 51.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 58.0 m -69.35 -6.37 29.35 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 41' ' ' ILE . 81.0 mttt -71.92 -31.93 66.86 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.113 0.959 . . . . 0.0 108.807 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -85.46 10.83 11.8 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.892 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 117.43 -167.88 12.8 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -89.91 145.24 25.28 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 66' ' ' LEU . 32.4 mm -73.23 110.44 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.4 m -75.48 -46.3 33.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 35.3 t-20 -152.76 152.69 31.94 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -144.48 136.75 26.37 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -126.64 113.0 16.14 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.06 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -107.67 106.59 58.82 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 63' ' ' TYR . 2.9 Cg_exo -68.66 174.73 8.08 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.525 1.483 . . . . 0.0 109.357 172.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 120.946 0.403 . . . . 0.0 110.466 -173.726 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.443 HG23 ' HA ' ' A' ' 25' ' ' GLN . 18.9 m . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 166.65 11.02 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.12 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 -0.73 9.44 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.91 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.496 ' O ' ' HD2' ' A' ' 54' ' ' PRO . 4.4 p90 -169.69 161.23 9.23 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -143.86 172.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 123.527 0.517 . . . . 0.0 110.35 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -136.24 138.73 42.13 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 109.744 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.0 mm? -118.39 131.91 56.28 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE2' ' HB2' ' A' ' 16' ' ' SER . 12.9 tp10 -116.72 117.51 29.99 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.55 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 80.5 m-85 -127.46 172.53 10.6 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.241 0.543 . . . . 0.0 110.312 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.23 14.26 14.79 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.583 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 51.0 m -68.27 163.35 53.14 Favored Pre-proline 0 CA--C 1.597 2.78 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -171.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.1 Cg_exo -38.25 8.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.348 2 C-N-CA 130.435 7.423 . . . . 0.0 122.955 178.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.528 ' HA ' ' CG ' ' A' ' 15' ' ' ASP . . . 87.37 63.34 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 124.465 2.079 . . . . 0.0 106.997 -158.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.586 ' HD1' HD11 ' A' ' 18' ' ' ILE . 32.2 p80 -85.69 -36.99 19.89 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 110.148 -3.205 . . . . 0.0 109.282 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . . . -63.36 -35.94 82.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.059 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.587 HG23 ' OD1' ' A' ' 15' ' ' ASP . 82.0 t -59.39 -59.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.459 170.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.68 -35.77 73.14 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.145 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.0 -30.89 70.26 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.494 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.81 -29.34 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 8.4 mmpt? -72.02 -42.82 65.92 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.308 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -114.21 -29.87 6.81 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.2 -3.13 27.86 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -170.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.3 117.34 18.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.874 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.86 31.33 12.62 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -101.5 135.27 43.28 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.495 -1.282 . . . . 0.0 109.488 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -107.68 129.29 55.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.192 -172.365 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.44 -68.04 0.77 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.245 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -160.02 159.32 31.92 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.424 ' HD2' HE22 ' A' ' 25' ' ' GLN . 40.2 ttmt 47.04 -88.7 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.048 1.739 . . . . 0.0 114.297 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -121.43 -2.13 9.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.263 -0.273 . . . . 0.0 111.035 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.749 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m170 -79.72 92.65 5.43 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.31 0.576 . . . . 0.0 110.594 -171.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 m -133.17 109.04 9.18 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -82.21 105.62 13.44 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.917 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.459 ' CG ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -94.03 121.45 35.53 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.96 115.1 47.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.008 -166.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.404 -2.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 C--O 1.244 0.815 0 CA-C-O 121.452 0.644 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -114.39 -8.96 12.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.28 137.34 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 121.875 -0.516 . . . . 0.0 109.873 -175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 8.9 mm -101.0 133.12 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.66 106.5 15.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 16.6 m -96.36 154.94 3.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.203 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 9.8 t70 -93.22 -178.29 4.72 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.443 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.279 0.2 OUTLIER -29.5 106.92 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -166.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 36.0 m -86.01 167.32 24.54 Favored Pre-proline 0 N--CA 1.421 -1.908 0 CA-C-N 113.052 -1.886 . . . . 0.0 108.198 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.718 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 86.7 Cg_exo -42.36 127.15 4.14 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.641 2.894 . . . . 0.0 113.351 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.428 ' HB3' HE22 ' A' ' 89' ' ' GLN . 0.0 OUTLIER -65.78 151.12 47.36 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.915 -177.084 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.549 ' CG2' ' HB ' ' A' ' 60' ' ' THR . 52.6 t -125.91 139.77 50.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-O 122.028 0.918 . . . . 0.0 112.774 -173.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.45 -143.48 6.18 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.63 126.88 13.92 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 120.658 2.229 . . . . 0.0 111.416 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 63.32 17.69 10.44 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.127 1.371 . . . . 0.0 113.237 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HB2' HG13 ' A' ' 26' ' ' VAL . 88.6 mtt180 -89.43 -15.86 32.21 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.079 -1.638 . . . . 0.0 111.305 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD12 ' HE3' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -73.94 -36.69 64.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 -177.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -64.95 -34.97 79.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.4 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -71.78 -40.53 69.19 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.8 tp -58.37 -44.0 88.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.818 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HE3' HD12 ' A' ' 31' ' ' LEU . 98.6 mttt -54.51 -30.18 52.7 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.183 0.593 . . . . 0.0 112.512 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.476 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 55.6 t30 -84.49 -32.41 23.98 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.196 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 34' ' ' LEU . 8.6 p -78.07 -27.48 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.969 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 34' ' ' LEU . 39.3 mm -54.3 -51.79 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.642 0.734 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -68.21 -17.79 64.41 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.552 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.8 mmtp -85.28 -38.02 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.868 0.842 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mm -73.78 -53.89 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.74 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.61 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 61.7 m-85 -78.67 -16.93 56.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.9 p -65.73 -19.73 66.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.725 0.774 . . . . 0.0 110.829 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -73.22 -7.43 51.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.569 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.87 4.36 27.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.527 0.68 . . . . 0.0 110.279 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.89 -161.62 23.79 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.393 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -87.77 128.02 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.6 mm -75.35 89.73 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.935 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p -79.83 -52.37 7.99 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.496 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 17.7 m120 -126.33 138.86 53.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.0 0.429 . . . . 0.0 110.447 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -141.62 137.48 31.89 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.212 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 56.0 m-85 -135.39 98.69 4.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.461 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -108.97 122.14 40.82 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.868 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.81 176.34 10.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.57 2.18 . . . . 0.0 109.972 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.199 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 26' ' ' VAL . 4.8 t . . . . . 0 N--CA 1.418 -2.025 0 CA-C-O 122.229 1.014 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.547 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -105.47 175.9 5.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.442 178.158 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.9 20.23 36.6 Favored Glycine 0 C--N 1.292 -1.874 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.115 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 7.0 p90 -170.74 151.73 3.55 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 122.293 0.237 . . . . 0.0 110.499 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 20' ' ' VAL . 18.8 pt -146.03 163.33 10.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 70.8 m-85 -119.39 136.8 54.12 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.75 0.31 . . . . 0.0 110.673 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.7 mm? -123.08 124.58 43.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 7.1 tp10 -119.41 128.16 53.78 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.61 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 25.7 m-85 -127.06 -178.28 4.36 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.53 10.95 11.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.354 0.597 . . . . 0.0 109.541 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.2 p -81.67 163.43 54.0 Favored Pre-proline 0 CA--C 1.583 2.222 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -34.96 9.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.663 2 C-N-CA 130.556 7.504 . . . . 0.0 123.358 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.649 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 86.18 65.59 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.731 0 CA-C-O 124.975 2.321 . . . . 0.0 108.557 -163.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 29.3 p-80 -79.49 -37.2 37.34 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 109.127 -3.67 . . . . 0.0 110.16 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.03 48.15 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.715 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 72' ' ' ALA . 3.0 p -65.5 -29.79 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.01 -45.95 13.45 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.83 71.06 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.728 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.2 t -65.1 -45.93 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-O 121.072 0.463 . . . . 0.0 111.748 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.39 -27.39 61.44 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -120.63 -45.47 2.41 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.483 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -88.27 -8.22 55.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -171.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.446 ' HA ' HG23 ' A' ' 94' ' ' VAL . 17.3 t70 -61.07 113.13 2.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.357 0.599 . . . . 0.0 112.366 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.01 47.89 3.75 Favored Glycine 0 N--CA 1.42 -2.426 0 CA-C-N 114.922 -1.035 . . . . 0.0 114.603 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 33.0 p90 -107.83 133.97 51.44 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.677 -1.209 . . . . 0.0 109.96 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -100.95 128.47 46.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.233 0.54 . . . . 0.0 112.342 -176.619 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.6 mt -84.79 -62.72 1.48 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.818 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -160.95 154.12 21.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.571 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 45.99 -107.19 0.14 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.428 HE22 ' HB3' ' A' ' 25' ' ' GLN . 14.3 pm0 -103.86 -10.23 18.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.718 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m80 -68.27 93.79 0.49 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.128 -171.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 3.4 m -132.73 118.87 19.61 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -90.37 105.41 17.79 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.499 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.8 mmm180 -83.15 143.03 30.78 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 82' ' ' ASP . 58.5 t -106.47 107.01 21.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.344 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 N--CA 1.403 -2.776 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.019 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.7 p -114.96 -14.36 11.87 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 60.2 t -139.16 137.17 41.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.963 -0.461 . . . . 0.0 110.762 -172.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 mm -97.25 135.14 32.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 54.4 t -116.1 105.92 19.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 1.7 m -107.82 122.89 62.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.156 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 21.7 t70 -92.73 138.03 31.84 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.613 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.47 24.9 p-10 45.94 86.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 128.513 2.725 . . . . 0.0 115.66 -175.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 35.5 m -89.27 165.78 24.59 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.771 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.3 Cg_endo -45.92 150.19 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.474 2.783 . . . . 0.0 114.125 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HA ' HG21 ' A' ' 60' ' ' THR . 5.7 pt20 -89.46 161.89 16.02 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.561 -173.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 27' ' ' GLY . 60.9 t -129.15 138.89 53.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.517 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 26' ' ' VAL . . . -102.34 -177.27 27.51 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.49 124.89 16.18 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 120.15 1.975 . . . . 0.0 112.067 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 53.76 23.44 3.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.187 1.795 . . . . 0.0 114.167 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB2' HG13 ' A' ' 26' ' ' VAL . 13.8 mtm180 -90.1 -2.61 58.12 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.183 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -63.17 -36.37 83.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 110.075 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -61.39 -47.42 85.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.542 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -74.83 -24.81 58.67 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.013 0.435 . . . . 0.0 110.135 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 38' ' ' ILE . 3.0 tm? -61.97 -49.39 76.29 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -55.51 -31.95 62.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.419 0.628 . . . . 0.0 111.123 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.45 -41.8 38.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.232 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.35 -30.71 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 34' ' ' LEU . 22.2 mm -62.59 -53.39 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -55.43 -36.74 66.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.955 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 40' ' ' LYS . 47.8 tptt -69.13 -53.12 21.85 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.476 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 34.9 mm -56.16 -50.24 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.689 0.757 . . . . 0.0 110.484 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.533 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.4 m-85 -77.04 -0.67 25.48 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.6 m -69.96 -12.51 61.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.275 0.559 . . . . 0.0 110.204 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 29.5 mmmt -72.13 -16.5 62.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.057 0.456 . . . . 0.0 109.998 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.4 6.98 40.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.699 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.58 -156.4 19.96 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.18 128.48 42.05 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.482 HD12 HD12 ' A' ' 66' ' ' LEU . 32.0 mm -74.11 115.14 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 m -86.96 -41.92 13.55 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 68.6 m-20 -154.77 160.92 41.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.903 0.881 . . . . 0.0 109.695 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 41.5 t0 -150.95 151.86 32.75 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -139.17 102.25 4.46 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.654 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -107.12 123.5 38.14 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.926 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 72.7 Cg_endo -82.21 177.57 7.08 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.061 2.507 . . . . 0.0 108.25 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.36 0 O-C-N 120.732 -1.23 . . . . 0.0 109.879 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 25' ' ' GLN . 13.3 m . . . . . 0 N--CA 1.424 -1.742 0 CA-C-O 121.823 0.821 . . . . 0.0 112.872 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -112.37 173.49 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.399 174.642 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.28 27.27 9.1 Favored Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.949 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 12.1 p90 -169.07 147.84 3.94 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 pt -146.03 176.18 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.347 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 92.6 m-85 -140.18 114.73 9.36 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.019 0.827 . . . . 0.0 111.481 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 48' ' ' ILE . 3.9 mm? -93.66 116.81 29.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.808 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 39.3 tt0 -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.71 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 3.5 m-85 -127.54 171.14 11.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.49 12.66 22.87 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.459 ' HB3' ' ND1' ' A' ' 73' ' ' HIS . 48.0 t -73.26 155.89 89.59 Favored Pre-proline 0 CA--C 1.59 2.495 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.177 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -36.4 8.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.529 3.593 1 C-N-CA 130.72 7.613 . . . . 0.0 122.27 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 86.45 62.59 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 124.981 2.324 . . . . 0.0 107.97 -164.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.71 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 24.1 p-80 -77.65 -36.4 51.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 109.184 -3.644 . . . . 0.0 109.999 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.48 69.21 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.982 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.12 -26.72 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.31 -46.91 12.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.2 79.9 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.448 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.47 -33.33 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.968 0.413 . . . . 0.0 112.046 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -85.42 -29.08 24.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.641 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -109.9 -39.11 5.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.412 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -93.35 0.97 57.1 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.15 103.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.433 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.54 47.69 3.42 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.694 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.412 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 24.3 p90 -103.78 127.29 51.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.523 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -98.01 130.24 44.85 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.652 -173.076 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -85.96 -71.82 0.52 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -171.86 172.36 4.84 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 52.58 -95.93 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.099 1.76 . . . . 0.0 114.693 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -121.58 -1.12 9.6 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.089 0.471 . . . . 0.0 109.917 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.771 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 10.8 m170 -87.1 99.03 11.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.219 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.44 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 3.6 m -133.34 110.0 9.75 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -81.84 108.7 15.58 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.372 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -90.52 130.24 36.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.7 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.46 105.88 19.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.693 0.758 . . . . 0.0 110.585 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.291 -1.943 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.943 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.736 ' HA ' ' HE2' ' A' ' 73' ' ' HIS . 12.5 m -100.01 13.36 34.24 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -170.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.4 p -137.08 138.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.911 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 mm -111.62 137.91 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.59 113.87 36.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG2' HG12 ' A' ' 64' ' ' ILE . 14.3 m -110.14 137.67 41.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.306 0.574 . . . . 0.0 110.768 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.447 ' C ' HD22 ' A' ' 22' ' ' ASN . 20.7 t70 -97.74 139.73 33.19 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.757 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.447 HD22 ' C ' ' A' ' 21' ' ' ASP 0.423 0.1 OUTLIER 46.06 86.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.82 2.448 . . . . 0.0 115.536 -179.837 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.506 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.4 m -84.83 163.61 45.6 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.151 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.791 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.7 Cg_endo -42.73 145.43 1.07 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 124.509 3.473 . . . . 0.0 117.556 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -62.53 151.72 36.81 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 111.648 -2.523 . . . . 0.0 111.085 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 27' ' ' GLY . 8.1 p -132.01 146.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.326 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -95.37 171.48 29.48 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 169.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.37 125.62 18.49 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 CA-C-N 120.465 2.133 . . . . 0.0 112.286 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.02 22.49 12.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.599 1.16 . . . . 0.0 111.786 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.467 ' HD2' ' H ' ' A' ' 27' ' ' GLY . 95.9 mtt180 -92.88 -2.5 55.81 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.697 -1.252 . . . . 0.0 111.102 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -62.1 -23.57 66.6 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.744 0.307 . . . . 0.0 110.703 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.48 -47.24 76.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.468 0.707 . . . . 0.0 109.194 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -69.7 -38.21 76.88 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.893 0.854 . . . . 0.0 109.502 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.434 HD23 HG23 ' A' ' 26' ' ' VAL . 4.1 mm? -72.09 -6.01 39.41 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.507 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 61.9 mttp -85.33 -31.41 23.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.162 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 22.6 t-20 -73.61 -44.61 56.68 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.158 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.46 -33.05 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.566 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.94 -62.54 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.185 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 36' ' ' ASN . 4.9 p-80 -65.3 -20.13 66.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -70.55 -60.13 2.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 81.9 mt -67.67 -44.12 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.02 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -68.72 -9.68 51.95 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -67.75 -2.28 6.79 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 19.0 ptmt -70.56 -35.22 72.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.111 0.482 . . . . 0.0 110.584 171.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CD2' ' HG3' ' A' ' 44' ' ' LYS . 97.3 m-85 -80.08 -14.97 58.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.326 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 145.52 -161.3 28.2 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -91.5 138.74 31.33 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.04 89.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.99 -38.98 52.06 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 3.3 t-20 -148.64 139.85 23.23 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -144.27 153.91 42.52 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 73.5 m-85 -132.13 103.26 6.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -108.54 106.74 59.27 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.69 173.17 13.8 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 121.156 1.238 . . . . 0.0 111.902 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--N 1.298 -1.663 0 C-N-CA 123.631 0.772 . . . . 0.0 109.481 -178.835 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 26' ' ' VAL . 5.8 t . . . . . 0 N--CA 1.422 -1.864 0 CA-C-O 122.881 1.325 . . . . 0.0 113.37 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 61' ' ' LYS . 5.6 pttp -53.55 161.02 1.12 Allowed 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.748 166.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.69 18.23 13.13 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.002 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 28.9 p90 -169.96 155.34 5.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.515 HG12 ' CG2' ' A' ' 20' ' ' VAL . 22.4 pt -146.65 168.36 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 49.4 m-85 -131.84 133.04 44.23 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 2.1 mm? -114.13 132.81 55.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 1.6 tm-20 -126.41 115.7 20.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.584 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 81.5 m-85 -123.29 175.91 6.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.626 0.727 . . . . 0.0 111.185 -174.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.12 13.98 12.17 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.54 1.136 . . . . 0.0 108.425 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.58 ' OG ' ' HD2' ' A' ' 71' ' ' PRO . 23.1 t -75.61 161.17 77.34 Favored Pre-proline 0 CA--C 1.596 2.732 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.297 -172.001 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HD2' ' OG ' ' A' ' 70' ' ' SER . 1.2 Cg_exo -36.1 8.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.967 1 C-N-CA 129.921 7.081 . . . . 0.0 121.931 177.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 75' ' ' VAL . . . 85.93 62.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.987 2.327 . . . . 0.0 108.08 -164.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.736 ' HE2' ' HA ' ' A' ' 16' ' ' SER . 17.5 p80 -73.43 -30.06 62.97 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 109.646 -3.434 . . . . 0.0 109.561 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.07 64.08 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.287 1.042 . . . . 0.0 108.582 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 78' ' ' VAL . 57.4 t -75.25 -30.22 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.254 176.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.65 -41.78 62.25 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.48 75.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.826 0.45 . . . . 0.0 111.218 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 75' ' ' VAL . 1.1 p -67.55 -26.73 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.381 0.61 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -33.82 67.01 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.206 1.003 . . . . 0.0 110.656 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.06 -76.55 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.658 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . 177.32 106.54 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 123.954 0.784 . . . . 0.0 110.489 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.546 ' HB2' HG22 ' A' ' 94' ' ' VAL . 1.6 t70 -65.52 108.81 2.13 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 170.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.78 52.53 1.51 Allowed Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 41.8 p90 -97.72 133.13 42.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.199 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -101.84 129.57 48.09 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.987 -172.119 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.21 -63.37 1.33 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.865 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -161.07 157.22 25.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.029 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 42.15 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.262 1.825 . . . . 0.0 114.187 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -119.5 8.78 11.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.524 0.602 . . . . 0.0 111.825 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.791 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 22.4 m170 -85.02 93.72 8.66 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -132.84 103.64 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.508 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.22 112.32 19.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.5 mpt_? -81.23 142.8 32.82 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 82' ' ' ASP . 14.6 m -120.1 128.94 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.878 -173.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.305 -1.367 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 170.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.481 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 35.6 t70 . . . . . 0 N--CA 1.424 -1.746 0 CA-C-O 122.88 1.324 . . . . 0.0 108.104 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.545 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 42.8 m -116.37 14.36 15.69 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.694 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 61.5 t -138.04 131.83 42.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.77 -0.581 . . . . 0.0 110.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 9.7 mm -88.93 135.32 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.97 121.46 62.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.858 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.498 HG13 ' HB3' ' A' ' 92' ' ' PHE . 90.9 t -121.1 133.51 67.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.319 0.387 . . . . 0.0 111.816 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.9 t70 -101.1 137.51 39.36 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 109.52 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.424 0.2 OUTLIER 45.88 104.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 127.106 2.162 . . . . 0.0 116.397 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.541 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 17.1 m -109.61 172.17 3.84 Favored Pre-proline 0 C--N 1.289 -2.063 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.437 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 80.9 Cg_exo -42.4 133.14 4.97 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.292 2.661 . . . . 0.0 112.043 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HA ' HG23 ' A' ' 60' ' ' THR . 4.7 pm0 -74.39 155.63 37.9 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.331 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 31' ' ' LEU . 2.3 t -123.05 165.68 18.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.778 -167.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.26 -169.62 30.11 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.53 124.69 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.867 2.333 . . . . 0.0 111.99 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 58.62 17.87 5.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.3 1.84 . . . . 0.0 113.326 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -79.55 -26.98 41.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.022 -1.049 . . . . 0.0 109.814 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.589 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.5 tm? -69.65 -27.48 65.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.427 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.29 -40.55 94.57 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.928 0.394 . . . . 0.0 111.053 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -91.81 -13.84 30.78 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.244 0.545 . . . . 0.0 111.569 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.605 ' O ' HG12 ' A' ' 38' ' ' ILE . 7.2 tt -68.12 -37.61 81.3 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 91.5 mttt -57.8 -25.62 60.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 27.9 t-20 -81.71 -44.68 16.75 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.153 -171.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 41' ' ' ILE . 14.7 p -67.68 -32.52 57.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.793 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.7 mm -67.63 -52.53 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.465 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -56.31 -38.46 71.32 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.583 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.0 mmmt -67.08 -48.02 69.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 37' ' ' VAL . 47.3 mm -66.78 -43.98 89.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.512 0.672 . . . . 0.0 110.573 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.494 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.2 m-85 -83.87 -9.86 58.43 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -171.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -72.4 -3.04 21.73 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.485 -0.759 . . . . 0.0 111.339 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.12 -21.72 42.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.174 0.511 . . . . 0.0 110.007 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -97.33 1.62 49.66 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.656 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.31 -151.79 22.04 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.88 128.01 52.92 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.546 HD12 HD12 ' A' ' 66' ' ' LEU . 47.3 mm -73.08 104.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -79.82 -41.33 26.62 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.177 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -156.14 161.14 40.38 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -142.66 144.69 32.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 117.977 0.353 . . . . 0.0 110.321 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.23 100.44 5.39 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.448 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -107.82 103.48 49.7 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.72 170.49 15.55 Favored 'Trans proline' 0 C--O 1.208 -0.979 0 C-N-CA 121.659 1.572 . . . . 0.0 109.95 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 14.6 pt-20 . . . . . 0 C--N 1.303 -1.447 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 25' ' ' GLN . 48.2 m . . . . . 0 N--CA 1.438 -1.057 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 49.1 mttm -74.0 169.37 17.62 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.07 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.29 -8.62 6.4 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.94 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -169.54 159.66 8.56 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 pt -147.21 172.05 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.767 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.9 m-85 -136.26 137.09 40.4 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.665 0.603 . . . . 0.0 109.975 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.546 HD12 HD12 ' A' ' 48' ' ' ILE . 3.6 mm? -111.94 116.48 30.68 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -99.44 124.03 44.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.648 0.737 . . . . 0.0 110.668 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 6.2 m-85 -123.13 -176.42 3.42 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.74 7.65 11.06 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.867 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.663 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.6 m -79.66 154.57 76.06 Favored Pre-proline 0 CA--C 1.591 2.548 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -165.461 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -39.16 6.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.96 2 C-N-CA 130.76 7.64 . . . . 0.0 123.16 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.481 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.23 65.25 0.01 OUTLIER 'General case' 0 C--N 1.367 1.329 0 CA-C-N 122.238 2.29 . . . . 0.0 108.86 -158.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 29.6 p80 -95.63 -24.67 16.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 109.36 -3.564 . . . . 0.0 107.738 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -81.11 -33.86 32.99 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.401 ' CG1' ' HB1' ' A' ' 72' ' ' ALA . 2.7 p -66.42 -26.88 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.611 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 15.8 t70 -69.5 -38.06 77.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.76 94.0 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.291 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 74' ' ' ALA . 92.8 t -57.84 -46.76 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -84.89 -15.58 44.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -109.89 -68.38 0.93 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 75.41 0.94 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.559 0.695 . . . . 0.0 111.759 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' A' ' 94' ' ' VAL . 6.0 t70 -111.42 134.91 52.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.731 175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.48 77.45 Favored Glycine 0 C--N 1.308 -0.993 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -92.33 130.97 37.88 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.097 0.475 . . . . 0.0 110.299 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.6 126.61 44.24 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.518 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.7 mt -87.29 -61.6 1.69 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -174.21 149.0 1.36 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.381 -174.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 58.92 -81.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -122.27 -9.52 8.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.298 1.039 . . . . 0.0 110.148 -172.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.575 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 11.4 m170 -92.97 88.63 6.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.915 -167.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 m -132.95 98.19 4.22 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.498 ' HB3' HG13 ' A' ' 20' ' ' VAL . 53.2 m-85 -83.35 113.91 21.06 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.472 -169.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 2.9 mpt_? -89.05 136.85 32.79 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 82' ' ' ASP . 4.8 m -113.82 151.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-O 121.619 0.723 . . . . 0.0 110.808 -172.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 . . . . . 0 N--CA 1.401 -2.921 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.584 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.63 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 5.6 t70 . . . . . 0 C--O 1.18 -2.585 0 CA-C-O 121.613 0.72 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.575 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 16.3 m -85.1 -1.49 56.93 Favored 'General case' 0 C--N 1.273 -2.751 0 O-C-N 120.585 -1.322 . . . . 0.0 113.72 -172.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 60.7 t -117.67 128.48 74.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.442 -175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 18.6 mm -94.85 136.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.01 119.34 23.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 15.5 m -125.09 133.33 69.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.87 135.5 39.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.33 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.483 0.2 OUTLIER 48.34 85.64 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.675 2.39 . . . . 0.0 116.983 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.46 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 16.8 m -81.93 169.76 17.43 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.467 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 2.0 Cg_endo -44.35 138.05 7.55 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 123.286 2.657 . . . . 0.0 112.312 173.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.565 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 3.8 pm0 -69.35 154.92 41.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.23 147.64 28.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.032 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.94 175.34 16.28 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.73 126.88 23.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.023 1.815 . . . . 0.0 111.928 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 68.17 17.41 9.39 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.002 1.321 . . . . 0.0 113.574 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -104.07 -6.18 21.37 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.163 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.539 HD21 ' HE2' ' A' ' 61' ' ' LYS . 1.2 tm? -66.87 -31.5 72.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.122 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.31 -40.03 92.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.44 -13.46 52.03 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.2 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 37' ' ' VAL . 8.6 tt -72.86 -28.35 62.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.21 -22.06 66.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.629 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 t-20 -79.78 -43.67 22.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.257 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 34' ' ' LEU . 9.0 p -63.9 -24.6 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.369 -174.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mm -55.61 -59.82 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.044 0.938 . . . . 0.0 110.408 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -73.08 -17.0 61.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 30.5 mmmt -71.39 -52.25 19.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.03 -52.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.127 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 22.7 m-85 -73.49 -6.43 46.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 p -71.82 -18.3 62.09 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.84 0.829 . . . . 0.0 110.455 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.557 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -84.8 -3.84 58.81 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.21 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 76.5 m-85 -120.23 18.55 12.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.14 -174.89 21.93 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -101.6 138.59 38.39 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.9 mm -75.68 88.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.3 m -82.06 -55.37 4.61 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.879 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 19.7 m120 -137.08 145.73 44.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -137.26 135.75 37.46 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -128.19 110.7 12.67 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.414 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.422 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 8.3 m-85 -106.05 106.29 56.44 Favored Pre-proline 0 N--CA 1.425 -1.685 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.59 173.67 12.0 Favored 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 122.182 1.922 . . . . 0.0 109.885 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 C--N 1.291 -1.977 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.271 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 121.404 0.621 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HE2' HD21 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -88.72 160.27 17.4 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.431 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.01 21.31 3.72 Favored Glycine 0 CA--C 1.489 -1.574 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.066 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 31.7 p90 -170.81 148.21 2.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.498 HG12 ' CG2' ' A' ' 20' ' ' VAL . 21.5 pt -141.41 166.16 18.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 76.8 m-85 -136.41 134.34 37.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.4 mp -120.6 145.32 47.49 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.789 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 9.3 tp10 -124.28 116.12 22.13 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.568 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 12.4 m-30 -118.31 171.6 8.02 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.78 14.26 13.37 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.63 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.3 m -75.74 160.15 79.64 Favored Pre-proline 0 CA--C 1.608 3.187 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -170.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 24.1 Cg_exo -39.99 7.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.054 2 C-N-CA 129.972 7.115 . . . . 0.0 123.997 -179.016 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.63 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.36 66.77 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 CA-C-N 122.46 2.391 . . . . 0.0 106.579 -155.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.63 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 26.6 p80 -97.02 -36.95 10.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.566 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.602 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -80.88 -20.84 41.37 Favored 'General case' 0 CA--C 1.474 -1.955 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.251 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 p -59.45 -30.07 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -83.53 -49.29 9.38 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 74' ' ' ALA . . . -55.49 -42.58 74.62 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.395 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 42.7 t -66.88 -22.85 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 123.181 0.592 . . . . 0.0 111.556 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -85.72 -47.52 9.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.153 0.978 . . . . 0.0 109.805 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.52 -11.69 50.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 -167.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.42 13.25 13.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.188 0.518 . . . . 0.0 110.278 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 9.3 t70 -78.93 106.37 10.91 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.46 51.68 6.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 114.518 -1.219 . . . . 0.0 115.405 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.2 m-85 -101.5 106.18 17.25 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 2.8 mptt -77.41 99.64 5.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.57 -52.45 65.52 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.001 0.429 . . . . 0.0 110.544 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.525 ' OD2' ' HG2' ' A' ' 88' ' ' LYS . 27.4 t70 -151.54 -76.13 0.14 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.877 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HG2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -100.86 -101.21 0.25 Allowed 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.376 0.607 . . . . 0.0 112.596 178.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.565 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -92.55 3.33 55.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 111.701 -175.911 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -86.99 96.54 10.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 39.5 m -133.41 123.98 26.31 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.88 101.85 13.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.476 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -93.92 126.42 39.11 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.3 150.62 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.31 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 N--CA 1.397 -3.108 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.658 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.5 -0.962 0 CA-C-O 121.152 0.501 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.563 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 21.4 m -107.28 6.2 28.31 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.3 t -139.27 135.72 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 mm -101.04 130.34 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.09 110.55 29.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 92' ' ' PHE . 70.6 t -97.83 135.51 32.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 123.924 0.765 . . . . 0.0 111.763 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -107.1 132.11 53.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 47.79 100.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.846 2.058 . . . . 0.0 116.49 -178.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.554 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 22.5 m -91.57 173.77 5.01 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.668 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.664 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 98.8 Cg_exo -42.53 146.0 0.86 Allowed 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.195 2.596 . . . . 0.0 113.772 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.42 121.25 26.48 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.407 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 31' ' ' LEU . 5.2 p -121.98 137.57 55.14 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.8 -173.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.54 169.35 13.16 Favored Glycine 0 N--CA 1.405 -3.394 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.27 127.67 22.88 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.123 2.548 . . . . 0.0 112.775 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 73.66 21.15 2.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.998 1.319 . . . . 0.0 112.904 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -116.63 -1.58 12.12 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.095 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' HB2' HG21 ' A' ' 26' ' ' VAL . 3.3 tm? -67.53 -35.65 79.49 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -173.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 40.8 tt0 -63.27 -37.0 85.53 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -78.05 -32.58 50.94 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.543 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.537 ' O ' HG12 ' A' ' 38' ' ' ILE . 9.4 mp -71.7 -26.02 62.32 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.162 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 ptmm? -82.47 -18.22 42.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.628 0.728 . . . . 0.0 109.412 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -82.19 -37.79 25.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.201 -177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 41' ' ' ILE . 10.3 p -66.09 -32.12 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.941 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 34' ' ' LEU . 30.4 mm -58.36 -55.27 23.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.374 0.607 . . . . 0.0 109.465 173.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -55.14 -41.59 71.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.6 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -60.96 -57.44 12.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.599 0.76 . . . . 0.0 111.403 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 37' ' ' VAL . 41.2 mm -55.7 -51.06 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.656 0.741 . . . . 0.0 111.229 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.564 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 65.8 m-85 -74.57 -6.17 47.03 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -173.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -70.57 -11.91 61.23 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.66 -0.65 . . . . 0.0 111.428 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -74.79 -14.92 60.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.447 0.642 . . . . 0.0 110.58 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.07 0.63 32.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.746 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 137.27 -166.18 25.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.94 129.22 37.95 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.479 HD12 HD12 ' A' ' 66' ' ' LEU . 26.3 mm -74.75 103.69 2.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.4 m -71.55 -55.34 8.02 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -145.22 169.31 18.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.604 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 51.5 t0 -158.35 160.52 37.04 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 175.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.63 103.26 5.17 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -171.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.449 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 21.7 m-85 -108.2 105.07 55.78 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.591 -175.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.486 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 96.7 Cg_endo -89.26 164.13 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.402 1.402 . . . . 0.0 109.592 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--N 1.305 -1.347 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.675 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.419 -2.007 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 3.4 pttm -69.97 160.33 32.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.192 165.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.69 14.77 12.87 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.129 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -169.05 152.49 5.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 117.185 0.493 . . . . 0.0 110.986 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -147.37 174.87 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.262 1.736 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 86.6 m-85 -141.56 113.94 8.2 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.313 0.506 . . . . 0.0 110.447 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.479 HD12 HD12 ' A' ' 48' ' ' ILE . 3.7 mm? -89.62 108.89 19.94 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.32 123.54 45.58 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 22.2 m-85 -121.17 175.86 5.89 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 13.78 12.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.529 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 11.7 m -77.3 158.99 78.7 Favored Pre-proline 0 CA--C 1.581 2.159 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -170.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 4.7 Cg_endo -39.88 7.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.511 2.515 1 C-N-CA 129.866 7.044 . . . . 0.0 121.743 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.615 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 84.41 65.45 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 124.706 2.193 . . . . 0.0 107.534 -160.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.563 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 27.2 p80 -82.6 -36.18 26.39 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 109.612 -3.449 . . . . 0.0 108.809 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.37 -28.44 63.01 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.501 -176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.7 p -68.09 -24.41 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.571 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 26.8 t70 -83.78 -41.84 17.15 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.83 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.51 79.49 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.365 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.458 HG12 HG23 ' A' ' 94' ' ' VAL . 34.4 m -66.03 -21.56 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.439 0.638 . . . . 0.0 111.69 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 27.3 ttpp -79.31 -43.6 23.28 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.785 0.803 . . . . 0.0 110.73 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.64 -56.09 4.06 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.344 -171.208 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.44 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . . . -155.9 87.97 1.09 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.173 -1.011 . . . . 0.0 113.4 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.474 ' CB ' HG22 ' A' ' 94' ' ' VAL . 2.7 t70 -77.42 109.83 11.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.273 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 56.17 0.57 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' THR . 78.7 m-85 -67.59 99.33 0.76 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.51 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -85.01 100.0 11.38 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -78.15 -50.84 11.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -150.22 174.53 12.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -30.97 -61.98 0.18 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.767 2.027 . . . . 0.0 114.979 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -105.1 12.71 31.79 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.882 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.664 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 15.7 m80 -117.05 100.67 7.89 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.249 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 9.0 m -133.02 101.1 5.1 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.005 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.2 m-85 -82.39 106.47 14.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.522 -171.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -78.88 137.4 37.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 173.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.474 HG22 ' CB ' ' A' ' 82' ' ' ASP . 6.4 m -114.66 149.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 123.697 0.623 . . . . 0.0 109.681 -170.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.282 -2.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 18.2 p-10 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 71' ' ' PRO . 5.1 m -101.37 11.66 38.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -167.502 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.8 141.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.909 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.481 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 32.5 mm -100.29 132.93 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 67.9 t -135.88 109.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.433 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 m -112.51 123.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.532 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.45 144.61 27.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.345 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' GLY 0.533 0.3 OUTLIER 42.93 80.5 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 -176.694 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 19.4 m -91.57 168.09 14.09 Favored Pre-proline 0 N--CA 1.425 -1.719 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.284 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.789 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 73.3 Cg_exo -45.58 129.05 11.1 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.597 2.865 . . . . 0.0 113.502 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.45 153.46 41.38 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.244 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' A' ' 60' ' ' THR . 10.7 p -92.71 134.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 118.589 -1.245 . . . . 0.0 111.382 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 30' ' ' ARG . . . -123.21 176.35 16.65 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 105.765 -2.934 . . . . 0.0 105.765 171.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -50.97 127.05 20.35 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.557 2.171 . . . . 0.0 112.14 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.31 23.42 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.122 1.369 . . . . 0.0 112.85 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 58.9 mtp180 -105.2 -10.99 16.75 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.36 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.412 ' HB2' HG21 ' A' ' 26' ' ' VAL . 1.7 tm? -73.35 -42.05 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.066 -175.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.59 -37.91 88.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.046 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -81.25 -17.7 48.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.658 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.6 tp -70.02 -39.7 75.65 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -39.61 84.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.163 0.982 . . . . 0.0 109.816 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.46 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 41.6 t-20 -78.35 -37.5 44.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.644 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 34' ' ' LEU . 5.1 p -65.28 -29.36 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 34' ' ' LEU . 36.5 mm -64.94 -50.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -63.48 -20.12 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.724 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.46 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 62.1 mttm -86.23 -60.1 2.1 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.412 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.584 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 77.9 mt -66.22 -42.22 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CD2' HD11 ' A' ' 66' ' ' LEU . 3.3 m-85 -79.31 -23.57 43.41 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -170.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 67.3 m -64.43 -8.17 12.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 21.7 ptmt -68.35 -33.04 73.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 77' ' ' ALA . 30.0 m-85 -83.33 -17.19 43.3 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.595 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 153.16 -177.84 30.56 Favored Glycine 0 C--O 1.219 -0.81 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -76.86 131.93 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.09 103.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -82.02 -60.68 2.14 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.789 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 91.3 m-20 -126.91 122.97 36.11 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.74 133.68 53.13 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.47 102.9 8.76 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.08 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 12.6 m-30 -101.0 104.72 34.07 Favored Pre-proline 0 N--CA 1.428 -1.564 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.466 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 91.9 Cg_endo -87.81 173.92 4.95 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.008 1.805 . . . . 0.0 111.432 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--N 1.281 -2.371 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.209 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.447 ' OG1' HG12 ' A' ' 26' ' ' VAL . 13.5 t . . . . . 0 N--CA 1.43 -1.457 0 CA-C-O 121.381 0.61 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 13.6 pttm -79.35 163.94 24.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.493 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 22' ' ' ASN . . . -129.58 2.99 6.13 Favored Glycine 0 C--O 1.182 -3.133 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.046 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -154.99 156.04 35.27 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.933 -0.745 . . . . 0.0 109.833 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 pt -141.27 167.33 17.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.5 m-85 -131.92 141.07 49.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 42' ' ' PHE . 26.9 mt -127.87 149.35 50.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 50' ' ' ASN . 44.2 mt-10 -128.04 153.35 46.88 Favored 'General case' 0 C--O 1.255 1.388 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.37 159.89 29.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.26 73.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.521 1.128 . . . . 0.0 111.212 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 73' ' ' HIS . 28.5 t -123.72 128.25 25.22 Favored Pre-proline 0 CA--C 1.461 -2.472 1 N-CA-C 97.14 -5.133 . . . . 0.0 97.14 173.101 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 23.2 Cg_exo -62.49 -52.0 2.86 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 CA-C-N 121.813 1.683 . . . . 0.0 110.647 -165.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 26.52 5.79 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.807 0 C-N-CA 131.551 3.94 . . . . 0.0 119.657 144.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 71' ' ' PRO . 88.4 m-70 -127.24 -28.95 2.78 Favored 'General case' 1 C--N 1.225 -4.81 0 CA-C-O 121.214 0.53 . . . . 0.0 109.884 -170.22 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -69.25 -26.77 64.95 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.048 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.65 -24.86 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.07 -45.1 28.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . . . -57.4 -47.14 82.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.911 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.38 -18.0 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.109 0.48 . . . . 0.0 111.599 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -84.2 -24.59 30.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.42 -84.18 0.05 Allowed 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.89 109.45 3.21 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.253 0.549 . . . . 0.0 112.024 -173.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 94' ' ' VAL . 1.2 t70 -95.46 120.22 35.33 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.86 173.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.05 53.8 2.29 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.576 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -106.42 119.14 38.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.196 -0.591 . . . . 0.0 110.369 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -79.56 130.47 35.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.873 -175.671 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.36 -63.3 1.34 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -172.15 169.63 5.44 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HG2' ' OE1' ' A' ' 89' ' ' GLN . 24.3 ttmm 51.79 -104.04 0.17 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.651 1.18 . . . . 0.0 112.44 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.457 ' OE1' ' HG2' ' A' ' 88' ' ' LYS . 5.7 pm0 -121.61 11.93 10.63 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.959 0.885 . . . . 0.0 109.217 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.789 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 7.4 m170 -90.33 88.48 7.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.458 HG23 ' HG3' ' A' ' 85' ' ' LYS . 61.9 m -133.49 114.82 14.04 Favored 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.452 -178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -82.53 100.64 10.23 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.79 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.74 122.59 31.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.6 m -107.65 126.12 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.572 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 4.8 p-10 . . . . . 0 C--N 1.312 -1.027 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.96 179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 120.256 0.074 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.426 ' HA ' ' HE1' ' A' ' 73' ' ' HIS . 38.5 m -106.48 -7.53 17.5 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -172.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -134.92 135.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.231 -175.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -92.66 134.82 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.4 t -123.89 112.9 34.71 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.41 HG23 HG12 ' A' ' 64' ' ' ILE . 1.8 m -121.98 118.42 55.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.446 -178.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.77 148.81 22.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.263 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.442 0.1 OUTLIER 47.41 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 128.204 2.602 . . . . 0.0 114.776 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 32.3 m -90.77 163.63 29.32 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.043 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.617 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 0.9 OUTLIER -42.7 142.54 1.99 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 124.531 3.487 . . . . 0.0 114.987 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -80.52 159.38 25.53 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.323 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 27' ' ' GLY . 14.0 p -128.53 136.93 58.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.957 -177.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -101.51 168.09 19.42 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.96 126.87 19.85 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.834 2.356 . . . . 0.0 113.19 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.15 24.08 10.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.096 1.359 . . . . 0.0 112.996 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 20.0 mtp180 -107.3 -3.78 19.34 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.487 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -68.51 -33.92 74.98 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.54 -45.68 63.07 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.094 1.358 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -85.08 -29.17 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.022 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 38' ' ' ILE . 78.2 mt -64.51 -39.48 93.86 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.56 -21.26 61.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.479 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.7 t-20 -84.38 -38.18 20.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.246 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.05 -26.28 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 34' ' ' LEU . 44.0 mm -57.69 -51.32 71.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.059 175.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -62.88 -31.16 72.15 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 34.4 mmtp -65.69 -47.8 74.18 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.66 -47.86 78.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.63 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.539 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 68.4 m-85 -83.98 -11.76 56.32 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.5 p -69.31 -16.54 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 121.555 -0.715 . . . . 0.0 110.827 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.6 mmpt? -64.73 -24.75 67.66 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.347 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.23 -8.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.758 0.313 . . . . 0.0 111.39 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.95 -149.12 21.23 Favored Glycine 0 N--CA 1.428 -1.87 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.35 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -103.18 118.29 36.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 66' ' ' LEU . 23.0 mm -73.82 103.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.9 p -88.5 -23.74 23.14 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.007 0.432 . . . . 0.0 111.411 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -158.23 139.03 12.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.411 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 4.5 p30 -130.53 142.35 50.47 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.843 -0.536 . . . . 0.0 110.982 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 97.4 m-85 -128.23 98.97 5.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 7.4 m-30 -108.12 104.66 54.41 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.35 163.07 19.67 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.153 1.235 . . . . 0.0 109.863 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 8.3 pt-20 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 26' ' ' VAL . 7.0 t . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 42.2 mttm -57.38 168.39 0.79 Allowed 'General case' 0 C--O 1.245 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 110.883 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.51 -13.93 7.18 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.669 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -170.47 159.45 6.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 20' ' ' VAL . 25.7 pt -146.9 166.28 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 63.7 m-85 -132.43 134.26 44.89 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.463 HD12 HD12 ' A' ' 48' ' ' ILE . 3.1 mm? -112.87 117.63 32.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -107.15 130.81 54.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . 0.583 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -127.38 177.62 6.6 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.72 13.51 14.21 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.448 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . 29.6 m -79.11 151.0 75.37 Favored Pre-proline 0 CA--C 1.574 1.867 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.59 8.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.04 2 C-N-CA 130.593 7.529 . . . . 0.0 122.751 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 85.33 64.64 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 124.576 2.131 . . . . 0.0 106.928 -160.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.583 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 53.4 p-80 -90.34 -36.35 14.7 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 109.129 -3.669 . . . . 0.0 107.662 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.67 -31.02 69.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.311 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 72' ' ' ALA . 4.0 p -65.92 -28.55 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.153 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -81.5 -40.0 23.89 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.854 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.43 75.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.626 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.58 -38.74 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 C-N-CA 124.439 1.096 . . . . 0.0 111.198 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -73.06 -20.91 60.87 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.422 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -93.59 -56.52 2.88 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.694 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.62 97.85 3.66 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.466 ' CG ' HG22 ' A' ' 94' ' ' VAL . 5.5 t0 -112.0 122.69 48.45 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.47 42.39 9.25 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.988 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' THR . 16.9 p90 -94.65 139.13 31.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.736 0.303 . . . . 0.0 110.939 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.51 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -103.36 123.84 47.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.029 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.09 -50.59 6.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.812 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.18 -167.19 2.48 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -27.6 -75.41 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.932 2.093 . . . . 0.0 115.541 -170.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.485 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 5.1 pm0 -111.12 12.62 21.92 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.27 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.617 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 6.3 m170 -88.46 88.88 7.77 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 5.1 m -133.49 102.07 5.38 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.39 118.54 22.76 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -167.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -88.34 125.19 34.57 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.466 HG22 ' CG ' ' A' ' 82' ' ' ASP . 4.1 m -94.56 147.78 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.067 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.297 -1.692 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 t70 . . . . . 0 C--O 1.193 -1.911 0 CA-C-O 121.967 0.889 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 t -109.04 -6.12 15.77 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 111.108 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 48.7 t -111.84 118.47 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 35.5 mm -84.11 139.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 49.9 t -130.71 113.09 23.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.103 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.62 HG12 HG12 ' A' ' 94' ' ' VAL . 12.0 m -120.24 131.93 71.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.22 142.88 29.34 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.994 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.484 0.2 OUTLIER 44.17 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.127 2.171 . . . . 0.0 115.815 -174.421 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.0 160.42 73.83 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.546 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' ND1' ' A' ' 90' ' ' HIS . 5.6 Cg_endo -46.64 132.94 16.78 Favored 'Trans proline' 0 CA--C 1.501 -1.138 0 C-N-CA 123.465 2.777 . . . . 0.0 114.28 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -54.7 138.05 42.69 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.311 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.11 138.42 27.47 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.205 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.4 -178.14 25.08 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.6 125.79 18.83 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.203 1.935 . . . . 0.0 112.299 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 51.71 22.53 1.68 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.519 1.928 . . . . 0.0 112.44 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -86.91 -17.92 32.08 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.354 -0.841 . . . . 0.0 111.253 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.17 -45.08 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -56.9 -56.95 15.06 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.465 0.478 . . . . 0.0 110.99 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -68.38 -24.19 64.75 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.522 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.61 ' O ' HG12 ' A' ' 38' ' ' ILE . 8.0 tt -70.69 -44.91 66.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -73.57 -18.07 61.11 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.324 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 93.0 m-20 -78.86 -41.73 29.17 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.591 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 34' ' ' LEU . 9.8 p -68.08 -32.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.989 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 34' ' ' LEU . 26.5 mm -61.09 -53.87 43.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 122.968 0.507 . . . . 0.0 109.661 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -53.34 -38.48 63.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.355 0.662 . . . . 0.0 109.916 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 28.0 mtpp -73.92 -48.87 27.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.082 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 88.4 mt -62.01 -40.74 88.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.135 0.493 . . . . 0.0 110.326 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 38' ' ' ILE . 2.4 m-30 -74.26 -11.99 60.43 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.31 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 -16.43 63.32 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.8 ptpt -67.32 -33.39 75.16 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 110.523 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 27.8 m-85 -79.79 -16.05 56.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.448 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.18 179.88 26.35 Favored Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.663 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -67.38 114.36 6.01 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.301 1.04 . . . . 0.0 110.816 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.3 mm -74.43 108.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.3 m -80.16 -45.2 18.52 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -154.03 153.15 31.41 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -131.62 150.69 52.06 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.037 0.535 . . . . 0.0 110.055 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.01 101.22 4.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . 0.507 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 34.8 m-85 -108.89 107.05 59.77 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.194 177.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 83.4 Cg_endo -95.44 173.22 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.864 1.709 . . . . 0.0 111.216 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 C-N-CA 125.7 1.6 . . . . 0.0 106.725 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 1.4 pttm -62.55 164.55 7.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.296 168.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.01 18.83 6.16 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.993 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -169.35 149.16 4.01 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ILE . . . . . 0.5 HG12 ' CG2' ' A' ' 20' ' ' VAL . 19.8 pt -142.84 168.18 13.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.4 m-85 -135.71 152.91 51.63 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.5 mp -135.0 154.48 51.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -130.24 128.17 41.09 Favored 'General case' 0 C--O 1.253 1.284 0 O-C-N 124.05 0.844 . . . . 0.0 109.273 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -104.75 176.59 5.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.98 -37.39 26.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.343 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 t -127.78 145.52 55.3 Favored Pre-proline 0 CA--C 1.466 -2.254 1 N-CA-C 99.534 -4.247 . . . . 0.0 99.534 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 73' ' ' HIS . 39.2 Cg_exo -63.64 -54.64 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.791 0 CA-C-N 122.193 1.819 . . . . 0.0 110.562 -171.162 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.8 4.07 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.654 1 C-N-CA 132.077 4.151 . . . . 0.0 119.824 148.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . 0.473 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 94.6 m-70 -129.32 -36.95 1.67 Allowed 'General case' 1 C--N 1.227 -4.754 0 C-N-CA 123.291 0.636 . . . . 0.0 110.045 -170.169 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.86 64.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.521 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.65 -31.9 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.256 0.551 . . . . 0.0 110.45 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -40.16 19.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.195 0.522 . . . . 0.0 109.759 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.8 86.05 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.639 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.572 ' HA ' HG21 ' A' ' 94' ' ' VAL . 53.2 t -65.59 -22.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.678 0.751 . . . . 0.0 111.16 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -83.8 -38.3 21.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -110.06 -25.91 9.98 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ALA . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . . . -101.47 7.11 42.62 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 122.018 -0.427 . . . . 0.0 111.793 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.613 ' HA ' HG22 ' A' ' 94' ' ' VAL . 14.4 t0 -76.63 103.35 6.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.59 8.41 Favored Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.585 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -105.3 136.38 44.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.101 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -106.72 129.33 54.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.662 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.5 mt -79.46 -62.45 1.69 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.891 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -155.48 133.81 11.67 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 53.1 -93.74 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 125.647 1.579 . . . . 0.0 114.792 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -107.33 -4.1 18.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 120.661 0.267 . . . . 0.0 110.819 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.495 ' ND1' ' HA ' ' A' ' 24' ' ' PRO . 6.9 m-70 -79.3 91.46 5.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.6 m -132.84 120.48 21.6 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.86 104.6 14.08 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.114 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.06 109.08 20.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.62 HG12 HG12 ' A' ' 20' ' ' VAL . 17.2 m -93.62 143.53 11.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 . . . . . 0 C--N 1.307 -1.263 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.066 176.459 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.565 0 N-CA-C 112.726 -0.15 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.5 135.32 33.67 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 117.354 0.577 . . . . 0.0 110.506 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.73 109.22 22.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.0 mt -101.57 -36.09 8.9 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -73.23 -46.94 47.36 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-O 121.506 0.669 . . . . 0.0 109.775 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.2 96.84 10.86 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -84.54 126.3 69.33 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.879 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.87 148.33 35.76 Favored 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 122.096 1.864 . . . . 0.0 110.766 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -106.02 157.38 17.56 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -74.9 -21.74 59.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.351 0.596 . . . . 0.0 109.807 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.07 134.62 34.66 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.985 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -164.96 137.43 4.47 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.48 -113.66 5.46 Favored Glycine 0 N--CA 1.443 -0.847 0 O-C-N 123.6 0.563 . . . . 0.0 113.33 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 tp -90.93 95.2 5.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 122.704 1.24 . . . . 0.0 111.182 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 6.7 p-10 -108.31 21.63 17.07 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.592 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -110.92 16.85 21.03 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.106 0.479 . . . . 0.0 111.438 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.19 132.23 63.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 9.6 mm -97.63 135.12 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.27 116.66 53.19 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 173.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 10.3 t -113.34 122.97 68.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.449 0.468 . . . . 0.0 110.216 -175.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.1 t70 -91.87 136.25 33.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.931 0.77 . . . . 0.0 111.182 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.48 29.9 p-10 41.5 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 128.043 2.537 . . . . 0.0 116.684 178.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.573 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 18.3 m -98.7 173.29 3.97 Favored Pre-proline 0 N--CA 1.427 -1.611 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.246 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.712 ' HA ' ' NE2' ' A' ' 90' ' ' HIS . 55.5 Cg_exo -41.16 127.58 2.9 Favored 'Trans proline' 0 C--O 1.266 1.903 0 C-N-CA 123.649 2.9 . . . . 0.0 114.223 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.84 -178.24 3.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.26 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 31' ' ' LEU . 6.6 p -111.93 134.23 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 118.885 -1.126 . . . . 0.0 113.325 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.78 157.08 15.28 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 104.263 -3.535 . . . . 0.0 104.263 166.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 9.3 Cg_endo -52.23 123.16 12.0 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 121.557 2.678 . . . . 0.0 112.266 -172.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 50.74 25.74 2.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.432 1.493 . . . . 0.0 112.89 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 28' ' ' PRO . 70.7 mtt180 -107.08 -8.4 16.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 122.061 -0.4 . . . . 0.0 110.952 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.608 ' HB2' HG23 ' A' ' 26' ' ' VAL . 2.9 tm? -73.53 -19.72 60.84 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.39 -48.39 74.4 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.978 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -79.17 -22.29 45.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.412 0.625 . . . . 0.0 110.372 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB2' HD22 ' A' ' 31' ' ' LEU . 97.7 mt -81.41 1.37 33.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 97.1 mttt -84.74 -43.23 14.47 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 48.9 t30 -75.71 -34.95 60.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.033 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.86 -32.78 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.656 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 mm -60.06 -59.01 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.539 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.06 -35.29 73.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.169 0.588 . . . . 0.0 110.542 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 29.9 mtpp -65.61 -39.91 92.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.794 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.3 -39.79 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.301 0.572 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.536 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 26.2 m-85 -76.22 -9.41 58.61 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -66.0 -19.31 65.81 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.636 0.732 . . . . 0.0 110.679 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -68.81 -21.16 64.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.951 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.85 -15.08 35.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.941 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.0 -152.74 24.86 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -96.11 125.72 40.84 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 mm -73.94 97.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -69.67 -54.37 14.2 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -135.84 135.19 39.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -134.14 126.98 31.12 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.87 0.843 . . . . 0.0 109.711 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -125.23 117.1 23.08 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.304 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.07 103.48 50.24 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -95.71 173.97 1.04 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.605 2.204 . . . . 0.0 111.101 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -105.66 -176.22 3.02 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 174.642 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -136.12 114.1 11.3 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.7 t0 62.87 27.99 16.21 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 122.054 0.93 . . . . 0.0 110.33 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.07 13.12 83.52 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.189 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 48.6 mtmt -128.44 -175.54 3.55 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 124.115 0.966 . . . . 0.0 109.923 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 m -34.66 129.19 0.43 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.53 1.932 . . . . 0.0 112.667 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE3' HD11 ' A' ' 31' ' ' LEU . 16.5 pttp -69.95 139.99 52.96 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.35 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.47 16.55 6.25 Favored Glycine 0 C--N 1.288 -2.098 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.855 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 24.4 p90 -169.92 158.33 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.2 pt -147.48 174.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 124.383 1.073 . . . . 0.0 108.117 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.48 136.89 43.48 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.386 0.429 . . . . 0.0 109.875 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.536 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 3.1 mm? -127.92 123.43 34.91 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.19 129.8 56.18 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 9.5 m-85 -127.34 170.35 12.59 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.34 14.33 12.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.513 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 49.6 m -71.57 173.33 5.32 Favored Pre-proline 0 CA--C 1.594 2.636 0 CA-C-N 113.231 -1.804 . . . . 0.0 115.565 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 6.3 Cg_exo -36.64 6.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.521 3.105 1 C-N-CA 130.041 7.16 . . . . 0.0 121.015 175.344 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 84.56 63.31 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 124.464 2.078 . . . . 0.0 108.478 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.591 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 17.3 p80 -74.16 -36.93 64.13 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 110.125 -3.216 . . . . 0.0 111.065 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -76.98 -37.29 55.47 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.57 -42.83 95.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.52 -49.31 69.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.669 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.23 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.005 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 74' ' ' ALA . 27.8 m -60.06 -31.62 48.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -84.87 -31.02 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -104.8 -41.38 5.66 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.16 84.67 2.02 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 94' ' ' VAL . 3.5 t70 -116.31 118.42 32.69 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.36 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.12 41.96 7.79 Favored Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.154 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . 0.251 39.6 p90 -88.48 120.58 29.99 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.033 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.57 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.8 OUTLIER -79.68 122.41 26.53 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.212 -176.142 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -87.08 -65.83 0.97 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.138 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -169.25 153.73 5.53 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 45.41 -91.47 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 C-N-CA 125.851 1.66 . . . . 0.0 114.705 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -111.49 -22.89 11.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.712 ' NE2' ' HA ' ' A' ' 24' ' ' PRO . 22.6 m170 -62.54 99.61 0.15 Allowed 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 122.814 0.446 . . . . 0.0 111.459 -171.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.57 HG23 ' HG3' ' A' ' 85' ' ' LYS . 7.5 m -134.45 103.0 5.52 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.8 100.25 10.19 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.888 -172.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.587 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.2 mpt_? -83.12 138.55 33.63 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 82' ' ' ASP . 3.9 m -124.73 136.3 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 O-C-N 123.574 0.546 . . . . 0.0 110.344 -173.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -158.1 -179.34 8.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.47 ' HG ' ' OG1' ' A' ' 98' ' ' THR . 0.5 OUTLIER -102.76 -166.56 1.29 Allowed 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.56 0.537 . . . . 0.0 111.424 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -83.59 11.73 6.76 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.511 -174.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.47 ' OG1' ' HG ' ' A' ' 96' ' ' LEU . 8.6 p -72.0 65.02 0.54 Allowed 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 122.556 1.17 . . . . 0.0 111.065 171.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.95 -12.55 35.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.888 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -71.92 140.61 49.29 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.053 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.56 -32.96 15.33 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.71 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.418 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -60.62 134.81 57.45 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -171.081 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -104.94 141.59 36.27 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 49.7 ttm -70.07 99.33 1.44 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.382 0.611 . . . . 0.0 111.57 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.001 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.272 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -95.63 151.09 19.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.928 0.364 . . . . 0.0 111.377 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 4.1 p 63.02 6.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 127.256 2.222 . . . . 0.0 113.761 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -106.84 -53.78 2.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.416 0.627 . . . . 0.0 110.63 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -76.05 -40.58 53.04 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -114.93 113.2 23.83 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 3' ' ' VAL . 78.1 mtp180 -119.88 138.19 26.6 Favored Pre-proline 0 C--N 1.285 -2.237 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.063 -174.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.1 128.24 17.28 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 105.495 -2.54 . . . . 0.0 105.495 164.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 11' ' ' ALA . 47.4 tp60 -85.95 149.76 24.97 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.61 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -74.82 -9.67 58.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.761 0.791 . . . . 0.0 109.984 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.563 ' H ' ' HG3' ' A' ' 9' ' ' GLN . . . -87.26 100.97 13.09 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.613 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -154.07 174.43 14.71 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.76 -7.25 35.98 Favored Glycine 0 CA--C 1.494 -1.277 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.5 tp -154.07 125.53 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.69 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 26.4 t70 -110.93 -24.53 10.34 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.051 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.501 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 36.0 m -89.38 -3.16 58.56 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 88.3 t -127.55 122.57 59.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 14.0 mm -89.99 135.82 25.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 59.9 t -128.74 120.51 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.73 138.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.681 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.61 139.86 42.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.581 0.2 OUTLIER 46.58 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 127.253 2.221 . . . . 0.0 115.889 -169.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.585 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 29.9 m -107.25 179.04 0.95 Allowed Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.141 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.6 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 54.3 Cg_exo -42.41 131.74 5.04 Favored 'Trans proline' 0 C--O 1.269 2.04 0 C-N-CA 123.01 2.474 . . . . 0.0 114.831 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.658 ' HA ' HG23 ' A' ' 60' ' ' THR . 9.1 pt20 -61.84 -165.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 128.06 2.544 . . . . 0.0 113.528 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.601 ' HB ' HD23 ' A' ' 31' ' ' LEU . 14.9 p -141.03 138.55 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-O 121.985 0.897 . . . . 0.0 110.691 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.93 141.85 15.38 Favored Glycine 0 C--N 1.275 -2.853 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 166.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.2 124.81 13.59 Favored 'Trans proline' 0 C--O 1.243 0.744 0 CA-C-N 121.274 2.537 . . . . 0.0 112.73 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 60.56 32.38 20.42 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.067 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.4 2.04 10.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.228 -0.92 . . . . 0.0 111.039 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.601 HD23 ' HB ' ' A' ' 26' ' ' VAL . 1.4 tm? -60.91 -27.01 67.88 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -174.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -57.7 -50.72 72.25 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.56 -23.53 61.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.661 0.743 . . . . 0.0 109.993 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.8 mt -81.2 -4.53 55.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.574 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 99.5 mttt -85.62 -37.46 19.49 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 168.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.49 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 4.4 m-20 -78.16 -33.89 50.04 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.921 -172.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.38 -32.5 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.944 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.47 -53.34 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.3 -31.68 67.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.842 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 52.9 mtpt -78.32 -41.6 33.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.5 mt -82.44 -41.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.708 0.765 . . . . 0.0 111.246 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 66' ' ' LEU . 3.9 m-85 -78.57 -10.81 59.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 1.8 p -71.78 -10.02 59.15 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.733 0.778 . . . . 0.0 111.578 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -71.21 -22.03 62.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.318 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.69 -15.42 39.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.729 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 150.83 -171.47 30.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -83.73 127.08 33.52 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 68' ' ' TYR . 20.1 mm -72.6 94.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.2 m -83.36 -37.25 23.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.097 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 39.5 t30 -154.04 145.57 23.19 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -146.64 151.25 36.95 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -135.99 106.14 6.34 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.783 0.677 . . . . 0.0 109.892 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.74 104.72 55.39 Favored Pre-proline 0 C--O 1.252 1.212 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.32 173.21 1.2 Allowed 'Trans proline' 0 N--CA 1.432 -2.128 0 C-N-CA 121.882 1.721 . . . . 0.0 110.898 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.15 175.88 9.54 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 174.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.789 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 39.7 mt-10 -137.5 117.53 13.38 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 56.29 26.22 10.26 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 123.58 0.752 . . . . 0.0 111.208 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.77 15.84 65.05 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 116.167 -0.47 . . . . 0.0 113.195 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.789 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 56.3 pttt -101.77 -176.83 3.25 Favored 'General case' 0 C--O 1.246 0.885 0 O-C-N 121.904 -0.763 . . . . 0.0 109.163 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.658 HG23 ' HA ' ' A' ' 25' ' ' GLN . 98.7 m -53.64 119.01 4.37 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 123.649 0.78 . . . . 0.0 111.532 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -67.86 145.54 54.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.438 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -118.33 3.19 16.06 Favored Glycine 0 C--N 1.286 -2.225 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.932 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -168.19 150.06 5.26 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.12 167.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -132.69 136.06 46.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.693 HD11 ' CD2' ' A' ' 42' ' ' PHE . 47.1 mt -121.46 154.01 37.15 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 42.3 tt0 -135.95 122.58 20.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.544 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 11.8 m-30 -118.88 157.56 27.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.37 13.86 28.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.219 1.009 . . . . 0.0 108.82 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 20.8 m -73.57 161.63 78.01 Favored Pre-proline 0 CA--C 1.604 3.034 0 CA-C-N 114.16 -1.382 . . . . 0.0 114.605 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.2 Cg_endo -37.66 8.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.945 2 C-N-CA 130.622 7.548 . . . . 0.0 124.316 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.69 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.47 67.42 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 123.066 2.666 . . . . 0.0 106.153 -156.112 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.544 ' NE2' ' HB2' ' A' ' 68' ' ' TYR . 22.9 p-80 -93.94 -37.87 11.47 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 109.067 -3.697 . . . . 0.0 112.197 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.6 -23.42 53.43 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.354 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.3 p -65.11 -22.89 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.764 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.04 -46.71 12.51 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.05 -43.79 66.91 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.982 0.801 . . . . 0.0 111.964 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.49 -19.57 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.92 0.39 . . . . 0.0 111.872 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -85.27 -22.98 28.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.173 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -71.91 0.14 Allowed 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.313 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -177.3 124.13 0.13 Allowed 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.642 0.588 . . . . 0.0 110.285 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 94' ' ' VAL . 5.5 t70 -81.43 115.67 20.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.49 52.5 4.18 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.335 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -93.67 126.61 38.94 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.092 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -82.99 117.19 22.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.786 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.65 -58.78 2.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.8 0.809 . . . . 0.0 109.197 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -135.12 -164.79 1.58 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -36.2 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.744 1.617 . . . . 0.0 115.069 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -96.29 -1.15 48.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.726 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.6 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 42.1 m170 -81.43 93.29 6.59 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' ' 85' ' ' LYS . 21.2 m -133.95 108.38 8.36 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.681 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -82.83 101.07 10.72 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.261 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.56 136.73 34.14 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 82' ' ' ASP . 17.1 m -105.86 138.17 32.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 123.792 0.682 . . . . 0.0 110.594 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.458 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -156.14 170.61 21.8 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.1 pt? -86.41 -174.14 4.88 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.718 0.77 . . . . 0.0 112.298 -176.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -106.71 -35.8 6.89 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.435 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.29 28.19 0.05 Allowed 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.445 1.498 . . . . 0.0 112.04 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -124.97 -43.26 1.98 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.262 0.553 . . . . 0.0 109.601 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -92.35 35.06 1.01 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.652 0.739 . . . . 0.0 112.379 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.81 62.12 0.93 Allowed 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 176.93 5.94 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.918 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -93.09 138.25 31.7 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 56.0 ttp -92.35 100.63 13.17 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.423 0.63 . . . . 0.0 110.566 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.42 -1.934 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 179.724 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.283 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -85.49 150.29 24.79 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 117.14 0.47 . . . . 0.0 111.147 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.28 -10.94 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.23 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.45 HD11 ' HD3' ' A' ' 79' ' ' LYS . 96.7 mt -69.0 -16.78 63.81 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 123.736 0.814 . . . . 0.0 111.521 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -82.18 -20.65 37.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.063 0.458 . . . . 0.0 110.091 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -89.46 -53.38 4.57 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.532 ' NH2' ' HB2' ' A' ' 10' ' ' GLU . 11.2 ptm180 -119.47 139.31 27.59 Favored Pre-proline 0 N--CA 1.415 -2.203 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.622 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.29 158.9 53.38 Favored 'Trans proline' 0 C--O 1.268 1.977 0 C-N-CA 121.451 1.434 . . . . 0.0 109.335 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.484 ' HG3' ' H ' ' A' ' 11' ' ' ALA . 60.4 tp60 -66.57 135.06 53.6 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' HB2' ' NH2' ' A' ' 7' ' ' ARG . 20.5 tt0 -79.42 -6.78 57.6 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.682 0.753 . . . . 0.0 111.511 -171.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' H ' ' HG3' ' A' ' 9' ' ' GLN . . . -95.85 97.94 10.04 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.396 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -159.92 129.56 5.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.525 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.45 -66.83 0.53 Allowed Glycine 0 C--N 1.298 -1.578 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.6 tp -150.11 92.14 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.02 0 CA-C-O 122.234 1.016 . . . . 0.0 110.94 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.532 ' OD1' ' HB2' ' A' ' 96' ' ' LEU . 23.5 m-20 -131.03 54.16 1.93 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 122.55 1.167 . . . . 0.0 107.992 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.626 ' HA ' ' HE2' ' A' ' 73' ' ' HIS . 44.9 m -96.48 7.18 47.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.265 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 38.7 t -127.93 126.53 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.981 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 30.5 mm -83.04 139.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.2 112.13 34.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.79 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.777 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 30.1 t70 -85.44 132.78 34.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.744 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.479 0.2 OUTLIER 45.7 97.92 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.9 m -86.63 167.94 20.55 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.617 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 48.9 Cg_exo -51.18 146.95 21.81 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.769 2.313 . . . . 0.0 116.098 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -61.06 145.3 51.32 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.19 -2.277 . . . . 0.0 109.503 175.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 ' HB2' ' A' ' 31' ' ' LEU . 7.3 p -137.87 151.0 25.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.715 0.769 . . . . 0.0 111.494 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.16 174.87 20.98 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.62 126.05 11.89 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.691 2.261 . . . . 0.0 113.642 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.9 t70 65.27 18.44 11.39 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.797 2.039 . . . . 0.0 112.9 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -100.89 -8.36 22.61 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.612 -1.305 . . . . 0.0 111.629 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HB2' HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -76.97 -21.9 54.02 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.63 -34.44 78.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.221 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -69.93 -36.96 75.74 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.581 ' O ' HG12 ' A' ' 38' ' ' ILE . 80.2 mt -73.59 -34.37 65.06 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.551 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HE3' HD12 ' A' ' 31' ' ' LEU . 98.5 mttt -58.47 -31.61 67.97 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.98 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -80.96 -31.25 34.93 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.789 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 34' ' ' LEU . 3.8 p -75.25 -28.99 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.6 mm -62.12 -51.76 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -65.45 -17.56 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.257 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -88.07 -60.08 2.06 Favored 'General case' 0 N--CA 1.415 -2.21 0 O-C-N 122.15 -0.344 . . . . 0.0 110.784 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.12 -42.7 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.354 0.597 . . . . 0.0 111.303 -175.362 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.536 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 58.2 m-85 -79.4 -17.76 53.7 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 68.4 m -74.28 -3.71 31.73 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.388 0.613 . . . . 0.0 111.397 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.05 -3.39 58.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -113.16 9.64 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.319 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 126.62 -162.53 20.76 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -94.5 133.27 38.29 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.277 0.539 . . . . 0.0 111.619 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.44 95.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.426 ' OG1' ' HA ' ' A' ' 68' ' ' TYR . 1.2 p -80.55 -34.64 35.27 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.379 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 63.3 t30 -152.19 147.22 26.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.991 -0.443 . . . . 0.0 110.177 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 81.2 m-85 -136.65 107.2 6.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.464 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 2.4 m-85 -107.37 104.83 54.04 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.661 -1.236 . . . . 0.0 107.661 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.55 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 73.4 Cg_endo -83.89 159.19 13.87 Favored 'Trans proline' 0 N--CA 1.436 -1.882 0 C-N-CA 120.921 1.081 . . . . 0.0 110.19 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.502 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 20.1 pt-20 -173.98 -176.78 1.24 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.72 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 41.7 mt-10 -138.76 133.59 32.37 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 172.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 54.6 25.28 6.17 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.778 0.831 . . . . 0.0 112.259 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.7 23.07 54.85 Favored Glycine 0 CA--C 1.549 2.181 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.297 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 56.6 pttt -97.37 -177.05 3.69 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 117.667 0.733 . . . . 0.0 110.618 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 m -56.95 92.26 0.01 OUTLIER 'General case' 0 C--O 1.252 1.189 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 54' ' ' PRO . 6.9 ptpp? -64.33 166.01 8.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 125.735 1.614 . . . . 0.0 110.072 170.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.04 14.66 4.88 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.229 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -170.66 152.46 3.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 pt -145.53 167.1 9.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 80.8 m-85 -128.88 136.15 50.05 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.2 0.524 . . . . 0.0 109.682 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 3.6 mm? -115.67 118.26 32.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 13.4 tp10 -103.52 122.08 44.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.536 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 m-85 -126.95 164.75 20.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.769 0.795 . . . . 0.0 111.952 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.66 13.58 26.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.605 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.493 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . 38.6 t -75.03 158.31 84.48 Favored Pre-proline 0 CA--C 1.585 2.319 0 C-N-CA 125.344 1.457 . . . . 0.0 113.469 -171.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -37.48 8.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.836 1 C-N-CA 130.31 7.34 . . . . 0.0 121.057 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.418 ' HB1' ' CG2' ' A' ' 75' ' ' VAL . . . 84.84 62.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 125.026 2.346 . . . . 0.0 108.058 -166.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.626 ' HE2' ' HA ' ' A' ' 16' ' ' SER . 14.3 p80 -72.41 -36.26 68.6 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 109.261 -3.608 . . . . 0.0 110.83 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -74.21 -33.33 63.36 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.418 ' CG2' ' HB1' ' A' ' 72' ' ' ALA . 84.4 t -64.73 -42.88 96.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.301 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.3 -41.85 80.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.768 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -50.47 73.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.437 0.695 . . . . 0.0 111.415 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -61.67 -32.39 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 123.536 0.734 . . . . 0.0 110.461 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -76.17 -38.11 57.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.209 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -92.86 -63.68 1.19 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -172.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.25 103.34 6.89 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.392 0.615 . . . . 0.0 111.926 -169.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' HB2' HG22 ' A' ' 94' ' ' VAL . 12.0 t0 -130.08 140.77 50.78 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.662 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.04 46.07 53.37 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -101.59 125.27 48.22 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 121.538 0.685 . . . . 0.0 110.418 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.91 129.0 45.23 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.198 -174.658 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.6 -59.83 2.16 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.495 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -162.6 151.4 14.87 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp 40.24 -95.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -110.43 3.46 19.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.858 -0.526 . . . . 0.0 110.842 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.617 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 12.1 m170 -80.7 89.16 5.74 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 m -133.23 115.31 14.82 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -85.54 116.18 23.69 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.56 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 3.5 mpt_? -91.42 121.63 33.3 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.7 m -103.5 148.85 7.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -175.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.6 p30 -149.19 178.34 8.83 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.5 pt? -87.87 -173.02 4.1 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 123.437 0.46 . . . . 0.0 112.211 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -119.04 -20.13 8.19 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.45 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.8 m -73.65 68.78 1.24 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.287 1.041 . . . . 0.0 110.889 175.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.55 -18.41 24.14 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.11 143.35 48.95 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.145 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -81.8 81.07 7.94 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.148 0.975 . . . . 0.0 108.627 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.475 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -50.42 146.89 4.87 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.136 174.362 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -80.18 122.3 26.66 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.42 126.5 32.27 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.083 0.468 . . . . 0.0 109.793 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.7 m . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.714 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.699 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -96.12 154.35 17.29 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.91 29.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.62 -48.98 4.33 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -96.4 -3.23 43.98 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . 3.9 p-10 -78.37 28.62 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.817 0.818 . . . . 0.0 112.568 -171.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -111.08 164.99 13.58 Favored Pre-proline 0 C--N 1.285 -2.196 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.61 128.23 21.77 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 N-CA-C 106.98 -1.969 . . . . 0.0 106.98 169.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -120.79 159.4 25.52 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.119 -1.032 . . . . 0.0 113.353 -169.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.45 19.8 2.24 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.029 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 120.96 9.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.185 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.89 121.85 18.86 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 98' ' ' THR . . . -62.41 94.43 0.1 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 116.714 1.445 . . . . 0.0 116.714 -171.574 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.8 tp -97.06 89.35 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-O 122.807 1.289 . . . . 0.0 107.766 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.679 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 14.0 t70 -92.85 -2.51 55.82 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.611 -173.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.686 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 30.3 t -92.34 -6.28 50.51 Favored 'General case' 0 C--N 1.275 -2.673 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.283 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.73 115.37 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.897 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 20.4 mm -93.59 143.41 11.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 98.0 t -121.0 123.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 79.7 t -119.15 139.88 44.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 20.2 t70 -107.21 145.9 32.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.043 0.537 . . . . 0.0 110.714 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.506 0.2 OUTLIER 31.68 104.76 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.985 2.587 . . . . 0.0 117.985 -174.931 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.523 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 27.1 m -107.98 177.22 1.34 Allowed Pre-proline 0 CA--C 1.562 1.418 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.739 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HA ' ' CE1' ' A' ' 90' ' ' HIS . 5.0 Cg_exo -43.89 138.21 6.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.828 3.019 . . . . 0.0 112.725 170.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HA ' HG21 ' A' ' 60' ' ' THR . 0.1 OUTLIER -88.41 172.23 9.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.777 -175.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 31' ' ' LEU . 14.1 p -117.39 142.51 31.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.132 0.968 . . . . 0.0 111.747 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.77 155.52 16.23 Favored Glycine 0 N--CA 1.414 -2.804 1 N-CA-C 102.657 -4.177 . . . . 0.0 102.657 165.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.84 125.22 12.51 Favored 'Trans proline' 0 C--O 1.25 1.111 0 CA-C-N 121.224 2.512 . . . . 0.0 114.136 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.68 24.74 9.27 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.107 1.763 . . . . 0.0 111.879 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -98.46 -15.49 19.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 121.738 -0.601 . . . . 0.0 111.407 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' HB2' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -79.55 -18.2 52.32 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.855 -174.08 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.3 -42.72 82.31 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.24 -29.64 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.376 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 38' ' ' ILE . 94.8 mt -69.27 -27.01 65.05 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.339 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -59.57 -39.75 85.11 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.699 0.761 . . . . 0.0 110.216 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -84.08 -28.23 27.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 34' ' ' LEU . 7.3 p -70.56 -32.68 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.347 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 34' ' ' LEU . 43.2 mm -59.6 -53.1 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -53.61 -35.38 60.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.569 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.93 -42.22 24.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 37' ' ' VAL . 45.8 mm -64.77 -42.88 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.918 0.866 . . . . 0.0 109.68 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -76.88 -6.69 53.45 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.029 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 22.8 t -73.02 -6.76 47.66 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-O 121.271 0.557 . . . . 0.0 109.632 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -71.5 -28.15 63.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.273 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -85.71 -15.14 43.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.23 0.538 . . . . 0.0 111.058 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 155.18 -162.99 31.28 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -96.11 129.13 43.48 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.489 HD13 ' CE2' ' A' ' 68' ' ' TYR . 24.0 mm -73.03 109.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -81.88 -48.64 11.28 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 37.2 m-20 -134.75 144.21 47.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.477 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.6 p30 -137.04 132.72 34.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.557 0.694 . . . . 0.0 110.902 175.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.31 97.77 5.35 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.233 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 2.5 m-85 -108.63 104.9 55.81 Favored Pre-proline 0 N--CA 1.416 -2.129 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.747 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 80.8 Cg_endo -83.88 170.8 11.01 Favored 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 120.932 1.088 . . . . 0.0 110.462 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' OE2' ' HA ' ' A' ' 60' ' ' THR . 1.0 OUTLIER -139.22 162.54 34.72 Favored 'General case' 0 N--CA 1.388 -3.575 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 175.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 40.2 mt-10 -134.04 103.56 5.85 Favored 'General case' 0 C--N 1.28 -2.437 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.566 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 62.9 27.6 16.04 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.785 0.802 . . . . 0.0 111.998 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.32 -4.83 85.92 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.352 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 62.2 pttt -103.26 171.51 7.33 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 25' ' ' GLN . 11.3 t -79.25 141.54 37.0 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-O 122.741 1.258 . . . . 0.0 113.108 -173.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.747 ' HD3' ' O ' ' A' ' 54' ' ' PRO 0.27 9.6 pttm -59.49 176.26 0.27 Allowed 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.478 167.06 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.64 20.91 4.82 Favored Glycine 0 C--N 1.288 -2.097 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 52.3 p90 -169.28 160.28 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 pt -147.09 171.98 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.92 136.94 44.59 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 123.952 0.783 . . . . 0.0 109.504 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 48' ' ' ILE . 2.4 mm? -124.53 138.74 54.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 16' ' ' SER . 41.8 mt-10 -126.43 129.99 49.81 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.567 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 19.1 m-85 -125.98 170.78 11.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.32 14.24 12.89 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 39.4 m -73.27 168.02 29.03 Favored Pre-proline 0 CA--C 1.589 2.447 0 CA-C-N 113.493 -1.685 . . . . 0.0 114.633 -173.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 5.7 Cg_exo -35.52 9.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.358 2 C-N-CA 130.624 7.549 . . . . 0.0 123.08 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.679 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.11 65.2 0.01 OUTLIER 'General case' 0 CA--C 1.473 -2.016 0 CA-C-O 124.788 2.232 . . . . 0.0 106.867 -160.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.686 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 21.2 p-80 -82.17 -36.49 27.3 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 108.995 -3.729 . . . . 0.0 111.98 -171.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HB1' HD21 ' A' ' 96' ' ' LEU . . . -70.1 -37.49 75.41 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.386 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.586 HG23 ' OD1' ' A' ' 15' ' ' ASP . 94.3 t -56.07 -48.42 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.489 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 3.1 t70 -65.7 -35.71 81.53 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.279 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.94 69.91 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.412 0.285 . . . . 0.0 110.888 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.1 -37.79 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 123.725 0.81 . . . . 0.0 109.706 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 76' ' ' ASP . 77.4 tttt -59.79 -36.46 76.76 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.414 1.485 . . . . 0.0 111.517 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -81.96 -77.31 0.23 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.32 113.01 3.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.084 -172.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' A' ' 94' ' ' VAL . 2.9 t70 -94.74 133.68 38.16 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.916 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 48.81 19.52 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.404 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -88.94 125.36 34.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.791 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.512 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -103.35 129.27 50.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.487 -172.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -86.28 -66.85 0.86 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -167.67 -173.81 2.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.23 -103.54 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -121.54 8.42 10.12 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.669 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 4.8 m-70 -87.28 91.74 8.83 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.359 -170.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 85' ' ' LYS . 5.9 m -133.44 105.0 6.68 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -82.61 101.17 10.62 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.626 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -87.34 137.36 32.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 82' ' ' ASP . 5.4 m -105.01 134.55 46.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 O-C-N 123.944 0.778 . . . . 0.0 109.991 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.66 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.1 OUTLIER -148.06 144.12 27.67 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.467 HD21 ' HB1' ' A' ' 74' ' ' ALA . 3.6 mp -109.96 -178.89 3.64 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 173.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -81.99 -44.77 16.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 171.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.522 HG21 ' HA2' ' A' ' 13' ' ' GLY . 17.9 m -94.66 73.49 3.68 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 168.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.64 -28.46 26.44 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.378 1.085 . . . . 0.0 109.046 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 6' ' ' ASP . 89.2 m-85 -92.77 88.35 6.2 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.743 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.42 -24.31 62.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.834 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.533 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -68.89 135.26 50.79 Favored 'General case' 0 N--CA 1.406 -2.634 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.556 173.413 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -129.3 169.96 14.2 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.617 -170.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.6 tpt -61.39 101.43 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.436 1.085 . . . . 0.0 108.279 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.424 -1.731 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.017 -174.831 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.742 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -96.28 150.41 20.58 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.346 0.593 . . . . 0.0 109.956 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 13.0 p -146.94 12.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.857 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.888 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.76 -53.41 3.3 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.752 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -92.5 -38.19 12.08 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 22.4 t70 -86.02 76.85 9.76 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -121.34 163.4 30.52 Favored Pre-proline 0 C--N 1.288 -2.088 0 CA-C-N 114.09 -1.414 . . . . 0.0 112.249 -167.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.99 169.22 16.53 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.074 1.85 . . . . 0.0 108.656 167.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.54 151.03 34.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -74.8 -20.7 59.68 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.726 0.298 . . . . 0.0 111.625 -174.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.24 91.39 3.77 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.506 0.67 . . . . 0.0 109.307 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -142.11 116.72 9.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.786 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.35 -53.22 0.22 Allowed Glycine 0 C--N 1.274 -2.908 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.0 tp -145.37 123.7 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.523 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 12.2 t70 -128.45 -17.43 4.18 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.8 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.4 m -98.4 7.28 46.4 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.4 t -146.17 124.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 26.3 mm -86.13 136.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.695 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 89.4 t -129.9 103.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 3.0 m -96.74 120.47 46.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.572 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 25.5 t70 -79.72 140.16 37.07 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.917 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.427 21.1 p-10 44.27 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 127.209 2.203 . . . . 0.0 114.552 -177.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 26.8 m -100.94 167.68 10.4 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.893 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -42.47 126.9 4.18 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.77 2.98 . . . . 0.0 114.692 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.508 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -91.02 149.0 22.01 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.459 -1.701 . . . . 0.0 108.337 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 27' ' ' GLY . 6.5 p -101.59 147.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -169.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -105.14 171.61 18.93 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 168.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.05 125.69 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 CA-C-N 121.101 2.45 . . . . 0.0 112.275 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 57.4 31.37 20.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.842 1.257 . . . . 0.0 113.792 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -109.73 1.02 19.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.22 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.14 -32.26 72.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -45.23 -49.34 12.43 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.029 1.332 . . . . 0.0 111.211 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -79.08 -31.85 44.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.531 -172.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -72.06 -35.22 69.24 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.194 -176.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -78.31 -20.83 50.67 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.109 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 49.6 t-20 -78.08 -37.8 45.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 34' ' ' LEU . 8.8 p -66.41 -31.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.435 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.9 mm -61.7 -49.88 82.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -63.04 -19.92 64.84 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.328 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 66.4 mttm -88.13 -60.01 2.08 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -63.19 -43.74 98.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.011 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -78.37 -14.75 59.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 m -75.76 -3.05 32.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.117 0.484 . . . . 0.0 111.308 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -79.32 -20.95 46.64 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -88.28 -15.03 36.88 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.639 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.82 -154.17 25.66 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.778 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.65 120.67 27.34 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 122.26 0.224 . . . . 0.0 110.602 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.6 mm -73.85 91.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.4 m -78.15 -52.66 8.37 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.321 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 85.9 m-20 -136.05 139.47 43.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -144.71 128.72 17.52 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.55 0.691 . . . . 0.0 109.671 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.75 116.01 19.56 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.258 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -107.9 105.18 55.72 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 96.5 Cg_endo -85.74 174.31 6.7 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 122.323 2.015 . . . . 0.0 110.72 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.3 pt-20 -102.08 177.75 4.8 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -162.2 114.85 1.73 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.154 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 60.19 28.48 18.07 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.859 1.264 . . . . 0.0 112.768 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.87 1.96 72.6 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.896 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -96.55 165.88 11.95 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 3.4 t -53.64 -54.55 36.12 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 124.885 1.366 . . . . 0.0 111.677 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER 179.87 167.92 1.23 Allowed 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 124.915 1.286 . . . . 0.0 108.29 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.09 -6.32 2.52 Favored Glycine 0 C--N 1.297 -1.619 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 20.3 p90 -167.68 156.62 9.69 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.34 163.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -113.3 129.71 56.45 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 123.807 0.692 . . . . 0.0 110.264 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 2.3 mm? -118.98 126.5 51.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 38.0 tt0 -121.69 119.31 31.43 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.604 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 87.6 m-85 -99.98 177.85 4.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.609 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.57 -15.82 56.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.3 m -119.51 167.31 12.41 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 73' ' ' HIS . 4.9 Cg_exo -77.46 -55.57 0.05 OUTLIER 'Trans proline' 0 C--O 1.176 -2.623 0 CA-C-N 123.887 2.424 . . . . 0.0 108.568 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.31 7.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 131.287 3.835 . . . . 0.0 121.307 142.128 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.604 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 31.1 p80 -125.28 -36.71 2.47 Favored 'General case' 1 C--N 1.241 -4.125 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.681 -165.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . . . -81.42 -22.82 37.97 Favored 'General case' 0 N--CA 1.383 -3.793 0 C-N-CA 119.251 -0.979 . . . . 0.0 108.644 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.5 -23.14 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.52 -33.88 25.41 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.4 63.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.337 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -32.49 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -67.49 -44.3 78.84 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.406 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -91.77 -52.4 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.2 104.74 3.83 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.305 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' HB2' HG22 ' A' ' 94' ' ' VAL . 2.6 p30 -114.44 136.41 53.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.0 51.03 61.36 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -96.76 124.17 40.67 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.733 0.778 . . . . 0.0 111.768 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -97.89 118.57 34.75 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.623 -176.7 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.75 -52.92 5.23 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.414 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 16.1 m-20 -145.42 -168.62 3.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.172 -174.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -44.16 -69.81 0.12 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.925 1.29 . . . . 0.0 114.195 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -100.18 11.26 39.79 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.674 -176.538 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.414 ' HB2' ' H ' ' A' ' 87' ' ' ASP . 14.8 m170 -102.45 86.97 2.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -135.29 94.09 3.07 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-O 120.708 0.29 . . . . 0.0 110.277 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.43 105.55 13.58 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.972 -168.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.522 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.1 mpt_? -83.45 141.96 31.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 82' ' ' ASP . 34.5 m -100.23 114.28 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.695 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 4.6 p-10 -154.78 -165.58 2.09 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.1 pt? -104.29 -173.04 2.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.005 0.431 . . . . 0.0 112.046 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.416 ' CE2' HG23 ' A' ' 98' ' ' THR . 20.0 p90 -121.89 -22.98 5.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.429 0.633 . . . . 0.0 111.8 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.416 HG23 ' CE2' ' A' ' 97' ' ' PHE . 2.2 p -91.94 -161.51 0.83 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.121 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.4 ' H ' ' HB ' ' A' ' 98' ' ' THR . 13.3 t70 -91.46 -15.73 28.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.143 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -59.14 66.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -174.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.82 75.25 1.33 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -87.95 -28.12 21.69 Favored 'General case' 0 CA--C 1.484 -1.574 0 CA-C-N 113.858 -1.519 . . . . 0.0 114.161 -172.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -80.26 86.75 5.61 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 122.096 0.951 . . . . 0.0 112.505 -175.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.2 ttm -120.72 91.31 3.5 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 C--N 1.296 -1.73 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.602 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.689 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 3' ' ' VAL . 5.5 p-10 -56.66 151.35 14.06 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.397 1.079 . . . . 0.0 111.353 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 2' ' ' ASP 0.286 5.4 m 67.23 -33.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 127.54 2.336 . . . . 0.0 114.355 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.04 -50.38 7.08 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -96.05 20.53 10.01 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.262 0.625 . . . . 0.0 110.506 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -71.88 95.09 1.5 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.275 0.56 . . . . 0.0 109.688 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -148.03 152.86 40.95 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.163 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.37 144.82 81.53 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 121.814 1.676 . . . . 0.0 109.156 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.602 ' NE2' ' H ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -108.38 164.81 12.0 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.602 ' H ' ' NE2' ' A' ' 9' ' ' GLN . 29.7 mm-40 -74.61 20.12 0.13 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.798 0.839 . . . . 0.0 112.436 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.79 97.42 5.21 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.874 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -148.02 163.9 35.47 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.02 -81.28 1.75 Allowed Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 tp -115.3 88.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-O 123.018 1.389 . . . . 0.0 108.867 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -118.74 31.21 6.77 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.689 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 8.4 m -96.3 -11.88 25.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.229 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.5 t -122.15 132.5 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.554 -172.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 30.1 mm -87.3 145.13 7.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.48 121.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 64' ' ' ILE . 27.4 m -118.41 157.76 19.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.236 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.76 133.42 55.93 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 42.57 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 28.7 m -91.21 167.04 16.76 Favored Pre-proline 0 N--CA 1.426 -1.637 0 CA-C-N 114.33 -1.305 . . . . 0.0 107.982 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 85.1 Cg_exo -42.44 138.94 3.14 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.985 3.124 . . . . 0.0 113.126 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HA ' HG23 ' A' ' 60' ' ' THR . 2.6 pm0 -71.56 153.23 42.31 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.804 -173.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 30' ' ' ARG . 16.7 t -119.26 132.91 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.476 -176.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.89 -131.91 3.12 Favored Glycine 0 C--N 1.274 -2.868 0 N-CA-C 106.672 -2.571 . . . . 0.0 106.672 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.36 125.23 10.56 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 CA-C-N 119.459 1.629 . . . . 0.0 111.447 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 55.9 18.04 2.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.131 1.772 . . . . 0.0 114.373 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.503 ' HB2' HG13 ' A' ' 26' ' ' VAL . 35.2 mmt180 -79.1 -25.87 43.0 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.076 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -73.86 -33.89 64.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.38 -58.33 7.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.169 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -81.74 -15.68 53.55 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.612 ' O ' HG12 ' A' ' 38' ' ' ILE . 51.3 tp -63.3 -36.35 83.4 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -56.7 -36.9 70.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -84.09 -40.92 17.69 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.32 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' LEU . 7.4 p -65.55 -31.88 55.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.356 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 34' ' ' LEU . 32.9 mm -67.33 -54.6 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -58.82 -36.09 73.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.39 -47.28 35.0 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.3 mm -70.15 -39.24 76.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.197 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.23 -7.79 59.63 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.1 p -67.38 -22.74 65.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.3 ptpt -61.74 -28.4 69.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.53 0.681 . . . . 0.0 111.755 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 30.3 m-85 -85.46 -15.7 42.07 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.1 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.76 176.19 23.45 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -74.81 125.04 27.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -72.83 140.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 m -126.38 -61.22 1.22 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 55.0 m-80 -122.23 140.63 52.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.53 138.81 46.25 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.085 0.469 . . . . 0.0 110.446 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 89.2 m-85 -134.2 98.88 4.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -107.32 104.77 53.77 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 64' ' ' ILE . 51.1 Cg_endo -82.47 174.08 10.08 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.713 1.609 . . . . 0.0 109.823 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.634 ' HB3' ' NZ ' ' A' ' 61' ' ' LYS . 19.9 pt-20 -160.48 179.26 8.76 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.717 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 6.2 tp10 -121.12 108.79 14.23 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 59.4 27.2 16.26 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 121.932 0.872 . . . . 0.0 111.83 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.71 8.03 88.03 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.293 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 26.7 pttt -121.82 -176.8 3.41 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 122.108 -0.642 . . . . 0.0 109.617 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 25' ' ' GLN . 83.4 m -28.79 108.0 0.04 OUTLIER 'General case' 0 C--O 1.244 0.801 0 C-N-CA 126.199 1.8 . . . . 0.0 115.386 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.634 ' NZ ' ' HB3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -84.78 156.37 21.41 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.354 176.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.57 8.59 9.44 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.442 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -170.15 151.95 4.08 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 20' ' ' VAL . 20.7 pt -142.06 166.29 16.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.3 m-85 -131.59 141.66 49.72 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.859 0.724 . . . . 0.0 109.048 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.3 mp -132.36 136.75 47.04 Favored 'General case' 0 C--O 1.198 -1.651 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.934 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 42.0 tt0 -122.05 136.97 54.97 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.15 0.5 . . . . 0.0 109.688 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.41 ' HE1' ' CG1' ' A' ' 18' ' ' ILE . 76.0 m-85 -104.83 177.53 4.82 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.367 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.33 -16.62 39.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.275 0.559 . . . . 0.0 111.369 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -135.35 144.97 51.87 Favored Pre-proline 0 C--N 1.294 -1.84 1 N-CA-C 99.34 -4.318 . . . . 0.0 99.34 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.6 Cg_exo -69.91 -54.12 0.23 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 CA-C-N 123.483 2.28 . . . . 0.0 109.57 -172.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.07 4.47 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 1 C-N-CA 132.374 4.27 . . . . 0.0 120.133 144.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.508 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 95.8 m-70 -128.43 -36.36 1.9 Allowed 'General case' 1 C--N 1.223 -4.923 0 CA-C-O 121.326 0.584 . . . . 0.0 109.624 -170.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -61.33 -32.1 71.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.517 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.76 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 123.315 0.384 . . . . 0.0 111.305 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.39 -32.49 37.56 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.242 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.27 -52.61 61.34 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.764 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 74' ' ' ALA . 31.2 m -63.13 -27.78 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -81.61 -21.81 38.08 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.9 0.88 . . . . 0.0 112.047 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -122.88 -23.96 4.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . . . -106.0 18.55 21.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 94' ' ' VAL . 37.0 t70 -85.06 121.78 28.33 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 118.157 -1.417 . . . . 0.0 114.056 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.58 60.5 2.47 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.537 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 91' ' ' THR . 17.8 m-85 -103.27 105.51 15.81 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.33 102.69 7.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.204 177.32 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.7 mt -80.01 -41.46 25.79 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.91 -171.74 3.99 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -48.61 -58.32 4.89 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.594 1.558 . . . . 0.0 113.413 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -95.0 -4.55 46.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.203 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.53 101.42 10.76 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.765 -172.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 37.1 m -133.55 117.78 17.51 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.285 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -82.69 101.71 11.03 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.076 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 91' ' ' THR . 3.6 mpt_? -86.87 131.15 34.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 82' ' ' ASP . 25.6 m -117.75 149.11 20.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.942 -175.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.72 -171.12 3.3 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -72.07 -175.4 1.47 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 179.138 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -108.14 58.45 0.61 Allowed 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -47.69 78.8 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 111.264 -2.698 . . . . 0.0 111.226 170.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -141.06 -45.7 0.39 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -101.21 20.6 15.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 122.188 0.994 . . . . 0.0 109.589 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -105.47 74.11 1.07 Allowed 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 105.898 -1.889 . . . . 0.0 105.898 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -105.17 169.63 8.33 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.331 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -140.41 -69.04 0.4 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.947 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 16.1 tpt -112.99 -27.16 8.17 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.401 -2.9 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.686 177.311 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 112.288 -0.325 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 14.0 t70 -74.66 152.8 39.13 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 m -80.68 -37.36 16.49 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.71 -54.05 2.54 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -79.16 -1.61 36.93 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -171.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 2' ' ' ASP . 10.9 t70 -93.76 98.84 11.37 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -91.23 128.1 48.62 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.92 137.77 45.95 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.285 1.99 . . . . 0.0 111.172 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -135.79 121.83 20.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.938 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -123.96 -24.96 4.31 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.613 171.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.32 102.43 14.17 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -80.11 104.97 11.04 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.36 96.32 0.08 OUTLIER Glycine 0 C--N 1.281 -2.488 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -167.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.64 91.74 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 163.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 10.5 m-20 -93.13 44.76 1.15 Allowed 'General case' 0 CA--C 1.444 -3.115 0 CA-C-N 113.809 -1.542 . . . . 0.0 113.569 -169.005 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.525 ' HB2' ' OE2' ' A' ' 67' ' ' GLU 0.251 69.6 p -118.25 -20.49 8.55 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 115.493 -2.483 . . . . 0.0 113.916 166.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 25.9 t -127.14 133.04 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.996 -171.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.586 HD11 ' HD1' ' A' ' 73' ' ' HIS . 25.9 mm -104.12 143.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.79 114.1 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.53 130.61 73.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB3' ' CG ' ' A' ' 93' ' ' ARG . 10.7 t70 -111.86 149.35 31.94 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.512 0.2 OUTLIER 44.57 85.65 0.02 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 127.057 2.143 . . . . 0.0 115.87 -176.155 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 26.8 m -97.77 -171.75 0.26 Allowed Pre-proline 0 N--CA 1.418 -2.029 0 CA-C-N 112.732 -2.031 . . . . 0.0 107.064 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.749 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 44.6 Cg_exo -54.05 143.82 60.32 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 121.686 1.591 . . . . 0.0 114.181 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HA ' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -89.37 164.33 14.93 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.879 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 31' ' ' LEU . 48.8 t -123.22 134.26 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 CA-C-O 121.675 0.75 . . . . 0.0 109.391 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.7 -127.96 5.65 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 105.722 -2.951 . . . . 0.0 105.722 173.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.74 124.39 4.53 Favored 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-N 120.22 2.01 . . . . 0.0 110.721 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 50.73 33.57 8.58 Favored 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.353 1.461 . . . . 0.0 113.014 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -95.76 -0.7 51.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.771 -1.206 . . . . 0.0 112.105 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 26' ' ' VAL . 3.2 tm? -71.0 -28.86 64.73 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.87 -51.03 69.84 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.76 0.314 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.14 -27.13 68.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.564 ' O ' HG12 ' A' ' 38' ' ' ILE . 6.0 tt -65.71 -43.91 87.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.32 -37.83 81.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 111.6 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -81.0 -33.77 33.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.705 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 34' ' ' LEU . 6.2 p -70.17 -30.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.763 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 34' ' ' LEU . 35.5 mm -63.79 -64.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.845 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -62.49 -25.37 67.98 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -64.33 -57.71 8.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.333 0.653 . . . . 0.0 110.522 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 82.0 mt -70.38 -38.84 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.286 0.565 . . . . 0.0 111.042 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.453 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 53.9 m-85 -73.86 -7.31 51.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 58.0 m -69.35 -6.37 29.35 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 41' ' ' ILE . 81.0 mttt -71.92 -31.93 66.86 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.113 0.959 . . . . 0.0 108.807 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -85.46 10.83 11.8 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.892 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 117.43 -167.88 12.8 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -89.91 145.24 25.28 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 66' ' ' LEU . 32.4 mm -73.23 110.44 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.4 m -75.48 -46.3 33.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 35.3 t-20 -152.76 152.69 31.94 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -144.48 136.75 26.37 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -126.64 113.0 16.14 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.06 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -107.67 106.59 58.82 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 63' ' ' TYR . 2.9 Cg_exo -68.66 174.73 8.08 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.525 1.483 . . . . 0.0 109.357 172.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -173.34 -175.3 1.14 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.946 0.403 . . . . 0.0 110.466 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -136.74 102.36 4.88 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 56.71 27.37 12.57 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.513 1.125 . . . . 0.0 112.715 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.92 0.06 85.96 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.361 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -100.03 -176.45 3.24 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 123.436 0.695 . . . . 0.0 110.04 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.443 HG23 ' HA ' ' A' ' 25' ' ' GLN . 18.9 m -34.03 124.13 0.47 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 126.5 1.92 . . . . 0.0 114.38 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 166.65 11.02 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.12 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 -0.73 9.44 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.91 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.496 ' O ' ' HD2' ' A' ' 54' ' ' PRO . 4.4 p90 -169.69 161.23 9.23 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -143.86 172.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 123.527 0.517 . . . . 0.0 110.35 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -136.24 138.73 42.13 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 109.744 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.0 mm? -118.39 131.91 56.28 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE2' ' HB2' ' A' ' 16' ' ' SER . 12.9 tp10 -116.72 117.51 29.99 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.55 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 80.5 m-85 -127.46 172.53 10.6 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.241 0.543 . . . . 0.0 110.312 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.23 14.26 14.79 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.583 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 51.0 m -68.27 163.35 53.14 Favored Pre-proline 0 CA--C 1.597 2.78 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -171.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.1 Cg_exo -38.25 8.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.348 2 C-N-CA 130.435 7.423 . . . . 0.0 122.955 178.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.528 ' HA ' ' CG ' ' A' ' 15' ' ' ASP . . . 87.37 63.34 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 124.465 2.079 . . . . 0.0 106.997 -158.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.586 ' HD1' HD11 ' A' ' 18' ' ' ILE . 32.2 p80 -85.69 -36.99 19.89 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 110.148 -3.205 . . . . 0.0 109.282 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . . . -63.36 -35.94 82.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.059 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.587 HG23 ' OD1' ' A' ' 15' ' ' ASP . 82.0 t -59.39 -59.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.459 170.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.68 -35.77 73.14 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.145 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.0 -30.89 70.26 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.494 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.81 -29.34 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 8.4 mmpt? -72.02 -42.82 65.92 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.308 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -114.21 -29.87 6.81 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.2 -3.13 27.86 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -170.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.3 117.34 18.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.874 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.86 31.33 12.62 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -101.5 135.27 43.28 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.495 -1.282 . . . . 0.0 109.488 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -107.68 129.29 55.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.192 -172.365 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.44 -68.04 0.77 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.245 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -160.02 159.32 31.92 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.424 ' HD2' HE22 ' A' ' 25' ' ' GLN . 40.2 ttmt 47.04 -88.7 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.048 1.739 . . . . 0.0 114.297 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -121.43 -2.13 9.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.263 -0.273 . . . . 0.0 111.035 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.749 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m170 -79.72 92.65 5.43 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.31 0.576 . . . . 0.0 110.594 -171.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 m -133.17 109.04 9.18 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -82.21 105.62 13.44 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.917 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.459 ' CG ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -94.03 121.45 35.53 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.96 115.1 47.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.008 -166.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.99 158.18 29.69 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.1 pt? -87.32 -172.12 3.79 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.27 0.557 . . . . 0.0 112.378 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 31.8 t80 -84.47 5.19 28.38 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.184 0.516 . . . . 0.0 110.539 -173.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 p -69.21 76.13 0.35 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -86.99 -24.17 24.77 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 167.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -52.4 134.98 34.11 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.595 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.33 76.02 5.9 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 121.894 0.854 . . . . 0.0 108.975 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -48.26 -46.61 35.86 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.046 -1.888 . . . . 0.0 112.342 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -67.89 126.39 29.3 Favored 'General case' 0 C--N 1.256 -3.466 0 CA-C-N 112.961 -1.927 . . . . 0.0 109.334 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.57 105.81 3.78 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.419 -1.982 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.83 -175.09 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.76 150.48 46.85 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 120.695 0.283 . . . . 0.0 111.269 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.486 HG23 ' H ' ' A' ' 4' ' ' LEU . 16.5 m -33.92 -76.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -168.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.486 ' H ' HG23 ' A' ' 3' ' ' VAL . 84.8 mt -74.35 -26.96 60.45 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -169.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.33 6.71 47.87 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.714 0.769 . . . . 0.0 111.215 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.05 -35.92 6.47 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.564 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -74.81 146.03 82.37 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.203 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.01 127.89 24.76 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 121.784 1.656 . . . . 0.0 109.304 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.477 ' HG3' ' H ' ' A' ' 11' ' ' ALA . 19.6 tp60 -104.11 157.59 17.02 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 95' ' ' ASN . 30.4 mp0 -74.21 -22.85 59.2 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.347 0.594 . . . . 0.0 109.729 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.477 ' H ' ' HG3' ' A' ' 9' ' ' GLN . . . -96.67 74.73 2.75 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -151.17 110.02 3.87 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.82 -64.54 3.39 Favored Glycine 0 C--N 1.277 -2.742 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 97' ' ' PHE . 8.2 tp -101.93 126.55 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.323 0.582 . . . . 0.0 109.714 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -141.84 28.17 1.78 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.325 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -114.39 -8.96 12.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.28 137.34 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 121.875 -0.516 . . . . 0.0 109.873 -175.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 8.9 mm -101.0 133.12 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.66 106.5 15.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 16.6 m -96.36 154.94 3.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.203 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 9.8 t70 -93.22 -178.29 4.72 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.443 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.279 0.2 OUTLIER -29.5 106.92 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -166.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 36.0 m -86.01 167.32 24.54 Favored Pre-proline 0 N--CA 1.421 -1.908 0 CA-C-N 113.052 -1.886 . . . . 0.0 108.198 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.718 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 86.7 Cg_exo -42.36 127.15 4.14 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.641 2.894 . . . . 0.0 113.351 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.428 ' HB3' HE22 ' A' ' 89' ' ' GLN . 0.0 OUTLIER -65.78 151.12 47.36 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.915 -177.084 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.549 ' CG2' ' HB ' ' A' ' 60' ' ' THR . 52.6 t -125.91 139.77 50.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-O 122.028 0.918 . . . . 0.0 112.774 -173.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.45 -143.48 6.18 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.63 126.88 13.92 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 120.658 2.229 . . . . 0.0 111.416 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 63.32 17.69 10.44 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.127 1.371 . . . . 0.0 113.237 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HB2' HG13 ' A' ' 26' ' ' VAL . 88.6 mtt180 -89.43 -15.86 32.21 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.079 -1.638 . . . . 0.0 111.305 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD12 ' HE3' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -73.94 -36.69 64.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 -177.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -64.95 -34.97 79.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.4 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -71.78 -40.53 69.19 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.8 tp -58.37 -44.0 88.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.818 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HE3' HD12 ' A' ' 31' ' ' LEU . 98.6 mttt -54.51 -30.18 52.7 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.183 0.593 . . . . 0.0 112.512 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.476 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 55.6 t30 -84.49 -32.41 23.98 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.196 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 34' ' ' LEU . 8.6 p -78.07 -27.48 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.969 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 34' ' ' LEU . 39.3 mm -54.3 -51.79 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.642 0.734 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -68.21 -17.79 64.41 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.552 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.8 mmtp -85.28 -38.02 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.868 0.842 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mm -73.78 -53.89 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.74 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.61 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 61.7 m-85 -78.67 -16.93 56.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.9 p -65.73 -19.73 66.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.725 0.774 . . . . 0.0 110.829 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -73.22 -7.43 51.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.569 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.87 4.36 27.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.527 0.68 . . . . 0.0 110.279 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.89 -161.62 23.79 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.393 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -87.77 128.02 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.6 mm -75.35 89.73 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.935 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p -79.83 -52.37 7.99 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.496 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 17.7 m120 -126.33 138.86 53.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.0 0.429 . . . . 0.0 110.447 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -141.62 137.48 31.89 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.212 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 56.0 m-85 -135.39 98.69 4.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.461 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -108.97 122.14 40.82 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.868 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.81 176.34 10.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.57 2.18 . . . . 0.0 109.972 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.8 164.46 25.97 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 35.9 tt0 -141.66 103.33 4.35 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.1 t70 58.08 27.46 14.96 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.401 1.096 . . . . 0.0 111.984 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.77 -1.75 87.57 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.021 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 20.5 pttp -107.41 -176.08 2.97 Favored 'General case' 0 C--O 1.259 1.576 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 26' ' ' VAL . 4.8 t -78.41 167.39 21.39 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 122.229 1.014 . . . . 0.0 111.822 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.547 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -105.47 175.9 5.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.442 178.158 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.9 20.23 36.6 Favored Glycine 0 C--N 1.292 -1.874 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.115 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 7.0 p90 -170.74 151.73 3.55 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 122.293 0.237 . . . . 0.0 110.499 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 20' ' ' VAL . 18.8 pt -146.03 163.33 10.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 70.8 m-85 -119.39 136.8 54.12 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.75 0.31 . . . . 0.0 110.673 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.7 mm? -123.08 124.58 43.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 7.1 tp10 -119.41 128.16 53.78 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.61 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 25.7 m-85 -127.06 -178.28 4.36 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.53 10.95 11.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.354 0.597 . . . . 0.0 109.541 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.2 p -81.67 163.43 54.0 Favored Pre-proline 0 CA--C 1.583 2.222 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -34.96 9.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.663 2 C-N-CA 130.556 7.504 . . . . 0.0 123.358 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.649 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 86.18 65.59 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.731 0 CA-C-O 124.975 2.321 . . . . 0.0 108.557 -163.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 29.3 p-80 -79.49 -37.2 37.34 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 109.127 -3.67 . . . . 0.0 110.16 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.03 48.15 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.715 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 72' ' ' ALA . 3.0 p -65.5 -29.79 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.01 -45.95 13.45 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.83 71.06 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.728 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.416 ' CG1' ' HB2' ' A' ' 10' ' ' GLU . 47.2 t -65.1 -45.93 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-O 121.072 0.463 . . . . 0.0 111.748 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.39 -27.39 61.44 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -120.63 -45.47 2.41 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.483 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -88.27 -8.22 55.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -171.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.446 ' HA ' HG23 ' A' ' 94' ' ' VAL . 17.3 t70 -61.07 113.13 2.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.357 0.599 . . . . 0.0 112.366 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.01 47.89 3.75 Favored Glycine 0 N--CA 1.42 -2.426 0 CA-C-N 114.922 -1.035 . . . . 0.0 114.603 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 33.0 p90 -107.83 133.97 51.44 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.677 -1.209 . . . . 0.0 109.96 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -100.95 128.47 46.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.233 0.54 . . . . 0.0 112.342 -176.619 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.6 mt -84.79 -62.72 1.48 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.818 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -160.95 154.12 21.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.571 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 45.99 -107.19 0.14 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.428 HE22 ' HB3' ' A' ' 25' ' ' GLN . 14.3 pm0 -103.86 -10.23 18.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.718 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m80 -68.27 93.79 0.49 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.128 -171.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 3.4 m -132.73 118.87 19.61 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -90.37 105.41 17.79 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.499 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.8 mmm180 -83.15 143.03 30.78 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 82' ' ' ASP . 58.5 t -106.47 107.01 21.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.344 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.471 ' HA ' ' HG2' ' A' ' 10' ' ' GLU . 6.1 t-20 -100.84 162.44 12.9 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -79.31 -166.06 0.88 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 124.27 1.028 . . . . 0.0 111.473 -176.151 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.514 ' HB3' HG12 ' A' ' 14' ' ' ILE . 73.3 t80 -139.06 -13.55 1.2 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.798 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.439 HG22 HD12 ' A' ' 96' ' ' LEU . 12.7 t -80.78 158.22 25.53 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.07 -44.08 93.49 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -173.234 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -108.24 132.29 53.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -85.57 68.28 10.37 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.082 1.42 . . . . 0.0 110.349 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.63 172.49 13.71 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.676 -1.602 . . . . 0.0 114.365 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -118.63 170.02 9.31 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.583 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -66.92 105.79 1.72 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.792 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.512 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.54 140.23 39.7 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.454 0.645 . . . . 0.0 110.131 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.3 19.01 2.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.022 0.915 . . . . 0.0 109.349 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.14 -40.52 82.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 5.57 50.37 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.294 -176.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.56 99.64 4.32 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -169.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -130.54 151.59 78.91 Favored Pre-proline 0 C--N 1.285 -2.238 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.29 153.29 61.68 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 121.38 1.386 . . . . 0.0 111.522 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -84.8 125.29 32.45 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -74.9 -6.07 47.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.58 95.39 1.82 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.59 136.63 57.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.67 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.51 81.79 0.83 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.478 ' CD1' ' H ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -65.74 133.73 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.454 ' OD1' ' HE2' ' A' ' 102' ' ' LYS . 8.6 p-10 -112.13 -5.54 14.23 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -169.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.7 p -114.96 -14.36 11.87 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.478 ' H ' ' CD1' ' A' ' 14' ' ' ILE . 60.2 t -139.16 137.17 41.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.963 -0.461 . . . . 0.0 110.762 -172.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 mm -97.25 135.14 32.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 54.4 t -116.1 105.92 19.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 1.7 m -107.82 122.89 62.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.156 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 21.7 t70 -92.73 138.03 31.84 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.613 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.47 24.9 p-10 45.94 86.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 128.513 2.725 . . . . 0.0 115.66 -175.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 35.5 m -89.27 165.78 24.59 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.771 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.3 Cg_endo -45.92 150.19 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.474 2.783 . . . . 0.0 114.125 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HA ' HG21 ' A' ' 60' ' ' THR . 5.7 pt20 -89.46 161.89 16.02 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.561 -173.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 27' ' ' GLY . 60.9 t -129.15 138.89 53.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.517 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 26' ' ' VAL . . . -102.34 -177.27 27.51 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.49 124.89 16.18 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 120.15 1.975 . . . . 0.0 112.067 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 53.76 23.44 3.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.187 1.795 . . . . 0.0 114.167 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB2' HG13 ' A' ' 26' ' ' VAL . 13.8 mtm180 -90.1 -2.61 58.12 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.183 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -63.17 -36.37 83.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 110.075 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -61.39 -47.42 85.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.542 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -74.83 -24.81 58.67 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.013 0.435 . . . . 0.0 110.135 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 38' ' ' ILE . 3.0 tm? -61.97 -49.39 76.29 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -55.51 -31.95 62.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.419 0.628 . . . . 0.0 111.123 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.45 -41.8 38.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.232 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.35 -30.71 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 34' ' ' LEU . 22.2 mm -62.59 -53.39 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -55.43 -36.74 66.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.955 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 40' ' ' LYS . 47.8 tptt -69.13 -53.12 21.85 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.476 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 34.9 mm -56.16 -50.24 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.689 0.757 . . . . 0.0 110.484 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.533 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.4 m-85 -77.04 -0.67 25.48 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.6 m -69.96 -12.51 61.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.275 0.559 . . . . 0.0 110.204 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 29.5 mmmt -72.13 -16.5 62.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.057 0.456 . . . . 0.0 109.998 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.4 6.98 40.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.699 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.58 -156.4 19.96 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.18 128.48 42.05 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.482 HD12 HD12 ' A' ' 66' ' ' LEU . 32.0 mm -74.11 115.14 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 m -86.96 -41.92 13.55 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 68.6 m-20 -154.77 160.92 41.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.903 0.881 . . . . 0.0 109.695 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 41.5 t0 -150.95 151.86 32.75 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -139.17 102.25 4.46 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.654 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -107.12 123.5 38.14 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.926 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 72.7 Cg_endo -82.21 177.57 7.08 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.061 2.507 . . . . 0.0 108.25 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.71 177.23 11.62 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 120.732 -1.23 . . . . 0.0 109.879 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -135.25 102.48 5.19 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.7 t70 54.75 26.09 7.23 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-O 122.561 1.172 . . . . 0.0 111.487 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.33 5.65 59.12 Favored Glycine 0 C--O 1.222 -0.602 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.248 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.61 -177.62 3.54 Favored 'General case' 0 C--O 1.258 1.542 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 25' ' ' GLN . 13.3 m -68.23 142.65 55.57 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.872 -175.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -112.37 173.49 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.399 174.642 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.28 27.27 9.1 Favored Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.949 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 12.1 p90 -169.07 147.84 3.94 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 pt -146.03 176.18 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.347 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 92.6 m-85 -140.18 114.73 9.36 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.019 0.827 . . . . 0.0 111.481 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 48' ' ' ILE . 3.9 mm? -93.66 116.81 29.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.808 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 39.3 tt0 -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.71 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 3.5 m-85 -127.54 171.14 11.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.49 12.66 22.87 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.459 ' HB3' ' ND1' ' A' ' 73' ' ' HIS . 48.0 t -73.26 155.89 89.59 Favored Pre-proline 0 CA--C 1.59 2.495 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.177 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -36.4 8.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.529 3.593 1 C-N-CA 130.72 7.613 . . . . 0.0 122.27 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 86.45 62.59 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 124.981 2.324 . . . . 0.0 107.97 -164.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.71 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 24.1 p-80 -77.65 -36.4 51.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 109.184 -3.644 . . . . 0.0 109.999 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.48 69.21 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.982 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.12 -26.72 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.31 -46.91 12.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.2 79.9 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.448 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.47 -33.33 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.968 0.413 . . . . 0.0 112.046 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -85.42 -29.08 24.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.641 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -109.9 -39.11 5.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.412 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -93.35 0.97 57.1 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.15 103.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.433 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.54 47.69 3.42 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.694 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.412 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 24.3 p90 -103.78 127.29 51.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.523 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -98.01 130.24 44.85 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.652 -173.076 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -85.96 -71.82 0.52 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -171.86 172.36 4.84 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 52.58 -95.93 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.099 1.76 . . . . 0.0 114.693 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -121.58 -1.12 9.6 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.089 0.471 . . . . 0.0 109.917 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.771 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 10.8 m170 -87.1 99.03 11.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.219 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.44 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 3.6 m -133.34 110.0 9.75 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -81.84 108.7 15.58 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.372 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -90.52 130.24 36.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.7 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.46 105.88 19.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.693 0.758 . . . . 0.0 110.585 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -108.15 166.48 10.71 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.943 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.5 pt? -75.25 -174.26 2.3 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.303 0.573 . . . . 0.0 111.162 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 99' ' ' ASP . 33.7 t80 -91.18 -16.35 27.84 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.0 m 66.53 -21.39 0.1 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.358 1.463 . . . . 0.0 113.659 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 97' ' ' PHE . 30.4 t70 -88.94 -34.49 16.88 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.261 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . 0.343 20.1 p90 37.31 89.75 0.01 OUTLIER 'General case' 0 C--N 1.348 0.502 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -86.34 71.09 10.53 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.434 1.111 . . . . 0.0 110.219 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HE2' ' OD1' ' A' ' 15' ' ' ASP . 1.6 mptm? -106.52 163.01 13.22 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.799 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -107.0 167.16 10.08 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -46.85 -45.76 20.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.044 0.938 . . . . 0.0 111.501 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.425 -1.714 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.002 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.144 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.16 144.98 26.6 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 121.192 0.52 . . . . 0.0 111.574 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.12 26.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.517 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.0 mt -84.29 -42.37 15.9 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.491 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -72.94 -48.47 36.57 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 120.838 0.351 . . . . 0.0 111.231 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -106.97 107.41 18.41 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.9 mtp180 -100.01 141.24 22.39 Favored Pre-proline 0 C--N 1.277 -2.579 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 -174.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 12.7 Cg_exo -70.59 128.98 15.99 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.872 1.714 . . . . 0.0 110.668 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 5.7 tp-100 -142.57 163.85 31.7 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' O ' HD21 ' A' ' 96' ' ' LEU . 4.4 mm-40 -78.01 15.77 0.84 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 124.292 1.037 . . . . 0.0 111.337 -174.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HB2' HG11 ' A' ' 78' ' ' VAL . . . -80.74 79.99 7.29 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.071 0.463 . . . . 0.0 111.999 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -167.47 158.31 11.39 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.27 -115.85 4.8 Favored Glycine 0 C--N 1.309 -0.917 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.387 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 tp -83.79 97.1 4.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 122.649 1.214 . . . . 0.0 112.032 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -78.41 -7.95 57.94 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.365 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.736 ' HA ' ' HE2' ' A' ' 73' ' ' HIS . 12.5 m -100.01 13.36 34.24 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -170.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.4 p -137.08 138.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.911 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 mm -111.62 137.91 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.4 t -125.59 113.87 36.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 173.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG2' HG12 ' A' ' 64' ' ' ILE . 14.3 m -110.14 137.67 41.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.306 0.574 . . . . 0.0 110.768 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.447 ' C ' HD22 ' A' ' 22' ' ' ASN . 20.7 t70 -97.74 139.73 33.19 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.757 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.447 HD22 ' C ' ' A' ' 21' ' ' ASP 0.423 0.1 OUTLIER 46.06 86.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.82 2.448 . . . . 0.0 115.536 -179.837 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.506 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.4 m -84.83 163.61 45.6 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.151 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.791 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.7 Cg_endo -42.73 145.43 1.07 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 124.509 3.473 . . . . 0.0 117.556 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 10.3 tm0? -62.53 151.72 36.81 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 111.648 -2.523 . . . . 0.0 111.085 177.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 27' ' ' GLY . 8.1 p -132.01 146.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.326 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -95.37 171.48 29.48 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 169.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.37 125.62 18.49 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 CA-C-N 120.465 2.133 . . . . 0.0 112.286 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.02 22.49 12.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.599 1.16 . . . . 0.0 111.786 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.467 ' HD2' ' H ' ' A' ' 27' ' ' GLY . 95.9 mtt180 -92.88 -2.5 55.81 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.697 -1.252 . . . . 0.0 111.102 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -62.1 -23.57 66.6 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.744 0.307 . . . . 0.0 110.703 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.48 -47.24 76.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.468 0.707 . . . . 0.0 109.194 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -69.7 -38.21 76.88 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.893 0.854 . . . . 0.0 109.502 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.434 HD23 HG23 ' A' ' 26' ' ' VAL . 4.1 mm? -72.09 -6.01 39.41 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.507 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 61.9 mttp -85.33 -31.41 23.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.162 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 22.6 t-20 -73.61 -44.61 56.68 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.158 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.46 -33.05 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.566 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.94 -62.54 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.185 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 36' ' ' ASN . 4.9 p-80 -65.3 -20.13 66.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -70.55 -60.13 2.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 81.9 mt -67.67 -44.12 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.02 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -68.72 -9.68 51.95 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -67.75 -2.28 6.79 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 19.0 ptmt -70.56 -35.22 72.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.111 0.482 . . . . 0.0 110.584 171.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CD2' ' HG3' ' A' ' 44' ' ' LYS . 97.3 m-85 -80.08 -14.97 58.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.326 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 145.52 -161.3 28.2 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -91.5 138.74 31.33 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.04 89.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.99 -38.98 52.06 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 3.3 t-20 -148.64 139.85 23.23 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -144.27 153.91 42.52 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 73.5 m-85 -132.13 103.26 6.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -108.54 106.74 59.27 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.69 173.17 13.8 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 121.156 1.238 . . . . 0.0 111.902 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -154.99 165.65 36.05 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.631 0.772 . . . . 0.0 109.481 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.599 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -149.4 101.44 3.11 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 173.551 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.78 27.36 1.54 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.283 1.833 . . . . 0.0 114.032 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.57 9.45 56.52 Favored Glycine 0 C--N 1.309 -0.941 0 O-C-N 121.395 -0.815 . . . . 0.0 112.366 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HE3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -103.54 170.9 7.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 26' ' ' VAL . 5.8 t -92.75 128.73 38.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 122.881 1.325 . . . . 0.0 113.37 -172.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 61' ' ' LYS . 5.6 pttp -53.55 161.02 1.12 Allowed 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.748 166.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.69 18.23 13.13 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.002 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 28.9 p90 -169.96 155.34 5.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.515 HG12 ' CG2' ' A' ' 20' ' ' VAL . 22.4 pt -146.65 168.36 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 49.4 m-85 -131.84 133.04 44.23 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 2.1 mm? -114.13 132.81 55.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 1.6 tm-20 -126.41 115.7 20.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.584 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 81.5 m-85 -123.29 175.91 6.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.626 0.727 . . . . 0.0 111.185 -174.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.12 13.98 12.17 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.54 1.136 . . . . 0.0 108.425 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.58 ' OG ' ' HD2' ' A' ' 71' ' ' PRO . 23.1 t -75.61 161.17 77.34 Favored Pre-proline 0 CA--C 1.596 2.732 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.297 -172.001 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HD2' ' OG ' ' A' ' 70' ' ' SER . 1.2 Cg_exo -36.1 8.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.967 1 C-N-CA 129.921 7.081 . . . . 0.0 121.931 177.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 75' ' ' VAL . . . 85.93 62.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.987 2.327 . . . . 0.0 108.08 -164.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.736 ' HE2' ' HA ' ' A' ' 16' ' ' SER . 17.5 p80 -73.43 -30.06 62.97 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 109.646 -3.434 . . . . 0.0 109.561 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.07 64.08 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.287 1.042 . . . . 0.0 108.582 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 78' ' ' VAL . 57.4 t -75.25 -30.22 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.254 176.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.65 -41.78 62.25 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.48 75.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.826 0.45 . . . . 0.0 111.218 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 75' ' ' VAL . 1.1 p -67.55 -26.73 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.381 0.61 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -33.82 67.01 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.206 1.003 . . . . 0.0 110.656 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.06 -76.55 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.658 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . 177.32 106.54 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 123.954 0.784 . . . . 0.0 110.489 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.546 ' HB2' HG22 ' A' ' 94' ' ' VAL . 1.6 t70 -65.52 108.81 2.13 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 170.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.78 52.53 1.51 Allowed Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 41.8 p90 -97.72 133.13 42.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.199 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -101.84 129.57 48.09 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.987 -172.119 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.21 -63.37 1.33 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.865 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -161.07 157.22 25.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.029 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 42.15 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.262 1.825 . . . . 0.0 114.187 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -119.5 8.78 11.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.524 0.602 . . . . 0.0 111.825 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.791 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 22.4 m170 -85.02 93.72 8.66 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -132.84 103.64 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.508 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.22 112.32 19.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.5 mpt_? -81.23 142.8 32.82 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 82' ' ' ASP . 14.6 m -120.1 128.94 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.878 -173.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -151.61 167.8 26.97 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 170.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -108.64 -163.1 0.85 Allowed 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 123.27 0.628 . . . . 0.0 111.216 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -91.75 6.31 46.46 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.336 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.627 ' HA ' ' CE1' ' A' ' 100' ' ' PHE . 83.5 m -78.64 67.46 4.39 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.94 1.353 . . . . 0.0 110.162 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -101.43 -9.96 20.63 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.566 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.627 ' CE1' ' HA ' ' A' ' 98' ' ' THR 0.264 8.7 p90 -59.49 151.34 24.38 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 177.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -49.72 -54.46 18.7 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.511 1.524 . . . . 0.0 114.889 -170.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -102.86 147.2 27.19 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.318 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -168.84 163.03 11.67 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 125.108 1.363 . . . . 0.0 107.513 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.0 tpt -72.22 121.91 20.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.382 0.61 . . . . 0.0 110.216 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.413 -2.29 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.506 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.585 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.51 150.4 26.01 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.7 m -93.14 2.14 9.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -175.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 mp -96.53 -61.53 1.41 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.997 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -103.46 -34.38 8.73 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.205 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.6 t70 57.7 65.79 1.26 Allowed 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 124.532 1.145 . . . . 0.0 108.998 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -146.75 159.27 44.31 Favored Pre-proline 0 C--N 1.304 -1.392 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.681 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.45 169.55 12.42 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.193 1.929 . . . . 0.0 107.73 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -58.16 120.93 9.51 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.809 0.814 . . . . 0.0 109.584 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -74.16 -16.72 60.98 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 126.125 1.77 . . . . 0.0 113.943 -169.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.86 135.03 46.44 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -151.81 114.74 4.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.551 0.691 . . . . 0.0 110.22 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.22 -71.82 2.91 Favored Glycine 0 C--N 1.286 -2.209 0 CA-C-N 115.034 -0.985 . . . . 0.0 113.334 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 tp -126.08 124.51 66.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.331 0.586 . . . . 0.0 111.377 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.611 ' OD1' ' HB2' ' A' ' 96' ' ' LEU . 35.6 t70 -151.22 62.37 0.9 Allowed 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.88 1.324 . . . . 0.0 108.104 172.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.545 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 42.8 m -116.37 14.36 15.69 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.694 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 97' ' ' PHE . 61.5 t -138.04 131.83 42.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.77 -0.581 . . . . 0.0 110.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 9.7 mm -88.93 135.32 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.97 121.46 62.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.858 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.498 HG13 ' HB3' ' A' ' 92' ' ' PHE . 90.9 t -121.1 133.51 67.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.319 0.387 . . . . 0.0 111.816 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.9 t70 -101.1 137.51 39.36 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 109.52 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.424 0.2 OUTLIER 45.88 104.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 127.106 2.162 . . . . 0.0 116.397 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.541 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 17.1 m -109.61 172.17 3.84 Favored Pre-proline 0 C--N 1.289 -2.063 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.437 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 80.9 Cg_exo -42.4 133.14 4.97 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.292 2.661 . . . . 0.0 112.043 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.472 ' HA ' HG23 ' A' ' 60' ' ' THR . 4.7 pm0 -74.39 155.63 37.9 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.331 -177.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 31' ' ' LEU . 2.3 t -123.05 165.68 18.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.778 -167.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.26 -169.62 30.11 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.53 124.69 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.867 2.333 . . . . 0.0 111.99 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 58.62 17.87 5.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.3 1.84 . . . . 0.0 113.326 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -79.55 -26.98 41.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.022 -1.049 . . . . 0.0 109.814 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.589 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.5 tm? -69.65 -27.48 65.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.427 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.29 -40.55 94.57 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.928 0.394 . . . . 0.0 111.053 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -91.81 -13.84 30.78 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.244 0.545 . . . . 0.0 111.569 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.605 ' O ' HG12 ' A' ' 38' ' ' ILE . 7.2 tt -68.12 -37.61 81.3 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 91.5 mttt -57.8 -25.62 60.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 27.9 t-20 -81.71 -44.68 16.75 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.153 -171.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 41' ' ' ILE . 14.7 p -67.68 -32.52 57.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.793 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.7 mm -67.63 -52.53 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.465 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -56.31 -38.46 71.32 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.583 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.0 mmmt -67.08 -48.02 69.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 37' ' ' VAL . 47.3 mm -66.78 -43.98 89.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.512 0.672 . . . . 0.0 110.573 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.494 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.2 m-85 -83.87 -9.86 58.43 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -171.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -72.4 -3.04 21.73 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.485 -0.759 . . . . 0.0 111.339 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.12 -21.72 42.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.174 0.511 . . . . 0.0 110.007 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -97.33 1.62 49.66 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.656 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.31 -151.79 22.04 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.88 128.01 52.92 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.546 HD12 HD12 ' A' ' 66' ' ' LEU . 47.3 mm -73.08 104.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -79.82 -41.33 26.62 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.177 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -156.14 161.14 40.38 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -142.66 144.69 32.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 117.977 0.353 . . . . 0.0 110.321 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.23 100.44 5.39 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.448 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -107.82 103.48 49.7 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.72 170.49 15.55 Favored 'Trans proline' 0 C--O 1.208 -0.979 0 C-N-CA 121.659 1.572 . . . . 0.0 109.95 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 14.6 pt-20 -173.8 -175.87 1.14 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.707 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 5.9 mm-40 -144.21 135.42 25.49 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 50.73 26.69 2.65 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.638 1.175 . . . . 0.0 113.734 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.76 27.54 70.18 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.566 -0.349 . . . . 0.0 112.805 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.707 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 62.7 pttt -117.35 -176.57 3.03 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 25' ' ' GLN . 48.2 m -43.8 119.29 1.66 Allowed 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 49.1 mttm -74.0 169.37 17.62 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.07 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.29 -8.62 6.4 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.94 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -169.54 159.66 8.56 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 pt -147.21 172.05 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.767 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.9 m-85 -136.26 137.09 40.4 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.665 0.603 . . . . 0.0 109.975 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.546 HD12 HD12 ' A' ' 48' ' ' ILE . 3.6 mm? -111.94 116.48 30.68 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -99.44 124.03 44.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.648 0.737 . . . . 0.0 110.668 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 6.2 m-85 -123.13 -176.42 3.42 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.74 7.65 11.06 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.867 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.663 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.6 m -79.66 154.57 76.06 Favored Pre-proline 0 CA--C 1.591 2.548 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -165.461 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -39.16 6.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.96 2 C-N-CA 130.76 7.64 . . . . 0.0 123.16 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.481 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.23 65.25 0.01 OUTLIER 'General case' 0 C--N 1.367 1.329 0 CA-C-N 122.238 2.29 . . . . 0.0 108.86 -158.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 29.6 p80 -95.63 -24.67 16.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 109.36 -3.564 . . . . 0.0 107.738 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -81.11 -33.86 32.99 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.401 ' CG1' ' HB1' ' A' ' 72' ' ' ALA . 2.7 p -66.42 -26.88 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.611 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 15.8 t70 -69.5 -38.06 77.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.76 94.0 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.291 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' A' ' 96' ' ' LEU . 92.8 t -57.84 -46.76 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -84.89 -15.58 44.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -109.89 -68.38 0.93 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 75.41 0.94 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.559 0.695 . . . . 0.0 111.759 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' A' ' 94' ' ' VAL . 6.0 t70 -111.42 134.91 52.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.731 175.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.48 77.45 Favored Glycine 0 C--N 1.308 -0.993 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -92.33 130.97 37.88 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.097 0.475 . . . . 0.0 110.299 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.6 126.61 44.24 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.518 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.7 mt -87.29 -61.6 1.69 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -174.21 149.0 1.36 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.381 -174.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 58.92 -81.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -122.27 -9.52 8.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.298 1.039 . . . . 0.0 110.148 -172.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.575 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 11.4 m170 -92.97 88.63 6.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.915 -167.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 m -132.95 98.19 4.22 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.498 ' HB3' HG13 ' A' ' 20' ' ' VAL . 53.2 m-85 -83.35 113.91 21.06 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.472 -169.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 2.9 mpt_? -89.05 136.85 32.79 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 82' ' ' ASP . 4.8 m -113.82 151.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-O 121.619 0.723 . . . . 0.0 110.808 -172.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -141.9 152.73 43.85 Favored 'General case' 0 N--CA 1.401 -2.921 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.611 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 1.1 pt? -84.78 -172.11 4.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.942 0.776 . . . . 0.0 111.581 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.526 ' CD1' ' HB ' ' A' ' 17' ' ' VAL . 6.2 t80 -108.97 2.64 21.48 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 117.14 -1.824 . . . . 0.0 112.287 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.0 m -78.39 82.48 4.67 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -77.61 -26.84 50.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.673 -176.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -84.66 110.21 18.58 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -101.71 79.61 1.95 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 122.057 0.932 . . . . 0.0 109.801 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 152.8 35.09 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.46 174.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -105.96 125.14 50.64 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.2 ttt -106.91 99.2 8.78 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.105 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.835 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.788 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 6' ' ' ASP . 3.4 m-20 -85.5 150.29 24.79 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.757 0.313 . . . . 0.0 110.338 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.3 m -106.02 -25.43 3.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.263 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.98 -45.56 4.71 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.396 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -71.32 -37.61 71.76 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.073 0.463 . . . . 0.0 111.632 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 2' ' ' ASP . 26.8 t70 -85.33 105.62 16.12 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -142.25 138.73 16.91 Favored Pre-proline 0 C--N 1.278 -2.513 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.338 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.75 128.15 10.7 Favored 'Trans proline' 0 N--CA 1.436 -1.873 0 N-CA-C 104.69 -2.85 . . . . 0.0 104.69 162.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -102.45 157.04 17.2 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 117.419 -1.712 . . . . 0.0 111.959 -172.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.87 19.6 0.14 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.102 1.361 . . . . 0.0 113.291 -172.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.54 93.99 3.65 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -118.93 119.68 35.04 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.775 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.25 -49.82 4.27 Favored Glycine 0 C--N 1.294 -1.786 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.931 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.438 HG21 ' HB3' ' A' ' 97' ' ' PHE . 8.1 tp -127.84 124.87 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.103 0.477 . . . . 0.0 111.295 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.63 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 5.6 t70 -108.03 -17.19 14.11 Favored 'General case' 0 C--O 1.18 -2.585 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.437 175.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.575 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 16.3 m -85.1 -1.49 56.93 Favored 'General case' 0 C--N 1.273 -2.751 0 O-C-N 120.585 -1.322 . . . . 0.0 113.72 -172.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 60.7 t -117.67 128.48 74.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.442 -175.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 18.6 mm -94.85 136.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.01 119.34 23.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 15.5 m -125.09 133.33 69.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.87 135.5 39.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.33 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.483 0.2 OUTLIER 48.34 85.64 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.675 2.39 . . . . 0.0 116.983 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.46 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 16.8 m -81.93 169.76 17.43 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.467 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 2.0 Cg_endo -44.35 138.05 7.55 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 123.286 2.657 . . . . 0.0 112.312 173.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.565 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 3.8 pm0 -69.35 154.92 41.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.23 147.64 28.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.032 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.94 175.34 16.28 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.73 126.88 23.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.023 1.815 . . . . 0.0 111.928 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 68.17 17.41 9.39 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.002 1.321 . . . . 0.0 113.574 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -104.07 -6.18 21.37 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.163 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.539 HD21 ' HE2' ' A' ' 61' ' ' LYS . 1.2 tm? -66.87 -31.5 72.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.122 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.31 -40.03 92.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.44 -13.46 52.03 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.2 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 37' ' ' VAL . 8.6 tt -72.86 -28.35 62.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.21 -22.06 66.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.629 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 t-20 -79.78 -43.67 22.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.257 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 34' ' ' LEU . 9.0 p -63.9 -24.6 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.369 -174.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mm -55.61 -59.82 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.044 0.938 . . . . 0.0 110.408 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -73.08 -17.0 61.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 30.5 mmmt -71.39 -52.25 19.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.03 -52.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.127 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 22.7 m-85 -73.49 -6.43 46.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 p -71.82 -18.3 62.09 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.84 0.829 . . . . 0.0 110.455 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.557 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -84.8 -3.84 58.81 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.21 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 76.5 m-85 -120.23 18.55 12.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.14 -174.89 21.93 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -101.6 138.59 38.39 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.9 mm -75.68 88.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.3 m -82.06 -55.37 4.61 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.879 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 19.7 m120 -137.08 145.73 44.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -137.26 135.75 37.46 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -128.19 110.7 12.67 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.414 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.422 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 8.3 m-85 -106.05 106.29 56.44 Favored Pre-proline 0 N--CA 1.425 -1.685 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.59 173.67 12.0 Favored 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 122.182 1.922 . . . . 0.0 109.885 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.45 170.01 18.97 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -120.67 99.76 6.72 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.6 t70 39.66 56.21 2.35 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.028 1.331 . . . . 0.0 111.553 -177.139 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.3 -3.12 41.59 Favored Glycine 0 N--CA 1.466 0.68 0 CA-C-N 113.466 -1.697 . . . . 0.0 115.197 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -100.0 -177.46 3.55 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 122.337 -0.508 . . . . 0.0 111.056 -176.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.1 m -45.66 129.19 8.89 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.027 1.731 . . . . 0.0 111.611 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HE2' HD21 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -88.72 160.27 17.4 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.431 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.01 21.31 3.72 Favored Glycine 0 CA--C 1.489 -1.574 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.066 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 31.7 p90 -170.81 148.21 2.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.498 HG12 ' CG2' ' A' ' 20' ' ' VAL . 21.5 pt -141.41 166.16 18.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 76.8 m-85 -136.41 134.34 37.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.4 mp -120.6 145.32 47.49 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.789 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 9.3 tp10 -124.28 116.12 22.13 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.568 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 12.4 m-30 -118.31 171.6 8.02 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.78 14.26 13.37 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.63 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.3 m -75.74 160.15 79.64 Favored Pre-proline 0 CA--C 1.608 3.187 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -170.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 24.1 Cg_exo -39.99 7.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.054 2 C-N-CA 129.972 7.115 . . . . 0.0 123.997 -179.016 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.63 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.36 66.77 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 CA-C-N 122.46 2.391 . . . . 0.0 106.579 -155.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.63 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 26.6 p80 -97.02 -36.95 10.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.566 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.602 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -80.88 -20.84 41.37 Favored 'General case' 0 CA--C 1.474 -1.955 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.251 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 p -59.45 -30.07 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -83.53 -49.29 9.38 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 74' ' ' ALA . . . -55.49 -42.58 74.62 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.395 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 42.7 t -66.88 -22.85 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 123.181 0.592 . . . . 0.0 111.556 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -85.72 -47.52 9.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.153 0.978 . . . . 0.0 109.805 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.52 -11.69 50.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 -167.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.42 13.25 13.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.188 0.518 . . . . 0.0 110.278 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 9.3 t70 -78.93 106.37 10.91 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.46 51.68 6.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 114.518 -1.219 . . . . 0.0 115.405 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.2 m-85 -101.5 106.18 17.25 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 2.8 mptt -77.41 99.64 5.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.57 -52.45 65.52 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.001 0.429 . . . . 0.0 110.544 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.525 ' OD2' ' HG2' ' A' ' 88' ' ' LYS . 27.4 t70 -151.54 -76.13 0.14 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.877 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HG2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -100.86 -101.21 0.25 Allowed 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.376 0.607 . . . . 0.0 112.596 178.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.565 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -92.55 3.33 55.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 111.701 -175.911 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -86.99 96.54 10.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 39.5 m -133.41 123.98 26.31 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.88 101.85 13.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.476 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -93.92 126.42 39.11 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.3 150.62 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.31 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -155.81 175.05 14.44 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.99 177.28 1.77 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.438 ' HB3' HG21 ' A' ' 14' ' ' ILE . 84.8 t80 -131.56 -27.69 1.91 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 112.961 -1.927 . . . . 0.0 109.43 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -25.37 60.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.75 0.786 . . . . 0.0 112.25 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -109.73 -19.53 13.13 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.17 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -113.22 153.45 28.33 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -173.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.2 t70 166.69 125.47 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 129.474 3.11 . . . . 0.0 103.002 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.16 145.23 3.29 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.752 0.787 . . . . 0.0 113.097 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' TYR . . . . . 0.431 ' CE2' ' HB ' ' A' ' 105' ' ' THR . 41.4 t80 -90.57 97.87 11.44 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.986 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.6 tmm? -109.62 97.67 7.18 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.431 ' HB ' ' CE2' ' A' ' 103' ' ' TYR . 38.2 m . . . . . 0 C--N 1.294 -1.845 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.831 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -92.38 146.29 23.81 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -111.23 96.03 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.883 0.849 . . . . 0.0 111.995 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 59.5 tp -84.19 -42.99 15.39 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.033 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.06 16.07 22.09 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.404 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.6 t70 72.32 -49.18 0.69 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.236 1.414 . . . . 0.0 112.09 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -69.47 124.71 91.07 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.32 128.38 25.32 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.343 2.695 . . . . 0.0 112.809 -177.237 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.44 131.89 39.33 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.813 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -123.46 -21.58 5.26 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.189 168.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 98.41 0.24 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.325 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -90.72 126.93 36.14 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.22 146.99 18.42 Favored Glycine 0 C--N 1.29 -1.975 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.917 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.542 HG23 ' HB3' ' A' ' 97' ' ' PHE . 4.4 tp -84.04 87.08 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 123.096 1.427 . . . . 0.0 109.429 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -103.75 40.49 1.42 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.739 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.563 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 21.4 m -107.28 6.2 28.31 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.3 t -139.27 135.72 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 mm -101.04 130.34 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.09 110.55 29.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 92' ' ' PHE . 70.6 t -97.83 135.51 32.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 123.924 0.765 . . . . 0.0 111.763 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -107.1 132.11 53.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 47.79 100.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.846 2.058 . . . . 0.0 116.49 -178.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.554 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 22.5 m -91.57 173.77 5.01 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.668 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.664 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 98.8 Cg_exo -42.53 146.0 0.86 Allowed 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.195 2.596 . . . . 0.0 113.772 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.42 121.25 26.48 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.407 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 31' ' ' LEU . 5.2 p -121.98 137.57 55.14 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.8 -173.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.54 169.35 13.16 Favored Glycine 0 N--CA 1.405 -3.394 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.27 127.67 22.88 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.123 2.548 . . . . 0.0 112.775 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 73.66 21.15 2.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.998 1.319 . . . . 0.0 112.904 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -116.63 -1.58 12.12 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.095 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' HB2' HG21 ' A' ' 26' ' ' VAL . 3.3 tm? -67.53 -35.65 79.49 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -173.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 40.8 tt0 -63.27 -37.0 85.53 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -78.05 -32.58 50.94 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.543 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.537 ' O ' HG12 ' A' ' 38' ' ' ILE . 9.4 mp -71.7 -26.02 62.32 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.162 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 ptmm? -82.47 -18.22 42.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.628 0.728 . . . . 0.0 109.412 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -82.19 -37.79 25.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.201 -177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 41' ' ' ILE . 10.3 p -66.09 -32.12 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.941 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 34' ' ' LEU . 30.4 mm -58.36 -55.27 23.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.374 0.607 . . . . 0.0 109.465 173.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -55.14 -41.59 71.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.6 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -60.96 -57.44 12.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.599 0.76 . . . . 0.0 111.403 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 37' ' ' VAL . 41.2 mm -55.7 -51.06 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.656 0.741 . . . . 0.0 111.229 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.564 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 65.8 m-85 -74.57 -6.17 47.03 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -173.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -70.57 -11.91 61.23 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.66 -0.65 . . . . 0.0 111.428 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -74.79 -14.92 60.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.447 0.642 . . . . 0.0 110.58 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.07 0.63 32.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.746 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 137.27 -166.18 25.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.94 129.22 37.95 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.479 HD12 HD12 ' A' ' 66' ' ' LEU . 26.3 mm -74.75 103.69 2.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.4 m -71.55 -55.34 8.02 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -145.22 169.31 18.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.604 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 51.5 t0 -158.35 160.52 37.04 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 175.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.63 103.26 5.17 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -171.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.449 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 21.7 m-85 -108.2 105.07 55.78 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.591 -175.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.486 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 96.7 Cg_endo -89.26 164.13 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.402 1.402 . . . . 0.0 109.592 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -176.37 -175.51 0.68 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 1.9 tm-20 -154.98 114.55 3.71 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.0 t70 64.89 26.47 12.84 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.932 1.293 . . . . 0.0 110.292 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.61 24.42 69.55 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.074 -0.966 . . . . 0.0 114.702 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 15.4 pttm -92.47 -177.95 4.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 117.565 0.682 . . . . 0.0 110.278 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.7 m -71.61 108.09 4.8 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -171.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 3.4 pttm -69.97 160.33 32.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.192 165.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.69 14.77 12.87 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.129 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -169.05 152.49 5.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 117.185 0.493 . . . . 0.0 110.986 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -147.37 174.87 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.262 1.736 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 86.6 m-85 -141.56 113.94 8.2 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.313 0.506 . . . . 0.0 110.447 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.479 HD12 HD12 ' A' ' 48' ' ' ILE . 3.7 mm? -89.62 108.89 19.94 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.32 123.54 45.58 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 22.2 m-85 -121.17 175.86 5.89 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 13.78 12.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.529 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 11.7 m -77.3 158.99 78.7 Favored Pre-proline 0 CA--C 1.581 2.159 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -170.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 4.7 Cg_endo -39.88 7.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.511 2.515 1 C-N-CA 129.866 7.044 . . . . 0.0 121.743 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.615 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 84.41 65.45 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 124.706 2.193 . . . . 0.0 107.534 -160.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.563 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 27.2 p80 -82.6 -36.18 26.39 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 109.612 -3.449 . . . . 0.0 108.809 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.37 -28.44 63.01 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.501 -176.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.7 p -68.09 -24.41 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.571 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 26.8 t70 -83.78 -41.84 17.15 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.83 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.51 79.49 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.365 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.458 HG12 HG23 ' A' ' 94' ' ' VAL . 34.4 m -66.03 -21.56 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.439 0.638 . . . . 0.0 111.69 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 27.3 ttpp -79.31 -43.6 23.28 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.785 0.803 . . . . 0.0 110.73 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.64 -56.09 4.06 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.344 -171.208 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.44 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . . . -155.9 87.97 1.09 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.173 -1.011 . . . . 0.0 113.4 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.474 ' CB ' HG22 ' A' ' 94' ' ' VAL . 2.7 t70 -77.42 109.83 11.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.273 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 56.17 0.57 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' THR . 78.7 m-85 -67.59 99.33 0.76 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.51 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -85.01 100.0 11.38 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -78.15 -50.84 11.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -150.22 174.53 12.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -30.97 -61.98 0.18 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.767 2.027 . . . . 0.0 114.979 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -105.1 12.71 31.79 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.882 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.664 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 15.7 m80 -117.05 100.67 7.89 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.249 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 9.0 m -133.02 101.1 5.1 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.005 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.2 m-85 -82.39 106.47 14.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.522 -171.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -78.88 137.4 37.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 173.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.474 HG22 ' CB ' ' A' ' 82' ' ' ASP . 6.4 m -114.66 149.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 123.697 0.623 . . . . 0.0 109.681 -170.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.69 159.54 33.09 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.8 pt? -79.42 -167.54 1.24 Allowed 'General case' 0 C--N 1.31 -1.128 0 O-C-N 124.116 0.885 . . . . 0.0 111.294 -177.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' HB3' HG23 ' A' ' 14' ' ' ILE . 28.6 t80 -82.93 -16.03 49.0 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.784 -176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.426 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 4.5 m -86.09 70.05 10.55 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.77 -21.45 59.33 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.418 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.13 26.55 2.81 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.82 0.819 . . . . 0.0 112.069 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 98' ' ' THR . 38.2 t70 -117.64 77.52 1.15 Allowed 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -94.9 167.33 11.48 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.765 -1.561 . . . . 0.0 108.523 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -118.06 76.36 1.07 Allowed 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 122.152 0.977 . . . . 0.0 109.203 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -95.57 -40.89 9.2 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 63.9 m . . . . . 0 N--CA 1.426 -1.669 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.939 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.423 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 3' ' ' VAL . 4.8 m-20 -91.33 111.61 23.17 Favored 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.339 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 2' ' ' ASP . 15.3 t 178.66 128.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 C-N-CA 130.466 3.506 . . . . 0.0 104.257 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.86 -26.07 66.72 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.153 0.501 . . . . 0.0 112.219 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -85.62 -10.97 55.04 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.893 178.206 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -99.88 79.01 2.17 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.961 0.886 . . . . 0.0 108.692 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -112.94 161.74 25.16 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.878 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.47 149.39 87.91 Favored 'Trans proline' 0 C--O 1.246 0.903 0 C-N-CA 121.929 1.752 . . . . 0.0 109.706 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -73.63 133.29 43.43 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 122.609 1.195 . . . . 0.0 109.635 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.69 -21.72 34.8 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 112.127 -2.306 . . . . 0.0 110.936 -171.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.07 153.09 36.62 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -102.8 174.06 6.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 101' ' ' ASP . . . -170.53 -139.75 2.83 Favored Glycine 0 CA--C 1.472 -2.633 0 C-N-CA 119.634 -1.27 . . . . 0.0 113.645 -173.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.813 HD13 ' H ' ' A' ' 16' ' ' SER . 1.4 pp -74.0 -172.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 CA-C-O 122.899 1.333 . . . . 0.0 113.242 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 18.2 p-10 -122.41 13.57 10.25 Favored 'General case' 0 C--N 1.26 -3.285 0 CA-C-N 112.905 -1.952 . . . . 0.0 107.889 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.813 ' H ' HD13 ' A' ' 14' ' ' ILE . 5.1 m -101.37 11.66 38.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -167.502 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.8 141.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.909 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.481 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 32.5 mm -100.29 132.93 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 67.9 t -135.88 109.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.433 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 m -112.51 123.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.532 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.45 144.61 27.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.345 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' GLY 0.533 0.3 OUTLIER 42.93 80.5 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 -176.694 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 19.4 m -91.57 168.09 14.09 Favored Pre-proline 0 N--CA 1.425 -1.719 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.284 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.789 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 73.3 Cg_exo -45.58 129.05 11.1 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.597 2.865 . . . . 0.0 113.502 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.45 153.46 41.38 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.244 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' A' ' 60' ' ' THR . 10.7 p -92.71 134.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 118.589 -1.245 . . . . 0.0 111.382 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 30' ' ' ARG . . . -123.21 176.35 16.65 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 105.765 -2.934 . . . . 0.0 105.765 171.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -50.97 127.05 20.35 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.557 2.171 . . . . 0.0 112.14 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.31 23.42 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.122 1.369 . . . . 0.0 112.85 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 58.9 mtp180 -105.2 -10.99 16.75 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.36 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.412 ' HB2' HG21 ' A' ' 26' ' ' VAL . 1.7 tm? -73.35 -42.05 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.066 -175.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.59 -37.91 88.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.046 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -81.25 -17.7 48.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.658 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.6 tp -70.02 -39.7 75.65 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -39.61 84.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.163 0.982 . . . . 0.0 109.816 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.46 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 41.6 t-20 -78.35 -37.5 44.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.644 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 34' ' ' LEU . 5.1 p -65.28 -29.36 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 34' ' ' LEU . 36.5 mm -64.94 -50.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -63.48 -20.12 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.724 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.46 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 62.1 mttm -86.23 -60.1 2.1 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.412 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.584 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 77.9 mt -66.22 -42.22 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CD2' HD11 ' A' ' 66' ' ' LEU . 3.3 m-85 -79.31 -23.57 43.41 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -170.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 67.3 m -64.43 -8.17 12.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 21.7 ptmt -68.35 -33.04 73.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 77' ' ' ALA . 30.0 m-85 -83.33 -17.19 43.3 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.595 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 153.16 -177.84 30.56 Favored Glycine 0 C--O 1.219 -0.81 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -76.86 131.93 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.09 103.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -82.02 -60.68 2.14 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.789 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 91.3 m-20 -126.91 122.97 36.11 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.74 133.68 53.13 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.47 102.9 8.76 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.08 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 12.6 m-30 -101.0 104.72 34.07 Favored Pre-proline 0 N--CA 1.428 -1.564 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.466 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 91.9 Cg_endo -87.81 173.92 4.95 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.008 1.805 . . . . 0.0 111.432 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.19 -175.66 4.79 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 37.6 tt0 -148.29 103.21 3.42 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 56.02 27.65 11.61 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.09 7.31 73.9 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.541 0.576 . . . . 0.0 114.541 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 15.6 ptpt -92.74 175.29 6.86 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 118.157 0.978 . . . . 0.0 108.866 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.447 ' OG1' HG12 ' A' ' 26' ' ' VAL . 13.5 t -72.16 137.56 47.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.381 0.61 . . . . 0.0 110.153 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 13.6 pttm -79.35 163.94 24.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.493 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 22' ' ' ASN . . . -129.58 2.99 6.13 Favored Glycine 0 C--O 1.182 -3.133 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.046 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -154.99 156.04 35.27 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.933 -0.745 . . . . 0.0 109.833 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 pt -141.27 167.33 17.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.5 m-85 -131.92 141.07 49.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 42' ' ' PHE . 26.9 mt -127.87 149.35 50.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 50' ' ' ASN . 44.2 mt-10 -128.04 153.35 46.88 Favored 'General case' 0 C--O 1.255 1.388 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.37 159.89 29.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.26 73.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.521 1.128 . . . . 0.0 111.212 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 73' ' ' HIS . 28.5 t -123.72 128.25 25.22 Favored Pre-proline 0 CA--C 1.461 -2.472 1 N-CA-C 97.14 -5.133 . . . . 0.0 97.14 173.101 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 23.2 Cg_exo -62.49 -52.0 2.86 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 CA-C-N 121.813 1.683 . . . . 0.0 110.647 -165.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 26.52 5.79 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.807 0 C-N-CA 131.551 3.94 . . . . 0.0 119.657 144.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 71' ' ' PRO . 88.4 m-70 -127.24 -28.95 2.78 Favored 'General case' 1 C--N 1.225 -4.81 0 CA-C-O 121.214 0.53 . . . . 0.0 109.884 -170.22 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -69.25 -26.77 64.95 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.048 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.65 -24.86 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.07 -45.1 28.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . . . -57.4 -47.14 82.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.911 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.38 -18.0 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.109 0.48 . . . . 0.0 111.599 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -84.2 -24.59 30.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.42 -84.18 0.05 Allowed 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.89 109.45 3.21 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.253 0.549 . . . . 0.0 112.024 -173.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 94' ' ' VAL . 1.2 t70 -95.46 120.22 35.33 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.86 173.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.05 53.8 2.29 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.576 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -106.42 119.14 38.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.196 -0.591 . . . . 0.0 110.369 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -79.56 130.47 35.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.873 -175.671 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.36 -63.3 1.34 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -172.15 169.63 5.44 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HG2' ' OE1' ' A' ' 89' ' ' GLN . 24.3 ttmm 51.79 -104.04 0.17 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.651 1.18 . . . . 0.0 112.44 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.457 ' OE1' ' HG2' ' A' ' 88' ' ' LYS . 5.7 pm0 -121.61 11.93 10.63 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.959 0.885 . . . . 0.0 109.217 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.789 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 7.4 m170 -90.33 88.48 7.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.458 HG23 ' HG3' ' A' ' 85' ' ' LYS . 61.9 m -133.49 114.82 14.04 Favored 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.452 -178.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -82.53 100.64 10.23 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.79 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.74 122.59 31.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.6 m -107.65 126.12 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.572 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -159.11 176.22 12.51 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.96 179.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 pp -109.76 -173.78 2.34 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 123.2 0.6 . . . . 0.0 109.406 171.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -123.43 -13.72 7.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.5 m -60.76 154.22 22.29 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 124.971 1.309 . . . . 0.0 111.189 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.19 -42.96 18.3 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -133.09 164.31 27.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.513 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 5.7 p-10 -90.08 -0.13 57.43 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.807 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.27 18.2 mmmt -66.06 127.51 32.39 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.876 -172.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -134.31 161.43 34.97 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 112.945 -1.934 . . . . 0.0 106.246 -169.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.6 tpt -71.02 102.97 2.56 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.413 -2.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.632 -178.447 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.577 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -78.56 150.13 32.89 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.23 0.538 . . . . 0.0 111.428 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -91.46 3.96 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.493 0.664 . . . . 0.0 110.086 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.23 -20.1 64.8 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.765 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -75.84 -18.07 59.59 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.825 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -92.01 82.12 5.1 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.084 0.469 . . . . 0.0 109.916 176.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -138.32 142.44 35.13 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.365 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -73.99 128.54 12.4 Favored 'Trans proline' 0 N--CA 1.435 -1.919 0 N-CA-C 104.866 -2.782 . . . . 0.0 104.866 167.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -67.09 119.5 12.13 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.644 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.3 -20.36 60.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.515 0.674 . . . . 0.0 110.197 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.41 86.82 3.96 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 173.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -127.8 161.3 29.32 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.53 -49.4 4.22 Favored Glycine 0 C--N 1.312 -0.793 0 O-C-N 123.317 0.385 . . . . 0.0 112.297 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.4 tp -75.03 132.52 33.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.124 0.488 . . . . 0.0 109.884 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -129.2 -13.14 4.5 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.844 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.426 ' HA ' ' HE1' ' A' ' 73' ' ' HIS . 38.5 m -106.48 -7.53 17.5 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -172.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -134.92 135.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.231 -175.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -92.66 134.82 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.4 t -123.89 112.9 34.71 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.41 HG23 HG12 ' A' ' 64' ' ' ILE . 1.8 m -121.98 118.42 55.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.446 -178.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.77 148.81 22.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.263 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.442 0.1 OUTLIER 47.41 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 128.204 2.602 . . . . 0.0 114.776 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 32.3 m -90.77 163.63 29.32 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.043 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.617 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 0.9 OUTLIER -42.7 142.54 1.99 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 124.531 3.487 . . . . 0.0 114.987 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -80.52 159.38 25.53 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.323 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 27' ' ' GLY . 14.0 p -128.53 136.93 58.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.957 -177.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -101.51 168.09 19.42 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.96 126.87 19.85 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.834 2.356 . . . . 0.0 113.19 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.15 24.08 10.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.096 1.359 . . . . 0.0 112.996 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 20.0 mtp180 -107.3 -3.78 19.34 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.487 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -68.51 -33.92 74.98 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.54 -45.68 63.07 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.094 1.358 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -85.08 -29.17 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.022 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 38' ' ' ILE . 78.2 mt -64.51 -39.48 93.86 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.56 -21.26 61.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.479 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.7 t-20 -84.38 -38.18 20.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.246 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.05 -26.28 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 34' ' ' LEU . 44.0 mm -57.69 -51.32 71.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.059 175.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -62.88 -31.16 72.15 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 34.4 mmtp -65.69 -47.8 74.18 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.66 -47.86 78.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.63 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.539 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 68.4 m-85 -83.98 -11.76 56.32 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.5 p -69.31 -16.54 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 121.555 -0.715 . . . . 0.0 110.827 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.6 mmpt? -64.73 -24.75 67.66 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.347 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.23 -8.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.758 0.313 . . . . 0.0 111.39 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.95 -149.12 21.23 Favored Glycine 0 N--CA 1.428 -1.87 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.35 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -103.18 118.29 36.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 66' ' ' LEU . 23.0 mm -73.82 103.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.9 p -88.5 -23.74 23.14 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.007 0.432 . . . . 0.0 111.411 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -158.23 139.03 12.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.411 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 4.5 p30 -130.53 142.35 50.47 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.843 -0.536 . . . . 0.0 110.982 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 97.4 m-85 -128.23 98.97 5.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 7.4 m-30 -108.12 104.66 54.41 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.35 163.07 19.67 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.153 1.235 . . . . 0.0 109.863 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 8.3 pt-20 -174.31 177.73 2.18 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -128.77 105.19 8.08 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 58.12 27.57 15.19 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.958 0.903 . . . . 0.0 111.979 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.435 ' HA2' ' OE1' ' A' ' 55' ' ' GLU . . . 79.1 15.2 80.86 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.104 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -92.03 -178.74 5.08 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 122.537 -0.39 . . . . 0.0 110.521 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 26' ' ' VAL . 7.0 t -57.15 106.16 0.29 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 42.2 mttm -57.38 168.39 0.79 Allowed 'General case' 0 C--O 1.245 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 110.883 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.51 -13.93 7.18 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.669 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -170.47 159.45 6.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 20' ' ' VAL . 25.7 pt -146.9 166.28 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 63.7 m-85 -132.43 134.26 44.89 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.463 HD12 HD12 ' A' ' 48' ' ' ILE . 3.1 mm? -112.87 117.63 32.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -107.15 130.81 54.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . 0.583 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -127.38 177.62 6.6 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.72 13.51 14.21 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.448 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . 29.6 m -79.11 151.0 75.37 Favored Pre-proline 0 CA--C 1.574 1.867 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.59 8.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.04 2 C-N-CA 130.593 7.529 . . . . 0.0 122.751 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 85.33 64.64 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 124.576 2.131 . . . . 0.0 106.928 -160.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.583 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 53.4 p-80 -90.34 -36.35 14.7 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 109.129 -3.669 . . . . 0.0 107.662 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.67 -31.02 69.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.311 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 72' ' ' ALA . 4.0 p -65.92 -28.55 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.153 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -81.5 -40.0 23.89 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.854 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.43 75.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.626 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.58 -38.74 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 C-N-CA 124.439 1.096 . . . . 0.0 111.198 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -73.06 -20.91 60.87 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.422 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -93.59 -56.52 2.88 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.694 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.62 97.85 3.66 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.466 ' CG ' HG22 ' A' ' 94' ' ' VAL . 5.5 t0 -112.0 122.69 48.45 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.47 42.39 9.25 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.988 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' THR . 16.9 p90 -94.65 139.13 31.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.736 0.303 . . . . 0.0 110.939 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.51 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -103.36 123.84 47.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.029 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.09 -50.59 6.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.812 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -155.18 -167.19 2.48 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -27.6 -75.41 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.932 2.093 . . . . 0.0 115.541 -170.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.485 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 5.1 pm0 -111.12 12.62 21.92 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.27 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.617 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 6.3 m170 -88.46 88.88 7.77 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 5.1 m -133.49 102.07 5.38 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.39 118.54 22.76 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -167.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -88.34 125.19 34.57 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.466 HG22 ' CG ' ' A' ' 82' ' ' ASP . 4.1 m -94.56 147.78 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.067 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -157.14 167.94 28.93 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.48 -175.45 0.83 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.424 1.106 . . . . 0.0 112.554 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -123.21 -40.15 2.41 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.299 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 p -87.5 83.29 7.29 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.629 0.728 . . . . 0.0 111.162 -178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.08 -32.82 71.09 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.572 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -112.39 84.96 2.06 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.739 174.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -98.06 -7.69 29.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 122.408 1.099 . . . . 0.0 108.559 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -73.02 164.03 27.3 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.162 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -139.11 155.16 48.1 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.8 ttt -94.75 94.39 8.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.9 m . . . . . 0 C--N 1.29 -1.99 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 177.77 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.998 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.47 150.72 21.1 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.576 0.703 . . . . 0.0 110.161 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 p -134.34 8.71 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.695 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.09 -24.79 24.45 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -76.05 -2.28 29.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.566 175.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -95.6 104.62 16.54 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -139.26 147.38 52.82 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.79 144.11 82.47 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 121.56 1.507 . . . . 0.0 109.107 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -73.16 109.45 6.7 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.197 0.999 . . . . 0.0 113.301 -174.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -125.78 -22.13 4.27 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.4 -1.727 . . . . 0.0 107.229 167.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.46 103.0 13.23 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.935 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.621 ' OD2' ' HB2' ' A' ' 96' ' ' LEU . 11.9 t70 -167.3 150.04 6.15 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.68 -6.46 40.71 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.734 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.2 tp -134.33 97.39 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 122.55 1.167 . . . . 0.0 112.096 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -96.02 18.34 13.62 Favored 'General case' 0 C--O 1.193 -1.911 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.376 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 t -109.04 -6.12 15.77 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 111.108 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 48.7 t -111.84 118.47 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 35.5 mm -84.11 139.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 49.9 t -130.71 113.09 23.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.103 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG12 HG12 ' A' ' 94' ' ' VAL . 12.0 m -120.24 131.93 71.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.22 142.88 29.34 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.994 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.484 0.2 OUTLIER 44.17 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.127 2.171 . . . . 0.0 115.815 -174.421 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.0 160.42 73.83 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.546 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' ND1' ' A' ' 90' ' ' HIS . 5.6 Cg_endo -46.64 132.94 16.78 Favored 'Trans proline' 0 CA--C 1.501 -1.138 0 C-N-CA 123.465 2.777 . . . . 0.0 114.28 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -54.7 138.05 42.69 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.311 175.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.11 138.42 27.47 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.205 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.4 -178.14 25.08 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.6 125.79 18.83 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.203 1.935 . . . . 0.0 112.299 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 51.71 22.53 1.68 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.519 1.928 . . . . 0.0 112.44 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -86.91 -17.92 32.08 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.354 -0.841 . . . . 0.0 111.253 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.17 -45.08 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -56.9 -56.95 15.06 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.465 0.478 . . . . 0.0 110.99 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -68.38 -24.19 64.75 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.522 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.61 ' O ' HG12 ' A' ' 38' ' ' ILE . 8.0 tt -70.69 -44.91 66.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -73.57 -18.07 61.11 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.324 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 93.0 m-20 -78.86 -41.73 29.17 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.591 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 34' ' ' LEU . 9.8 p -68.08 -32.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.989 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 34' ' ' LEU . 26.5 mm -61.09 -53.87 43.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 122.968 0.507 . . . . 0.0 109.661 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -53.34 -38.48 63.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.355 0.662 . . . . 0.0 109.916 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 28.0 mtpp -73.92 -48.87 27.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.082 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 88.4 mt -62.01 -40.74 88.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.135 0.493 . . . . 0.0 110.326 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 38' ' ' ILE . 2.4 m-30 -74.26 -11.99 60.43 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.31 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 -16.43 63.32 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.8 ptpt -67.32 -33.39 75.16 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 110.523 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 27.8 m-85 -79.79 -16.05 56.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.448 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.18 179.88 26.35 Favored Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.663 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -67.38 114.36 6.01 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.301 1.04 . . . . 0.0 110.816 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.3 mm -74.43 108.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.3 m -80.16 -45.2 18.52 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -154.03 153.15 31.41 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -131.62 150.69 52.06 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.037 0.535 . . . . 0.0 110.055 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.01 101.22 4.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . 0.507 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 34.8 m-85 -108.89 107.05 59.77 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.194 177.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 83.4 Cg_endo -95.44 173.22 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.864 1.709 . . . . 0.0 111.216 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -175.05 -175.49 0.86 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 125.7 1.6 . . . . 0.0 106.725 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 7.6 pt-20 -128.41 128.36 44.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 54.5 26.95 7.72 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.905 1.282 . . . . 0.0 111.282 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.53 21.38 76.15 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.047 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 14.9 ptpt -92.75 -177.77 4.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.082 0.941 . . . . 0.0 109.198 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.7 m -66.86 106.03 1.77 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 1.4 pttm -62.55 164.55 7.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.296 168.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.01 18.83 6.16 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.993 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -169.35 149.16 4.01 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ILE . . . . . 0.5 HG12 ' CG2' ' A' ' 20' ' ' VAL . 19.8 pt -142.84 168.18 13.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.4 m-85 -135.71 152.91 51.63 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.5 mp -135.0 154.48 51.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -130.24 128.17 41.09 Favored 'General case' 0 C--O 1.253 1.284 0 O-C-N 124.05 0.844 . . . . 0.0 109.273 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -104.75 176.59 5.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.98 -37.39 26.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.343 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 t -127.78 145.52 55.3 Favored Pre-proline 0 CA--C 1.466 -2.254 1 N-CA-C 99.534 -4.247 . . . . 0.0 99.534 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 73' ' ' HIS . 39.2 Cg_exo -63.64 -54.64 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.791 0 CA-C-N 122.193 1.819 . . . . 0.0 110.562 -171.162 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.8 4.07 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.654 1 C-N-CA 132.077 4.151 . . . . 0.0 119.824 148.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . 0.473 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 94.6 m-70 -129.32 -36.95 1.67 Allowed 'General case' 1 C--N 1.227 -4.754 0 C-N-CA 123.291 0.636 . . . . 0.0 110.045 -170.169 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.86 64.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.521 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.65 -31.9 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.256 0.551 . . . . 0.0 110.45 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -40.16 19.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.195 0.522 . . . . 0.0 109.759 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.8 86.05 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.639 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.572 ' HA ' HG21 ' A' ' 94' ' ' VAL . 53.2 t -65.59 -22.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.678 0.751 . . . . 0.0 111.16 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -83.8 -38.3 21.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -110.06 -25.91 9.98 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ALA . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . . . -101.47 7.11 42.62 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 122.018 -0.427 . . . . 0.0 111.793 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.613 ' HA ' HG22 ' A' ' 94' ' ' VAL . 14.4 t0 -76.63 103.35 6.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.59 8.41 Favored Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.585 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -105.3 136.38 44.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.101 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -106.72 129.33 54.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.662 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.5 mt -79.46 -62.45 1.69 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.891 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -155.48 133.81 11.67 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 53.1 -93.74 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 125.647 1.579 . . . . 0.0 114.792 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -107.33 -4.1 18.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 120.661 0.267 . . . . 0.0 110.819 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.495 ' ND1' ' HA ' ' A' ' 24' ' ' PRO . 6.9 m-70 -79.3 91.46 5.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.6 m -132.84 120.48 21.6 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.86 104.6 14.08 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.114 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.06 109.08 20.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.62 HG12 HG12 ' A' ' 20' ' ' VAL . 17.2 m -93.62 143.53 11.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -158.08 -172.0 3.73 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.066 176.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.621 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 2.0 pp -66.77 176.94 1.8 Allowed 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 124.913 1.285 . . . . 0.0 112.181 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -124.96 -14.03 6.73 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.042 -175.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.9 p -71.61 78.0 0.81 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.623 1.201 . . . . 0.0 112.825 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.11 -13.89 60.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.054 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -64.33 154.87 34.04 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.684 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -87.44 79.68 8.33 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.936 0.874 . . . . 0.0 110.929 -174.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 151.37 37.69 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 168.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -64.35 103.5 0.65 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.9 ttm -69.95 107.34 3.54 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 6.1 m . . . . . 0 N--CA 1.414 -2.27 0 CA-C-O 117.953 -1.022 . . . . 0.0 108.889 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 6.7 p-10 . . . . . 0 C--O 1.207 -1.181 0 CA-C-O 121.066 0.46 . . . . 0.0 110.592 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -110.92 16.85 21.03 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.106 0.479 . . . . 0.0 111.438 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.19 132.23 63.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 9.6 mm -97.63 135.12 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.27 116.66 53.19 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 173.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 10.3 t -113.34 122.97 68.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.449 0.468 . . . . 0.0 110.216 -175.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.1 t70 -91.87 136.25 33.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.931 0.77 . . . . 0.0 111.182 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.48 0.1 OUTLIER 41.5 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 128.043 2.537 . . . . 0.0 116.684 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.573 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 18.3 m -98.7 173.29 3.97 Favored Pre-proline 0 N--CA 1.427 -1.611 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.246 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.712 ' HA ' ' NE2' ' A' ' 90' ' ' HIS . 55.5 Cg_exo -41.16 127.58 2.9 Favored 'Trans proline' 0 C--O 1.266 1.903 0 C-N-CA 123.649 2.9 . . . . 0.0 114.223 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.84 -178.24 3.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.26 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 31' ' ' LEU . 6.6 p -111.93 134.23 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 118.885 -1.126 . . . . 0.0 113.325 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.78 157.08 15.28 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 104.263 -3.535 . . . . 0.0 104.263 166.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . 0.473 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 9.3 Cg_endo -52.23 123.16 12.0 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 121.557 2.678 . . . . 0.0 112.266 -172.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 50.74 25.74 2.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.432 1.493 . . . . 0.0 112.89 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 28' ' ' PRO . 70.7 mtt180 -107.08 -8.4 16.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 122.061 -0.4 . . . . 0.0 110.952 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.608 ' HB2' HG23 ' A' ' 26' ' ' VAL . 2.9 tm? -73.53 -19.72 60.84 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.39 -48.39 74.4 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.978 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -79.17 -22.29 45.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.412 0.625 . . . . 0.0 110.372 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB2' HD22 ' A' ' 31' ' ' LEU . 97.7 mt -81.41 1.37 33.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 97.1 mttt -84.74 -43.23 14.47 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 48.9 t30 -75.71 -34.95 60.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.033 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.86 -32.78 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.656 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 mm -60.06 -59.01 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.539 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.06 -35.29 73.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.169 0.588 . . . . 0.0 110.542 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 29.9 mtpp -65.61 -39.91 92.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.794 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.3 -39.79 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.301 0.572 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.536 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 26.2 m-85 -76.22 -9.41 58.61 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -66.0 -19.31 65.81 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.636 0.732 . . . . 0.0 110.679 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -68.81 -21.16 64.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.951 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.85 -15.08 35.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.941 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.0 -152.74 24.86 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -96.11 125.72 40.84 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 mm -73.94 97.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -69.67 -54.37 14.2 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -135.84 135.19 39.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -134.14 126.98 31.12 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.87 0.843 . . . . 0.0 109.711 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -125.23 117.1 23.08 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.304 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.07 103.48 50.24 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -95.71 173.97 1.04 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.605 2.204 . . . . 0.0 111.101 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.666 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 174.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 m . . . . . 0 N--CA 1.441 -0.896 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE3' HD11 ' A' ' 31' ' ' LEU . 16.5 pttp -69.95 139.99 52.96 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.35 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.47 16.55 6.25 Favored Glycine 0 C--N 1.288 -2.098 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.855 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 24.4 p90 -169.92 158.33 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.2 pt -147.48 174.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 124.383 1.073 . . . . 0.0 108.117 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.48 136.89 43.48 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.386 0.429 . . . . 0.0 109.875 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.536 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 3.1 mm? -127.92 123.43 34.91 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.19 129.8 56.18 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 9.5 m-85 -127.34 170.35 12.59 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.34 14.33 12.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.513 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 49.6 m -71.57 173.33 5.32 Favored Pre-proline 0 CA--C 1.594 2.636 0 CA-C-N 113.231 -1.804 . . . . 0.0 115.565 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 6.3 Cg_exo -36.64 6.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.521 3.105 1 C-N-CA 130.041 7.16 . . . . 0.0 121.015 175.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 84.56 63.31 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 124.464 2.078 . . . . 0.0 108.478 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.591 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 17.3 p80 -74.16 -36.93 64.13 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 110.125 -3.216 . . . . 0.0 111.065 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -76.98 -37.29 55.47 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.57 -42.83 95.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.52 -49.31 69.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.669 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.23 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.005 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 74' ' ' ALA . 27.8 m -60.06 -31.62 48.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -84.87 -31.02 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -104.8 -41.38 5.66 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.16 84.67 2.02 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 94' ' ' VAL . 3.5 t70 -116.31 118.42 32.69 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.36 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.12 41.96 7.79 Favored Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.154 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . 0.251 39.6 p90 -88.48 120.58 29.99 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.033 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.57 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.8 OUTLIER -79.68 122.41 26.53 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.212 -176.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -87.08 -65.83 0.97 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.138 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -169.25 153.73 5.53 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 45.41 -91.47 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 C-N-CA 125.851 1.66 . . . . 0.0 114.705 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -111.49 -22.89 11.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.712 ' NE2' ' HA ' ' A' ' 24' ' ' PRO . 22.6 m170 -62.54 99.61 0.15 Allowed 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 122.814 0.446 . . . . 0.0 111.459 -171.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.57 HG23 ' HG3' ' A' ' 85' ' ' LYS . 7.5 m -134.45 103.0 5.52 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.8 100.25 10.19 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.888 -172.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.587 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.2 mpt_? -83.12 138.55 33.63 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 82' ' ' ASP . 3.9 m -124.73 136.3 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 O-C-N 123.574 0.546 . . . . 0.0 110.344 -173.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.568 HD22 ' C ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.488 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.69 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 26.4 t70 . . . . . 0 C--O 1.186 -2.273 0 CA-C-O 120.761 0.315 . . . . 0.0 111.051 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.501 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 36.0 m -89.38 -3.16 58.56 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 88.3 t -127.55 122.57 59.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.436 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 14.0 mm -89.99 135.82 25.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 59.9 t -128.74 120.51 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.73 138.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.681 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.61 139.86 42.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.581 0.2 OUTLIER 46.58 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 127.253 2.221 . . . . 0.0 115.889 -169.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.585 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 29.9 m -107.25 179.04 0.95 Allowed Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.141 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.6 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 54.3 Cg_exo -42.41 131.74 5.04 Favored 'Trans proline' 0 C--O 1.269 2.04 0 C-N-CA 123.01 2.474 . . . . 0.0 114.831 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.658 ' HA ' HG23 ' A' ' 60' ' ' THR . 9.1 pt20 -61.84 -165.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 128.06 2.544 . . . . 0.0 113.528 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.601 ' HB ' HD23 ' A' ' 31' ' ' LEU . 14.9 p -141.03 138.55 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-O 121.985 0.897 . . . . 0.0 110.691 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.93 141.85 15.38 Favored Glycine 0 C--N 1.275 -2.853 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 166.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.2 124.81 13.59 Favored 'Trans proline' 0 C--O 1.243 0.744 0 CA-C-N 121.274 2.537 . . . . 0.0 112.73 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 60.56 32.38 20.42 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.067 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.4 2.04 10.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.228 -0.92 . . . . 0.0 111.039 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.601 HD23 ' HB ' ' A' ' 26' ' ' VAL . 1.4 tm? -60.91 -27.01 67.88 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -174.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -57.7 -50.72 72.25 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.56 -23.53 61.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.661 0.743 . . . . 0.0 109.993 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.8 mt -81.2 -4.53 55.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.574 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 99.5 mttt -85.62 -37.46 19.49 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 168.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.49 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 4.4 m-20 -78.16 -33.89 50.04 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.921 -172.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.38 -32.5 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.944 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.47 -53.34 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.3 -31.68 67.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.842 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 52.9 mtpt -78.32 -41.6 33.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.5 mt -82.44 -41.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.708 0.765 . . . . 0.0 111.246 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 66' ' ' LEU . 3.9 m-85 -78.57 -10.81 59.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 1.8 p -71.78 -10.02 59.15 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.733 0.778 . . . . 0.0 111.578 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -71.21 -22.03 62.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.318 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.69 -15.42 39.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.729 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 150.83 -171.47 30.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -83.73 127.08 33.52 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 68' ' ' TYR . 20.1 mm -72.6 94.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.2 m -83.36 -37.25 23.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.097 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 39.5 t30 -154.04 145.57 23.19 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -146.64 151.25 36.95 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -135.99 106.14 6.34 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.783 0.677 . . . . 0.0 109.892 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.74 104.72 55.39 Favored Pre-proline 0 C--O 1.252 1.212 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.32 173.21 1.2 Allowed 'Trans proline' 0 N--CA 1.432 -2.128 0 C-N-CA 121.882 1.721 . . . . 0.0 110.898 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.286 -2.167 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 174.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.658 HG23 ' HA ' ' A' ' 25' ' ' GLN . 98.7 m . . . . . 0 N--CA 1.429 -1.512 0 CA-C-O 121.165 0.507 . . . . 0.0 111.532 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -67.86 145.54 54.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.438 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -118.33 3.19 16.06 Favored Glycine 0 C--N 1.286 -2.225 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.932 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -168.19 150.06 5.26 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.12 167.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -132.69 136.06 46.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.693 HD11 ' CD2' ' A' ' 42' ' ' PHE . 47.1 mt -121.46 154.01 37.15 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 42.3 tt0 -135.95 122.58 20.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.544 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 11.8 m-30 -118.88 157.56 27.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.37 13.86 28.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.219 1.009 . . . . 0.0 108.82 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 20.8 m -73.57 161.63 78.01 Favored Pre-proline 0 CA--C 1.604 3.034 0 CA-C-N 114.16 -1.382 . . . . 0.0 114.605 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.2 Cg_endo -37.66 8.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.945 2 C-N-CA 130.622 7.548 . . . . 0.0 124.316 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.69 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.47 67.42 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 123.066 2.666 . . . . 0.0 106.153 -156.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.544 ' NE2' ' HB2' ' A' ' 68' ' ' TYR . 22.9 p-80 -93.94 -37.87 11.47 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 109.067 -3.697 . . . . 0.0 112.197 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.6 -23.42 53.43 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.354 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.3 p -65.11 -22.89 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.764 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.04 -46.71 12.51 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.05 -43.79 66.91 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.982 0.801 . . . . 0.0 111.964 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.49 -19.57 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.92 0.39 . . . . 0.0 111.872 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -85.27 -22.98 28.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.173 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -71.91 0.14 Allowed 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.313 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -177.3 124.13 0.13 Allowed 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.642 0.588 . . . . 0.0 110.285 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 94' ' ' VAL . 5.5 t70 -81.43 115.67 20.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.49 52.5 4.18 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.335 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -93.67 126.61 38.94 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.092 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -82.99 117.19 22.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.786 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.65 -58.78 2.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.8 0.809 . . . . 0.0 109.197 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -135.12 -164.79 1.58 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -36.2 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.744 1.617 . . . . 0.0 115.069 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -96.29 -1.15 48.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.726 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.6 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 42.1 m170 -81.43 93.29 6.59 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' ' 85' ' ' LYS . 21.2 m -133.95 108.38 8.36 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.681 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -82.83 101.07 10.72 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.261 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.56 136.73 34.14 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 82' ' ' ASP . 17.1 m -105.86 138.17 32.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 123.792 0.682 . . . . 0.0 110.594 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.458 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.289 -2.052 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.405 ' HB3' ' HB3' ' A' ' 74' ' ' ALA . 23.5 m-20 . . . . . 0 N--CA 1.422 -1.828 0 CA-C-O 122.55 1.167 . . . . 0.0 107.992 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.626 ' HA ' ' HE2' ' A' ' 73' ' ' HIS . 44.9 m -96.48 7.18 47.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.265 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 38.7 t -127.93 126.53 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.981 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 30.5 mm -83.04 139.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.2 112.13 34.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.79 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.777 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 30.1 t70 -85.44 132.78 34.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.744 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.479 0.2 OUTLIER 45.7 97.92 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.9 m -86.63 167.94 20.55 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.617 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 48.9 Cg_exo -51.18 146.95 21.81 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.769 2.313 . . . . 0.0 116.098 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 25' ' ' GLN . 3.7 tt0 -61.06 145.3 51.32 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.19 -2.277 . . . . 0.0 109.503 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 ' HB2' ' A' ' 31' ' ' LEU . 7.3 p -137.87 151.0 25.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.715 0.769 . . . . 0.0 111.494 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.16 174.87 20.98 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.62 126.05 11.89 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.691 2.261 . . . . 0.0 113.642 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.9 t70 65.27 18.44 11.39 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.797 2.039 . . . . 0.0 112.9 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -100.89 -8.36 22.61 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.612 -1.305 . . . . 0.0 111.629 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HB2' HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -76.97 -21.9 54.02 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.63 -34.44 78.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.221 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -69.93 -36.96 75.74 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.581 ' O ' HG12 ' A' ' 38' ' ' ILE . 80.2 mt -73.59 -34.37 65.06 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.551 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HE3' HD12 ' A' ' 31' ' ' LEU . 98.5 mttt -58.47 -31.61 67.97 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.98 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -80.96 -31.25 34.93 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.789 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 34' ' ' LEU . 3.8 p -75.25 -28.99 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.6 mm -62.12 -51.76 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -65.45 -17.56 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.257 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -88.07 -60.08 2.06 Favored 'General case' 0 N--CA 1.415 -2.21 0 O-C-N 122.15 -0.344 . . . . 0.0 110.784 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.12 -42.7 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.354 0.597 . . . . 0.0 111.303 -175.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.536 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 58.2 m-85 -79.4 -17.76 53.7 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 68.4 m -74.28 -3.71 31.73 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.388 0.613 . . . . 0.0 111.397 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.05 -3.39 58.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -113.16 9.64 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.319 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 126.62 -162.53 20.76 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -94.5 133.27 38.29 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.277 0.539 . . . . 0.0 111.619 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.44 95.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.426 ' OG1' ' HA ' ' A' ' 68' ' ' TYR . 1.2 p -80.55 -34.64 35.27 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.379 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 63.3 t30 -152.19 147.22 26.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.991 -0.443 . . . . 0.0 110.177 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 81.2 m-85 -136.65 107.2 6.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.464 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 2.4 m-85 -107.37 104.83 54.04 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.661 -1.236 . . . . 0.0 107.661 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.55 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 73.4 Cg_endo -83.89 159.19 13.87 Favored 'Trans proline' 0 N--CA 1.436 -1.882 0 C-N-CA 120.921 1.081 . . . . 0.0 110.19 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.502 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 20.1 pt-20 . . . . . 0 C--N 1.285 -2.204 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 C--O 1.252 1.189 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 54' ' ' PRO . 6.9 ptpp? -64.33 166.01 8.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 125.735 1.614 . . . . 0.0 110.072 170.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.04 14.66 4.88 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.229 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -170.66 152.46 3.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 pt -145.53 167.1 9.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 80.8 m-85 -128.88 136.15 50.05 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.2 0.524 . . . . 0.0 109.682 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 3.6 mm? -115.67 118.26 32.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 13.4 tp10 -103.52 122.08 44.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.536 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 m-85 -126.95 164.75 20.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.769 0.795 . . . . 0.0 111.952 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.66 13.58 26.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.605 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.493 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . 38.6 t -75.03 158.31 84.48 Favored Pre-proline 0 CA--C 1.585 2.319 0 C-N-CA 125.344 1.457 . . . . 0.0 113.469 -171.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -37.48 8.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.836 1 C-N-CA 130.31 7.34 . . . . 0.0 121.057 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.418 ' HB1' ' CG2' ' A' ' 75' ' ' VAL . . . 84.84 62.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 125.026 2.346 . . . . 0.0 108.058 -166.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.626 ' HE2' ' HA ' ' A' ' 16' ' ' SER . 14.3 p80 -72.41 -36.26 68.6 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 109.261 -3.608 . . . . 0.0 110.83 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -74.21 -33.33 63.36 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.418 ' CG2' ' HB1' ' A' ' 72' ' ' ALA . 84.4 t -64.73 -42.88 96.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.301 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.3 -41.85 80.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.768 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -50.47 73.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.437 0.695 . . . . 0.0 111.415 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -61.67 -32.39 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 123.536 0.734 . . . . 0.0 110.461 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -76.17 -38.11 57.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.209 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.86 -63.68 1.19 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -172.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.25 103.34 6.89 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.392 0.615 . . . . 0.0 111.926 -169.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.54 ' HB2' HG22 ' A' ' 94' ' ' VAL . 12.0 t0 -130.08 140.77 50.78 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.662 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.04 46.07 53.37 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -101.59 125.27 48.22 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 121.538 0.685 . . . . 0.0 110.418 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.91 129.0 45.23 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.198 -174.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.6 -59.83 2.16 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.495 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -162.6 151.4 14.87 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp 40.24 -95.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -110.43 3.46 19.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.858 -0.526 . . . . 0.0 110.842 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.617 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 12.1 m170 -80.7 89.16 5.74 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 m -133.23 115.31 14.82 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -85.54 116.18 23.69 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.56 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 3.5 mpt_? -91.42 121.63 33.3 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.7 m -103.5 148.85 7.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -175.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.504 HD22 ' C ' ' A' ' 95' ' ' ASN . 0.1 OUTLIER . . . . . 0 C--N 1.287 -2.115 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.679 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 14.0 t70 . . . . . 0 C--O 1.195 -1.77 0 CA-C-O 121.861 0.838 . . . . 0.0 110.611 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.686 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 30.3 t -92.34 -6.28 50.51 Favored 'General case' 0 C--N 1.275 -2.673 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.283 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.73 115.37 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.897 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 20.4 mm -93.59 143.41 11.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 98.0 t -121.0 123.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 79.7 t -119.15 139.88 44.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 20.2 t70 -107.21 145.9 32.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.043 0.537 . . . . 0.0 110.714 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.506 0.2 OUTLIER 31.68 104.76 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.985 2.587 . . . . 0.0 117.985 -174.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.523 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 27.1 m -107.98 177.22 1.34 Allowed Pre-proline 0 CA--C 1.562 1.418 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.739 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HA ' ' CE1' ' A' ' 90' ' ' HIS . 5.0 Cg_exo -43.89 138.21 6.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.828 3.019 . . . . 0.0 112.725 170.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HA ' HG21 ' A' ' 60' ' ' THR . 0.1 OUTLIER -88.41 172.23 9.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.777 -175.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 31' ' ' LEU . 14.1 p -117.39 142.51 31.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.132 0.968 . . . . 0.0 111.747 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.77 155.52 16.23 Favored Glycine 0 N--CA 1.414 -2.804 1 N-CA-C 102.657 -4.177 . . . . 0.0 102.657 165.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.84 125.22 12.51 Favored 'Trans proline' 0 C--O 1.25 1.111 0 CA-C-N 121.224 2.512 . . . . 0.0 114.136 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.68 24.74 9.27 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.107 1.763 . . . . 0.0 111.879 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -98.46 -15.49 19.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 121.738 -0.601 . . . . 0.0 111.407 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' HB2' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -79.55 -18.2 52.32 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.855 -174.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.3 -42.72 82.31 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.24 -29.64 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.376 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 38' ' ' ILE . 94.8 mt -69.27 -27.01 65.05 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.339 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -59.57 -39.75 85.11 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.699 0.761 . . . . 0.0 110.216 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -84.08 -28.23 27.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 34' ' ' LEU . 7.3 p -70.56 -32.68 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.347 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 34' ' ' LEU . 43.2 mm -59.6 -53.1 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -53.61 -35.38 60.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.569 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.93 -42.22 24.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 37' ' ' VAL . 45.8 mm -64.77 -42.88 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.918 0.866 . . . . 0.0 109.68 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -76.88 -6.69 53.45 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.029 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 22.8 t -73.02 -6.76 47.66 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-O 121.271 0.557 . . . . 0.0 109.632 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -71.5 -28.15 63.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.273 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -85.71 -15.14 43.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.23 0.538 . . . . 0.0 111.058 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 155.18 -162.99 31.28 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -96.11 129.13 43.48 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.489 HD13 ' CE2' ' A' ' 68' ' ' TYR . 24.0 mm -73.03 109.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -81.88 -48.64 11.28 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 37.2 m-20 -134.75 144.21 47.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.477 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.6 p30 -137.04 132.72 34.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.557 0.694 . . . . 0.0 110.902 175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.31 97.77 5.35 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.233 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 2.5 m-85 -108.63 104.9 55.81 Favored Pre-proline 0 N--CA 1.416 -2.129 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.747 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 80.8 Cg_endo -83.88 170.8 11.01 Favored 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 120.932 1.088 . . . . 0.0 110.462 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' OE2' ' HA ' ' A' ' 60' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.388 -3.575 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 175.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 25' ' ' GLN . 11.3 t . . . . . 0 N--CA 1.413 -2.311 0 CA-C-O 122.741 1.258 . . . . 0.0 113.108 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.747 ' HD3' ' O ' ' A' ' 54' ' ' PRO 0.27 9.6 pttm -59.49 176.26 0.27 Allowed 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.478 167.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.64 20.91 4.82 Favored Glycine 0 C--N 1.288 -2.097 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 52.3 p90 -169.28 160.28 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 pt -147.09 171.98 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.92 136.94 44.59 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 123.952 0.783 . . . . 0.0 109.504 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 48' ' ' ILE . 2.4 mm? -124.53 138.74 54.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 16' ' ' SER . 41.8 mt-10 -126.43 129.99 49.81 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.567 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 19.1 m-85 -125.98 170.78 11.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.32 14.24 12.89 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 39.4 m -73.27 168.02 29.03 Favored Pre-proline 0 CA--C 1.589 2.447 0 CA-C-N 113.493 -1.685 . . . . 0.0 114.633 -173.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 5.7 Cg_exo -35.52 9.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.358 2 C-N-CA 130.624 7.549 . . . . 0.0 123.08 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.679 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.11 65.2 0.01 OUTLIER 'General case' 0 CA--C 1.473 -2.016 0 CA-C-O 124.788 2.232 . . . . 0.0 106.867 -160.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.686 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 21.2 p-80 -82.17 -36.49 27.3 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 108.995 -3.729 . . . . 0.0 111.98 -171.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.1 -37.49 75.41 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.386 175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.586 HG23 ' OD1' ' A' ' 15' ' ' ASP . 94.3 t -56.07 -48.42 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.489 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 3.1 t70 -65.7 -35.71 81.53 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.279 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.94 69.91 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.412 0.285 . . . . 0.0 110.888 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.1 -37.79 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 123.725 0.81 . . . . 0.0 109.706 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 76' ' ' ASP . 77.4 tttt -59.79 -36.46 76.76 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.414 1.485 . . . . 0.0 111.517 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -81.96 -77.31 0.23 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.32 113.01 3.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.084 -172.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' A' ' 94' ' ' VAL . 2.9 t70 -94.74 133.68 38.16 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.916 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 48.81 19.52 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.404 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -88.94 125.36 34.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.791 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.512 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -103.35 129.27 50.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.487 -172.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -86.28 -66.85 0.86 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -167.67 -173.81 2.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.23 -103.54 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -121.54 8.42 10.12 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.669 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 4.8 m-70 -87.28 91.74 8.83 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.359 -170.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 85' ' ' LYS . 5.9 m -133.44 105.0 6.68 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -82.61 101.17 10.62 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.626 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -87.34 137.36 32.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 82' ' ' ASP . 5.4 m -105.01 134.55 46.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 O-C-N 123.944 0.778 . . . . 0.0 109.991 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.66 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 0 CA--C 1.471 -2.064 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.523 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 12.2 t70 . . . . . 0 C--O 1.205 -1.259 0 CA-C-O 121.727 0.775 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.4 m -98.4 7.28 46.4 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.4 t -146.17 124.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 26.3 mm -86.13 136.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.695 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 89.4 t -129.9 103.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 3.0 m -96.74 120.47 46.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.572 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 25.5 t70 -79.72 140.16 37.07 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.917 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.44 HD22 ' C ' ' A' ' 21' ' ' ASP 0.427 0.1 OUTLIER 44.27 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 127.209 2.203 . . . . 0.0 114.552 -177.295 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.488 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 26.8 m -100.94 167.68 10.4 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.893 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -42.47 126.9 4.18 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.77 2.98 . . . . 0.0 114.692 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.508 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -91.02 149.0 22.01 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.459 -1.701 . . . . 0.0 108.337 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 27' ' ' GLY . 6.5 p -101.59 147.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -169.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -105.14 171.61 18.93 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 168.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.05 125.69 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 CA-C-N 121.101 2.45 . . . . 0.0 112.275 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 57.4 31.37 20.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.842 1.257 . . . . 0.0 113.792 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -109.73 1.02 19.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.22 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.14 -32.26 72.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -45.23 -49.34 12.43 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.029 1.332 . . . . 0.0 111.211 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -79.08 -31.85 44.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.531 -172.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -72.06 -35.22 69.24 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.194 -176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -78.31 -20.83 50.67 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.109 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 49.6 t-20 -78.08 -37.8 45.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 34' ' ' LEU . 8.8 p -66.41 -31.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.435 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.9 mm -61.7 -49.88 82.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -63.04 -19.92 64.84 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.328 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 66.4 mttm -88.13 -60.01 2.08 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -63.19 -43.74 98.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.011 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -78.37 -14.75 59.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 m -75.76 -3.05 32.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.117 0.484 . . . . 0.0 111.308 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -79.32 -20.95 46.64 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -88.28 -15.03 36.88 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.639 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.82 -154.17 25.66 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.778 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.65 120.67 27.34 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 122.26 0.224 . . . . 0.0 110.602 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.6 mm -73.85 91.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.4 m -78.15 -52.66 8.37 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.321 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 85.9 m-20 -136.05 139.47 43.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -144.71 128.72 17.52 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.55 0.691 . . . . 0.0 109.671 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.75 116.01 19.56 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.258 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -107.9 105.18 55.72 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 96.5 Cg_endo -85.74 174.31 6.7 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 122.323 2.015 . . . . 0.0 110.72 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.3 pt-20 . . . . . 0 C--N 1.303 -1.429 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 3.4 t . . . . . 0 N--CA 1.435 -1.208 0 CA-C-O 120.649 0.261 . . . . 0.0 111.677 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER 179.87 167.92 1.23 Allowed 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 124.915 1.286 . . . . 0.0 108.29 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.09 -6.32 2.52 Favored Glycine 0 C--N 1.297 -1.619 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 20.3 p90 -167.68 156.62 9.69 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.34 163.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -113.3 129.71 56.45 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 123.807 0.692 . . . . 0.0 110.264 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 2.3 mm? -118.98 126.5 51.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 38.0 tt0 -121.69 119.31 31.43 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.604 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 87.6 m-85 -99.98 177.85 4.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.609 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.57 -15.82 56.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.3 m -119.51 167.31 12.41 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 73' ' ' HIS . 4.9 Cg_exo -77.46 -55.57 0.05 OUTLIER 'Trans proline' 0 C--O 1.176 -2.623 0 CA-C-N 123.887 2.424 . . . . 0.0 108.568 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.31 7.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 131.287 3.835 . . . . 0.0 121.307 142.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.604 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 31.1 p80 -125.28 -36.71 2.47 Favored 'General case' 1 C--N 1.241 -4.125 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.681 -165.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . . . -81.42 -22.82 37.97 Favored 'General case' 0 N--CA 1.383 -3.793 0 C-N-CA 119.251 -0.979 . . . . 0.0 108.644 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.5 -23.14 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.52 -33.88 25.41 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.4 63.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.337 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -32.49 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -67.49 -44.3 78.84 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.406 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -91.77 -52.4 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.2 104.74 3.83 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.305 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.473 ' HB2' HG22 ' A' ' 94' ' ' VAL . 2.6 p30 -114.44 136.41 53.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.0 51.03 61.36 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -96.76 124.17 40.67 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.733 0.778 . . . . 0.0 111.768 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -97.89 118.57 34.75 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.623 -176.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.75 -52.92 5.23 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.414 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 16.1 m-20 -145.42 -168.62 3.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.172 -174.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -44.16 -69.81 0.12 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.925 1.29 . . . . 0.0 114.195 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -100.18 11.26 39.79 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.674 -176.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.414 ' HB2' ' H ' ' A' ' 87' ' ' ASP . 14.8 m170 -102.45 86.97 2.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -135.29 94.09 3.07 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-O 120.708 0.29 . . . . 0.0 110.277 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.43 105.55 13.58 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.972 -168.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.522 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.1 mpt_? -83.45 141.96 31.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 82' ' ' ASP . 34.5 m -100.23 114.28 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.695 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.215 -0.731 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 . . . . . 0 CA--C 1.5 -0.947 0 CA-C-O 122.28 1.038 . . . . 0.0 108.689 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 8.4 m -96.3 -11.88 25.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.229 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.5 t -122.15 132.5 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.554 -172.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 30.1 mm -87.3 145.13 7.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.48 121.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 64' ' ' ILE . 27.4 m -118.41 157.76 19.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.236 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.76 133.42 55.93 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 42.57 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 28.7 m -91.21 167.04 16.76 Favored Pre-proline 0 N--CA 1.426 -1.637 0 CA-C-N 114.33 -1.305 . . . . 0.0 107.982 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 85.1 Cg_exo -42.44 138.94 3.14 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.985 3.124 . . . . 0.0 113.126 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HA ' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -71.56 153.23 42.31 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.804 -173.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 30' ' ' ARG . 16.7 t -119.26 132.91 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.476 -176.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.89 -131.91 3.12 Favored Glycine 0 C--N 1.274 -2.868 0 N-CA-C 106.672 -2.571 . . . . 0.0 106.672 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.36 125.23 10.56 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 CA-C-N 119.459 1.629 . . . . 0.0 111.447 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 55.9 18.04 2.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.131 1.772 . . . . 0.0 114.373 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.503 ' HB2' HG13 ' A' ' 26' ' ' VAL . 35.2 mmt180 -79.1 -25.87 43.0 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.076 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -73.86 -33.89 64.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.38 -58.33 7.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.169 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -81.74 -15.68 53.55 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.612 ' O ' HG12 ' A' ' 38' ' ' ILE . 51.3 tp -63.3 -36.35 83.4 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -56.7 -36.9 70.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -84.09 -40.92 17.69 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.32 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' LEU . 7.4 p -65.55 -31.88 55.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.356 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 34' ' ' LEU . 32.9 mm -67.33 -54.6 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -58.82 -36.09 73.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.39 -47.28 35.0 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.3 mm -70.15 -39.24 76.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.197 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.23 -7.79 59.63 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.1 p -67.38 -22.74 65.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.3 ptpt -61.74 -28.4 69.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.53 0.681 . . . . 0.0 111.755 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 30.3 m-85 -85.46 -15.7 42.07 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.1 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.76 176.19 23.45 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -74.81 125.04 27.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -72.83 140.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 m -126.38 -61.22 1.22 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 55.0 m-80 -122.23 140.63 52.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.53 138.81 46.25 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.085 0.469 . . . . 0.0 110.446 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 89.2 m-85 -134.2 98.88 4.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -107.32 104.77 53.77 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 64' ' ' ILE . 51.1 Cg_endo -82.47 174.08 10.08 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.713 1.609 . . . . 0.0 109.823 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.634 ' HB3' ' NZ ' ' A' ' 61' ' ' LYS . 19.9 pt-20 . . . . . 0 CA--C 1.477 -1.845 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 25' ' ' GLN . 83.4 m . . . . . 0 C--O 1.244 0.801 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.634 ' NZ ' ' HB3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -84.78 156.37 21.41 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.354 176.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.57 8.59 9.44 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.442 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -170.15 151.95 4.08 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 20' ' ' VAL . 20.7 pt -142.06 166.29 16.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.3 m-85 -131.59 141.66 49.72 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.859 0.724 . . . . 0.0 109.048 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.3 mp -132.36 136.75 47.04 Favored 'General case' 0 C--O 1.198 -1.651 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.934 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 42.0 tt0 -122.05 136.97 54.97 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.15 0.5 . . . . 0.0 109.688 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.41 ' HE1' ' CG1' ' A' ' 18' ' ' ILE . 76.0 m-85 -104.83 177.53 4.82 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.367 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.33 -16.62 39.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.275 0.559 . . . . 0.0 111.369 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -135.35 144.97 51.87 Favored Pre-proline 0 C--N 1.294 -1.84 1 N-CA-C 99.34 -4.318 . . . . 0.0 99.34 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.6 Cg_exo -69.91 -54.12 0.23 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 CA-C-N 123.483 2.28 . . . . 0.0 109.57 -172.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.07 4.47 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 1 C-N-CA 132.374 4.27 . . . . 0.0 120.133 144.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.508 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 95.8 m-70 -128.43 -36.36 1.9 Allowed 'General case' 1 C--N 1.223 -4.923 0 CA-C-O 121.326 0.584 . . . . 0.0 109.624 -170.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -61.33 -32.1 71.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.517 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.76 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 123.315 0.384 . . . . 0.0 111.305 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.39 -32.49 37.56 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.242 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.27 -52.61 61.34 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.764 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 74' ' ' ALA . 31.2 m -63.13 -27.78 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -81.61 -21.81 38.08 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.9 0.88 . . . . 0.0 112.047 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -122.88 -23.96 4.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . . . -106.0 18.55 21.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 94' ' ' VAL . 37.0 t70 -85.06 121.78 28.33 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 118.157 -1.417 . . . . 0.0 114.056 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.58 60.5 2.47 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.537 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 91' ' ' THR . 17.8 m-85 -103.27 105.51 15.81 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.33 102.69 7.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.204 177.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.7 mt -80.01 -41.46 25.79 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.91 -171.74 3.99 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -48.61 -58.32 4.89 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.594 1.558 . . . . 0.0 113.413 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -95.0 -4.55 46.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.203 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.53 101.42 10.76 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.765 -172.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 37.1 m -133.55 117.78 17.51 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.285 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -82.69 101.71 11.03 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.076 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 91' ' ' THR . 3.6 mpt_? -86.87 131.15 34.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 82' ' ' ASP . 25.6 m -117.75 149.11 20.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.942 -175.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.321 -0.667 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 10.5 m-20 . . . . . 0 CA--C 1.444 -3.115 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.525 ' HB2' ' OE2' ' A' ' 67' ' ' GLU 0.251 69.6 p -118.25 -20.49 8.55 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 115.493 -2.483 . . . . 0.0 113.916 166.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 25.9 t -127.14 133.04 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.996 -171.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.586 HD11 ' HD1' ' A' ' 73' ' ' HIS . 25.9 mm -104.12 143.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.79 114.1 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.53 130.61 73.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB3' ' CG ' ' A' ' 93' ' ' ARG . 10.7 t70 -111.86 149.35 31.94 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.512 0.2 OUTLIER 44.57 85.65 0.02 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 127.057 2.143 . . . . 0.0 115.87 -176.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 26.8 m -97.77 -171.75 0.26 Allowed Pre-proline 0 N--CA 1.418 -2.029 0 CA-C-N 112.732 -2.031 . . . . 0.0 107.064 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.749 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 44.6 Cg_exo -54.05 143.82 60.32 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 121.686 1.591 . . . . 0.0 114.181 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HA ' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -89.37 164.33 14.93 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.879 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 31' ' ' LEU . 48.8 t -123.22 134.26 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 CA-C-O 121.675 0.75 . . . . 0.0 109.391 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.7 -127.96 5.65 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 105.722 -2.951 . . . . 0.0 105.722 173.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.74 124.39 4.53 Favored 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-N 120.22 2.01 . . . . 0.0 110.721 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 50.73 33.57 8.58 Favored 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.353 1.461 . . . . 0.0 113.014 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -95.76 -0.7 51.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.771 -1.206 . . . . 0.0 112.105 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 26' ' ' VAL . 3.2 tm? -71.0 -28.86 64.73 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.87 -51.03 69.84 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.76 0.314 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.14 -27.13 68.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.564 ' O ' HG12 ' A' ' 38' ' ' ILE . 6.0 tt -65.71 -43.91 87.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.32 -37.83 81.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 111.6 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -81.0 -33.77 33.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.705 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 34' ' ' LEU . 6.2 p -70.17 -30.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.763 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 34' ' ' LEU . 35.5 mm -63.79 -64.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.845 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -62.49 -25.37 67.98 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -64.33 -57.71 8.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.333 0.653 . . . . 0.0 110.522 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 82.0 mt -70.38 -38.84 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.286 0.565 . . . . 0.0 111.042 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.453 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 53.9 m-85 -73.86 -7.31 51.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 58.0 m -69.35 -6.37 29.35 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 41' ' ' ILE . 81.0 mttt -71.92 -31.93 66.86 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.113 0.959 . . . . 0.0 108.807 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -85.46 10.83 11.8 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.892 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 117.43 -167.88 12.8 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -89.91 145.24 25.28 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 66' ' ' LEU . 32.4 mm -73.23 110.44 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.4 m -75.48 -46.3 33.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 35.3 t-20 -152.76 152.69 31.94 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -144.48 136.75 26.37 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -126.64 113.0 16.14 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.06 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -107.67 106.59 58.82 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 63' ' ' TYR . 2.9 Cg_exo -68.66 174.73 8.08 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.525 1.483 . . . . 0.0 109.357 172.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 . . . . . 0 C--N 1.303 -1.449 0 CA-C-O 120.946 0.403 . . . . 0.0 110.466 -173.726 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.443 HG23 ' HA ' ' A' ' 25' ' ' GLN . 18.9 m . . . . . 0 N--CA 1.446 -0.662 0 N-CA-C 114.38 1.252 . . . . 0.0 114.38 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 166.65 11.02 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.12 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 -0.73 9.44 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.91 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.496 ' O ' ' HD2' ' A' ' 54' ' ' PRO . 4.4 p90 -169.69 161.23 9.23 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -143.86 172.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 123.527 0.517 . . . . 0.0 110.35 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -136.24 138.73 42.13 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 109.744 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.0 mm? -118.39 131.91 56.28 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE2' ' HB2' ' A' ' 16' ' ' SER . 12.9 tp10 -116.72 117.51 29.99 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.55 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 80.5 m-85 -127.46 172.53 10.6 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.241 0.543 . . . . 0.0 110.312 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.23 14.26 14.79 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.583 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 51.0 m -68.27 163.35 53.14 Favored Pre-proline 0 CA--C 1.597 2.78 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -171.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.1 Cg_exo -38.25 8.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.348 2 C-N-CA 130.435 7.423 . . . . 0.0 122.955 178.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.528 ' HA ' ' CG ' ' A' ' 15' ' ' ASP . . . 87.37 63.34 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 124.465 2.079 . . . . 0.0 106.997 -158.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.586 ' HD1' HD11 ' A' ' 18' ' ' ILE . 32.2 p80 -85.69 -36.99 19.89 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 110.148 -3.205 . . . . 0.0 109.282 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . . . -63.36 -35.94 82.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.059 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.587 HG23 ' OD1' ' A' ' 15' ' ' ASP . 82.0 t -59.39 -59.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.459 170.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.68 -35.77 73.14 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.145 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.0 -30.89 70.26 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.494 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.81 -29.34 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 8.4 mmpt? -72.02 -42.82 65.92 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.308 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -114.21 -29.87 6.81 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.2 -3.13 27.86 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -170.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.3 117.34 18.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.874 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.86 31.33 12.62 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -101.5 135.27 43.28 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.495 -1.282 . . . . 0.0 109.488 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -107.68 129.29 55.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.192 -172.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.44 -68.04 0.77 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.245 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -160.02 159.32 31.92 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.424 ' HD2' HE22 ' A' ' 25' ' ' GLN . 40.2 ttmt 47.04 -88.7 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.048 1.739 . . . . 0.0 114.297 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -121.43 -2.13 9.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.263 -0.273 . . . . 0.0 111.035 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.749 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m170 -79.72 92.65 5.43 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.31 0.576 . . . . 0.0 110.594 -171.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 m -133.17 109.04 9.18 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -82.21 105.62 13.44 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.917 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.459 ' CG ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -94.03 121.45 35.53 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.96 115.1 47.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.008 -166.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.404 -2.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 . . . . . 0 C--O 1.244 0.815 0 CA-C-O 121.452 0.644 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -114.39 -8.96 12.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.28 137.34 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 121.875 -0.516 . . . . 0.0 109.873 -175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 8.9 mm -101.0 133.12 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.66 106.5 15.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 16.6 m -96.36 154.94 3.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.203 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 9.8 t70 -93.22 -178.29 4.72 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.443 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.279 0.2 OUTLIER -29.5 106.92 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -166.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 36.0 m -86.01 167.32 24.54 Favored Pre-proline 0 N--CA 1.421 -1.908 0 CA-C-N 113.052 -1.886 . . . . 0.0 108.198 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.718 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 86.7 Cg_exo -42.36 127.15 4.14 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.641 2.894 . . . . 0.0 113.351 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.428 ' HB3' HE22 ' A' ' 89' ' ' GLN . 0.0 OUTLIER -65.78 151.12 47.36 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.915 -177.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.549 ' CG2' ' HB ' ' A' ' 60' ' ' THR . 52.6 t -125.91 139.77 50.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-O 122.028 0.918 . . . . 0.0 112.774 -173.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.45 -143.48 6.18 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.63 126.88 13.92 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 120.658 2.229 . . . . 0.0 111.416 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 63.32 17.69 10.44 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.127 1.371 . . . . 0.0 113.237 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HB2' HG13 ' A' ' 26' ' ' VAL . 88.6 mtt180 -89.43 -15.86 32.21 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.079 -1.638 . . . . 0.0 111.305 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.417 HD12 ' HE3' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -73.94 -36.69 64.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 -177.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -64.95 -34.97 79.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.4 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -71.78 -40.53 69.19 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.8 tp -58.37 -44.0 88.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.818 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HE3' HD12 ' A' ' 31' ' ' LEU . 98.6 mttt -54.51 -30.18 52.7 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.183 0.593 . . . . 0.0 112.512 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.476 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 55.6 t30 -84.49 -32.41 23.98 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.196 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 34' ' ' LEU . 8.6 p -78.07 -27.48 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.969 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 34' ' ' LEU . 39.3 mm -54.3 -51.79 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.642 0.734 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -68.21 -17.79 64.41 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.552 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.8 mmtp -85.28 -38.02 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.868 0.842 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mm -73.78 -53.89 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.74 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.61 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 61.7 m-85 -78.67 -16.93 56.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.9 p -65.73 -19.73 66.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.725 0.774 . . . . 0.0 110.829 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -73.22 -7.43 51.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.569 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.87 4.36 27.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.527 0.68 . . . . 0.0 110.279 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.89 -161.62 23.79 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.393 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -87.77 128.02 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.6 mm -75.35 89.73 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.935 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p -79.83 -52.37 7.99 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.496 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 17.7 m120 -126.33 138.86 53.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.0 0.429 . . . . 0.0 110.447 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -141.62 137.48 31.89 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.212 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 56.0 m-85 -135.39 98.69 4.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.461 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -108.97 122.14 40.82 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.868 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.81 176.34 10.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.57 2.18 . . . . 0.0 109.972 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--N 1.289 -2.028 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.199 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 26' ' ' VAL . 4.8 t . . . . . 0 N--CA 1.418 -2.025 0 CA-C-O 122.229 1.014 . . . . 0.0 111.822 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.547 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -105.47 175.9 5.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.442 178.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.9 20.23 36.6 Favored Glycine 0 C--N 1.292 -1.874 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.115 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 7.0 p90 -170.74 151.73 3.55 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 122.293 0.237 . . . . 0.0 110.499 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 20' ' ' VAL . 18.8 pt -146.03 163.33 10.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 70.8 m-85 -119.39 136.8 54.12 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.75 0.31 . . . . 0.0 110.673 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.7 mm? -123.08 124.58 43.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 7.1 tp10 -119.41 128.16 53.78 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.61 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 25.7 m-85 -127.06 -178.28 4.36 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.53 10.95 11.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.354 0.597 . . . . 0.0 109.541 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.2 p -81.67 163.43 54.0 Favored Pre-proline 0 CA--C 1.583 2.222 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -34.96 9.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.663 2 C-N-CA 130.556 7.504 . . . . 0.0 123.358 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.649 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 86.18 65.59 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.731 0 CA-C-O 124.975 2.321 . . . . 0.0 108.557 -163.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 29.3 p-80 -79.49 -37.2 37.34 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 109.127 -3.67 . . . . 0.0 110.16 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.03 48.15 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.715 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 72' ' ' ALA . 3.0 p -65.5 -29.79 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.01 -45.95 13.45 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.83 71.06 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.728 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 47.2 t -65.1 -45.93 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-O 121.072 0.463 . . . . 0.0 111.748 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.39 -27.39 61.44 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -120.63 -45.47 2.41 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.483 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -88.27 -8.22 55.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -171.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.446 ' HA ' HG23 ' A' ' 94' ' ' VAL . 17.3 t70 -61.07 113.13 2.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.357 0.599 . . . . 0.0 112.366 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.01 47.89 3.75 Favored Glycine 0 N--CA 1.42 -2.426 0 CA-C-N 114.922 -1.035 . . . . 0.0 114.603 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 33.0 p90 -107.83 133.97 51.44 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.677 -1.209 . . . . 0.0 109.96 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -100.95 128.47 46.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.233 0.54 . . . . 0.0 112.342 -176.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.6 mt -84.79 -62.72 1.48 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.818 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -160.95 154.12 21.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.571 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 45.99 -107.19 0.14 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.428 HE22 ' HB3' ' A' ' 25' ' ' GLN . 14.3 pm0 -103.86 -10.23 18.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.718 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m80 -68.27 93.79 0.49 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.128 -171.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 3.4 m -132.73 118.87 19.61 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -90.37 105.41 17.79 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.499 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.8 mmm180 -83.15 143.03 30.78 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 82' ' ' ASP . 58.5 t -106.47 107.01 21.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.344 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 2.6 t30 . . . . . 0 N--CA 1.403 -2.776 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.019 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 . . . . . 0 N--CA 1.441 -0.91 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.7 p -114.96 -14.36 11.87 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.431 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 60.2 t -139.16 137.17 41.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.963 -0.461 . . . . 0.0 110.762 -172.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 mm -97.25 135.14 32.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 54.4 t -116.1 105.92 19.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 1.7 m -107.82 122.89 62.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.156 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 21.7 t70 -92.73 138.03 31.84 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.613 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.47 0.1 OUTLIER 45.94 86.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 128.513 2.725 . . . . 0.0 115.66 -175.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 35.5 m -89.27 165.78 24.59 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.771 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.3 Cg_endo -45.92 150.19 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.474 2.783 . . . . 0.0 114.125 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HA ' HG21 ' A' ' 60' ' ' THR . 5.7 pt20 -89.46 161.89 16.02 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.561 -173.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 27' ' ' GLY . 60.9 t -129.15 138.89 53.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.517 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 26' ' ' VAL . . . -102.34 -177.27 27.51 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.49 124.89 16.18 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 120.15 1.975 . . . . 0.0 112.067 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 53.76 23.44 3.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.187 1.795 . . . . 0.0 114.167 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB2' HG13 ' A' ' 26' ' ' VAL . 13.8 mtm180 -90.1 -2.61 58.12 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.183 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -63.17 -36.37 83.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 110.075 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -61.39 -47.42 85.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.542 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -74.83 -24.81 58.67 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.013 0.435 . . . . 0.0 110.135 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 38' ' ' ILE . 3.0 tm? -61.97 -49.39 76.29 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -55.51 -31.95 62.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.419 0.628 . . . . 0.0 111.123 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.45 -41.8 38.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.232 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.35 -30.71 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 34' ' ' LEU . 22.2 mm -62.59 -53.39 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -55.43 -36.74 66.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.955 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 40' ' ' LYS . 47.8 tptt -69.13 -53.12 21.85 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.476 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 34.9 mm -56.16 -50.24 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.689 0.757 . . . . 0.0 110.484 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.533 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.4 m-85 -77.04 -0.67 25.48 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.6 m -69.96 -12.51 61.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.275 0.559 . . . . 0.0 110.204 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 29.5 mmmt -72.13 -16.5 62.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.057 0.456 . . . . 0.0 109.998 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.4 6.98 40.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.699 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.58 -156.4 19.96 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.18 128.48 42.05 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.482 HD12 HD12 ' A' ' 66' ' ' LEU . 32.0 mm -74.11 115.14 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 m -86.96 -41.92 13.55 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 68.6 m-20 -154.77 160.92 41.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.903 0.881 . . . . 0.0 109.695 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 41.5 t0 -150.95 151.86 32.75 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -139.17 102.25 4.46 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.654 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -107.12 123.5 38.14 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 72.7 Cg_endo -82.21 177.57 7.08 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.061 2.507 . . . . 0.0 108.25 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.36 0 O-C-N 120.732 -1.23 . . . . 0.0 109.879 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 25' ' ' GLN . 13.3 m . . . . . 0 N--CA 1.424 -1.742 0 CA-C-O 121.823 0.821 . . . . 0.0 112.872 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -112.37 173.49 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.399 174.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.28 27.27 9.1 Favored Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.949 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 12.1 p90 -169.07 147.84 3.94 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 pt -146.03 176.18 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.347 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 92.6 m-85 -140.18 114.73 9.36 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.019 0.827 . . . . 0.0 111.481 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 48' ' ' ILE . 3.9 mm? -93.66 116.81 29.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.808 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 39.3 tt0 -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.71 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 3.5 m-85 -127.54 171.14 11.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.49 12.66 22.87 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.459 ' HB3' ' ND1' ' A' ' 73' ' ' HIS . 48.0 t -73.26 155.89 89.59 Favored Pre-proline 0 CA--C 1.59 2.495 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.177 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -36.4 8.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.529 3.593 1 C-N-CA 130.72 7.613 . . . . 0.0 122.27 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 86.45 62.59 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 124.981 2.324 . . . . 0.0 107.97 -164.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.71 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 24.1 p-80 -77.65 -36.4 51.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 109.184 -3.644 . . . . 0.0 109.999 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.48 69.21 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.982 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.12 -26.72 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.31 -46.91 12.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.2 79.9 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.448 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.47 -33.33 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.968 0.413 . . . . 0.0 112.046 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -85.42 -29.08 24.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.641 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -109.9 -39.11 5.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.412 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -93.35 0.97 57.1 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.15 103.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.433 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.54 47.69 3.42 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.694 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.412 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 24.3 p90 -103.78 127.29 51.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.523 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -98.01 130.24 44.85 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.652 -173.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -85.96 -71.82 0.52 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -171.86 172.36 4.84 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 52.58 -95.93 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.099 1.76 . . . . 0.0 114.693 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -121.58 -1.12 9.6 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.089 0.471 . . . . 0.0 109.917 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.771 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 10.8 m170 -87.1 99.03 11.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.219 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.44 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 3.6 m -133.34 110.0 9.75 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -81.84 108.7 15.58 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.372 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -90.52 130.24 36.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.46 105.88 19.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.693 0.758 . . . . 0.0 110.585 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--N 1.291 -1.943 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.943 -179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 . . . . . 0 N--CA 1.47 0.543 0 N-CA-C 112.365 0.506 . . . . 0.0 112.365 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.736 ' HA ' ' HE2' ' A' ' 73' ' ' HIS . 12.5 m -100.01 13.36 34.24 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -170.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.4 p -137.08 138.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.911 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 mm -111.62 137.91 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.53 ' HB ' HD22 ' A' ' 95' ' ' ASN . 60.4 t -125.59 113.87 36.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 173.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG2' HG12 ' A' ' 64' ' ' ILE . 14.3 m -110.14 137.67 41.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.306 0.574 . . . . 0.0 110.768 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.447 ' C ' HD22 ' A' ' 22' ' ' ASN . 20.7 t70 -97.74 139.73 33.19 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.757 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.447 HD22 ' C ' ' A' ' 21' ' ' ASP 0.423 0.1 OUTLIER 46.06 86.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.82 2.448 . . . . 0.0 115.536 -179.837 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.506 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.4 m -84.83 163.61 45.6 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.151 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.791 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.7 Cg_endo -42.73 145.43 1.07 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 124.509 3.473 . . . . 0.0 117.556 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.53 151.72 36.81 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 111.648 -2.523 . . . . 0.0 111.085 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 27' ' ' GLY . 8.1 p -132.01 146.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.326 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -95.37 171.48 29.48 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 169.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.37 125.62 18.49 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 CA-C-N 120.465 2.133 . . . . 0.0 112.286 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.02 22.49 12.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.599 1.16 . . . . 0.0 111.786 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.467 ' HD2' ' H ' ' A' ' 27' ' ' GLY . 95.9 mtt180 -92.88 -2.5 55.81 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.697 -1.252 . . . . 0.0 111.102 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -62.1 -23.57 66.6 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.744 0.307 . . . . 0.0 110.703 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.48 -47.24 76.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.468 0.707 . . . . 0.0 109.194 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -69.7 -38.21 76.88 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.893 0.854 . . . . 0.0 109.502 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.434 HD23 HG23 ' A' ' 26' ' ' VAL . 4.1 mm? -72.09 -6.01 39.41 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.507 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 61.9 mttp -85.33 -31.41 23.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.586 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 22.6 t-20 -73.61 -44.61 56.68 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.158 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.46 -33.05 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.566 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.94 -62.54 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.185 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 36' ' ' ASN . 4.9 p-80 -65.3 -20.13 66.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -70.55 -60.13 2.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 81.9 mt -67.67 -44.12 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.02 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -68.72 -9.68 51.95 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -67.75 -2.28 6.79 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 19.0 ptmt -70.56 -35.22 72.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.111 0.482 . . . . 0.0 110.584 171.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CD2' ' HG3' ' A' ' 44' ' ' LYS . 97.3 m-85 -80.08 -14.97 58.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.326 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 145.52 -161.3 28.2 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -91.5 138.74 31.33 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.04 89.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.99 -38.98 52.06 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 3.3 t-20 -148.64 139.85 23.23 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -144.27 153.91 42.52 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 73.5 m-85 -132.13 103.26 6.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -108.54 106.74 59.27 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.69 173.17 13.8 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 121.156 1.238 . . . . 0.0 111.902 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 . . . . . 0 C--N 1.298 -1.663 0 C-N-CA 123.631 0.772 . . . . 0.0 109.481 -178.835 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 26' ' ' VAL . 5.8 t . . . . . 0 N--CA 1.422 -1.864 0 CA-C-O 122.881 1.325 . . . . 0.0 113.37 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 61' ' ' LYS . 5.6 pttp -53.55 161.02 1.12 Allowed 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.748 166.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.69 18.23 13.13 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.002 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 28.9 p90 -169.96 155.34 5.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.515 HG12 ' CG2' ' A' ' 20' ' ' VAL . 22.4 pt -146.65 168.36 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 49.4 m-85 -131.84 133.04 44.23 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 2.1 mm? -114.13 132.81 55.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 1.6 tm-20 -126.41 115.7 20.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.584 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 81.5 m-85 -123.29 175.91 6.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.626 0.727 . . . . 0.0 111.185 -174.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.12 13.98 12.17 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.54 1.136 . . . . 0.0 108.425 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.58 ' OG ' ' HD2' ' A' ' 71' ' ' PRO . 23.1 t -75.61 161.17 77.34 Favored Pre-proline 0 CA--C 1.596 2.732 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.297 -172.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HD2' ' OG ' ' A' ' 70' ' ' SER . 1.2 Cg_exo -36.1 8.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.967 1 C-N-CA 129.921 7.081 . . . . 0.0 121.931 177.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 75' ' ' VAL . . . 85.93 62.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.987 2.327 . . . . 0.0 108.08 -164.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.736 ' HE2' ' HA ' ' A' ' 16' ' ' SER . 17.5 p80 -73.43 -30.06 62.97 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 109.646 -3.434 . . . . 0.0 109.561 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.07 64.08 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.287 1.042 . . . . 0.0 108.582 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 78' ' ' VAL . 57.4 t -75.25 -30.22 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.254 176.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.65 -41.78 62.25 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.48 75.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.826 0.45 . . . . 0.0 111.218 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 75' ' ' VAL . 1.1 p -67.55 -26.73 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.381 0.61 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -33.82 67.01 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.206 1.003 . . . . 0.0 110.656 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.06 -76.55 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.658 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . 177.32 106.54 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 123.954 0.784 . . . . 0.0 110.489 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.546 ' HB2' HG22 ' A' ' 94' ' ' VAL . 1.6 t70 -65.52 108.81 2.13 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 170.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.78 52.53 1.51 Allowed Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 41.8 p90 -97.72 133.13 42.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.199 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -101.84 129.57 48.09 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.987 -172.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.21 -63.37 1.33 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.865 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -161.07 157.22 25.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.029 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 42.15 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.262 1.825 . . . . 0.0 114.187 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -119.5 8.78 11.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.524 0.602 . . . . 0.0 111.825 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.791 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 22.4 m170 -85.02 93.72 8.66 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -132.84 103.64 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.508 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.22 112.32 19.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.5 mpt_? -81.23 142.8 32.82 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 82' ' ' ASP . 14.6 m -120.1 128.94 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.878 -173.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.53 HD22 ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.305 -1.367 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 170.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.481 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 35.6 t70 . . . . . 0 N--CA 1.424 -1.746 0 CA-C-O 122.88 1.324 . . . . 0.0 108.104 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.545 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 42.8 m -116.37 14.36 15.69 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.694 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.409 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 61.5 t -138.04 131.83 42.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.77 -0.581 . . . . 0.0 110.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 9.7 mm -88.93 135.32 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.97 121.46 62.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.858 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.498 HG13 ' HB3' ' A' ' 92' ' ' PHE . 90.9 t -121.1 133.51 67.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.319 0.387 . . . . 0.0 111.816 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.9 t70 -101.1 137.51 39.36 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 109.52 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.424 0.2 OUTLIER 45.88 104.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 127.106 2.162 . . . . 0.0 116.397 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.541 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 17.1 m -109.61 172.17 3.84 Favored Pre-proline 0 C--N 1.289 -2.063 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.437 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 80.9 Cg_exo -42.4 133.14 4.97 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.292 2.661 . . . . 0.0 112.043 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.584 ' HB3' HE22 ' A' ' 89' ' ' GLN . 0.0 OUTLIER -74.39 155.63 37.9 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.331 -177.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 31' ' ' LEU . 2.3 t -123.05 165.68 18.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.778 -167.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.26 -169.62 30.11 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.53 124.69 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.867 2.333 . . . . 0.0 111.99 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 58.62 17.87 5.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.3 1.84 . . . . 0.0 113.326 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -79.55 -26.98 41.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.022 -1.049 . . . . 0.0 109.814 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.589 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.5 tm? -69.65 -27.48 65.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.427 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.29 -40.55 94.57 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.928 0.394 . . . . 0.0 111.053 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -91.81 -13.84 30.78 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.244 0.545 . . . . 0.0 111.569 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.605 ' O ' HG12 ' A' ' 38' ' ' ILE . 7.2 tt -68.12 -37.61 81.3 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 91.5 mttt -57.8 -25.62 60.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 27.9 t-20 -81.71 -44.68 16.75 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.153 -171.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 41' ' ' ILE . 14.7 p -67.68 -32.52 57.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.793 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.7 mm -67.63 -52.53 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.465 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -56.31 -38.46 71.32 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.583 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.0 mmmt -67.08 -48.02 69.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 37' ' ' VAL . 47.3 mm -66.78 -43.98 89.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.512 0.672 . . . . 0.0 110.573 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.494 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.2 m-85 -83.87 -9.86 58.43 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -171.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -72.4 -3.04 21.73 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.485 -0.759 . . . . 0.0 111.339 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.12 -21.72 42.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.174 0.511 . . . . 0.0 110.007 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -97.33 1.62 49.66 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.656 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.31 -151.79 22.04 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.88 128.01 52.92 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.546 HD12 HD12 ' A' ' 66' ' ' LEU . 47.3 mm -73.08 104.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -79.82 -41.33 26.62 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.177 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -156.14 161.14 40.38 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -142.66 144.69 32.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 117.977 0.353 . . . . 0.0 110.321 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.23 100.44 5.39 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.448 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -107.82 103.48 49.7 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.72 170.49 15.55 Favored 'Trans proline' 0 C--O 1.208 -0.979 0 C-N-CA 121.659 1.572 . . . . 0.0 109.95 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 14.6 pt-20 . . . . . 0 C--N 1.303 -1.447 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 25' ' ' GLN . 48.2 m . . . . . 0 N--CA 1.438 -1.057 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 49.1 mttm -74.0 169.37 17.62 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.07 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.29 -8.62 6.4 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.94 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -169.54 159.66 8.56 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 pt -147.21 172.05 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.767 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.9 m-85 -136.26 137.09 40.4 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.665 0.603 . . . . 0.0 109.975 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.546 HD12 HD12 ' A' ' 48' ' ' ILE . 3.6 mm? -111.94 116.48 30.68 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -99.44 124.03 44.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.648 0.737 . . . . 0.0 110.668 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 6.2 m-85 -123.13 -176.42 3.42 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.74 7.65 11.06 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.867 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.663 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.6 m -79.66 154.57 76.06 Favored Pre-proline 0 CA--C 1.591 2.548 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -165.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -39.16 6.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.96 2 C-N-CA 130.76 7.64 . . . . 0.0 123.16 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.481 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.23 65.25 0.01 OUTLIER 'General case' 0 C--N 1.367 1.329 0 CA-C-N 122.238 2.29 . . . . 0.0 108.86 -158.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 29.6 p80 -95.63 -24.67 16.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 109.36 -3.564 . . . . 0.0 107.738 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -81.11 -33.86 32.99 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.401 ' CG1' ' HB1' ' A' ' 72' ' ' ALA . 2.7 p -66.42 -26.88 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.611 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 15.8 t70 -69.5 -38.06 77.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.76 94.0 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.291 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 74' ' ' ALA . 92.8 t -57.84 -46.76 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -84.89 -15.58 44.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -109.89 -68.38 0.93 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 75.41 0.94 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.559 0.695 . . . . 0.0 111.759 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' A' ' 94' ' ' VAL . 6.0 t70 -111.42 134.91 52.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.731 175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.48 77.45 Favored Glycine 0 C--N 1.308 -0.993 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -92.33 130.97 37.88 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.097 0.475 . . . . 0.0 110.299 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.6 126.61 44.24 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.7 mt -87.29 -61.6 1.69 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -174.21 149.0 1.36 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.381 -174.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 58.92 -81.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.584 HE22 ' HB3' ' A' ' 25' ' ' GLN . 41.2 tt0 -122.27 -9.52 8.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.298 1.039 . . . . 0.0 110.148 -172.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.575 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 11.4 m170 -92.97 88.63 6.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.915 -167.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 m -132.95 98.19 4.22 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.498 ' HB3' HG13 ' A' ' 20' ' ' VAL . 53.2 m-85 -83.35 113.91 21.06 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.472 -169.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 2.9 mpt_? -89.05 136.85 32.79 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 82' ' ' ASP . 4.8 m -113.82 151.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-O 121.619 0.723 . . . . 0.0 110.808 -172.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.401 -2.921 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.63 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 5.6 t70 . . . . . 0 C--O 1.18 -2.585 0 CA-C-O 121.613 0.72 . . . . 0.0 111.437 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.575 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 16.3 m -85.1 -1.49 56.93 Favored 'General case' 0 C--N 1.273 -2.751 0 O-C-N 120.585 -1.322 . . . . 0.0 113.72 -172.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 60.7 t -117.67 128.48 74.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.442 -175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 18.6 mm -94.85 136.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.01 119.34 23.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 15.5 m -125.09 133.33 69.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.87 135.5 39.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.33 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.483 0.2 OUTLIER 48.34 85.64 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.675 2.39 . . . . 0.0 116.983 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.46 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 16.8 m -81.93 169.76 17.43 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.467 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 2.0 Cg_endo -44.35 138.05 7.55 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 123.286 2.657 . . . . 0.0 112.312 173.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.565 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 3.8 pm0 -69.35 154.92 41.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.23 147.64 28.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.032 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.94 175.34 16.28 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.73 126.88 23.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.023 1.815 . . . . 0.0 111.928 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 68.17 17.41 9.39 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.002 1.321 . . . . 0.0 113.574 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -104.07 -6.18 21.37 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.163 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.539 HD21 ' HE2' ' A' ' 61' ' ' LYS . 1.2 tm? -66.87 -31.5 72.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.122 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.31 -40.03 92.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.44 -13.46 52.03 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.2 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 37' ' ' VAL . 8.6 tt -72.86 -28.35 62.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.21 -22.06 66.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.629 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 t-20 -79.78 -43.67 22.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.257 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 34' ' ' LEU . 9.0 p -63.9 -24.6 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.369 -174.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mm -55.61 -59.82 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.044 0.938 . . . . 0.0 110.408 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -73.08 -17.0 61.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 30.5 mmmt -71.39 -52.25 19.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.03 -52.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.127 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 22.7 m-85 -73.49 -6.43 46.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 p -71.82 -18.3 62.09 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.84 0.829 . . . . 0.0 110.455 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.557 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -84.8 -3.84 58.81 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.21 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 76.5 m-85 -120.23 18.55 12.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.14 -174.89 21.93 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -101.6 138.59 38.39 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.9 mm -75.68 88.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.3 m -82.06 -55.37 4.61 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.879 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 19.7 m120 -137.08 145.73 44.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -137.26 135.75 37.46 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -128.19 110.7 12.67 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.414 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.422 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 8.3 m-85 -106.05 106.29 56.44 Favored Pre-proline 0 N--CA 1.425 -1.685 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.59 173.67 12.0 Favored 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 122.182 1.922 . . . . 0.0 109.885 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 C--N 1.291 -1.977 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.271 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.1 m . . . . . 0 N--CA 1.433 -1.315 0 CA-C-O 121.404 0.621 . . . . 0.0 111.611 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HE2' HD21 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -88.72 160.27 17.4 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.01 21.31 3.72 Favored Glycine 0 CA--C 1.489 -1.574 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.066 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 31.7 p90 -170.81 148.21 2.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.498 HG12 ' CG2' ' A' ' 20' ' ' VAL . 21.5 pt -141.41 166.16 18.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 76.8 m-85 -136.41 134.34 37.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.4 mp -120.6 145.32 47.49 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 9.3 tp10 -124.28 116.12 22.13 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.568 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 12.4 m-30 -118.31 171.6 8.02 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.78 14.26 13.37 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.63 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.3 m -75.74 160.15 79.64 Favored Pre-proline 0 CA--C 1.608 3.187 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -170.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 24.1 Cg_exo -39.99 7.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.054 2 C-N-CA 129.972 7.115 . . . . 0.0 123.997 -179.016 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.63 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.36 66.77 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 CA-C-N 122.46 2.391 . . . . 0.0 106.579 -155.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.63 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 26.6 p80 -97.02 -36.95 10.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.566 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.602 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -80.88 -20.84 41.37 Favored 'General case' 0 CA--C 1.474 -1.955 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.251 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 p -59.45 -30.07 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -83.53 -49.29 9.38 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 74' ' ' ALA . . . -55.49 -42.58 74.62 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.395 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 42.7 t -66.88 -22.85 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 123.181 0.592 . . . . 0.0 111.556 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -85.72 -47.52 9.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.153 0.978 . . . . 0.0 109.805 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.52 -11.69 50.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 -167.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.42 13.25 13.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.188 0.518 . . . . 0.0 110.278 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 9.3 t70 -78.93 106.37 10.91 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.46 51.68 6.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 114.518 -1.219 . . . . 0.0 115.405 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.2 m-85 -101.5 106.18 17.25 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 2.8 mptt -77.41 99.64 5.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.57 -52.45 65.52 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.001 0.429 . . . . 0.0 110.544 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.525 ' OD2' ' HG2' ' A' ' 88' ' ' LYS . 27.4 t70 -151.54 -76.13 0.14 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.877 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HG2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -100.86 -101.21 0.25 Allowed 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.376 0.607 . . . . 0.0 112.596 178.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.565 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -92.55 3.33 55.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 111.701 -175.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -86.99 96.54 10.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 39.5 m -133.41 123.98 26.31 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.88 101.85 13.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.476 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -93.92 126.42 39.11 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.3 150.62 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.31 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 t30 . . . . . 0 N--CA 1.397 -3.108 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.658 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 . . . . . 0 CA--C 1.5 -0.962 0 CA-C-O 121.152 0.501 . . . . 0.0 109.739 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.563 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 21.4 m -107.28 6.2 28.31 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.3 t -139.27 135.72 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 mm -101.04 130.34 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.09 110.55 29.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 92' ' ' PHE . 70.6 t -97.83 135.51 32.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 123.924 0.765 . . . . 0.0 111.763 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -107.1 132.11 53.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 47.79 100.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.846 2.058 . . . . 0.0 116.49 -178.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.554 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 22.5 m -91.57 173.77 5.01 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.668 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HA ' ' CE1' ' A' ' 90' ' ' HIS . 98.8 Cg_exo -42.53 146.0 0.86 Allowed 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.195 2.596 . . . . 0.0 113.772 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.42 121.25 26.48 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.407 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 31' ' ' LEU . 5.2 p -121.98 137.57 55.14 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.8 -173.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.54 169.35 13.16 Favored Glycine 0 N--CA 1.405 -3.394 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.27 127.67 22.88 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.123 2.548 . . . . 0.0 112.775 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 73.66 21.15 2.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.998 1.319 . . . . 0.0 112.904 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -116.63 -1.58 12.12 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.095 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.409 ' HB2' HG21 ' A' ' 26' ' ' VAL . 3.3 tm? -67.53 -35.65 79.49 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -173.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 40.8 tt0 -63.27 -37.0 85.53 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -78.05 -32.58 50.94 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.543 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.537 ' O ' HG12 ' A' ' 38' ' ' ILE . 9.4 mp -71.7 -26.02 62.32 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.162 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 ptmm? -82.47 -18.22 42.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.628 0.728 . . . . 0.0 109.412 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -82.19 -37.79 25.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.201 -177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 41' ' ' ILE . 10.3 p -66.09 -32.12 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.941 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 34' ' ' LEU . 30.4 mm -58.36 -55.27 23.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.374 0.607 . . . . 0.0 109.465 173.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -55.14 -41.59 71.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.6 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -60.96 -57.44 12.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.599 0.76 . . . . 0.0 111.403 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 37' ' ' VAL . 41.2 mm -55.7 -51.06 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.656 0.741 . . . . 0.0 111.229 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.564 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 65.8 m-85 -74.57 -6.17 47.03 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -173.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -70.57 -11.91 61.23 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.66 -0.65 . . . . 0.0 111.428 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -74.79 -14.92 60.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.447 0.642 . . . . 0.0 110.58 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.07 0.63 32.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.746 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 137.27 -166.18 25.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.94 129.22 37.95 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.479 HD12 HD12 ' A' ' 66' ' ' LEU . 26.3 mm -74.75 103.69 2.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.4 m -71.55 -55.34 8.02 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -145.22 169.31 18.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.604 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 51.5 t0 -158.35 160.52 37.04 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 175.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.63 103.26 5.17 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -171.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.449 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 21.7 m-85 -108.2 105.07 55.78 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.591 -175.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.486 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 96.7 Cg_endo -89.26 164.13 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.402 1.402 . . . . 0.0 109.592 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 . . . . . 0 C--N 1.305 -1.347 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.675 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 N--CA 1.419 -2.007 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 3.4 pttm -69.97 160.33 32.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.192 165.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.69 14.77 12.87 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.129 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -169.05 152.49 5.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 117.185 0.493 . . . . 0.0 110.986 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -147.37 174.87 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.262 1.736 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 86.6 m-85 -141.56 113.94 8.2 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.313 0.506 . . . . 0.0 110.447 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.479 HD12 HD12 ' A' ' 48' ' ' ILE . 3.7 mm? -89.62 108.89 19.94 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.32 123.54 45.58 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 22.2 m-85 -121.17 175.86 5.89 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 13.78 12.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.529 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 11.7 m -77.3 158.99 78.7 Favored Pre-proline 0 CA--C 1.581 2.159 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -170.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 4.7 Cg_endo -39.88 7.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.511 2.515 1 C-N-CA 129.866 7.044 . . . . 0.0 121.743 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.615 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 84.41 65.45 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 124.706 2.193 . . . . 0.0 107.534 -160.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.563 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 27.2 p80 -82.6 -36.18 26.39 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 109.612 -3.449 . . . . 0.0 108.809 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.37 -28.44 63.01 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.501 -176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.7 p -68.09 -24.41 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.571 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 26.8 t70 -83.78 -41.84 17.15 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.83 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.51 79.49 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.365 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.458 HG12 HG23 ' A' ' 94' ' ' VAL . 34.4 m -66.03 -21.56 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.439 0.638 . . . . 0.0 111.69 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 27.3 ttpp -79.31 -43.6 23.28 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.785 0.803 . . . . 0.0 110.73 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.64 -56.09 4.06 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.344 -171.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.44 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . . . -155.9 87.97 1.09 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.173 -1.011 . . . . 0.0 113.4 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.474 ' CB ' HG22 ' A' ' 94' ' ' VAL . 2.7 t70 -77.42 109.83 11.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 56.17 0.57 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' THR . 78.7 m-85 -67.59 99.33 0.76 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.51 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -85.01 100.0 11.38 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -78.15 -50.84 11.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -150.22 174.53 12.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -30.97 -61.98 0.18 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.767 2.027 . . . . 0.0 114.979 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -105.1 12.71 31.79 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.882 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.724 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 20.0 m-70 -117.05 100.67 7.89 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.249 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 9.0 m -133.02 101.1 5.1 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.005 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.421 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.2 m-85 -82.39 106.47 14.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.522 -171.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -78.88 137.4 37.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 173.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.474 HG22 ' CB ' ' A' ' 82' ' ' ASP . 6.4 m -114.66 149.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 123.697 0.623 . . . . 0.0 109.681 -170.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.282 -2.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.508 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 18.2 p-10 . . . . . 0 N--CA 1.444 -0.767 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 71' ' ' PRO . 5.1 m -101.37 11.66 38.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -167.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.8 141.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.909 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.481 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 32.5 mm -100.29 132.93 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 67.9 t -135.88 109.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.433 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 m -112.51 123.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.532 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.45 144.61 27.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.345 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' GLY 0.533 0.3 OUTLIER 42.93 80.5 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 -176.694 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 19.4 m -91.57 168.09 14.09 Favored Pre-proline 0 N--CA 1.425 -1.719 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.284 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.789 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 73.3 Cg_exo -45.58 129.05 11.1 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.597 2.865 . . . . 0.0 113.502 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.45 153.46 41.38 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.244 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' A' ' 60' ' ' THR . 10.7 p -92.71 134.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 118.589 -1.245 . . . . 0.0 111.382 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 30' ' ' ARG . . . -123.21 176.35 16.65 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 105.765 -2.934 . . . . 0.0 105.765 171.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -50.97 127.05 20.35 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.557 2.171 . . . . 0.0 112.14 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.31 23.42 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.122 1.369 . . . . 0.0 112.85 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 58.9 mtp180 -105.2 -10.99 16.75 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.36 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.412 ' HB2' HG21 ' A' ' 26' ' ' VAL . 1.7 tm? -73.35 -42.05 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.066 -175.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.59 -37.91 88.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.046 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -81.25 -17.7 48.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.658 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.6 tp -70.02 -39.7 75.65 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -39.61 84.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.163 0.982 . . . . 0.0 109.816 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.46 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 41.6 t-20 -78.35 -37.5 44.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.644 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 34' ' ' LEU . 5.1 p -65.28 -29.36 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 34' ' ' LEU . 36.5 mm -64.94 -50.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -63.48 -20.12 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.724 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.46 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 62.1 mttm -86.23 -60.1 2.1 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.412 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.584 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 77.9 mt -66.22 -42.22 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CD2' HD11 ' A' ' 66' ' ' LEU . 3.3 m-85 -79.31 -23.57 43.41 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -170.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 67.3 m -64.43 -8.17 12.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 21.7 ptmt -68.35 -33.04 73.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 77' ' ' ALA . 30.0 m-85 -83.33 -17.19 43.3 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.595 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 153.16 -177.84 30.56 Favored Glycine 0 C--O 1.219 -0.81 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -76.86 131.93 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.09 103.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -82.02 -60.68 2.14 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.789 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 91.3 m-20 -126.91 122.97 36.11 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.74 133.68 53.13 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.47 102.9 8.76 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.08 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.442 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 12.6 m-30 -101.0 104.72 34.07 Favored Pre-proline 0 N--CA 1.428 -1.564 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.466 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 91.9 Cg_endo -87.81 173.92 4.95 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.008 1.805 . . . . 0.0 111.432 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 . . . . . 0 C--N 1.281 -2.371 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.209 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.447 ' OG1' HG12 ' A' ' 26' ' ' VAL . 13.5 t . . . . . 0 N--CA 1.43 -1.457 0 CA-C-O 121.381 0.61 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 13.6 pttm -79.35 163.94 24.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.493 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 22' ' ' ASN . . . -129.58 2.99 6.13 Favored Glycine 0 C--O 1.182 -3.133 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.046 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -154.99 156.04 35.27 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.933 -0.745 . . . . 0.0 109.833 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 pt -141.27 167.33 17.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.5 m-85 -131.92 141.07 49.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 42' ' ' PHE . 26.9 mt -127.87 149.35 50.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 50' ' ' ASN . 44.2 mt-10 -128.04 153.35 46.88 Favored 'General case' 0 C--O 1.255 1.388 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.37 159.89 29.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.26 73.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.521 1.128 . . . . 0.0 111.212 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 73' ' ' HIS . 28.5 t -123.72 128.25 25.22 Favored Pre-proline 0 CA--C 1.461 -2.472 1 N-CA-C 97.14 -5.133 . . . . 0.0 97.14 173.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 23.2 Cg_exo -62.49 -52.0 2.86 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 CA-C-N 121.813 1.683 . . . . 0.0 110.647 -165.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 26.52 5.79 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.807 0 C-N-CA 131.551 3.94 . . . . 0.0 119.657 144.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 71' ' ' PRO . 88.4 m-70 -127.24 -28.95 2.78 Favored 'General case' 1 C--N 1.225 -4.81 0 CA-C-O 121.214 0.53 . . . . 0.0 109.884 -170.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -69.25 -26.77 64.95 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.048 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.65 -24.86 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.07 -45.1 28.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . . . -57.4 -47.14 82.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.911 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.38 -18.0 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.109 0.48 . . . . 0.0 111.599 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -84.2 -24.59 30.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.42 -84.18 0.05 Allowed 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.89 109.45 3.21 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.253 0.549 . . . . 0.0 112.024 -173.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 94' ' ' VAL . 1.2 t70 -95.46 120.22 35.33 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.86 173.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.05 53.8 2.29 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.576 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -106.42 119.14 38.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.196 -0.591 . . . . 0.0 110.369 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -79.56 130.47 35.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.873 -175.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.36 -63.3 1.34 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -172.15 169.63 5.44 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HG2' ' OE1' ' A' ' 89' ' ' GLN . 24.3 ttmm 51.79 -104.04 0.17 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.651 1.18 . . . . 0.0 112.44 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.457 ' OE1' ' HG2' ' A' ' 88' ' ' LYS . 5.7 pm0 -121.61 11.93 10.63 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.959 0.885 . . . . 0.0 109.217 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.789 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 7.4 m170 -90.33 88.48 7.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.458 HG23 ' HG3' ' A' ' 85' ' ' LYS . 61.9 m -133.49 114.82 14.04 Favored 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.452 -178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -82.53 100.64 10.23 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.79 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.74 122.59 31.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.6 m -107.65 126.12 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.572 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.312 -1.027 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.96 179.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.442 -0.861 0 CA-C-O 120.256 0.074 . . . . 0.0 110.844 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.426 ' HA ' ' HE1' ' A' ' 73' ' ' HIS . 38.5 m -106.48 -7.53 17.5 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -172.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -134.92 135.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.231 -175.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -92.66 134.82 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.4 t -123.89 112.9 34.71 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.41 HG23 HG12 ' A' ' 64' ' ' ILE . 1.8 m -121.98 118.42 55.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.446 -178.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.77 148.81 22.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.263 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.442 0.1 OUTLIER 47.41 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 128.204 2.602 . . . . 0.0 114.776 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 32.3 m -90.77 163.63 29.32 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.043 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 0.9 OUTLIER -42.7 142.54 1.99 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 124.531 3.487 . . . . 0.0 114.987 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.485 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -80.52 159.38 25.53 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.323 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 27' ' ' GLY . 14.0 p -128.53 136.93 58.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.957 -177.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -101.51 168.09 19.42 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.96 126.87 19.85 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.834 2.356 . . . . 0.0 113.19 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.15 24.08 10.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.096 1.359 . . . . 0.0 112.996 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 20.0 mtp180 -107.3 -3.78 19.34 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.487 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -68.51 -33.92 74.98 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.54 -45.68 63.07 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.094 1.358 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.474 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -85.08 -29.17 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.022 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 38' ' ' ILE . 78.2 mt -64.51 -39.48 93.86 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.56 -21.26 61.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.479 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.7 t-20 -84.38 -38.18 20.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.246 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.05 -26.28 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 34' ' ' LEU . 44.0 mm -57.69 -51.32 71.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.059 175.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -62.88 -31.16 72.15 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 34.4 mmtp -65.69 -47.8 74.18 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.66 -47.86 78.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.63 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.539 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 68.4 m-85 -83.98 -11.76 56.32 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.5 p -69.31 -16.54 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 121.555 -0.715 . . . . 0.0 110.827 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.6 mmpt? -64.73 -24.75 67.66 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.347 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.23 -8.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.758 0.313 . . . . 0.0 111.39 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.95 -149.12 21.23 Favored Glycine 0 N--CA 1.428 -1.87 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.35 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -103.18 118.29 36.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 66' ' ' LEU . 23.0 mm -73.82 103.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.9 p -88.5 -23.74 23.14 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.007 0.432 . . . . 0.0 111.411 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -158.23 139.03 12.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.411 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 4.5 p30 -130.53 142.35 50.47 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.843 -0.536 . . . . 0.0 110.982 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 97.4 m-85 -128.23 98.97 5.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 7.4 m-30 -108.12 104.66 54.41 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.35 163.07 19.67 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.153 1.235 . . . . 0.0 109.863 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 8.3 pt-20 . . . . . 0 C--N 1.293 -1.889 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -175.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 26' ' ' VAL . 7.0 t . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 42.2 mttm -57.38 168.39 0.79 Allowed 'General case' 0 C--O 1.245 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 110.883 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.51 -13.93 7.18 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.669 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -170.47 159.45 6.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 20' ' ' VAL . 25.7 pt -146.9 166.28 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 63.7 m-85 -132.43 134.26 44.89 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.463 HD12 HD12 ' A' ' 48' ' ' ILE . 3.1 mm? -112.87 117.63 32.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -107.15 130.81 54.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . 0.583 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -127.38 177.62 6.6 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.72 13.51 14.21 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.448 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . 29.6 m -79.11 151.0 75.37 Favored Pre-proline 0 CA--C 1.574 1.867 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.59 8.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.04 2 C-N-CA 130.593 7.529 . . . . 0.0 122.751 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 85.33 64.64 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 124.576 2.131 . . . . 0.0 106.928 -160.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.583 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 53.4 p-80 -90.34 -36.35 14.7 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 109.129 -3.669 . . . . 0.0 107.662 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.67 -31.02 69.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.311 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 72' ' ' ALA . 4.0 p -65.92 -28.55 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.153 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -81.5 -40.0 23.89 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.854 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.43 75.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.626 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.58 -38.74 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 C-N-CA 124.439 1.096 . . . . 0.0 111.198 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -73.06 -20.91 60.87 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.422 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -93.59 -56.52 2.88 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.694 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.62 97.85 3.66 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.466 ' CG ' HG22 ' A' ' 94' ' ' VAL . 5.5 t0 -112.0 122.69 48.45 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.47 42.39 9.25 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.988 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' THR . 16.9 p90 -94.65 139.13 31.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.736 0.303 . . . . 0.0 110.939 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.51 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -103.36 123.84 47.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.09 -50.59 6.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.812 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HB3' ' CD2' ' A' ' 90' ' ' HIS . 9.8 t70 -155.18 -167.19 2.48 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -27.6 -75.41 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.932 2.093 . . . . 0.0 115.541 -170.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.485 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 5.1 pm0 -111.12 12.62 21.92 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.27 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.417 ' ND1' ' HA ' ' A' ' 24' ' ' PRO . 3.7 m-70 -88.46 88.88 7.77 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 5.1 m -133.49 102.07 5.38 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.39 118.54 22.76 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -167.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -88.34 125.19 34.57 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.466 HG22 ' CG ' ' A' ' 82' ' ' ASP . 4.1 m -94.56 147.78 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.067 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.692 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 t70 . . . . . 0 C--O 1.193 -1.911 0 CA-C-O 121.967 0.889 . . . . 0.0 109.376 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 t -109.04 -6.12 15.77 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 111.108 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 48.7 t -111.84 118.47 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 35.5 mm -84.11 139.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 49.9 t -130.71 113.09 23.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.103 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.62 HG12 HG12 ' A' ' 94' ' ' VAL . 12.0 m -120.24 131.93 71.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.22 142.88 29.34 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.994 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.484 0.2 OUTLIER 44.17 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.127 2.171 . . . . 0.0 115.815 -174.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.0 160.42 73.83 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.546 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' ND1' ' A' ' 90' ' ' HIS . 5.6 Cg_endo -46.64 132.94 16.78 Favored 'Trans proline' 0 CA--C 1.501 -1.138 0 C-N-CA 123.465 2.777 . . . . 0.0 114.28 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.7 138.05 42.69 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.311 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.11 138.42 27.47 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.205 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.4 -178.14 25.08 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.6 125.79 18.83 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.203 1.935 . . . . 0.0 112.299 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 51.71 22.53 1.68 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.519 1.928 . . . . 0.0 112.44 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -86.91 -17.92 32.08 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.354 -0.841 . . . . 0.0 111.253 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.17 -45.08 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -56.9 -56.95 15.06 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.465 0.478 . . . . 0.0 110.99 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -68.38 -24.19 64.75 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.522 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.61 ' O ' HG12 ' A' ' 38' ' ' ILE . 8.0 tt -70.69 -44.91 66.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -73.57 -18.07 61.11 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.324 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 11.3 m120 -78.86 -41.73 29.17 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.591 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 34' ' ' LEU . 9.8 p -68.08 -32.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.989 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 34' ' ' LEU . 26.5 mm -61.09 -53.87 43.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 122.968 0.507 . . . . 0.0 109.661 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -53.34 -38.48 63.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.355 0.662 . . . . 0.0 109.916 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 28.0 mtpp -73.92 -48.87 27.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.082 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 88.4 mt -62.01 -40.74 88.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.135 0.493 . . . . 0.0 110.326 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 38' ' ' ILE . 2.4 m-30 -74.26 -11.99 60.43 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.31 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 -16.43 63.32 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.8 ptpt -67.32 -33.39 75.16 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 110.523 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 27.8 m-85 -79.79 -16.05 56.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.448 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.18 179.88 26.35 Favored Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.663 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -67.38 114.36 6.01 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.301 1.04 . . . . 0.0 110.816 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.3 mm -74.43 108.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.3 m -80.16 -45.2 18.52 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -154.03 153.15 31.41 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -131.62 150.69 52.06 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.037 0.535 . . . . 0.0 110.055 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.01 101.22 4.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . 0.507 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 34.8 m-85 -108.89 107.05 59.77 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.194 177.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 83.4 Cg_endo -95.44 173.22 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.864 1.709 . . . . 0.0 111.216 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 C-N-CA 125.7 1.6 . . . . 0.0 106.725 171.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.429 -1.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 1.4 pttm -62.55 164.55 7.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.296 168.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.01 18.83 6.16 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.993 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -169.35 149.16 4.01 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ILE . . . . . 0.5 HG12 ' CG2' ' A' ' 20' ' ' VAL . 19.8 pt -142.84 168.18 13.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.4 m-85 -135.71 152.91 51.63 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.5 mp -135.0 154.48 51.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -130.24 128.17 41.09 Favored 'General case' 0 C--O 1.253 1.284 0 O-C-N 124.05 0.844 . . . . 0.0 109.273 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -104.75 176.59 5.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.98 -37.39 26.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.343 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 t -127.78 145.52 55.3 Favored Pre-proline 0 CA--C 1.466 -2.254 1 N-CA-C 99.534 -4.247 . . . . 0.0 99.534 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 73' ' ' HIS . 39.2 Cg_exo -63.64 -54.64 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.791 0 CA-C-N 122.193 1.819 . . . . 0.0 110.562 -171.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.8 4.07 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.654 1 C-N-CA 132.077 4.151 . . . . 0.0 119.824 148.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . 0.473 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 94.6 m-70 -129.32 -36.95 1.67 Allowed 'General case' 1 C--N 1.227 -4.754 0 C-N-CA 123.291 0.636 . . . . 0.0 110.045 -170.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.86 64.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.521 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.65 -31.9 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.256 0.551 . . . . 0.0 110.45 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -40.16 19.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.195 0.522 . . . . 0.0 109.759 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.8 86.05 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.639 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.572 ' HA ' HG21 ' A' ' 94' ' ' VAL . 53.2 t -65.59 -22.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.678 0.751 . . . . 0.0 111.16 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -83.8 -38.3 21.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -110.06 -25.91 9.98 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ALA . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . . . -101.47 7.11 42.62 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 122.018 -0.427 . . . . 0.0 111.793 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.613 ' HA ' HG22 ' A' ' 94' ' ' VAL . 14.4 t0 -76.63 103.35 6.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.59 8.41 Favored Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.585 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -105.3 136.38 44.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.101 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -106.72 129.33 54.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.5 mt -79.46 -62.45 1.69 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.891 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -155.48 133.81 11.67 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 53.1 -93.74 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 125.647 1.579 . . . . 0.0 114.792 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -107.33 -4.1 18.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 120.661 0.267 . . . . 0.0 110.819 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.495 ' ND1' ' HA ' ' A' ' 24' ' ' PRO . 6.9 m-70 -79.3 91.46 5.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.6 m -132.84 120.48 21.6 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.86 104.6 14.08 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.114 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.06 109.08 20.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.62 HG12 HG12 ' A' ' 20' ' ' VAL . 17.2 m -93.62 143.53 11.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.263 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.066 176.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.565 0 N-CA-C 112.726 -0.15 . . . . 0.0 112.726 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.5 135.32 33.67 Favored 'General case' 0 CA--C 1.487 -1.445 0 CA-C-N 117.354 0.577 . . . . 0.0 110.506 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -95.73 109.22 22.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.782 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 174.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 94.0 mt -101.57 -36.09 8.9 Favored 'General case' 0 C--N 1.314 -0.978 0 N-CA-C 113.079 0.77 . . . . 0.0 113.079 -172.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -73.23 -46.94 47.36 Favored 'General case' 0 C--O 1.249 1.031 0 CA-C-O 121.506 0.669 . . . . 0.0 109.775 -178.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -90.2 96.84 10.86 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 176.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 19.8 mtp180 -84.54 126.3 69.33 Favored Pre-proline 0 C--N 1.298 -1.673 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.879 -178.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -74.87 148.33 35.76 Favored 'Trans proline' 0 N--CA 1.44 -1.642 0 C-N-CA 122.096 1.864 . . . . 0.0 110.766 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 18.5 tp60 -106.02 157.38 17.56 Favored 'General case' 0 C--N 1.293 -1.861 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 22.6 mp0 -74.9 -21.74 59.04 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.351 0.596 . . . . 0.0 109.807 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -92.07 134.62 34.66 Favored 'General case' 0 N--CA 1.433 -1.29 0 CA-C-N 115.135 -0.939 . . . . 0.0 109.985 -178.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -164.96 137.43 4.47 Favored 'General case' 0 C--N 1.309 -1.178 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 178.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.48 -113.66 5.46 Favored Glycine 0 N--CA 1.443 -0.847 0 O-C-N 123.6 0.563 . . . . 0.0 113.33 176.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 6.9 tp -90.93 95.2 5.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.165 0 CA-C-O 122.704 1.24 . . . . 0.0 111.182 -179.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 6.7 p-10 -108.31 21.63 17.07 Favored 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.127 -1.397 . . . . 0.0 110.592 -176.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 20.1 m -110.92 16.85 21.03 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-O 121.106 0.479 . . . . 0.0 111.438 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.5 p -131.19 132.23 63.32 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.215 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 -179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.407 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 9.6 mm -97.63 135.12 33.16 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.197 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 44.6 t -112.27 116.66 53.19 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.945 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 173.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.519 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 10.3 t -113.34 122.97 68.51 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 O-C-N 123.449 0.468 . . . . 0.0 110.216 -175.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.587 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.1 t70 -91.87 136.25 33.3 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 123.931 0.77 . . . . 0.0 111.182 -179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.48 0.1 OUTLIER 41.5 89.18 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 128.043 2.537 . . . . 0.0 116.684 178.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.573 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 18.3 m -98.7 173.29 3.97 Favored Pre-proline 0 N--CA 1.427 -1.611 0 CA-C-N 112.799 -2.0 . . . . 0.0 109.246 -178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.712 ' HA ' ' NE2' ' A' ' 90' ' ' HIS . 55.5 Cg_exo -41.16 127.58 2.9 Favored 'Trans proline' 0 C--O 1.266 1.903 0 C-N-CA 123.649 2.9 . . . . 0.0 114.223 177.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -74.84 -178.24 3.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 113.985 -1.461 . . . . 0.0 110.26 -177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.608 HG23 ' HB2' ' A' ' 31' ' ' LEU . 6.6 p -111.93 134.23 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.159 0 C-N-CA 118.885 -1.126 . . . . 0.0 113.325 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.78 157.08 15.28 Favored Glycine 0 N--CA 1.429 -1.777 0 N-CA-C 104.263 -3.535 . . . . 0.0 104.263 166.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.473 ' O ' ' HG3' ' A' ' 30' ' ' ARG . 9.3 Cg_endo -52.23 123.16 12.0 Favored 'Trans proline' 0 CA--C 1.535 0.538 0 CA-C-N 121.557 2.678 . . . . 0.0 112.266 -172.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 50.74 25.74 2.24 Favored 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 125.432 1.493 . . . . 0.0 112.89 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 28' ' ' PRO . 70.7 mtt180 -107.08 -8.4 16.53 Favored 'General case' 0 CA--C 1.501 -0.939 0 O-C-N 122.061 -0.4 . . . . 0.0 110.952 -178.143 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.608 ' HB2' HG23 ' A' ' 26' ' ' VAL . 2.9 tm? -73.53 -19.72 60.84 Favored 'General case' 0 C--O 1.22 -0.478 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -55.39 -48.39 74.4 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 114.672 -1.149 . . . . 0.0 110.978 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -79.17 -22.29 45.22 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.412 0.625 . . . . 0.0 110.372 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.426 ' HB2' HD22 ' A' ' 31' ' ' LEU . 97.7 mt -81.41 1.37 33.3 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.16 -179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 97.1 mttt -84.74 -43.23 14.47 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 170.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.425 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 48.9 t30 -75.71 -34.95 60.41 Favored 'General case' 0 CA--C 1.498 -1.053 0 CA-C-N 114.254 -1.339 . . . . 0.0 110.033 -172.069 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.9 p -56.86 -32.78 39.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.656 -179.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 40.9 mm -60.06 -59.01 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.929 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.539 177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.4 t60 -59.06 -35.29 73.1 Favored 'General case' 0 CA--C 1.555 1.147 0 C-N-CA 123.169 0.588 . . . . 0.0 110.542 -177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 29.9 mtpp -65.61 -39.91 92.03 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.794 178.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 87.0 mt -83.3 -39.79 15.59 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.133 0 CA-C-O 121.301 0.572 . . . . 0.0 110.562 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.536 ' CD2' ' HG ' ' A' ' 66' ' ' LEU . 26.2 m-85 -76.22 -9.41 58.61 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -172.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.0 p -66.0 -19.31 65.81 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-O 121.636 0.732 . . . . 0.0 110.679 175.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 32.2 mmmt -68.81 -21.16 64.33 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.345 -0.843 . . . . 0.0 111.951 178.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -88.85 -15.08 35.38 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.941 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 147.0 -152.74 24.86 Favored Glycine 0 N--CA 1.431 -1.658 0 N-CA-C 110.833 -0.907 . . . . 0.0 110.833 -178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -96.11 125.72 40.84 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 19.0 mm -73.94 97.27 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.428 -1.554 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 -179.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.0 m -69.67 -54.37 14.2 Favored 'General case' 0 N--CA 1.432 -1.37 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 72.0 m-20 -135.84 135.19 39.61 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 177.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.6 p-10 -134.14 126.98 31.12 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.87 0.843 . . . . 0.0 109.711 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 -125.23 117.1 23.08 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.304 -173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -108.07 103.48 50.24 Favored Pre-proline 0 C--N 1.3 -1.587 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 176.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -95.71 173.97 1.04 Allowed 'Trans proline' 0 N--CA 1.442 -1.549 0 C-N-CA 122.605 2.204 . . . . 0.0 111.101 176.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 59' ' ' LYS . 0.6 OUTLIER -105.66 -176.22 3.02 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 174.642 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -136.12 114.1 11.3 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.7 t0 62.87 27.99 16.21 Favored 'General case' 0 CA--C 1.549 0.921 0 CA-C-O 122.054 0.93 . . . . 0.0 110.33 174.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.07 13.12 83.52 Favored Glycine 0 C--N 1.343 0.972 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.189 -179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.412 ' O ' ' HB2' ' A' ' 55' ' ' GLU . 48.6 mtmt -128.44 -175.54 3.55 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 124.115 0.966 . . . . 0.0 109.923 -176.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.5 m -34.66 129.19 0.43 Allowed 'General case' 0 N--CA 1.441 -0.896 0 C-N-CA 126.53 1.932 . . . . 0.0 112.667 177.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE3' HD11 ' A' ' 31' ' ' LEU . 16.5 pttp -69.95 139.99 52.96 Favored 'General case' 0 N--CA 1.43 -1.474 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.35 178.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.47 16.55 6.25 Favored Glycine 0 C--N 1.288 -2.098 0 CA-C-N 114.894 -1.048 . . . . 0.0 110.855 -179.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.519 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 24.4 p90 -169.92 158.33 7.19 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 109.399 -0.593 . . . . 0.0 109.399 178.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 23.2 pt -147.48 174.07 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 C-N-CA 124.383 1.073 . . . . 0.0 108.117 176.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -134.48 136.89 43.48 Favored 'General case' 0 C--N 1.318 -0.766 0 O-C-N 123.386 0.429 . . . . 0.0 109.875 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.536 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 3.1 mm? -127.92 123.43 34.91 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -117.19 129.8 56.18 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 175.286 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.591 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 9.5 m-85 -127.34 170.35 12.59 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.34 14.33 12.89 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 173.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.513 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 49.6 m -71.57 173.33 5.32 Favored Pre-proline 0 CA--C 1.594 2.636 0 CA-C-N 113.231 -1.804 . . . . 0.0 115.565 -171.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 6.3 Cg_exo -36.64 6.9 0.0 OUTLIER 'Trans proline' 0 N--CA 1.521 3.105 1 C-N-CA 130.041 7.16 . . . . 0.0 121.015 175.344 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 84.56 63.31 0.01 OUTLIER 'General case' 0 CA--C 1.494 -1.209 0 CA-C-O 124.464 2.078 . . . . 0.0 108.478 -167.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.591 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 17.3 p80 -74.16 -36.93 64.13 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-N 110.125 -3.216 . . . . 0.0 111.065 -174.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.468 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -76.98 -37.29 55.47 Favored 'General case' 0 CA--C 1.475 -1.907 0 N-CA-C 107.928 -1.138 . . . . 0.0 107.928 -177.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 65.0 t -61.57 -42.83 95.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-N 114.37 -1.286 . . . . 0.0 109.472 176.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -65.52 -49.31 69.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.669 177.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.7 -54.23 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.005 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.432 HG22 ' O ' ' A' ' 74' ' ' ALA . 27.8 m -60.06 -31.62 48.33 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.328 0 N-CA-C 112.84 0.681 . . . . 0.0 112.84 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 15.0 tppt? -84.87 -31.02 23.97 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -177.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.6 m-80 -104.8 -41.38 5.66 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 -172.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -139.16 84.67 2.02 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 113.064 0.764 . . . . 0.0 113.064 -174.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 94' ' ' VAL . 3.5 t70 -116.31 118.42 32.69 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.36 174.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.12 41.96 7.79 Favored Glycine 0 C--N 1.292 -1.887 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.154 178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . 0.251 39.6 p90 -88.48 120.58 29.99 Favored 'General case' 0 N--CA 1.436 -1.133 0 C-N-CA 119.306 -0.957 . . . . 0.0 112.033 -178.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.57 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.8 OUTLIER -79.68 122.41 26.53 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 113.993 -1.458 . . . . 0.0 111.212 -176.142 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.6 mt -87.08 -65.83 0.97 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.138 172.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -169.25 153.73 5.53 Favored 'General case' 0 C--O 1.243 0.728 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -175.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 4.3 mppt? 45.41 -91.47 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 C-N-CA 125.851 1.66 . . . . 0.0 114.705 -172.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -111.49 -22.89 11.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.513 0.19 . . . . 0.0 111.513 -175.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.712 ' NE2' ' HA ' ' A' ' 24' ' ' PRO . 22.6 m170 -62.54 99.61 0.15 Allowed 'General case' 0 CA--C 1.501 -0.905 0 C-N-CA 122.814 0.446 . . . . 0.0 111.459 -171.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.57 HG23 ' HG3' ' A' ' 85' ' ' LYS . 7.5 m -134.45 103.0 5.52 Favored 'General case' 0 C--N 1.284 -2.278 0 N-CA-C 108.463 -0.939 . . . . 0.0 108.463 -179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.0 m-85 -82.8 100.25 10.19 Favored 'General case' 0 C--N 1.285 -2.209 0 C-N-CA 118.564 -1.254 . . . . 0.0 110.888 -172.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.587 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.2 mpt_? -83.12 138.55 33.63 Favored 'General case' 0 CA--C 1.492 -1.254 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 173.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.614 HG22 ' HB2' ' A' ' 82' ' ' ASP . 3.9 m -124.73 136.3 61.16 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.438 0 O-C-N 123.574 0.546 . . . . 0.0 110.344 -173.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.568 HD22 ' C ' ' A' ' 95' ' ' ASN . 0.2 OUTLIER -158.1 -179.34 8.03 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 170.205 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.47 ' HG ' ' OG1' ' A' ' 98' ' ' THR . 0.5 OUTLIER -102.76 -166.56 1.29 Allowed 'General case' 0 C--N 1.288 -2.095 0 O-C-N 123.56 0.537 . . . . 0.0 111.424 178.22 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -83.59 11.73 6.76 Favored 'General case' 0 N--CA 1.44 -0.943 0 C-N-CA 120.187 -0.605 . . . . 0.0 111.511 -174.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.47 ' OG1' ' HG ' ' A' ' 96' ' ' LEU . 8.6 p -72.0 65.02 0.54 Allowed 'General case' 0 CA--C 1.556 1.178 0 CA-C-O 122.556 1.17 . . . . 0.0 111.065 171.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -90.95 -12.55 35.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.508 -1.224 . . . . 0.0 109.888 -176.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -71.92 140.61 49.29 Favored 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.053 179.177 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -91.56 -32.96 15.33 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.71 -175.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.418 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -60.62 134.81 57.45 Favored 'General case' 0 CA--C 1.509 -0.631 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 -171.081 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -104.94 141.59 36.27 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.276 -1.75 . . . . 0.0 106.276 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 49.7 ttm -70.07 99.33 1.44 Allowed 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.382 0.611 . . . . 0.0 111.57 -176.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.4 m . . . . . 0 C--N 1.296 -1.731 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 175.001 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.272 0 N-CA-C 111.648 -0.581 . . . . 0.0 111.648 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -95.63 151.09 19.65 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.928 0.364 . . . . 0.0 111.377 -178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 7' ' ' ARG . 4.1 p 63.02 6.57 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 C-N-CA 127.256 2.222 . . . . 0.0 113.761 177.564 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -106.84 -53.78 2.57 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 121.416 0.627 . . . . 0.0 110.63 -178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.5 mmmm -76.05 -40.58 53.04 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -177.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -114.93 113.2 23.83 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.461 ' HG2' ' O ' ' A' ' 3' ' ' VAL . 78.1 mtp180 -119.88 138.19 26.6 Favored Pre-proline 0 C--N 1.285 -2.237 0 C-N-CA 120.261 -0.576 . . . . 0.0 112.063 -174.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.1 128.24 17.28 Favored 'Trans proline' 0 N--CA 1.454 -0.81 0 N-CA-C 105.495 -2.54 . . . . 0.0 105.495 164.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.563 ' HG3' ' H ' ' A' ' 11' ' ' ALA . 47.4 tp60 -85.95 149.76 24.97 Favored 'General case' 0 C--N 1.292 -1.927 0 C-N-CA 119.201 -1.0 . . . . 0.0 110.61 -172.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -74.82 -9.67 58.77 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.761 0.791 . . . . 0.0 109.984 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.563 ' H ' ' HG3' ' A' ' 9' ' ' GLN . . . -87.26 100.97 13.09 Favored 'General case' 0 N--CA 1.425 -1.696 0 CA-C-N 115.075 -0.966 . . . . 0.0 108.613 176.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -154.07 174.43 14.71 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 107.76 -7.25 35.98 Favored Glycine 0 CA--C 1.494 -1.277 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -178.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.5 tp -154.07 125.53 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.406 -2.627 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.69 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 26.4 t70 -110.93 -24.53 10.34 Favored 'General case' 0 C--N 1.283 -2.32 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.051 177.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.501 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 36.0 m -89.38 -3.16 58.56 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -172.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.429 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 88.3 t -127.55 122.57 59.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.073 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -178.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.436 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 14.0 mm -89.99 135.82 25.33 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 59.9 t -128.74 120.51 52.5 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.37 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 -179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.6 m -135.73 138.34 47.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.681 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -108.61 139.86 42.79 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.581 0.2 OUTLIER 46.58 92.03 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 127.253 2.221 . . . . 0.0 115.889 -169.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.585 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 29.9 m -107.25 179.04 0.95 Allowed Pre-proline 0 N--CA 1.418 -2.064 0 CA-C-N 112.635 -2.075 . . . . 0.0 107.141 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.6 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 54.3 Cg_exo -42.41 131.74 5.04 Favored 'Trans proline' 0 C--O 1.269 2.04 0 C-N-CA 123.01 2.474 . . . . 0.0 114.831 178.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.658 ' HA ' HG23 ' A' ' 60' ' ' THR . 9.1 pt20 -61.84 -165.82 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.753 0 C-N-CA 128.06 2.544 . . . . 0.0 113.528 -175.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.601 ' HB ' HD23 ' A' ' 31' ' ' LEU . 14.9 p -141.03 138.55 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.583 0 CA-C-O 121.985 0.897 . . . . 0.0 110.691 173.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.93 141.85 15.38 Favored Glycine 0 C--N 1.275 -2.853 1 N-CA-C 102.829 -4.108 . . . . 0.0 102.829 166.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_endo -50.2 124.81 13.59 Favored 'Trans proline' 0 C--O 1.243 0.744 0 CA-C-N 121.274 2.537 . . . . 0.0 112.73 -173.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 32.8 t70 60.56 32.38 20.42 Favored 'General case' 0 CA--C 1.552 1.055 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.067 -178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -121.4 2.04 10.21 Favored 'General case' 0 N--CA 1.473 0.685 0 O-C-N 121.228 -0.92 . . . . 0.0 111.039 176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.601 HD23 ' HB ' ' A' ' 26' ' ' VAL . 1.4 tm? -60.91 -27.01 67.88 Favored 'General case' 0 CA--C 1.555 1.163 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -174.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -57.7 -50.72 72.25 Favored 'General case' 0 N--CA 1.479 1.022 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -178.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -71.56 -23.53 61.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.661 0.743 . . . . 0.0 109.993 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 77.8 mt -81.2 -4.53 55.75 Favored 'General case' 0 N--CA 1.44 -0.936 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.574 -179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 99.5 mttt -85.62 -37.46 19.49 Favored 'General case' 0 C--O 1.222 -0.372 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 168.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.49 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 4.4 m-20 -78.16 -33.89 50.04 Favored 'General case' 0 CA--C 1.485 -1.542 0 CA-C-N 114.767 -1.106 . . . . 0.0 110.921 -172.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.1 p -58.38 -32.5 45.37 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.846 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.944 177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 mm -61.47 -53.34 49.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 176.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 8.5 t60 -58.3 -31.68 67.74 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.842 -177.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.49 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 52.9 mtpt -78.32 -41.6 33.2 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -178.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 78.5 mt -82.44 -41.39 17.73 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.145 0 CA-C-O 121.708 0.765 . . . . 0.0 111.246 -177.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.693 ' CD2' HD11 ' A' ' 66' ' ' LEU . 3.9 m-85 -78.57 -10.81 59.87 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 113.477 0.917 . . . . 0.0 113.477 -171.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 1.8 p -71.78 -10.02 59.15 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.733 0.778 . . . . 0.0 111.578 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 31.9 mmmt -71.21 -22.03 62.06 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.318 174.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -86.69 -15.42 39.62 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.729 177.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 150.83 -171.47 30.59 Favored Glycine 0 N--CA 1.425 -2.091 0 N-CA-C 110.561 -1.016 . . . . 0.0 110.561 -178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -83.73 127.08 33.52 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -177.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 68' ' ' TYR . 20.1 mm -72.6 94.74 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.13 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 13.2 m -83.36 -37.25 23.57 Favored 'General case' 0 N--CA 1.429 -1.475 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.097 -174.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.456 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 39.5 t30 -154.04 145.57 23.19 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 178.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -146.64 151.25 36.95 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 -175.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -135.99 106.14 6.34 Favored 'General case' 0 CA--C 1.501 -0.924 0 O-C-N 123.783 0.677 . . . . 0.0 109.892 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -108.74 104.72 55.39 Favored Pre-proline 0 C--O 1.252 1.212 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 176.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -95.32 173.21 1.2 Allowed 'Trans proline' 0 N--CA 1.432 -2.128 0 C-N-CA 121.882 1.721 . . . . 0.0 110.898 174.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -143.15 175.88 9.54 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.807 -1.553 . . . . 0.0 106.807 174.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.789 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 39.7 mt-10 -137.5 117.53 13.38 Favored 'General case' 0 C--N 1.282 -2.349 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 -175.102 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 56.29 26.22 10.26 Favored 'General case' 0 N--CA 1.498 1.951 0 C-N-CA 123.58 0.752 . . . . 0.0 111.208 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.77 15.84 65.05 Favored Glycine 0 CA--C 1.538 1.475 0 CA-C-N 116.167 -0.47 . . . . 0.0 113.195 -176.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.789 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 56.3 pttt -101.77 -176.83 3.25 Favored 'General case' 0 C--O 1.246 0.885 0 O-C-N 121.904 -0.763 . . . . 0.0 109.163 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.658 HG23 ' HA ' ' A' ' 25' ' ' GLN . 98.7 m -53.64 119.01 4.37 Favored 'General case' 0 N--CA 1.429 -1.512 0 C-N-CA 123.649 0.78 . . . . 0.0 111.532 179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -67.86 145.54 54.53 Favored 'General case' 0 N--CA 1.425 -1.714 0 CA-C-N 115.219 -0.901 . . . . 0.0 109.438 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -118.33 3.19 16.06 Favored Glycine 0 C--N 1.286 -2.225 0 C-N-CA 119.828 -1.177 . . . . 0.0 112.932 -173.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -168.19 150.06 5.26 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 109.781 -0.452 . . . . 0.0 109.781 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 27.8 pt -145.12 167.02 10.66 Favored 'Isoleucine or valine' 0 C--O 1.244 0.791 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -132.69 136.06 46.19 Favored 'General case' 0 CA--C 1.489 -1.395 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 177.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.693 HD11 ' CD2' ' A' ' 42' ' ' PHE . 47.1 mt -121.46 154.01 37.15 Favored 'General case' 0 C--N 1.28 -2.415 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.456 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 42.3 tt0 -135.95 122.58 20.92 Favored 'General case' 0 C--N 1.28 -2.43 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 177.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.544 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 11.8 m-30 -118.88 157.56 27.39 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -106.37 13.86 28.09 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 122.219 1.009 . . . . 0.0 108.82 175.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.438 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 20.8 m -73.57 161.63 78.01 Favored Pre-proline 0 CA--C 1.604 3.034 0 CA-C-N 114.16 -1.382 . . . . 0.0 114.605 -173.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.438 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.2 Cg_endo -37.66 8.05 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.945 2 C-N-CA 130.622 7.548 . . . . 0.0 124.316 179.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.69 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.47 67.42 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.033 0 CA-C-N 123.066 2.666 . . . . 0.0 106.153 -156.112 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.544 ' NE2' ' HB2' ' A' ' 68' ' ' TYR . 22.9 p-80 -93.94 -37.87 11.47 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 109.067 -3.697 . . . . 0.0 112.197 -172.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -76.6 -23.42 53.43 Favored 'General case' 0 CA--C 1.497 -1.088 0 C-N-CA 119.335 -0.946 . . . . 0.0 109.354 179.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.3 p -65.11 -22.89 32.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 115.042 -0.981 . . . . 0.0 108.764 176.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -83.04 -46.71 12.51 Favored 'General case' 0 CA--C 1.497 -1.07 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 174.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.05 -43.79 66.91 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.982 0.801 . . . . 0.0 111.964 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.9 m -69.49 -19.57 23.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 CA-C-O 120.92 0.39 . . . . 0.0 111.872 179.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 7.5 ttpm? -85.27 -22.98 28.38 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.173 176.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.23 -71.91 0.14 Allowed 'General case' 0 CA--C 1.505 -0.778 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.313 -177.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -177.3 124.13 0.13 Allowed 'General case' 0 CA--C 1.506 -0.738 0 O-C-N 123.642 0.588 . . . . 0.0 110.285 -178.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.523 ' HB2' HG22 ' A' ' 94' ' ' VAL . 5.5 t70 -81.43 115.67 20.87 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 172.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.49 52.5 4.18 Favored Glycine 0 C--N 1.3 -1.463 0 CA-C-N 115.609 -0.723 . . . . 0.0 112.335 178.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 38.9 p90 -93.67 126.61 38.94 Favored 'General case' 0 C--O 1.245 0.857 0 C-N-CA 119.81 -0.756 . . . . 0.0 111.092 179.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.519 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.8 OUTLIER -82.99 117.19 22.63 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.42 -1.264 . . . . 0.0 111.786 -175.913 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.1 mt -84.65 -58.78 2.58 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 121.8 0.809 . . . . 0.0 109.197 172.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -135.12 -164.79 1.58 Allowed 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 -177.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -36.2 -81.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.744 1.617 . . . . 0.0 115.069 -174.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 29.2 pt20 -96.29 -1.15 48.53 Favored 'General case' 0 C--N 1.319 -0.723 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.726 -178.033 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.6 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 42.1 m170 -81.43 93.29 6.59 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 -176.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' ' 85' ' ' LYS . 21.2 m -133.95 108.38 8.36 Favored 'General case' 0 C--N 1.271 -2.839 0 CA-C-N 115.884 -0.598 . . . . 0.0 109.681 -178.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -82.83 101.07 10.72 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.394 -0.922 . . . . 0.0 112.261 -173.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -83.56 136.73 34.14 Favored 'General case' 0 CA--C 1.493 -1.247 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 173.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.523 HG22 ' HB2' ' A' ' 82' ' ' ASP . 17.1 m -105.86 138.17 32.4 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.706 0 O-C-N 123.792 0.682 . . . . 0.0 110.594 -173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.458 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -156.14 170.61 21.8 Favored 'General case' 0 C--N 1.289 -2.052 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.1 pt? -86.41 -174.14 4.88 Favored 'General case' 0 N--CA 1.437 -1.076 0 CA-C-O 121.718 0.77 . . . . 0.0 112.298 -176.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -106.71 -35.8 6.89 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.435 -175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.29 28.19 0.05 Allowed 'General case' 0 CA--C 1.563 1.466 0 C-N-CA 125.445 1.498 . . . . 0.0 112.04 -175.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -124.97 -43.26 1.98 Allowed 'General case' 0 C--N 1.307 -1.256 0 CA-C-O 121.262 0.553 . . . . 0.0 109.601 -178.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -92.35 35.06 1.01 Allowed 'General case' 0 C--O 1.24 0.566 0 CA-C-O 121.652 0.739 . . . . 0.0 112.379 -176.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -150.81 62.12 0.93 Allowed 'General case' 0 C--N 1.29 -2.009 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 176.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.83 176.93 5.94 Favored 'General case' 0 C--N 1.3 -1.561 0 CA-C-N 114.807 -1.088 . . . . 0.0 110.918 178.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -93.09 138.25 31.7 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 175.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 56.0 ttp -92.35 100.63 13.17 Favored 'General case' 0 C--N 1.295 -1.787 0 CA-C-O 121.423 0.63 . . . . 0.0 110.566 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 13.2 t . . . . . 0 N--CA 1.42 -1.934 0 N-CA-C 105.936 -1.876 . . . . 0.0 105.936 179.724 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.493 -1.283 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -85.49 150.29 24.79 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 117.14 0.47 . . . . 0.0 111.147 178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -66.28 -10.94 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.23 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.45 HD11 ' HD3' ' A' ' 79' ' ' LYS . 96.7 mt -69.0 -16.78 63.81 Favored 'General case' 0 C--N 1.315 -0.893 0 C-N-CA 123.736 0.814 . . . . 0.0 111.521 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 mmmp? -82.18 -20.65 37.4 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.063 0.458 . . . . 0.0 110.091 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -89.46 -53.38 4.57 Favored 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.532 ' NH2' ' HB2' ' A' ' 10' ' ' GLU . 11.2 ptm180 -119.47 139.31 27.59 Favored Pre-proline 0 N--CA 1.415 -2.203 0 CA-C-N 115.204 -0.907 . . . . 0.0 109.622 177.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -71.29 158.9 53.38 Favored 'Trans proline' 0 C--O 1.268 1.977 0 C-N-CA 121.451 1.434 . . . . 0.0 109.335 173.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.484 ' HG3' ' H ' ' A' ' 11' ' ' ALA . 60.4 tp60 -66.57 135.06 53.6 Favored 'General case' 0 N--CA 1.438 -1.066 0 N-CA-C 107.812 -1.181 . . . . 0.0 107.812 177.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.532 ' HB2' ' NH2' ' A' ' 7' ' ' ARG . 20.5 tt0 -79.42 -6.78 57.6 Favored 'General case' 0 C--N 1.305 -1.333 0 CA-C-O 121.682 0.753 . . . . 0.0 111.511 -171.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.484 ' H ' ' HG3' ' A' ' 9' ' ' GLN . . . -95.85 97.94 10.04 Favored 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.396 177.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -159.92 129.56 5.3 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.525 176.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 138.45 -66.83 0.53 Allowed Glycine 0 C--N 1.298 -1.578 0 N-CA-C 110.4 -1.08 . . . . 0.0 110.4 -179.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.6 tp -150.11 92.14 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.419 -2.02 0 CA-C-O 122.234 1.016 . . . . 0.0 110.94 175.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.532 ' OD1' ' HB2' ' A' ' 96' ' ' LEU . 23.5 m-20 -131.03 54.16 1.93 Allowed 'General case' 0 C--N 1.283 -2.318 0 CA-C-O 122.55 1.167 . . . . 0.0 107.992 178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.626 ' HA ' ' HE2' ' A' ' 73' ' ' HIS . 44.9 m -96.48 7.18 47.13 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 113.66 -1.609 . . . . 0.0 110.265 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 38.7 t -127.93 126.53 66.73 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.272 -0.876 . . . . 0.0 108.981 -178.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.432 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 30.5 mm -83.04 139.34 17.91 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 173.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.5 t -121.2 112.13 34.33 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.5 m -122.79 120.57 61.11 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.777 -179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.475 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 30.1 t70 -85.44 132.78 34.16 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.963 -1.017 . . . . 0.0 109.744 178.401 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.479 0.2 OUTLIER 45.7 97.92 0.01 OUTLIER 'General case' 0 CA--C 1.503 -0.842 0 N-CA-C 116.953 2.205 . . . . 0.0 116.953 -177.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.419 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.9 m -86.63 167.94 20.55 Favored Pre-proline 0 N--CA 1.402 -2.861 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 175.141 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.617 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 48.9 Cg_exo -51.18 146.95 21.81 Favored 'Trans proline' 0 N--CA 1.456 -0.734 0 C-N-CA 122.769 2.313 . . . . 0.0 116.098 -178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 25' ' ' GLN . 3.7 tt0 -61.06 145.3 51.32 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-N 112.19 -2.277 . . . . 0.0 109.503 175.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.455 HG21 ' HB2' ' A' ' 31' ' ' LEU . 7.3 p -137.87 151.0 25.24 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.47 0 CA-C-O 121.715 0.769 . . . . 0.0 111.494 -176.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -135.16 174.87 20.98 Favored Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 105.7 -2.96 . . . . 0.0 105.7 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -47.62 126.05 11.89 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 122.691 2.261 . . . . 0.0 113.642 -176.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.9 t70 65.27 18.44 11.39 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 126.797 2.039 . . . . 0.0 112.9 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.5 mtm180 -100.89 -8.36 22.61 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 120.612 -1.305 . . . . 0.0 111.629 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.455 ' HB2' HG21 ' A' ' 26' ' ' VAL . 1.0 OUTLIER -76.97 -21.9 54.02 Favored 'General case' 0 C--O 1.212 -0.898 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -64.63 -34.44 78.28 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.221 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.4 mttm -69.93 -36.96 75.74 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.581 ' O ' HG12 ' A' ' 38' ' ' ILE . 80.2 mt -73.59 -34.37 65.06 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 114.169 -1.378 . . . . 0.0 111.551 -176.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' HE3' HD12 ' A' ' 31' ' ' LEU . 98.5 mttt -58.47 -31.61 67.97 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.124 0.488 . . . . 0.0 110.98 176.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -80.96 -31.25 34.93 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.789 -176.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 34' ' ' LEU . 3.8 p -75.25 -28.99 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 N-CA-C 109.411 -0.589 . . . . 0.0 109.411 -179.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 34' ' ' LEU . 29.6 mm -62.12 -51.76 68.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 176.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -65.45 -17.56 64.64 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.257 -179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -88.07 -60.08 2.06 Favored 'General case' 0 N--CA 1.415 -2.21 0 O-C-N 122.15 -0.344 . . . . 0.0 110.784 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 75.7 mt -66.12 -42.7 91.81 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.438 0 CA-C-O 121.354 0.597 . . . . 0.0 111.303 -175.362 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.536 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 58.2 m-85 -79.4 -17.76 53.7 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -173.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 68.4 m -74.28 -3.71 31.73 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.388 0.613 . . . . 0.0 111.397 175.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 29.4 mmmt -84.05 -3.39 58.02 Favored 'General case' 0 N--CA 1.438 -1.035 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 177.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -113.16 9.64 18.52 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.319 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 126.62 -162.53 20.76 Favored Glycine 0 N--CA 1.44 -1.065 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 -179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 14.5 ttmm -94.5 133.27 38.29 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.277 0.539 . . . . 0.0 111.619 -179.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 28.1 mm -74.44 95.23 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.127 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 177.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.426 ' OG1' ' HA ' ' A' ' 68' ' ' TYR . 1.2 p -80.55 -34.64 35.27 Favored 'General case' 0 N--CA 1.422 -1.835 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.379 -179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.414 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 63.3 t30 -152.19 147.22 26.15 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 176.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -138.91 149.96 45.39 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.991 -0.443 . . . . 0.0 110.177 -177.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 81.2 m-85 -136.65 107.2 6.51 Favored 'General case' 0 C--N 1.312 -1.031 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.464 ' HB3' ' HE2' ' A' ' 61' ' ' LYS . 2.4 m-85 -107.37 104.83 54.04 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.661 -1.236 . . . . 0.0 107.661 174.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.55 ' O ' ' HE3' ' A' ' 61' ' ' LYS . 73.4 Cg_endo -83.89 159.19 13.87 Favored 'Trans proline' 0 N--CA 1.436 -1.882 0 C-N-CA 120.921 1.081 . . . . 0.0 110.19 176.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.502 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 20.1 pt-20 -173.98 -176.78 1.24 Allowed 'General case' 0 C--N 1.285 -2.204 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 -175.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.72 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 41.7 mt-10 -138.76 133.59 32.37 Favored 'General case' 0 C--N 1.279 -2.472 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 172.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 54.6 25.28 6.17 Favored 'General case' 0 N--CA 1.49 1.525 0 C-N-CA 123.778 0.831 . . . . 0.0 112.259 175.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 58.7 23.07 54.85 Favored Glycine 0 CA--C 1.549 2.181 0 C-N-CA 120.914 -0.66 . . . . 0.0 113.297 -174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.72 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 56.6 pttt -97.37 -177.05 3.69 Favored 'General case' 0 C--O 1.247 0.959 0 CA-C-N 117.667 0.733 . . . . 0.0 110.618 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 11.0 m -56.95 92.26 0.01 OUTLIER 'General case' 0 C--O 1.252 1.189 0 N-CA-C 115.024 1.49 . . . . 0.0 115.024 -175.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.55 ' HE3' ' O ' ' A' ' 54' ' ' PRO . 6.9 ptpp? -64.33 166.01 8.76 Favored 'General case' 0 N--CA 1.437 -1.115 0 C-N-CA 125.735 1.614 . . . . 0.0 110.072 170.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -133.04 14.66 4.88 Favored Glycine 0 C--N 1.305 -1.173 0 C-N-CA 119.592 -1.289 . . . . 0.0 113.229 -179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 15.0 p90 -170.66 152.46 3.81 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 176.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 30.5 pt -145.53 167.1 9.57 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 175.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.405 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 80.8 m-85 -128.88 136.15 50.05 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.2 0.524 . . . . 0.0 109.682 -179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 3.6 mm? -115.67 118.26 32.58 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 176.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.414 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 13.4 tp10 -103.52 122.08 44.19 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -176.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.536 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 21.3 m-85 -126.95 164.75 20.77 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.769 0.795 . . . . 0.0 111.952 -177.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -107.66 13.58 26.46 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 114.135 -1.393 . . . . 0.0 107.605 172.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.493 ' HB3' ' CD2' ' A' ' 73' ' ' HIS . 38.6 t -75.03 158.31 84.48 Favored Pre-proline 0 CA--C 1.585 2.319 0 C-N-CA 125.344 1.457 . . . . 0.0 113.469 -171.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -37.48 8.71 0.0 OUTLIER 'Trans proline' 0 N--CA 1.516 2.836 1 C-N-CA 130.31 7.34 . . . . 0.0 121.057 175.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.418 ' HB1' ' CG2' ' A' ' 75' ' ' VAL . . . 84.84 62.21 0.01 OUTLIER 'General case' 0 CA--C 1.49 -1.363 0 CA-C-O 125.026 2.346 . . . . 0.0 108.058 -166.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.626 ' HE2' ' HA ' ' A' ' 16' ' ' SER . 14.3 p80 -72.41 -36.26 68.6 Favored 'General case' 0 C--N 1.291 -1.969 0 CA-C-N 109.261 -3.608 . . . . 0.0 110.83 -176.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 15' ' ' ASP . . . -74.21 -33.33 63.36 Favored 'General case' 0 CA--C 1.499 -1.009 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 -179.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.418 ' CG2' ' HB1' ' A' ' 72' ' ' ALA . 84.4 t -64.73 -42.88 96.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 114.221 -1.354 . . . . 0.0 108.301 175.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -68.3 -41.85 80.31 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.768 179.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.88 -50.47 73.22 Favored 'General case' 0 CA--C 1.515 -0.373 0 C-N-CA 123.437 0.695 . . . . 0.0 111.415 178.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 78.4 t -61.67 -32.39 53.61 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.644 0 C-N-CA 123.536 0.734 . . . . 0.0 110.461 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -76.17 -38.11 57.05 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.209 178.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.86 -63.68 1.19 Allowed 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 -172.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -129.25 103.34 6.89 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-O 121.392 0.615 . . . . 0.0 111.926 -169.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.54 ' HB2' HG22 ' A' ' 94' ' ' VAL . 12.0 t0 -130.08 140.77 50.78 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-N 114.583 -1.189 . . . . 0.0 108.662 176.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 70.04 46.07 53.37 Favored Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -101.59 125.27 48.22 Favored 'General case' 0 N--CA 1.414 -2.227 0 CA-C-O 121.538 0.685 . . . . 0.0 110.418 -178.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.408 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.91 129.0 45.23 Favored 'General case' 0 C--N 1.297 -1.709 0 CA-C-N 114.504 -1.225 . . . . 0.0 112.198 -174.658 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 53.8 mt -86.6 -59.83 2.16 Favored 'General case' 0 C--N 1.301 -1.513 0 CA-C-N 115.05 -0.977 . . . . 0.0 109.495 175.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -162.6 151.4 14.87 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 -175.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 30.7 mtpp 40.24 -95.56 0.02 OUTLIER 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 11.0 pm0 -110.43 3.46 19.7 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.858 -0.526 . . . . 0.0 110.842 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.617 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 12.1 m170 -80.7 89.16 5.74 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -175.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.2 m -133.23 115.31 14.82 Favored 'General case' 0 C--N 1.268 -2.967 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 -179.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -85.54 116.18 23.69 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.56 -175.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 3.5 mpt_? -91.42 121.63 33.3 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.829 -1.915 . . . . 0.0 105.829 172.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.54 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.7 m -103.5 148.85 7.95 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -175.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.504 HD22 ' C ' ' A' ' 95' ' ' ASN . 0.1 OUTLIER -149.19 178.34 8.83 Favored 'General case' 0 C--N 1.287 -2.115 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 169.914 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.5 pt? -87.87 -173.02 4.1 Favored 'General case' 0 C--N 1.288 -2.09 0 O-C-N 123.437 0.46 . . . . 0.0 112.211 -174.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 57.7 t80 -119.04 -20.13 8.19 Favored 'General case' 0 N--CA 1.427 -1.599 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.45 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 25.8 m -73.65 68.78 1.24 Allowed 'General case' 0 CA--C 1.551 0.999 0 CA-C-O 122.287 1.041 . . . . 0.0 110.889 175.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -91.55 -18.41 24.14 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 106.168 -1.79 . . . . 0.0 106.168 174.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -59.11 143.35 48.95 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.145 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -81.8 81.07 7.94 Favored 'General case' 0 N--CA 1.424 -1.759 0 CA-C-O 122.148 0.975 . . . . 0.0 108.627 177.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.475 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.2 OUTLIER -50.42 146.89 4.87 Favored 'General case' 0 C--N 1.289 -2.028 0 CA-C-N 112.454 -2.157 . . . . 0.0 111.136 174.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -80.18 122.3 26.66 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -82.42 126.5 32.27 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.083 0.468 . . . . 0.0 109.793 -175.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.7 m . . . . . 0 C--N 1.296 -1.755 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.714 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.699 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -96.12 154.35 17.29 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.91 29.25 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 -171.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mp -100.62 -48.98 4.33 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 72.3 mttt -96.4 -3.23 43.98 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 -177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 100' ' ' PHE . 3.9 p-10 -78.37 28.62 0.19 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.817 0.818 . . . . 0.0 112.568 -171.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 13.1 ptp180 -111.08 164.99 13.58 Favored Pre-proline 0 C--N 1.285 -2.196 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -177.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -63.61 128.23 21.77 Favored 'Trans proline' 0 N--CA 1.457 -0.619 0 N-CA-C 106.98 -1.969 . . . . 0.0 106.98 169.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.79 159.4 25.52 Favored 'General case' 0 C--N 1.297 -1.701 0 C-N-CA 119.119 -1.032 . . . . 0.0 113.353 -169.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -85.45 19.8 2.24 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.223 -1.353 . . . . 0.0 109.029 178.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.49 120.96 9.16 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.052 -0.976 . . . . 0.0 112.185 -172.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -70.89 121.85 18.86 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 177.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 98' ' ' THR . . . -62.41 94.43 0.1 Allowed Glycine 0 C--N 1.305 -1.151 0 N-CA-C 116.714 1.445 . . . . 0.0 116.714 -171.574 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.8 tp -97.06 89.35 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.623 0 CA-C-O 122.807 1.289 . . . . 0.0 107.766 170.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.679 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 14.0 t70 -92.85 -2.51 55.82 Favored 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 113.563 -1.653 . . . . 0.0 110.611 -173.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.686 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 30.3 t -92.34 -6.28 50.51 Favored 'General case' 0 C--N 1.275 -2.673 0 C-N-CA 119.956 -0.697 . . . . 0.0 112.283 -172.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 60.4 t -120.73 115.37 46.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 C-N-CA 120.6 -0.44 . . . . 0.0 110.897 -176.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.452 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 20.4 mm -93.59 143.41 11.62 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.003 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.66 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 98.0 t -121.0 123.5 70.23 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 174.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.431 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 79.7 t -119.15 139.88 44.99 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.727 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -176.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 20.2 t70 -107.21 145.9 32.07 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 123.043 0.537 . . . . 0.0 110.714 178.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.506 0.2 OUTLIER 31.68 104.76 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 117.985 2.587 . . . . 0.0 117.985 -174.931 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.523 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 27.1 m -107.98 177.22 1.34 Allowed Pre-proline 0 CA--C 1.562 1.418 0 CA-C-N 113.311 -1.768 . . . . 0.0 110.739 -175.145 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.669 ' HA ' ' CE1' ' A' ' 90' ' ' HIS . 5.0 Cg_exo -43.89 138.21 6.32 Favored 'Trans proline' 0 C--N 1.379 2.147 0 C-N-CA 123.828 3.019 . . . . 0.0 112.725 170.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.481 ' HA ' HG21 ' A' ' 60' ' ' THR . 0.1 OUTLIER -88.41 172.23 9.53 Favored 'General case' 0 N--CA 1.435 -1.187 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.777 -175.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 31' ' ' LEU . 14.1 p -117.39 142.51 31.15 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-O 122.132 0.968 . . . . 0.0 111.747 -177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -120.77 155.52 16.23 Favored Glycine 0 N--CA 1.414 -2.804 1 N-CA-C 102.657 -4.177 . . . . 0.0 102.657 165.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -48.84 125.22 12.51 Favored 'Trans proline' 0 C--O 1.25 1.111 0 CA-C-N 121.224 2.512 . . . . 0.0 114.136 -172.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 27.9 t70 56.68 24.74 9.27 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 126.107 1.763 . . . . 0.0 111.879 178.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -98.46 -15.49 19.59 Favored 'General case' 0 CA--C 1.51 -0.572 0 O-C-N 121.738 -0.601 . . . . 0.0 111.407 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' HB2' HG23 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -79.55 -18.2 52.32 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 120.351 -0.539 . . . . 0.0 109.855 -174.08 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -57.3 -42.72 82.31 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 111.623 0.231 . . . . 0.0 111.623 -178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.3 ptpt -78.24 -29.64 48.29 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 119.759 -0.776 . . . . 0.0 110.376 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.603 ' O ' HG12 ' A' ' 38' ' ' ILE . 94.8 mt -69.27 -27.01 65.05 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.339 -177.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 34.9 mmtm -59.57 -39.75 85.11 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 121.699 0.761 . . . . 0.0 110.216 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -84.08 -28.23 27.69 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.226 -171.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.418 HG12 ' O ' ' A' ' 34' ' ' LEU . 7.3 p -70.56 -32.68 50.51 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.145 0 C-N-CA 120.322 -0.551 . . . . 0.0 110.347 -179.169 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.603 HG12 ' O ' ' A' ' 34' ' ' LEU . 43.2 mm -59.6 -53.1 53.05 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.454 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 15.4 t60 -53.61 -35.38 60.84 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 115.019 -0.992 . . . . 0.0 110.569 -178.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -79.93 -42.22 24.5 Favored 'General case' 0 N--CA 1.442 -0.873 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.416 HG12 ' O ' ' A' ' 37' ' ' VAL . 45.8 mm -64.77 -42.88 96.17 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.711 0 CA-C-O 121.918 0.866 . . . . 0.0 109.68 178.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -76.88 -6.69 53.45 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.029 -176.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 22.8 t -73.02 -6.76 47.66 Favored 'General case' 0 CA--C 1.551 0.985 0 CA-C-O 121.271 0.557 . . . . 0.0 109.632 176.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -71.5 -28.15 63.71 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 120.9 0.381 . . . . 0.0 110.273 175.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -85.71 -15.14 43.18 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.23 0.538 . . . . 0.0 111.058 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 155.18 -162.99 31.28 Favored Glycine 0 N--CA 1.432 -1.613 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.2 tttm -96.11 129.13 43.48 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 107.406 -1.331 . . . . 0.0 107.406 178.462 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.489 HD13 ' CE2' ' A' ' 68' ' ' TYR . 24.0 mm -73.03 109.49 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.038 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 -178.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 18.7 m -81.88 -48.64 11.28 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.519 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 37.2 m-20 -134.75 144.21 47.58 Favored 'General case' 0 CA--C 1.503 -0.845 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 175.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.477 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 3.6 p30 -137.04 132.72 34.59 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-O 121.557 0.694 . . . . 0.0 110.902 175.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -125.31 97.77 5.35 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.233 -179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.477 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 2.5 m-85 -108.63 104.9 55.81 Favored Pre-proline 0 N--CA 1.416 -2.129 0 N-CA-C 105.591 -2.003 . . . . 0.0 105.591 173.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.747 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 80.8 Cg_endo -83.88 170.8 11.01 Favored 'Trans proline' 0 N--CA 1.428 -2.332 0 C-N-CA 120.932 1.088 . . . . 0.0 110.462 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' OE2' ' HA ' ' A' ' 60' ' ' THR . 1.0 OUTLIER -139.22 162.54 34.72 Favored 'General case' 0 N--CA 1.388 -3.575 0 N-CA-C 104.088 -2.56 . . . . 0.0 104.088 175.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.652 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 40.2 mt-10 -134.04 103.56 5.85 Favored 'General case' 0 C--N 1.28 -2.437 0 C-N-CA 120.319 -0.553 . . . . 0.0 109.566 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 62.9 27.6 16.04 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.785 0.802 . . . . 0.0 111.998 177.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.32 -4.83 85.92 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.352 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.652 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 62.2 pttt -103.26 171.51 7.33 Favored 'General case' 0 N--CA 1.432 -1.363 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 176.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 25' ' ' GLN . 11.3 t -79.25 141.54 37.0 Favored 'General case' 0 N--CA 1.413 -2.311 0 CA-C-O 122.741 1.258 . . . . 0.0 113.108 -173.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.747 ' HD3' ' O ' ' A' ' 54' ' ' PRO 0.27 9.6 pttm -59.49 176.26 0.27 Allowed 'General case' 0 C--N 1.282 -2.342 0 CA-C-N 112.036 -2.347 . . . . 0.0 109.478 167.06 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -130.64 20.91 4.82 Favored Glycine 0 C--N 1.288 -2.097 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 175.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 52.3 p90 -169.28 160.28 9.41 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -176.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 29.1 pt -147.09 171.98 3.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.924 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -133.92 136.94 44.59 Favored 'General case' 0 C--O 1.245 0.846 0 O-C-N 123.952 0.783 . . . . 0.0 109.504 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD12 HD12 ' A' ' 48' ' ' ILE . 2.4 mm? -124.53 138.74 54.31 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 -179.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.646 ' HA ' ' O ' ' A' ' 16' ' ' SER . 41.8 mt-10 -126.43 129.99 49.81 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 109.452 -0.574 . . . . 0.0 109.452 172.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.567 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 19.1 m-85 -125.98 170.78 11.36 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.32 14.24 12.89 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 107.602 -1.258 . . . . 0.0 107.602 173.657 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.495 ' HB3' ' HD2' ' A' ' 71' ' ' PRO . 39.4 m -73.27 168.02 29.03 Favored Pre-proline 0 CA--C 1.589 2.447 0 CA-C-N 113.493 -1.685 . . . . 0.0 114.633 -173.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 5.7 Cg_exo -35.52 9.27 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.358 2 C-N-CA 130.624 7.549 . . . . 0.0 123.08 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.679 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.11 65.2 0.01 OUTLIER 'General case' 0 CA--C 1.473 -2.016 0 CA-C-O 124.788 2.232 . . . . 0.0 106.867 -160.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.686 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 21.2 p-80 -82.17 -36.49 27.3 Favored 'General case' 0 N--CA 1.423 -1.79 0 CA-C-N 108.995 -3.729 . . . . 0.0 111.98 -171.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HB1' HD21 ' A' ' 96' ' ' LEU . . . -70.1 -37.49 75.41 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 119.108 -1.037 . . . . 0.0 108.386 175.441 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.586 HG23 ' OD1' ' A' ' 15' ' ' ASP . 94.3 t -56.07 -48.42 78.99 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-N 114.905 -1.043 . . . . 0.0 108.489 171.268 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.443 ' HA ' ' HD3' ' A' ' 79' ' ' LYS . 3.1 t70 -65.7 -35.71 81.53 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.279 -175.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.11 -50.94 69.91 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 122.412 0.285 . . . . 0.0 110.888 177.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 84.0 t -64.1 -37.79 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.494 0 C-N-CA 123.725 0.81 . . . . 0.0 109.706 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.443 ' HD3' ' HA ' ' A' ' 76' ' ' ASP . 77.4 tttt -59.79 -36.46 76.76 Favored 'General case' 0 C--N 1.313 -1.009 0 C-N-CA 125.414 1.485 . . . . 0.0 111.517 176.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -81.96 -77.31 0.23 Allowed 'General case' 0 CA--C 1.501 -0.906 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -177.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.32 113.01 3.86 Favored 'General case' 0 N--CA 1.431 -1.377 0 C-N-CA 120.068 -0.653 . . . . 0.0 112.084 -172.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.528 ' HB2' HG22 ' A' ' 94' ' ' VAL . 2.9 t70 -94.74 133.68 38.16 Favored 'General case' 0 C--N 1.286 -2.168 0 CA-C-N 114.887 -1.051 . . . . 0.0 108.916 171.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 72.9 48.81 19.52 Favored Glycine 0 N--CA 1.431 -1.661 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.404 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 17.2 p90 -88.94 125.36 34.93 Favored 'General case' 0 N--CA 1.433 -1.308 0 C-N-CA 120.146 -0.622 . . . . 0.0 109.791 178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.512 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.4 OUTLIER -103.35 129.27 50.36 Favored 'General case' 0 N--CA 1.425 -1.691 0 CA-C-N 115.273 -0.876 . . . . 0.0 111.487 -172.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 65.8 mt -86.28 -66.85 0.86 Allowed 'General case' 0 C--N 1.29 -1.982 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 175.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.8 t0 -167.67 -173.81 2.28 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 105.195 -2.15 . . . . 0.0 105.195 -177.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 38.23 -103.54 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.846 1.425 . . . . 0.0 114.846 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -121.54 8.42 10.12 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.774 -0.825 . . . . 0.0 108.774 -177.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.669 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 4.8 m-70 -87.28 91.74 8.83 Favored 'General case' 0 CA--C 1.489 -1.391 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.359 -170.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.48 HG23 ' HB3' ' A' ' 85' ' ' LYS . 5.9 m -133.44 105.0 6.68 Favored 'General case' 0 C--N 1.265 -3.089 0 N-CA-C 107.36 -1.348 . . . . 0.0 107.36 178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -82.61 101.17 10.62 Favored 'General case' 0 C--N 1.282 -2.356 0 C-N-CA 120.253 -0.579 . . . . 0.0 110.626 -172.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -87.34 137.36 32.41 Favored 'General case' 0 CA--C 1.484 -1.593 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 175.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.528 HG22 ' HB2' ' A' ' 82' ' ' ASP . 5.4 m -105.01 134.55 46.14 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.046 0 O-C-N 123.944 0.778 . . . . 0.0 109.991 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.66 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -148.06 144.12 27.67 Favored 'General case' 0 CA--C 1.471 -2.064 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 169.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.467 HD21 ' HB1' ' A' ' 74' ' ' ALA . 3.6 mp -109.96 -178.89 3.64 Favored 'General case' 0 C--N 1.265 -3.091 0 N-CA-C 115.888 1.81 . . . . 0.0 115.888 173.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -81.99 -44.77 16.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 105.137 -2.172 . . . . 0.0 105.137 171.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.522 HG21 ' HA2' ' A' ' 13' ' ' GLY . 17.9 m -94.66 73.49 3.68 Favored 'General case' 0 N--CA 1.424 -1.758 0 N-CA-C 105.9 -1.889 . . . . 0.0 105.9 168.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -84.64 -28.46 26.44 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 122.378 1.085 . . . . 0.0 109.046 -177.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 6' ' ' ASP . 89.2 m-85 -92.77 88.35 6.2 Favored 'General case' 0 N--CA 1.42 -1.95 0 CA-C-N 114.754 -1.112 . . . . 0.0 109.743 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -70.42 -24.31 62.89 Favored 'General case' 0 CA--C 1.509 -0.6 0 CA-C-N 114.745 -1.116 . . . . 0.0 108.834 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.533 ' HD3' ' H ' ' A' ' 102' ' ' LYS . 0.0 OUTLIER -68.89 135.26 50.79 Favored 'General case' 0 N--CA 1.406 -2.634 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.556 173.413 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 38.4 p90 -129.3 169.96 14.2 Favored 'General case' 0 C--N 1.275 -2.651 0 CA-C-N 114.815 -1.084 . . . . 0.0 110.617 -170.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.6 tpt -61.39 101.43 0.17 Allowed 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.436 1.085 . . . . 0.0 108.279 -179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.424 -1.731 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.017 -174.831 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.502 -0.742 0 N-CA-C 110.818 -0.913 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -96.28 150.41 20.58 Favored 'General case' 0 CA--C 1.492 -1.26 0 CA-C-O 121.346 0.593 . . . . 0.0 109.956 178.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 6' ' ' ASP . 13.0 p -146.94 12.25 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.27 -2.857 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.888 -177.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.6 mp -98.76 -53.41 3.3 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 115.263 -0.881 . . . . 0.0 108.752 -178.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.6 mppt? -92.5 -38.19 12.08 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 175.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 3' ' ' VAL . 22.4 t70 -86.02 76.85 9.76 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 174.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 12.5 ptm85 -121.34 163.4 30.52 Favored Pre-proline 0 C--N 1.288 -2.088 0 CA-C-N 114.09 -1.414 . . . . 0.0 112.249 -167.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -80.99 169.22 16.53 Favored 'Trans proline' 0 N--CA 1.444 -1.432 0 C-N-CA 122.074 1.85 . . . . 0.0 108.656 167.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.521 ' NE2' ' H ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -77.54 151.03 34.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 178.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.521 ' H ' ' NE2' ' A' ' 9' ' ' GLN . 2.4 mp0 -74.8 -20.7 59.68 Favored 'General case' 0 C--N 1.304 -1.393 0 CA-C-O 120.726 0.298 . . . . 0.0 111.625 -174.154 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.24 91.39 3.77 Favored 'General case' 0 N--CA 1.432 -1.333 0 CA-C-O 121.506 0.67 . . . . 0.0 109.307 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -142.11 116.72 9.72 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-N 114.786 -1.097 . . . . 0.0 109.786 176.158 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 168.35 -53.22 0.22 Allowed Glycine 0 C--N 1.274 -2.908 0 N-CA-C 107.024 -2.43 . . . . 0.0 107.024 -177.089 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.0 tp -145.37 123.7 5.16 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.375 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 172.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.523 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 12.2 t70 -128.45 -17.43 4.18 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.8 175.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 25.4 m -98.4 7.28 46.4 Favored 'General case' 0 C--N 1.309 -1.181 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -173.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.4 t -146.17 124.61 4.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.535 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 26.3 mm -86.13 136.17 23.45 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.327 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.695 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 89.4 t -129.9 103.32 8.39 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.952 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 174.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.402 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 3.0 m -96.74 120.47 46.12 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.703 0 CA-C-N 114.192 -1.367 . . . . 0.0 110.572 178.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 25.5 t70 -79.72 140.16 37.07 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.53 -1.214 . . . . 0.0 109.917 -178.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.44 HD22 ' C ' ' A' ' 21' ' ' ASP 0.427 0.1 OUTLIER 44.27 90.57 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 C-N-CA 127.209 2.203 . . . . 0.0 114.552 -177.295 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.488 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 26.8 m -100.94 167.68 10.4 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.046 -1.888 . . . . 0.0 109.893 -177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 6.1 Cg_exo -42.47 126.9 4.18 Favored 'Trans proline' 0 C--N 1.37 1.665 0 C-N-CA 123.77 2.98 . . . . 0.0 114.692 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.508 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.0 OUTLIER -91.02 149.0 22.01 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-N 113.459 -1.701 . . . . 0.0 108.337 178.28 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.643 HG22 ' O ' ' A' ' 27' ' ' GLY . 6.5 p -101.59 147.54 8.35 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.173 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 -169.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.643 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -105.14 171.61 18.93 Favored Glycine 0 C--N 1.304 -1.245 0 N-CA-C 106.21 -2.756 . . . . 0.0 106.21 168.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -60.05 125.69 18.29 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 CA-C-N 121.101 2.45 . . . . 0.0 112.275 -176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 57.4 31.37 20.09 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.842 1.257 . . . . 0.0 113.792 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -109.73 1.02 19.17 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 120.282 -0.567 . . . . 0.0 112.22 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -62.14 -32.26 72.83 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 -176.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -45.23 -49.34 12.43 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 125.029 1.332 . . . . 0.0 111.211 174.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.2 mttm -79.08 -31.85 44.49 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-N 114.468 -1.242 . . . . 0.0 109.531 -172.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.48 ' O ' HG12 ' A' ' 38' ' ' ILE . 82.1 mt -72.06 -35.22 69.24 Favored 'General case' 0 N--CA 1.426 -1.629 0 CA-C-N 114.819 -1.082 . . . . 0.0 111.194 -176.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -78.31 -20.83 50.67 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 119.593 -0.843 . . . . 0.0 111.109 177.268 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.515 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 49.6 t-20 -78.08 -37.8 45.68 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -176.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.447 HG12 ' O ' ' A' ' 34' ' ' LEU . 8.8 p -66.41 -31.09 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.435 179.312 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.48 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.9 mm -61.7 -49.88 82.5 Favored 'Isoleucine or valine' 0 C--N 1.344 0.369 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 175.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 28.9 t-80 -63.04 -19.92 64.84 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.73 -1.123 . . . . 0.0 111.328 -178.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.515 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 66.4 mttm -88.13 -60.01 2.08 Favored 'General case' 0 C--N 1.31 -1.133 0 O-C-N 121.62 -0.675 . . . . 0.0 111.307 175.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.4 mm -63.19 -43.74 98.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.011 -174.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -78.37 -14.75 59.26 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 66.3 m -75.76 -3.05 32.74 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.117 0.484 . . . . 0.0 111.308 178.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -79.32 -20.95 46.64 Favored 'General case' 0 N--CA 1.443 -0.809 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.88 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -88.28 -15.03 36.88 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.639 177.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 148.82 -154.17 25.66 Favored Glycine 0 N--CA 1.43 -1.708 0 C-N-CA 120.08 -1.057 . . . . 0.0 112.778 178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.1 ttmt -85.65 120.67 27.34 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 122.26 0.224 . . . . 0.0 110.602 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.6 mm -73.85 91.53 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.075 0 N-CA-C 105.949 -1.871 . . . . 0.0 105.949 176.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.4 m -78.15 -52.66 8.37 Favored 'General case' 0 N--CA 1.419 -1.988 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.321 -174.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.446 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 85.9 m-20 -136.05 139.47 43.08 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 175.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -144.71 128.72 17.52 Favored 'General case' 0 C--N 1.291 -1.957 0 CA-C-O 121.55 0.691 . . . . 0.0 109.671 -178.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -127.75 116.01 19.56 Favored 'General case' 0 C--N 1.291 -1.937 0 CA-C-N 115.162 -0.926 . . . . 0.0 109.258 -173.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -107.9 105.18 55.72 Favored Pre-proline 0 C--N 1.304 -1.392 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 176.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.488 ' O ' ' HB3' ' A' ' 61' ' ' LYS . 96.5 Cg_endo -85.74 174.31 6.7 Favored 'Trans proline' 0 C--N 1.324 -0.725 0 C-N-CA 122.323 2.015 . . . . 0.0 110.72 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.487 ' HA ' ' O ' ' A' ' 60' ' ' THR . 12.3 pt-20 -102.08 177.75 4.8 Favored 'General case' 0 C--N 1.303 -1.429 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 174.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -162.2 114.85 1.73 Allowed 'General case' 0 C--N 1.31 -1.112 0 C-N-CA 119.808 -0.757 . . . . 0.0 111.154 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 60.19 28.48 18.07 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 124.859 1.264 . . . . 0.0 112.768 177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.87 1.96 72.6 Favored Glycine 0 C--N 1.305 -1.182 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.896 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -96.55 165.88 11.95 Favored 'General case' 0 CA--C 1.482 -1.647 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 55' ' ' GLU . 3.4 t -53.64 -54.55 36.12 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 124.885 1.366 . . . . 0.0 111.677 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HB3' ' O ' ' A' ' 54' ' ' PRO . 0.1 OUTLIER 179.87 167.92 1.23 Allowed 'General case' 0 N--CA 1.428 -1.568 0 C-N-CA 124.915 1.286 . . . . 0.0 108.29 179.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -134.09 -6.32 2.52 Favored Glycine 0 C--N 1.297 -1.619 0 N-CA-C 110.915 -0.874 . . . . 0.0 110.915 177.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.402 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 20.3 p90 -167.68 156.62 9.69 Favored 'General case' 0 N--CA 1.431 -1.406 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 -176.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 26.5 pt -137.34 163.72 30.92 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 177.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -113.3 129.71 56.45 Favored 'General case' 0 C--N 1.31 -1.129 0 O-C-N 123.807 0.692 . . . . 0.0 110.264 -177.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.535 ' HB2' ' HB ' ' A' ' 18' ' ' ILE . 2.3 mm? -118.98 126.5 51.89 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 175.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 38.0 tt0 -121.69 119.31 31.43 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 176.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.604 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 87.6 m-85 -99.98 177.85 4.98 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.609 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -79.57 -15.82 56.99 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.198 1.184 . . . . 0.0 114.198 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.3 m -119.51 167.31 12.41 Favored Pre-proline 0 C--N 1.291 -1.977 0 N-CA-C 104.704 -2.332 . . . . 0.0 104.704 177.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.426 ' O ' ' N ' ' A' ' 73' ' ' HIS . 4.9 Cg_exo -77.46 -55.57 0.05 OUTLIER 'Trans proline' 0 C--O 1.176 -2.623 0 CA-C-N 123.887 2.424 . . . . 0.0 108.568 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.31 7.78 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 131.287 3.835 . . . . 0.0 121.307 142.128 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.604 ' CD2' ' HB2' ' A' ' 68' ' ' TYR . 31.1 p80 -125.28 -36.71 2.47 Favored 'General case' 1 C--N 1.241 -4.125 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.681 -165.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . . . -81.42 -22.82 37.97 Favored 'General case' 0 N--CA 1.383 -3.793 0 C-N-CA 119.251 -0.979 . . . . 0.0 108.644 -179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.2 p -77.5 -23.14 14.28 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.785 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 172.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -83.52 -33.88 25.41 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.33 -52.4 63.81 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.337 177.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.7 m -60.78 -32.49 52.16 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 CA-C-O 121.213 0.53 . . . . 0.0 110.838 179.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 29.7 ttmt -67.49 -44.3 78.84 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 124.154 0.982 . . . . 0.0 111.406 178.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.6 m-80 -91.77 -52.4 4.76 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -146.2 104.74 3.83 Favored 'General case' 0 N--CA 1.439 -1.024 0 CA-C-O 121.207 0.527 . . . . 0.0 112.305 -173.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.473 ' HB2' HG22 ' A' ' 94' ' ' VAL . 2.6 p30 -114.44 136.41 53.03 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 174.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.0 51.03 61.36 Favored Glycine 0 CA--C 1.509 -0.298 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.9 p90 -96.76 124.17 40.67 Favored 'General case' 0 N--CA 1.427 -1.603 0 CA-C-O 121.733 0.778 . . . . 0.0 111.768 -175.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -97.89 118.57 34.75 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 114.518 -1.219 . . . . 0.0 111.623 -176.7 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 40.2 mt -86.75 -52.92 5.23 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 175.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.414 ' H ' ' HB2' ' A' ' 90' ' ' HIS . 16.1 m-20 -145.42 -168.62 3.01 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-N 114.081 -1.418 . . . . 0.0 108.172 -174.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 38.6 ttpt -44.16 -69.81 0.12 Allowed 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.925 1.29 . . . . 0.0 114.195 -176.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.508 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -100.18 11.26 39.79 Favored 'General case' 0 C--N 1.313 -0.98 0 C-N-CA 120.079 -0.648 . . . . 0.0 111.674 -176.538 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.414 ' HB2' ' H ' ' A' ' 87' ' ' ASP . 14.8 m170 -102.45 86.97 2.9 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 176.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 11.9 m -135.29 94.09 3.07 Favored 'General case' 0 C--N 1.276 -2.628 0 CA-C-O 120.708 0.29 . . . . 0.0 110.277 177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -82.43 105.55 13.58 Favored 'General case' 0 C--N 1.28 -2.441 0 C-N-CA 120.35 -0.54 . . . . 0.0 111.972 -168.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.522 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.1 mpt_? -83.45 141.96 31.3 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 172.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 82' ' ' ASP . 34.5 m -100.23 114.28 38.38 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.183 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 -176.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.695 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -154.78 -165.58 2.09 Favored 'General case' 0 C--O 1.215 -0.731 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -179.688 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.418 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.1 pt? -104.29 -173.04 2.21 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.005 0.431 . . . . 0.0 112.046 178.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.416 ' CE2' HG23 ' A' ' 98' ' ' THR . 20.0 p90 -121.89 -22.98 5.57 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.429 0.633 . . . . 0.0 111.8 -176.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.416 HG23 ' CE2' ' A' ' 97' ' ' PHE . 2.2 p -91.94 -161.51 0.83 Allowed 'General case' 0 C--N 1.294 -1.805 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.121 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.4 ' H ' ' HB ' ' A' ' 98' ' ' THR . 13.3 t70 -91.46 -15.73 28.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.143 179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -59.14 66.52 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -174.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -123.82 75.25 1.33 Allowed 'General case' 0 C--N 1.298 -1.655 0 N-CA-C 105.386 -2.079 . . . . 0.0 105.386 172.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.8 mttp -87.95 -28.12 21.69 Favored 'General case' 0 CA--C 1.484 -1.574 0 CA-C-N 113.858 -1.519 . . . . 0.0 114.161 -172.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -80.26 86.75 5.61 Favored 'General case' 0 C--N 1.267 -3.014 0 CA-C-O 122.096 0.951 . . . . 0.0 112.505 -175.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 50.2 ttm -120.72 91.31 3.5 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 106.511 -1.662 . . . . 0.0 106.511 174.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 45.1 m . . . . . 0 C--N 1.296 -1.73 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -179.602 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.503 -0.689 0 N-CA-C 111.153 -0.779 . . . . 0.0 111.153 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.411 ' O ' HG22 ' A' ' 3' ' ' VAL . 5.5 p-10 -56.66 151.35 14.06 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 124.397 1.079 . . . . 0.0 111.353 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.411 HG22 ' O ' ' A' ' 2' ' ' ASP 0.286 5.4 m 67.23 -33.54 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.868 0 C-N-CA 127.54 2.336 . . . . 0.0 114.355 -179.788 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 88.4 mt -86.04 -50.38 7.08 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -96.05 20.53 10.01 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.262 0.625 . . . . 0.0 110.506 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -71.88 95.09 1.5 Allowed 'General case' 0 C--N 1.314 -0.945 0 CA-C-O 121.275 0.56 . . . . 0.0 109.688 -178.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 56.9 mtp180 -148.03 152.86 40.95 Favored Pre-proline 0 C--N 1.297 -1.694 0 CA-C-N 114.865 -1.062 . . . . 0.0 109.163 177.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -65.37 144.82 81.53 Favored 'Trans proline' 0 C--O 1.249 1.056 0 C-N-CA 121.814 1.676 . . . . 0.0 109.156 169.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.602 ' NE2' ' H ' ' A' ' 10' ' ' GLU . 0.0 OUTLIER -108.38 164.81 12.0 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 106.862 -1.533 . . . . 0.0 106.862 -179.134 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.602 ' H ' ' NE2' ' A' ' 9' ' ' GLN . 29.7 mm-40 -74.61 20.12 0.13 Allowed 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 123.798 0.839 . . . . 0.0 112.436 -175.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -77.79 97.42 5.21 Favored 'General case' 0 N--CA 1.431 -1.424 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.874 179.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -148.02 163.9 35.47 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 177.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.02 -81.28 1.75 Allowed Glycine 0 CA--C 1.492 -1.404 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 -175.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 tp -115.3 88.89 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.412 -2.338 0 CA-C-O 123.018 1.389 . . . . 0.0 108.867 173.046 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -118.74 31.21 6.77 Favored 'General case' 0 C--N 1.286 -2.195 0 CA-C-N 113.659 -1.61 . . . . 0.0 108.689 -176.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.473 ' O ' ' HA ' ' A' ' 67' ' ' GLU . 8.4 m -96.3 -11.88 25.27 Favored 'General case' 0 C--N 1.295 -1.774 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.229 -179.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.5 t -122.15 132.5 70.88 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.968 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.554 -172.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.481 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 30.1 mm -87.3 145.13 7.95 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 99.4 t -133.48 121.16 40.74 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.228 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.513 ' CG2' HG12 ' A' ' 64' ' ' ILE . 27.4 m -118.41 157.76 19.75 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.774 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.236 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -114.76 133.42 55.93 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 178.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 42.57 95.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 117.094 2.257 . . . . 0.0 117.094 179.801 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.463 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 28.7 m -91.21 167.04 16.76 Favored Pre-proline 0 N--CA 1.426 -1.637 0 CA-C-N 114.33 -1.305 . . . . 0.0 107.982 178.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.463 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 85.1 Cg_exo -42.44 138.94 3.14 Favored 'Trans proline' 0 CA--C 1.55 1.307 0 C-N-CA 123.985 3.124 . . . . 0.0 113.126 176.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HA ' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -71.56 153.23 42.31 Favored 'General case' 0 N--CA 1.444 -0.739 0 CA-C-N 115.78 -0.646 . . . . 0.0 109.804 -173.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.503 HG13 ' HB2' ' A' ' 30' ' ' ARG . 16.7 t -119.26 132.91 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.22 0 C-N-CA 118.483 -1.287 . . . . 0.0 110.476 -176.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -134.89 -131.91 3.12 Favored Glycine 0 C--N 1.274 -2.868 0 N-CA-C 106.672 -2.571 . . . . 0.0 106.672 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -72.36 125.23 10.56 Favored 'Trans proline' 0 N--CA 1.44 -1.639 0 CA-C-N 119.459 1.629 . . . . 0.0 111.447 177.002 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 55.9 18.04 2.83 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 126.131 1.772 . . . . 0.0 114.373 177.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.503 ' HB2' HG13 ' A' ' 26' ' ' VAL . 35.2 mmt180 -79.1 -25.87 43.0 Favored 'General case' 0 CA--C 1.492 -1.251 0 C-N-CA 120.076 -0.65 . . . . 0.0 110.076 -178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 31' ' ' LEU . 0.8 OUTLIER -73.86 -33.89 64.26 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -53.38 -58.33 7.48 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.169 -178.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 48.7 pttt -81.74 -15.68 53.55 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -179.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.612 ' O ' HG12 ' A' ' 38' ' ' ILE . 51.3 tp -63.3 -36.35 83.4 Favored 'General case' 0 C--O 1.22 -0.484 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 177.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 31.9 mmtp -56.7 -36.9 70.18 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.461 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 46.4 t30 -84.09 -40.92 17.69 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.32 -172.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG12 ' HA ' ' A' ' 34' ' ' LEU . 7.4 p -65.55 -31.88 55.77 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.025 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.356 -175.358 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.612 HG12 ' O ' ' A' ' 34' ' ' LEU . 32.9 mm -67.33 -54.6 22.52 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.466 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -58.82 -36.09 73.94 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.084 -176.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 49.0 mmtm -74.39 -47.28 35.0 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -178.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.615 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 35.3 mm -70.15 -39.24 76.8 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 C-N-CA 120.53 -0.468 . . . . 0.0 111.197 -179.322 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -82.23 -7.79 59.63 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -170.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 79.1 p -67.38 -22.74 65.54 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.3 ptpt -61.74 -28.4 69.4 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-O 121.53 0.681 . . . . 0.0 111.755 176.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 30.3 m-85 -85.46 -15.7 42.07 Favored 'General case' 0 C--N 1.296 -1.751 0 CA-C-N 115.391 -0.822 . . . . 0.0 111.1 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.508 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.76 176.19 23.45 Favored Glycine 0 N--CA 1.437 -1.27 0 N-CA-C 111.754 -0.539 . . . . 0.0 111.754 178.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 19.8 ttpp -74.81 125.04 27.95 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 38.7 mm -72.83 140.51 17.79 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 62.7 m -126.38 -61.22 1.22 Allowed 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.861 0.362 . . . . 0.0 110.831 -176.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 55.0 m-80 -122.23 140.63 52.37 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -133.53 138.81 46.25 Favored 'General case' 0 C--N 1.281 -2.4 0 CA-C-O 121.085 0.469 . . . . 0.0 110.446 -176.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.442 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 89.2 m-85 -134.2 98.88 4.24 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -107.32 104.77 53.77 Favored Pre-proline 0 N--CA 1.43 -1.438 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 178.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 64' ' ' ILE . 51.1 Cg_endo -82.47 174.08 10.08 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.713 1.609 . . . . 0.0 109.823 177.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.634 ' HB3' ' NZ ' ' A' ' 61' ' ' LYS . 19.9 pt-20 -160.48 179.26 8.76 Favored 'General case' 0 CA--C 1.477 -1.845 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 177.553 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.717 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 6.2 tp10 -121.12 108.79 14.23 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 -174.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 59.4 27.2 16.26 Favored 'General case' 0 CA--C 1.56 1.362 0 CA-C-O 121.932 0.872 . . . . 0.0 111.83 174.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 79.71 8.03 88.03 Favored Glycine 0 CA--C 1.529 0.933 0 CA-C-N 115.853 -0.612 . . . . 0.0 113.293 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.717 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 26.7 pttt -121.82 -176.8 3.41 Favored 'General case' 0 N--CA 1.429 -1.524 0 O-C-N 122.108 -0.642 . . . . 0.0 109.617 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.448 HG23 ' HA ' ' A' ' 25' ' ' GLN . 83.4 m -28.79 108.0 0.04 OUTLIER 'General case' 0 C--O 1.244 0.801 0 C-N-CA 126.199 1.8 . . . . 0.0 115.386 -175.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.634 ' NZ ' ' HB3' ' A' ' 55' ' ' GLU . 0.1 OUTLIER -84.78 156.37 21.41 Favored 'General case' 0 N--CA 1.421 -1.911 0 CA-C-N 113.394 -1.73 . . . . 0.0 108.354 176.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -122.57 8.59 9.44 Favored Glycine 0 C--N 1.302 -1.312 0 C-N-CA 119.07 -1.538 . . . . 0.0 113.442 -176.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -170.15 151.95 4.08 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 20' ' ' VAL . 20.7 pt -142.06 166.29 16.73 Favored 'Isoleucine or valine' 0 C--O 1.246 0.911 0 N-CA-C 108.342 -0.985 . . . . 0.0 108.342 177.104 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.481 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.3 m-85 -131.59 141.66 49.72 Favored 'General case' 0 C--N 1.314 -0.969 0 O-C-N 123.859 0.724 . . . . 0.0 109.048 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.629 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.3 mp -132.36 136.75 47.04 Favored 'General case' 0 C--O 1.198 -1.651 0 CA-C-N 116.279 -0.419 . . . . 0.0 109.934 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.512 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 42.0 tt0 -122.05 136.97 54.97 Favored 'General case' 0 C--N 1.296 -1.76 0 CA-C-O 121.15 0.5 . . . . 0.0 109.688 178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.41 ' HE1' ' CG1' ' A' ' 18' ' ' ILE . 76.0 m-85 -104.83 177.53 4.82 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.367 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -85.33 -16.62 39.37 Favored 'General case' 0 N--CA 1.469 0.497 0 CA-C-O 121.275 0.559 . . . . 0.0 111.369 -176.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.0 t -135.35 144.97 51.87 Favored Pre-proline 0 C--N 1.294 -1.84 1 N-CA-C 99.34 -4.318 . . . . 0.0 99.34 176.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 16' ' ' SER . 9.6 Cg_exo -69.91 -54.12 0.23 Allowed 'Trans proline' 0 N--CA 1.435 -1.956 0 CA-C-N 123.483 2.28 . . . . 0.0 109.57 -172.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.07 4.47 0.0 OUTLIER 'General case' 0 N--CA 1.522 3.158 1 C-N-CA 132.374 4.27 . . . . 0.0 120.133 144.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.508 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 95.8 m-70 -128.43 -36.36 1.9 Allowed 'General case' 1 C--N 1.223 -4.923 0 CA-C-O 121.326 0.584 . . . . 0.0 109.624 -170.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 78' ' ' VAL . . . -61.33 -32.1 71.97 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.517 176.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -66.76 -37.09 78.78 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.771 0 O-C-N 123.315 0.384 . . . . 0.0 111.305 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -80.39 -32.49 37.56 Favored 'General case' 0 CA--C 1.501 -0.918 0 C-N-CA 120.317 -0.553 . . . . 0.0 110.242 177.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.27 -52.61 61.34 Favored 'General case' 0 C--O 1.212 -0.911 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.764 177.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 74' ' ' ALA . 31.2 m -63.13 -27.78 43.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 -178.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.0 tttm -81.61 -21.81 38.08 Favored 'General case' 0 N--CA 1.427 -1.604 0 C-N-CA 123.9 0.88 . . . . 0.0 112.047 -178.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 45.1 m-80 -122.88 -23.96 4.91 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . . . -106.0 18.55 21.91 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 113.244 0.831 . . . . 0.0 113.244 -173.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.458 ' HA ' HG22 ' A' ' 94' ' ' VAL . 37.0 t70 -85.06 121.78 28.33 Favored 'General case' 0 C--N 1.307 -1.278 0 C-N-CA 118.157 -1.417 . . . . 0.0 114.056 -178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.58 60.5 2.47 Favored Glycine 0 C--N 1.305 -1.153 0 CA-C-N 113.909 -1.496 . . . . 0.0 113.537 175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.598 ' O ' ' HA ' ' A' ' 91' ' ' THR . 17.8 m-85 -103.27 105.51 15.81 Favored 'General case' 0 CA--C 1.477 -1.834 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 -179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -78.33 102.69 7.83 Favored 'General case' 0 N--CA 1.422 -1.84 0 CA-C-N 114.863 -1.062 . . . . 0.0 109.204 177.32 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 29.7 mt -80.01 -41.46 25.79 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -153.91 -171.74 3.99 Favored 'General case' 0 C--N 1.309 -1.176 0 N-CA-C 107.643 -1.243 . . . . 0.0 107.643 -178.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 1.8 tppp? -48.61 -58.32 4.89 Favored 'General case' 0 N--CA 1.438 -1.048 0 C-N-CA 125.594 1.558 . . . . 0.0 113.413 -173.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 16.7 pt20 -95.0 -4.55 46.37 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 119.722 -0.791 . . . . 0.0 112.203 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -107.53 101.42 10.76 Favored 'General case' 0 CA--C 1.493 -1.231 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.765 -172.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 37.1 m -133.55 117.78 17.51 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.285 176.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 70.8 m-85 -82.69 101.71 11.03 Favored 'General case' 0 CA--C 1.498 -1.039 0 C-N-CA 119.497 -0.881 . . . . 0.0 111.076 -173.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.424 ' HD2' ' O ' ' A' ' 91' ' ' THR . 3.6 mpt_? -86.87 131.15 34.19 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 173.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.458 HG22 ' HA ' ' A' ' 82' ' ' ASP . 25.6 m -117.75 149.11 20.16 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.026 0 C-N-CA 119.789 -0.764 . . . . 0.0 111.942 -175.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -158.72 -171.12 3.3 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.444 HD23 ' H ' ' A' ' 96' ' ' LEU . 0.5 OUTLIER -72.07 -175.4 1.47 Allowed 'General case' 0 C--N 1.314 -0.97 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 179.138 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -108.14 58.45 0.61 Allowed 'General case' 0 N--CA 1.413 -2.324 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 m -47.69 78.8 0.0 OUTLIER 'General case' 0 C--N 1.273 -2.731 0 CA-C-N 111.264 -2.698 . . . . 0.0 111.226 170.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -141.06 -45.7 0.39 Allowed 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 177.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -101.21 20.6 15.43 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 122.188 0.994 . . . . 0.0 109.589 174.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -105.47 74.11 1.07 Allowed 'General case' 0 C--N 1.284 -2.247 0 N-CA-C 105.898 -1.889 . . . . 0.0 105.898 -179.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -105.17 169.63 8.33 Favored 'General case' 0 C--N 1.282 -2.353 0 CA-C-N 113.923 -1.49 . . . . 0.0 111.331 -172.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -140.41 -69.04 0.4 Allowed 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.947 175.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 16.1 tpt -112.99 -27.16 8.17 Favored 'General case' 0 C--N 1.293 -1.881 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 176.087 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 4.1 p . . . . . 0 N--CA 1.401 -2.9 0 CA-C-N 114.327 -1.306 . . . . 0.0 109.686 177.311 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 112.288 -0.325 . . . . 0.0 112.288 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 6' ' ' ASP . 14.0 t70 -74.66 152.8 39.13 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 11.4 m -80.68 -37.36 16.49 Favored 'Isoleucine or valine' 0 C--N 1.265 -3.107 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.71 -54.05 2.54 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.449 ' N ' ' HD3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -79.16 -1.61 36.93 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -171.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 2' ' ' ASP . 10.9 t70 -93.76 98.84 11.37 Favored 'General case' 0 C--N 1.295 -1.784 0 N-CA-C 106.048 -1.834 . . . . 0.0 106.048 176.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.9 mmm180 -91.23 128.1 48.62 Favored Pre-proline 0 C--N 1.293 -1.88 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 -177.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_endo -66.92 137.77 45.95 Favored 'Trans proline' 0 N--CA 1.453 -0.859 0 C-N-CA 122.285 1.99 . . . . 0.0 111.172 179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -135.79 121.83 20.1 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.938 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 -123.96 -24.96 4.31 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.195 -0.911 . . . . 0.0 108.613 171.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.32 102.43 14.17 Favored 'General case' 0 N--CA 1.428 -1.536 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 175.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -80.11 104.97 11.04 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 176.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.36 96.32 0.08 OUTLIER Glycine 0 C--N 1.281 -2.488 0 N-CA-C 118.191 2.036 . . . . 0.0 118.191 -167.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -92.64 91.74 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.291 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 163.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.601 ' HA ' ' HB3' ' A' ' 74' ' ' ALA . 10.5 m-20 -93.13 44.76 1.15 Allowed 'General case' 0 CA--C 1.444 -3.115 0 CA-C-N 113.809 -1.542 . . . . 0.0 113.569 -169.005 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.525 ' HB2' ' OE2' ' A' ' 67' ' ' GLU 0.251 69.6 p -118.25 -20.49 8.55 Favored 'General case' 0 C--N 1.273 -2.747 0 C-N-CA 115.493 -2.483 . . . . 0.0 113.916 166.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.473 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 25.9 t -127.14 133.04 69.11 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 119.037 -1.065 . . . . 0.0 112.996 -171.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.586 HD11 ' HD1' ' A' ' 73' ' ' HIS . 25.9 mm -104.12 143.05 16.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 88.1 t -119.79 114.1 43.05 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 176.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 44.8 t -119.53 130.61 73.83 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -177.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.459 ' HB3' ' CG ' ' A' ' 93' ' ' ARG . 10.7 t70 -111.86 149.35 31.94 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.512 0.2 OUTLIER 44.57 85.65 0.02 OUTLIER 'General case' 0 C--O 1.242 0.706 0 C-N-CA 127.057 2.143 . . . . 0.0 115.87 -176.155 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.542 ' HB ' ' CD ' ' A' ' 24' ' ' PRO . 26.8 m -97.77 -171.75 0.26 Allowed Pre-proline 0 N--CA 1.418 -2.029 0 CA-C-N 112.732 -2.031 . . . . 0.0 107.064 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.749 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 44.6 Cg_exo -54.05 143.82 60.32 Favored 'Trans proline' 0 C--N 1.373 1.827 0 C-N-CA 121.686 1.591 . . . . 0.0 114.181 179.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HA ' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -89.37 164.33 14.93 Favored 'General case' 0 N--CA 1.419 -1.984 0 CA-C-N 114.111 -1.404 . . . . 0.0 107.879 -178.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.413 HG21 HD23 ' A' ' 31' ' ' LEU . 48.8 t -123.22 134.26 66.75 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.12 0 CA-C-O 121.675 0.75 . . . . 0.0 109.391 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -108.7 -127.96 5.65 Favored Glycine 0 N--CA 1.418 -2.56 0 N-CA-C 105.722 -2.951 . . . . 0.0 105.722 173.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -81.74 124.39 4.53 Favored 'Trans proline' 0 N--CA 1.427 -2.433 0 CA-C-N 120.22 2.01 . . . . 0.0 110.721 173.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.0 t70 50.73 33.57 8.58 Favored 'General case' 0 CA--C 1.57 1.723 0 C-N-CA 125.353 1.461 . . . . 0.0 113.014 172.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -95.76 -0.7 51.05 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.771 -1.206 . . . . 0.0 112.105 -179.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.413 HD23 HG21 ' A' ' 26' ' ' VAL . 3.2 tm? -71.0 -28.86 64.73 Favored 'General case' 0 CA--C 1.552 1.037 0 N-CA-C 112.28 0.474 . . . . 0.0 112.28 -175.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -61.87 -51.03 69.84 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 120.76 0.314 . . . . 0.0 111.583 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 19.4 ptpt -65.14 -27.13 68.52 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.617 -177.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.564 ' O ' HG12 ' A' ' 38' ' ' ILE . 6.0 tt -65.71 -43.91 87.72 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 179.774 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -60.32 -37.83 81.8 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.858 0.361 . . . . 0.0 111.6 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -81.0 -33.77 33.45 Favored 'General case' 0 N--CA 1.431 -1.403 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.705 -174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' O ' ' A' ' 34' ' ' LEU . 6.2 p -70.17 -30.79 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.022 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.763 -176.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 34' ' ' LEU . 35.5 mm -63.79 -64.47 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.845 179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -62.49 -25.37 67.98 Favored 'General case' 0 C--O 1.219 -0.511 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -176.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.9 tttp -64.33 -57.71 8.6 Favored 'General case' 0 N--CA 1.433 -1.314 0 C-N-CA 123.333 0.653 . . . . 0.0 110.522 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.447 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 82.0 mt -70.38 -38.84 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-O 121.286 0.565 . . . . 0.0 111.042 -177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.453 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 53.9 m-85 -73.86 -7.31 51.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 114.182 1.179 . . . . 0.0 114.182 -175.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 58.0 m -69.35 -6.37 29.35 Favored 'General case' 0 CA--C 1.562 1.406 0 N-CA-C 112.976 0.732 . . . . 0.0 112.976 175.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' A' ' 41' ' ' ILE . 81.0 mttt -71.92 -31.93 66.86 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 122.113 0.959 . . . . 0.0 108.807 175.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 58.6 m-85 -85.46 10.83 11.8 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 114.545 -1.207 . . . . 0.0 110.892 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.426 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 117.43 -167.88 12.8 Favored Glycine 0 N--CA 1.431 -1.664 0 N-CA-C 109.214 -1.554 . . . . 0.0 109.214 -179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 22.6 ttpp -89.91 145.24 25.28 Favored 'General case' 0 C--N 1.293 -1.867 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 178.353 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.406 HD12 HD12 ' A' ' 66' ' ' LEU . 32.4 mm -73.23 110.44 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 -179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 20.4 m -75.48 -46.3 33.25 Favored 'General case' 0 N--CA 1.434 -1.253 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.495 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 35.3 t-20 -152.76 152.69 31.94 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 105.986 -1.857 . . . . 0.0 105.986 176.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -144.48 136.75 26.37 Favored 'General case' 0 C--N 1.284 -2.248 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 -178.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -126.64 113.0 16.14 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.06 -177.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 6.1 m-30 -107.67 106.59 58.82 Favored Pre-proline 0 C--N 1.299 -1.593 0 N-CA-C 108.555 -0.905 . . . . 0.0 108.555 177.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 63' ' ' TYR . 2.9 Cg_exo -68.66 174.73 8.08 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 121.525 1.483 . . . . 0.0 109.357 172.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -173.34 -175.3 1.14 Allowed 'General case' 0 C--N 1.303 -1.449 0 CA-C-O 120.946 0.403 . . . . 0.0 110.466 -173.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -136.74 102.36 4.88 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 177.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 56.71 27.37 12.57 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 124.513 1.125 . . . . 0.0 112.715 178.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.92 0.06 85.96 Favored Glycine 0 C--N 1.316 -0.566 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.361 -179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.2 mtmt -100.03 -176.45 3.24 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 123.436 0.695 . . . . 0.0 110.04 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.443 HG23 ' HA ' ' A' ' 25' ' ' GLN . 18.9 m -34.03 124.13 0.47 Allowed 'General case' 0 N--CA 1.446 -0.662 0 C-N-CA 126.5 1.92 . . . . 0.0 114.38 -177.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.65 166.65 11.02 Favored 'General case' 0 N--CA 1.419 -1.994 0 CA-C-N 114.445 -1.252 . . . . 0.0 109.12 179.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.35 -0.73 9.44 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.91 -177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.496 ' O ' ' HD2' ' A' ' 54' ' ' PRO . 4.4 p90 -169.69 161.23 9.23 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -178.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -143.86 172.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 O-C-N 123.527 0.517 . . . . 0.0 110.35 178.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -136.24 138.73 42.13 Favored 'General case' 0 C--O 1.243 0.729 0 C-N-CA 123.588 0.755 . . . . 0.0 109.744 179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.485 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.0 mm? -118.39 131.91 56.28 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.525 ' OE2' ' HB2' ' A' ' 16' ' ' SER . 12.9 tp10 -116.72 117.51 29.99 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.55 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 80.5 m-85 -127.46 172.53 10.6 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-O 121.241 0.543 . . . . 0.0 110.312 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.23 14.26 14.79 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 173.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.583 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 51.0 m -68.27 163.35 53.14 Favored Pre-proline 0 CA--C 1.597 2.78 0 N-CA-C 116.519 2.044 . . . . 0.0 116.519 -171.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.504 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 2.1 Cg_exo -38.25 8.83 0.0 OUTLIER 'Trans proline' 0 N--CA 1.525 3.348 2 C-N-CA 130.435 7.423 . . . . 0.0 122.955 178.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.528 ' HA ' ' CG ' ' A' ' 15' ' ' ASP . . . 87.37 63.34 0.01 OUTLIER 'General case' 0 CA--C 1.472 -2.047 0 CA-C-O 124.465 2.079 . . . . 0.0 106.997 -158.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.586 ' HD1' HD11 ' A' ' 18' ' ' ILE . 32.2 p80 -85.69 -36.99 19.89 Favored 'General case' 0 N--CA 1.423 -1.804 0 CA-C-N 110.148 -3.205 . . . . 0.0 109.282 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.601 ' HB3' ' HA ' ' A' ' 15' ' ' ASP . . . -63.36 -35.94 82.07 Favored 'General case' 0 N--CA 1.437 -1.083 0 C-N-CA 119.447 -0.901 . . . . 0.0 110.059 176.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.587 HG23 ' OD1' ' A' ' 15' ' ' ASP . 82.0 t -59.39 -59.17 4.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.624 -0.716 . . . . 0.0 109.459 170.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -58.68 -35.77 73.14 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.324 -0.853 . . . . 0.0 113.145 -175.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.0 -30.89 70.26 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.494 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.81 -29.34 12.92 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.899 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.438 ' HE2' ' HA ' ' A' ' 79' ' ' LYS . 8.4 mmpt? -72.02 -42.82 65.92 Favored 'General case' 0 C--N 1.303 -1.455 0 CA-C-N 114.28 -1.327 . . . . 0.0 111.308 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -114.21 -29.87 6.81 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 115.421 1.637 . . . . 0.0 115.421 -170.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -102.2 -3.13 27.86 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -170.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -77.3 117.34 18.71 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 119.4 -0.92 . . . . 0.0 111.874 -178.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.86 31.33 12.62 Favored Glycine 0 C--N 1.306 -1.136 0 N-CA-C 115.091 0.796 . . . . 0.0 115.091 171.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -101.5 135.27 43.28 Favored 'General case' 0 C--N 1.309 -1.183 0 C-N-CA 118.495 -1.282 . . . . 0.0 109.488 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.516 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -107.68 129.29 55.03 Favored 'General case' 0 N--CA 1.429 -1.492 0 CA-C-N 115.803 -0.635 . . . . 0.0 112.192 -172.365 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.6 mt -86.44 -68.04 0.77 Allowed 'General case' 0 C--N 1.303 -1.417 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.245 176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -160.02 159.32 31.92 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -177.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.424 ' HD2' HE22 ' A' ' 25' ' ' GLN . 40.2 ttmt 47.04 -88.7 0.01 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 126.048 1.739 . . . . 0.0 114.297 177.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 19.7 pt20 -121.43 -2.13 9.53 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.263 -0.273 . . . . 0.0 111.035 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.749 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m170 -79.72 92.65 5.43 Favored 'General case' 0 CA--C 1.49 -1.329 0 CA-C-O 121.31 0.576 . . . . 0.0 110.594 -171.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 m -133.17 109.04 9.18 Favored 'General case' 0 C--N 1.273 -2.742 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -82.21 105.62 13.44 Favored 'General case' 0 C--N 1.284 -2.252 0 C-N-CA 119.957 -0.697 . . . . 0.0 109.917 -172.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.459 ' CG ' ' HB3' ' A' ' 21' ' ' ASP . 0.9 OUTLIER -94.03 121.45 35.53 Favored 'General case' 0 N--CA 1.414 -2.27 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.7 t -116.96 115.1 47.83 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.174 0 CA-C-N 114.286 -1.325 . . . . 0.0 111.008 -166.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -121.99 158.18 29.69 Favored 'General case' 0 N--CA 1.404 -2.732 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 176.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.455 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.1 pt? -87.32 -172.12 3.79 Favored 'General case' 0 C--N 1.292 -1.922 0 CA-C-O 121.27 0.557 . . . . 0.0 112.378 -177.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.455 ' HB2' ' HB ' ' A' ' 17' ' ' VAL . 31.8 t80 -84.47 5.19 28.38 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-O 121.184 0.516 . . . . 0.0 110.539 -173.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 9.4 p -69.21 76.13 0.35 Allowed 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -86.99 -24.17 24.77 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 105.001 -2.222 . . . . 0.0 105.001 167.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -52.4 134.98 34.11 Favored 'General case' 0 C--O 1.245 0.841 0 CA-C-N 112.586 -2.097 . . . . 0.0 110.595 173.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -79.33 76.02 5.9 Favored 'General case' 0 CA--C 1.492 -1.273 0 CA-C-O 121.894 0.854 . . . . 0.0 108.975 178.024 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 15.4 pttp -48.26 -46.61 35.86 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-N 113.046 -1.888 . . . . 0.0 112.342 176.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -67.89 126.39 29.3 Favored 'General case' 0 C--N 1.256 -3.466 0 CA-C-N 112.961 -1.927 . . . . 0.0 109.334 175.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -71.57 105.81 3.78 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 5.0 m . . . . . 0 N--CA 1.419 -1.982 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.83 -175.09 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -69.76 150.48 46.85 Favored 'General case' 0 CA--C 1.504 -0.813 0 CA-C-O 120.695 0.283 . . . . 0.0 111.269 -178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.486 HG23 ' H ' ' A' ' 4' ' ' LEU . 16.5 m -33.92 -76.86 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.888 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -168.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.486 ' H ' HG23 ' A' ' 3' ' ' VAL . 84.8 mt -74.35 -26.96 60.45 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 113.334 0.864 . . . . 0.0 113.334 -169.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.33 6.71 47.87 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.714 0.769 . . . . 0.0 111.215 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -108.05 -35.92 6.47 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.564 174.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 5.5 mmp_? -74.81 146.03 82.37 Favored Pre-proline 0 N--CA 1.436 -1.13 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.203 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -60.01 127.89 24.76 Favored 'Trans proline' 0 C--O 1.252 1.213 0 C-N-CA 121.784 1.656 . . . . 0.0 109.304 171.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.477 ' HG3' ' H ' ' A' ' 11' ' ' ALA . 19.6 tp60 -104.11 157.59 17.02 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.471 ' HG2' ' HA ' ' A' ' 95' ' ' ASN . 30.4 mp0 -74.21 -22.85 59.2 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.347 0.594 . . . . 0.0 109.729 178.23 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.477 ' H ' ' HG3' ' A' ' 9' ' ' GLN . . . -96.67 74.73 2.75 Favored 'General case' 0 N--CA 1.428 -1.534 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 176.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -151.17 110.02 3.87 Favored 'General case' 0 C--N 1.289 -2.024 0 N-CA-C 106.751 -1.574 . . . . 0.0 106.751 178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 88.82 -64.54 3.39 Favored Glycine 0 C--N 1.277 -2.742 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 -178.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.514 HG12 ' HB3' ' A' ' 97' ' ' PHE . 8.2 tp -101.93 126.55 55.89 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.323 0.582 . . . . 0.0 109.714 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -141.84 28.17 1.78 Allowed 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.325 -177.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 15.2 m -114.39 -8.96 12.81 Favored 'General case' 0 C--N 1.314 -0.967 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -174.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 47.1 t -132.28 137.34 54.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 121.875 -0.516 . . . . 0.0 109.873 -175.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.42 ' HB ' ' HB2' ' A' ' 66' ' ' LEU . 8.9 mm -101.0 133.12 45.27 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.16 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -127.66 106.5 15.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.927 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 93' ' ' ARG . 16.6 m -96.36 154.94 3.51 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.582 0 C-N-CA 120.58 -0.448 . . . . 0.0 112.203 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' HB2' ' HB2' ' A' ' 93' ' ' ARG . 9.8 t70 -93.22 -178.29 4.72 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 114.962 -1.017 . . . . 0.0 108.443 176.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.279 0.2 OUTLIER -29.5 106.92 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -166.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.474 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 36.0 m -86.01 167.32 24.54 Favored Pre-proline 0 N--CA 1.421 -1.908 0 CA-C-N 113.052 -1.886 . . . . 0.0 108.198 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.718 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 86.7 Cg_exo -42.36 127.15 4.14 Favored 'Trans proline' 0 C--N 1.368 1.595 0 C-N-CA 123.641 2.894 . . . . 0.0 113.351 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.428 ' HB3' HE22 ' A' ' 89' ' ' GLN . 0.0 OUTLIER -65.78 151.12 47.36 Favored 'General case' 0 C--O 1.25 1.12 0 CA-C-N 114.913 -1.04 . . . . 0.0 109.915 -177.084 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.549 ' CG2' ' HB ' ' A' ' 60' ' ' THR . 52.6 t -125.91 139.77 50.49 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.175 0 CA-C-O 122.028 0.918 . . . . 0.0 112.774 -173.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -124.45 -143.48 6.18 Favored Glycine 0 C--N 1.289 -2.064 0 N-CA-C 106.668 -2.573 . . . . 0.0 106.668 173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -69.63 126.88 13.92 Favored 'Trans proline' 0 C--N 1.318 -1.074 0 CA-C-N 120.658 2.229 . . . . 0.0 111.416 178.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 21.3 t70 63.32 17.69 10.44 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 125.127 1.371 . . . . 0.0 113.237 175.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HB2' HG13 ' A' ' 26' ' ' VAL . 88.6 mtt180 -89.43 -15.86 32.21 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 120.079 -1.638 . . . . 0.0 111.305 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.417 HD12 ' HE3' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -73.94 -36.69 64.68 Favored 'General case' 0 C--N 1.316 -0.855 0 N-CA-C 108.696 -0.854 . . . . 0.0 108.696 -177.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -64.95 -34.97 79.7 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.4 178.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 50.5 mttm -71.78 -40.53 69.19 Favored 'General case' 0 C--O 1.244 0.781 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.544 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.8 tp -58.37 -44.0 88.67 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 114.662 -1.154 . . . . 0.0 110.818 -179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.417 ' HE3' HD12 ' A' ' 31' ' ' LEU . 98.6 mttt -54.51 -30.18 52.7 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.183 0.593 . . . . 0.0 112.512 179.517 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.476 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 55.6 t30 -84.49 -32.41 23.98 Favored 'General case' 0 N--CA 1.435 -1.189 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.196 -173.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.433 HG12 ' O ' ' A' ' 34' ' ' LEU . 8.6 p -78.07 -27.48 14.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 C-N-CA 120.732 -0.387 . . . . 0.0 110.969 -177.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 34' ' ' LEU . 39.3 mm -54.3 -51.79 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.874 0 CA-C-O 121.642 0.734 . . . . 0.0 110.403 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 73.8 m80 -68.21 -17.79 64.41 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.888 -1.051 . . . . 0.0 112.552 -177.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.8 mmtp -85.28 -38.02 19.33 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 121.868 0.842 . . . . 0.0 109.517 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 51.2 mm -73.78 -53.89 16.57 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.74 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.61 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 61.7 m-85 -78.67 -16.93 56.7 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -168.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.9 p -65.73 -19.73 66.01 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.725 0.774 . . . . 0.0 110.829 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -73.22 -7.43 51.42 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.569 176.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -106.87 4.36 27.31 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 121.527 0.68 . . . . 0.0 110.279 174.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 131.89 -161.62 23.79 Favored Glycine 0 N--CA 1.437 -1.267 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.393 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -87.77 128.02 35.32 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.6 mm -75.35 89.73 0.73 Allowed 'Isoleucine or valine' 0 C--O 1.247 0.935 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.8 p -79.83 -52.37 7.99 Favored 'General case' 0 N--CA 1.424 -1.749 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.496 179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.49 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 17.7 m120 -126.33 138.86 53.63 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 121.0 0.429 . . . . 0.0 110.447 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -141.62 137.48 31.89 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.212 -178.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 56.0 m-85 -135.39 98.69 4.02 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.12 -177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.461 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -108.97 122.14 40.82 Favored Pre-proline 0 C--N 1.305 -1.346 0 C-N-CA 119.017 -1.073 . . . . 0.0 108.868 172.921 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -75.81 176.34 10.13 Favored 'Trans proline' 0 C--N 1.325 -0.693 0 C-N-CA 122.57 2.18 . . . . 0.0 109.972 172.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -131.8 164.46 25.97 Favored 'General case' 0 C--N 1.289 -2.028 0 N-CA-C 107.364 -1.347 . . . . 0.0 107.364 173.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.644 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 35.9 tt0 -141.66 103.33 4.35 Favored 'General case' 0 C--N 1.283 -2.322 0 N-CA-C 107.794 -1.188 . . . . 0.0 107.794 -178.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 36.1 t70 58.08 27.46 14.96 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 122.401 1.096 . . . . 0.0 111.984 178.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.77 -1.75 87.57 Favored Glycine 0 C--O 1.244 0.731 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.021 179.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 20.5 pttp -107.41 -176.08 2.97 Favored 'General case' 0 C--O 1.259 1.576 0 N-CA-C 106.542 -1.651 . . . . 0.0 106.542 177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.549 ' HB ' ' CG2' ' A' ' 26' ' ' VAL . 4.8 t -78.41 167.39 21.39 Favored 'General case' 0 N--CA 1.418 -2.025 0 CA-C-O 122.229 1.014 . . . . 0.0 111.822 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.547 ' H ' ' HD2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -105.47 175.9 5.34 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 112.974 -1.921 . . . . 0.0 108.442 178.158 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -105.9 20.23 36.6 Favored Glycine 0 C--N 1.292 -1.874 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.115 -179.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 7.0 p90 -170.74 151.73 3.55 Favored 'General case' 0 C--O 1.247 0.948 0 C-N-CA 122.293 0.237 . . . . 0.0 110.499 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.513 HG12 ' CG2' ' A' ' 20' ' ' VAL . 18.8 pt -146.03 163.33 10.42 Favored 'Isoleucine or valine' 0 C--O 1.243 0.745 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 175.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.418 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 70.8 m-85 -119.39 136.8 54.12 Favored 'General case' 0 C--O 1.245 0.847 0 CA-C-O 120.75 0.31 . . . . 0.0 110.673 -179.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.423 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 3.7 mm? -123.08 124.58 43.41 Favored 'General case' 0 C--N 1.313 -0.985 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 174.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 7.1 tp10 -119.41 128.16 53.78 Favored 'General case' 0 C--N 1.303 -1.435 0 N-CA-C 107.251 -1.389 . . . . 0.0 107.251 179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.61 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 25.7 m-85 -127.06 -178.28 4.36 Favored 'General case' 0 C--O 1.209 -1.041 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -177.074 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.53 10.95 11.24 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-O 121.354 0.597 . . . . 0.0 109.541 173.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.2 p -81.67 163.43 54.0 Favored Pre-proline 0 CA--C 1.583 2.222 0 N-CA-C 115.353 1.612 . . . . 0.0 115.353 -171.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -34.96 9.18 0.0 OUTLIER 'Trans proline' 0 N--CA 1.513 2.663 2 C-N-CA 130.556 7.504 . . . . 0.0 123.358 -178.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.649 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 86.18 65.59 0.01 OUTLIER 'General case' 0 CA--C 1.48 -1.731 0 CA-C-O 124.975 2.321 . . . . 0.0 108.557 -163.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.47 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 29.3 p-80 -79.49 -37.2 37.34 Favored 'General case' 0 C--N 1.291 -1.974 0 CA-C-N 109.127 -3.67 . . . . 0.0 110.16 178.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.04 -26.03 48.15 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.979 -0.555 . . . . 0.0 109.715 -177.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.649 HG12 ' O ' ' A' ' 72' ' ' ALA . 3.0 p -65.5 -29.79 48.18 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.112 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -83.01 -45.95 13.45 Favored 'General case' 0 C--O 1.241 0.615 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.322 178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -54.0 -47.83 71.06 Favored 'General case' 0 C--O 1.213 -0.834 0 CA-C-N 115.23 -0.896 . . . . 0.0 111.728 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.416 ' CG1' ' HB2' ' A' ' 10' ' ' GLU . 47.2 t -65.1 -45.93 92.75 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.743 0 CA-C-O 121.072 0.463 . . . . 0.0 111.748 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -73.39 -27.39 61.44 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 112.197 0.444 . . . . 0.0 112.197 -173.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -120.63 -45.47 2.41 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.82 1.045 . . . . 0.0 113.82 -174.293 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.483 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -88.27 -8.22 55.55 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -171.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.446 ' HA ' HG23 ' A' ' 94' ' ' VAL . 17.3 t70 -61.07 113.13 2.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.357 0.599 . . . . 0.0 112.366 176.192 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.01 47.89 3.75 Favored Glycine 0 N--CA 1.42 -2.426 0 CA-C-N 114.922 -1.035 . . . . 0.0 114.603 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.483 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 33.0 p90 -107.83 133.97 51.44 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 118.677 -1.209 . . . . 0.0 109.96 174.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.406 ' HA ' ' HA ' ' A' ' 91' ' ' THR . 0.0 OUTLIER -100.95 128.47 46.98 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.233 0.54 . . . . 0.0 112.342 -176.619 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 68.6 mt -84.79 -62.72 1.48 Allowed 'General case' 0 C--N 1.302 -1.483 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.818 178.106 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -160.95 154.12 21.5 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 114.347 -1.297 . . . . 0.0 107.571 -172.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 57.1 mtpt 45.99 -107.19 0.14 Allowed 'General case' 0 CA--C 1.55 0.947 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.428 HE22 ' HB3' ' A' ' 25' ' ' GLN . 14.3 pm0 -103.86 -10.23 18.37 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 110.013 -178.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.718 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 21.8 m80 -68.27 93.79 0.49 Allowed 'General case' 0 CA--C 1.497 -1.084 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.128 -171.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.406 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 3.4 m -132.73 118.87 19.61 Favored 'General case' 0 C--N 1.276 -2.612 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -90.37 105.41 17.79 Favored 'General case' 0 C--N 1.286 -2.159 0 C-N-CA 119.956 -0.698 . . . . 0.0 110.499 -176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.583 ' O ' ' HA ' ' A' ' 20' ' ' VAL . 10.8 mmm180 -83.15 143.03 30.78 Favored 'General case' 0 CA--C 1.483 -1.61 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 171.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.446 HG23 ' HA ' ' A' ' 82' ' ' ASP . 58.5 t -106.47 107.01 21.69 Favored 'Isoleucine or valine' 0 C--N 1.259 -3.344 0 N-CA-C 107.467 -1.309 . . . . 0.0 107.467 177.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.471 ' HA ' ' HG2' ' A' ' 10' ' ' GLU . 2.6 t30 -100.84 162.44 12.9 Favored 'General case' 0 N--CA 1.403 -2.776 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.0 -177.019 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.558 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.0 OUTLIER -79.31 -166.06 0.88 Allowed 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 124.27 1.028 . . . . 0.0 111.473 -176.151 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.514 ' HB3' HG12 ' A' ' 14' ' ' ILE . 73.3 t80 -139.06 -13.55 1.2 Allowed 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 120.221 -0.592 . . . . 0.0 111.798 -177.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.439 HG22 HD12 ' A' ' 96' ' ' LEU . 12.7 t -80.78 158.22 25.53 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 176.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -64.07 -44.08 93.49 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 -173.234 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -108.24 132.29 53.81 Favored 'General case' 0 C--N 1.304 -1.411 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -85.57 68.28 10.37 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 123.082 1.42 . . . . 0.0 110.349 178.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.63 172.49 13.71 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 113.676 -1.602 . . . . 0.0 114.365 178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 32.1 t80 -118.63 170.02 9.31 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-N 113.5 -1.682 . . . . 0.0 106.583 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.8 tmm? -66.92 105.79 1.72 Allowed 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.677 -1.231 . . . . 0.0 107.677 175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 72.5 m . . . . . 0 N--CA 1.422 -1.835 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -176.792 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.512 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -77.54 140.23 39.7 Favored 'General case' 0 CA--C 1.51 -0.592 0 CA-C-O 121.454 0.645 . . . . 0.0 110.131 178.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 4.2 t -99.3 19.01 2.38 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.022 0.915 . . . . 0.0 109.349 -176.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -68.14 -40.52 82.42 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 113.047 0.758 . . . . 0.0 113.047 -174.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.75 5.57 50.37 Favored 'General case' 0 C--N 1.318 -0.767 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.294 -176.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -75.56 99.64 4.32 Favored 'General case' 0 N--CA 1.438 -1.067 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -169.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -130.54 151.59 78.91 Favored Pre-proline 0 C--N 1.285 -2.238 0 N-CA-C 105.842 -1.911 . . . . 0.0 105.842 173.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.29 153.29 61.68 Favored 'Trans proline' 0 C--O 1.246 0.915 0 C-N-CA 121.38 1.386 . . . . 0.0 111.522 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 24.1 tp60 -84.8 125.29 32.45 Favored 'General case' 0 C--N 1.297 -1.709 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 178.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -74.9 -6.07 47.18 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -175.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.58 95.39 1.82 Allowed 'General case' 0 N--CA 1.434 -1.235 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 176.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -63.59 136.63 57.67 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.67 178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -74.51 81.79 0.83 Allowed Glycine 0 N--CA 1.437 -1.237 0 N-CA-C 110.78 -0.928 . . . . 0.0 110.78 178.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.478 ' CD1' ' H ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -65.74 133.73 30.5 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.135 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.454 ' OD1' ' HE2' ' A' ' 102' ' ' LYS . 8.6 p-10 -112.13 -5.54 14.23 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 114.161 1.171 . . . . 0.0 114.161 -169.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 12.7 p -114.96 -14.36 11.87 Favored 'General case' 0 CA--C 1.551 0.991 0 N-CA-C 116.987 2.217 . . . . 0.0 116.987 -173.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.478 ' H ' ' CD1' ' A' ' 14' ' ' ILE . 60.2 t -139.16 137.17 41.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 O-C-N 121.963 -0.461 . . . . 0.0 110.762 -172.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.1 mm -97.25 135.14 32.53 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.921 0 N-CA-C 106.891 -1.522 . . . . 0.0 106.891 175.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.402 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 54.4 t -116.1 105.92 19.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 1.7 m -107.82 122.89 62.79 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.26 0 CA-C-N 115.1 -0.955 . . . . 0.0 112.156 -176.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 21.7 t70 -92.73 138.03 31.84 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 114.256 -1.338 . . . . 0.0 109.613 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.47 0.1 OUTLIER 45.94 86.65 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 128.513 2.725 . . . . 0.0 115.66 -175.452 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.447 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 35.5 m -89.27 165.78 24.59 Favored Pre-proline 0 C--N 1.312 -1.041 0 CA-C-N 113.398 -1.728 . . . . 0.0 109.535 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.771 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.3 Cg_endo -45.92 150.19 1.88 Allowed 'Trans proline' 0 C--N 1.373 1.857 0 C-N-CA 123.474 2.783 . . . . 0.0 114.125 177.066 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.448 ' HA ' HG21 ' A' ' 60' ' ' THR . 5.7 pt20 -89.46 161.89 16.02 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.561 -173.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 27' ' ' GLY . 60.9 t -129.15 138.89 53.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.227 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.517 -172.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.467 ' O ' HG12 ' A' ' 26' ' ' VAL . . . -102.34 -177.27 27.51 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 107.601 -2.2 . . . . 0.0 107.601 174.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -52.49 124.89 16.18 Favored 'Trans proline' 0 CA--C 1.54 0.777 0 CA-C-N 120.15 1.975 . . . . 0.0 112.067 -176.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 34.8 m-20 53.76 23.44 3.75 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.187 1.795 . . . . 0.0 114.167 179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.433 ' HB2' HG13 ' A' ' 26' ' ' VAL . 13.8 mtm180 -90.1 -2.61 58.12 Favored 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 118.833 -1.147 . . . . 0.0 110.183 177.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -63.17 -36.37 83.38 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.889 0.376 . . . . 0.0 110.075 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -61.39 -47.42 85.9 Favored 'General case' 0 C--N 1.311 -1.109 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.542 178.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -74.83 -24.81 58.67 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-O 121.013 0.435 . . . . 0.0 110.135 179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.622 ' O ' HG12 ' A' ' 38' ' ' ILE . 3.0 tm? -61.97 -49.39 76.29 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 175.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -55.51 -31.95 62.49 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.419 0.628 . . . . 0.0 111.123 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.45 -41.8 38.37 Favored 'General case' 0 CA--C 1.497 -1.089 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.232 -173.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.1 p -71.35 -30.71 40.87 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 115.867 -0.606 . . . . 0.0 109.989 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.622 HG12 ' O ' ' A' ' 34' ' ' LEU . 22.2 mm -62.59 -53.39 47.69 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 176.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -55.43 -36.74 66.82 Favored 'General case' 0 CA--C 1.516 -0.363 0 CA-C-N 115.299 -0.864 . . . . 0.0 110.955 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.419 ' HA ' ' HD2' ' A' ' 40' ' ' LYS . 47.8 tptt -69.13 -53.12 21.85 Favored 'General case' 0 N--CA 1.423 -1.818 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.192 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.476 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 34.9 mm -56.16 -50.24 71.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.791 0 CA-C-O 121.689 0.757 . . . . 0.0 110.484 179.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.533 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.4 m-85 -77.04 -0.67 25.48 Favored 'General case' 0 N--CA 1.415 -2.184 0 N-CA-C 114.3 1.222 . . . . 0.0 114.3 -173.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.6 m -69.96 -12.51 61.67 Favored 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 121.275 0.559 . . . . 0.0 110.204 173.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.476 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 29.5 mmmt -72.13 -16.5 62.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-O 121.057 0.456 . . . . 0.0 109.998 177.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.1 m-85 -102.4 6.98 40.5 Favored 'General case' 0 C--O 1.243 0.718 0 CA-C-O 121.279 0.561 . . . . 0.0 110.699 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 126.58 -156.4 19.96 Favored Glycine 0 N--CA 1.434 -1.464 0 N-CA-C 111.169 -0.773 . . . . 0.0 111.169 179.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -95.18 128.48 42.05 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 108.979 -0.748 . . . . 0.0 108.979 179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.482 HD12 HD12 ' A' ' 66' ' ' LEU . 32.0 mm -74.11 115.14 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.311 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 11.6 m -86.96 -41.92 13.55 Favored 'General case' 0 N--CA 1.419 -2.024 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.4 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 68.6 m-20 -154.77 160.92 41.62 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 123.903 0.881 . . . . 0.0 109.695 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.538 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 41.5 t0 -150.95 151.86 32.75 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 104.882 -2.266 . . . . 0.0 104.882 172.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -139.17 102.25 4.46 Favored 'General case' 0 C--N 1.285 -2.238 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -170.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.654 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 0.5 OUTLIER -107.12 123.5 38.14 Favored Pre-proline 0 C--N 1.29 -2.017 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -175.926 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.456 ' O ' ' HG2' ' A' ' 61' ' ' LYS . 72.7 Cg_endo -82.21 177.57 7.08 Favored 'Trans proline' 0 N--CA 1.451 -0.986 0 C-N-CA 123.061 2.507 . . . . 0.0 108.25 172.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -155.71 177.23 11.62 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 120.732 -1.23 . . . . 0.0 109.879 173.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -135.25 102.48 5.19 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 177.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 26.7 t70 54.75 26.09 7.23 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-O 122.561 1.172 . . . . 0.0 111.487 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.33 5.65 59.12 Favored Glycine 0 C--O 1.222 -0.602 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.248 175.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -100.61 -177.62 3.54 Favored 'General case' 0 C--O 1.258 1.542 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 25' ' ' GLN . 13.3 m -68.23 142.65 55.57 Favored 'General case' 0 N--CA 1.424 -1.742 0 CA-C-N 114.003 -1.453 . . . . 0.0 112.872 -175.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.654 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 0.0 OUTLIER -112.37 173.49 6.34 Favored 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.082 -1.417 . . . . 0.0 108.399 174.642 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -114.28 27.27 9.1 Favored Glycine 0 C--N 1.293 -1.851 0 C-N-CA 120.684 -0.77 . . . . 0.0 111.949 179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 12.1 p90 -169.07 147.84 3.94 Favored 'General case' 0 C--O 1.242 0.696 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 178.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 25.1 pt -146.03 176.18 1.88 Allowed 'Isoleucine or valine' 0 C--O 1.255 1.347 0 N-CA-C 106.225 -1.769 . . . . 0.0 106.225 176.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.538 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 92.6 m-85 -140.18 114.73 9.36 Favored 'General case' 0 CA--C 1.496 -1.116 0 CA-C-N 119.019 0.827 . . . . 0.0 111.481 -175.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.482 HD12 HD12 ' A' ' 48' ' ' ILE . 3.9 mm? -93.66 116.81 29.32 Favored 'General case' 0 C--N 1.288 -2.097 0 CA-C-N 115.197 -0.91 . . . . 0.0 108.808 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 39.3 tt0 -110.95 128.27 55.77 Favored 'General case' 0 C--N 1.288 -2.1 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 -179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.71 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 3.5 m-85 -127.54 171.14 11.88 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -110.49 12.66 22.87 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 172.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.459 ' HB3' ' ND1' ' A' ' 73' ' ' HIS . 48.0 t -73.26 155.89 89.59 Favored Pre-proline 0 CA--C 1.59 2.495 0 CA-C-N 114.015 -1.448 . . . . 0.0 112.177 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -36.4 8.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.529 3.593 1 C-N-CA 130.72 7.613 . . . . 0.0 122.27 -178.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 86.45 62.59 0.01 OUTLIER 'General case' 0 CA--C 1.487 -1.466 0 CA-C-O 124.981 2.324 . . . . 0.0 107.97 -164.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.71 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 24.1 p-80 -77.65 -36.4 51.53 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 109.184 -3.644 . . . . 0.0 109.999 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.14 -29.48 69.21 Favored 'General case' 0 C--O 1.207 -1.179 0 CA-C-N 115.504 -0.771 . . . . 0.0 108.982 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 78.0 t -65.12 -26.72 40.5 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.077 0 CA-C-N 114.318 -1.31 . . . . 0.0 110.523 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -83.31 -46.91 12.06 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 174.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.36 -44.2 79.9 Favored 'General case' 0 C--O 1.218 -0.588 0 CA-C-N 114.837 -1.074 . . . . 0.0 112.448 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.3 m -62.47 -33.33 58.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 120.968 0.413 . . . . 0.0 112.046 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -85.42 -29.08 24.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.641 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -109.9 -39.11 5.17 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 -174.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.412 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . -93.35 0.97 57.1 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -168.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -66.15 103.28 0.95 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 119.841 -0.743 . . . . 0.0 111.433 177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.54 47.69 3.42 Favored Glycine 0 N--CA 1.428 -1.845 0 CA-C-N 115.445 -0.798 . . . . 0.0 113.694 174.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.412 ' HD1' ' O ' ' A' ' 81' ' ' ALA . 24.3 p90 -103.78 127.29 51.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 119.257 -0.977 . . . . 0.0 109.523 175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.436 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -98.01 130.24 44.85 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 115.353 -0.839 . . . . 0.0 112.652 -173.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 74.1 mt -85.96 -71.82 0.52 Allowed 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 173.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -171.86 172.36 4.84 Favored 'General case' 0 C--O 1.242 0.699 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 29.2 mtpp 52.58 -95.93 0.05 OUTLIER 'General case' 0 N--CA 1.43 -1.43 0 C-N-CA 126.099 1.76 . . . . 0.0 114.693 -179.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 28.5 pt20 -121.58 -1.12 9.6 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.089 0.471 . . . . 0.0 109.917 -178.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.771 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 10.8 m170 -87.1 99.03 11.62 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.219 -166.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.44 ' O ' ' HD3' ' A' ' 93' ' ' ARG . 3.6 m -133.34 110.0 9.75 Favored 'General case' 0 C--N 1.287 -2.14 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 179.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -81.84 108.7 15.58 Favored 'General case' 0 C--N 1.289 -2.048 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.372 -172.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.482 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 0.2 OUTLIER -90.52 130.24 36.59 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 173.7 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 96.1 t -110.46 105.88 19.66 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 CA-C-O 121.693 0.758 . . . . 0.0 110.585 -173.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.402 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.3 OUTLIER -108.15 166.48 10.71 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 114.835 -1.075 . . . . 0.0 108.943 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.5 pt? -75.25 -174.26 2.3 Favored 'General case' 0 C--O 1.214 -0.779 0 CA-C-O 121.303 0.573 . . . . 0.0 111.162 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.461 ' C ' ' H ' ' A' ' 99' ' ' ASP . 33.7 t80 -91.18 -16.35 27.84 Favored 'General case' 0 C--N 1.309 -1.155 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 -174.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 15.0 m 66.53 -21.39 0.1 Allowed 'General case' 0 CA--C 1.557 1.226 0 C-N-CA 125.358 1.463 . . . . 0.0 113.659 177.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.461 ' H ' ' C ' ' A' ' 97' ' ' PHE . 30.4 t70 -88.94 -34.49 16.88 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.261 176.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . 0.343 20.1 p90 37.31 89.75 0.01 OUTLIER 'General case' 0 C--N 1.348 0.502 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -177.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -86.34 71.09 10.53 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 122.434 1.111 . . . . 0.0 110.219 -174.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . 0.454 ' HE2' ' OD1' ' A' ' 15' ' ' ASP . 1.6 mptm? -106.52 163.01 13.22 Favored 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 113.597 -1.638 . . . . 0.0 110.799 176.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -107.0 167.16 10.08 Favored 'General case' 0 C--N 1.29 -2.017 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 176.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 1.5 tmt? -46.85 -45.76 20.46 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.044 0.938 . . . . 0.0 111.501 177.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.5 m . . . . . 0 N--CA 1.425 -1.714 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.002 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.496 -1.144 0 N-CA-C 110.451 -1.06 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -87.16 144.98 26.6 Favored 'General case' 0 CA--C 1.495 -1.155 0 CA-C-O 121.192 0.52 . . . . 0.0 111.574 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.12 26.74 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.517 -176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 79.0 mt -84.29 -42.37 15.9 Favored 'General case' 0 C--N 1.316 -0.859 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.491 178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 ptmm? -72.94 -48.47 36.57 Favored 'General case' 0 CA--C 1.547 0.83 0 CA-C-O 120.838 0.351 . . . . 0.0 111.231 176.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -106.97 107.41 18.41 Favored 'General case' 0 CA--C 1.479 -1.765 0 N-CA-C 105.616 -1.994 . . . . 0.0 105.616 175.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.459 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . 18.9 mtp180 -100.01 141.24 22.39 Favored Pre-proline 0 C--N 1.277 -2.579 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.949 -174.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 7' ' ' ARG . 12.7 Cg_exo -70.59 128.98 15.99 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.872 1.714 . . . . 0.0 110.668 178.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -142.57 163.85 31.7 Favored 'General case' 0 N--CA 1.419 -2.018 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 176.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' O ' HD21 ' A' ' 96' ' ' LEU . 4.4 mm-40 -78.01 15.77 0.84 Allowed 'General case' 0 C--N 1.306 -1.318 0 C-N-CA 124.292 1.037 . . . . 0.0 111.337 -174.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HB2' HG11 ' A' ' 78' ' ' VAL . . . -80.74 79.99 7.29 Favored 'General case' 0 C--O 1.24 0.589 0 CA-C-O 121.071 0.463 . . . . 0.0 111.999 -174.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -167.47 158.31 11.39 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 177.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 91.27 -115.85 4.8 Favored Glycine 0 C--N 1.309 -0.917 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.387 175.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 7.1 tp -83.79 97.1 4.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 122.649 1.214 . . . . 0.0 112.032 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -78.41 -7.95 57.94 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.357 -1.292 . . . . 0.0 112.365 -174.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.736 ' HA ' ' HE2' ' A' ' 73' ' ' HIS . 12.5 m -100.01 13.36 34.24 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 -170.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 13.4 p -137.08 138.3 45.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 118.732 -1.187 . . . . 0.0 112.911 -177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 11.3 mm -111.62 137.91 42.32 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.953 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.53 ' HB ' HD22 ' A' ' 95' ' ' ASN . 60.4 t -125.59 113.87 36.85 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.479 0 N-CA-C 106.491 -1.67 . . . . 0.0 106.491 173.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.515 ' CG2' HG12 ' A' ' 64' ' ' ILE . 14.3 m -110.14 137.67 41.36 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 CA-C-O 121.306 0.574 . . . . 0.0 110.768 178.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.447 ' C ' HD22 ' A' ' 22' ' ' ASN . 20.7 t70 -97.74 139.73 33.19 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.757 -177.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.447 HD22 ' C ' ' A' ' 21' ' ' ASP 0.423 0.1 OUTLIER 46.06 86.79 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 127.82 2.448 . . . . 0.0 115.536 -179.837 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.506 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 33.4 m -84.83 163.61 45.6 Favored Pre-proline 0 C--N 1.309 -1.178 0 CA-C-N 113.873 -1.512 . . . . 0.0 110.151 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.791 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 1.7 Cg_endo -42.73 145.43 1.07 Allowed 'Trans proline' 0 C--O 1.257 1.469 0 C-N-CA 124.509 3.473 . . . . 0.0 117.556 -179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -62.53 151.72 36.81 Favored 'General case' 0 N--CA 1.435 -1.222 0 CA-C-N 111.648 -2.523 . . . . 0.0 111.085 177.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 27' ' ' GLY . 8.1 p -132.01 146.64 32.93 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.326 -177.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -95.37 171.48 29.48 Favored Glycine 0 C--N 1.29 -2.002 0 N-CA-C 107.011 -2.436 . . . . 0.0 107.011 169.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_exo -59.37 125.62 18.49 Favored 'Trans proline' 0 C--N 1.325 -0.664 0 CA-C-N 120.465 2.133 . . . . 0.0 112.286 -175.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.9 t70 61.02 22.49 12.74 Favored 'General case' 0 N--CA 1.478 0.947 0 C-N-CA 124.599 1.16 . . . . 0.0 111.786 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.467 ' HD2' ' H ' ' A' ' 27' ' ' GLY . 95.9 mtt180 -92.88 -2.5 55.81 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 120.697 -1.252 . . . . 0.0 111.102 175.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.532 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 0.6 OUTLIER -62.1 -23.57 66.6 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-O 120.744 0.307 . . . . 0.0 110.703 -174.084 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -55.48 -47.24 76.45 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 123.468 0.707 . . . . 0.0 109.194 172.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -69.7 -38.21 76.88 Favored 'General case' 0 CA--C 1.505 -0.788 0 CA-C-O 121.893 0.854 . . . . 0.0 109.502 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.434 HD23 HG23 ' A' ' 26' ' ' VAL . 4.1 mm? -72.09 -6.01 39.41 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.047 -0.979 . . . . 0.0 112.507 -178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.532 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 61.9 mttp -85.33 -31.41 23.03 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 170.162 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.586 ' HA ' ' CE1' ' A' ' 39' ' ' HIS . 22.6 t-20 -73.61 -44.61 56.68 Favored 'General case' 0 CA--C 1.48 -1.745 0 CA-C-N 114.746 -1.116 . . . . 0.0 110.158 -173.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.2 p -57.46 -33.05 43.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.046 -0.979 . . . . 0.0 110.566 -179.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.0 mm -66.94 -62.54 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.436 -1.143 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.185 178.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 36' ' ' ASN . 4.9 p-80 -65.3 -20.13 66.27 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 -175.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 21.6 tptm -70.55 -60.13 2.44 Favored 'General case' 0 N--CA 1.419 -2.009 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.52 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 81.9 mt -67.67 -44.12 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.599 0 CA-C-N 116.191 -0.459 . . . . 0.0 112.02 -176.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -68.72 -9.68 51.95 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 114.139 1.163 . . . . 0.0 114.139 -174.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.45 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -67.75 -2.28 6.79 Favored 'General case' 0 CA--C 1.553 1.089 0 N-CA-C 112.084 0.401 . . . . 0.0 112.084 174.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 19.0 ptmt -70.56 -35.22 72.96 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.111 0.482 . . . . 0.0 110.584 171.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CD2' ' HG3' ' A' ' 44' ' ' LYS . 97.3 m-85 -80.08 -14.97 58.1 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.164 -0.926 . . . . 0.0 111.326 -176.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 145.52 -161.3 28.2 Favored Glycine 0 N--CA 1.426 -2.005 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.3 ttmm -91.5 138.74 31.33 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 26.1 mm -74.04 89.78 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.371 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 178.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -76.99 -38.98 52.06 Favored 'General case' 0 N--CA 1.414 -2.233 0 CA-C-N 115.374 -0.83 . . . . 0.0 110.678 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.509 ' HB3' ' HB3' ' A' ' 67' ' ' GLU . 3.3 t-20 -148.64 139.85 23.23 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 176.122 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -144.27 153.91 42.52 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 -178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 73.5 m-85 -132.13 103.26 6.16 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 8.1 m-30 -108.54 106.74 59.27 Favored Pre-proline 0 C--N 1.308 -1.206 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 177.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -72.69 173.17 13.8 Favored 'Trans proline' 0 CA--C 1.545 1.049 0 C-N-CA 121.156 1.238 . . . . 0.0 111.902 174.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -154.99 165.65 36.05 Favored 'General case' 0 C--N 1.298 -1.663 0 C-N-CA 123.631 0.772 . . . . 0.0 109.481 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.599 ' O ' ' HE3' ' A' ' 59' ' ' LYS . 1.0 OUTLIER -149.4 101.44 3.11 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.648 -1.241 . . . . 0.0 107.648 173.551 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 34.3 t70 48.78 27.36 1.54 Allowed 'General case' 0 N--CA 1.498 1.95 0 C-N-CA 126.283 1.833 . . . . 0.0 114.032 174.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.57 9.45 56.52 Favored Glycine 0 C--N 1.309 -0.941 0 O-C-N 121.395 -0.815 . . . . 0.0 112.366 176.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.599 ' HE3' ' O ' ' A' ' 56' ' ' GLU . 0.0 OUTLIER -103.54 170.9 7.67 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.449 ' HB ' ' CG1' ' A' ' 26' ' ' VAL . 5.8 t -92.75 128.73 38.71 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 122.881 1.325 . . . . 0.0 113.37 -172.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 61' ' ' LYS . 5.6 pttp -53.55 161.02 1.12 Allowed 'General case' 0 C--N 1.28 -2.421 0 CA-C-N 111.809 -2.45 . . . . 0.0 110.748 166.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -116.69 18.23 13.13 Favored Glycine 0 C--N 1.298 -1.575 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.002 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.403 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 28.9 p90 -169.96 155.34 5.58 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.515 HG12 ' CG2' ' A' ' 20' ' ' VAL . 22.4 pt -146.65 168.36 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 174.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.433 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 49.4 m-85 -131.84 133.04 44.23 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.526 ' HB3' ' CE1' ' A' ' 68' ' ' TYR . 2.1 mm? -114.13 132.81 55.93 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.61 -1.626 . . . . 0.0 106.61 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.509 ' HB3' ' HB3' ' A' ' 50' ' ' ASN . 1.6 tm-20 -126.41 115.7 20.02 Favored 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.927 -1.508 . . . . 0.0 106.927 -178.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.584 ' HB2' ' NE2' ' A' ' 73' ' ' HIS . 81.5 m-85 -123.29 175.91 6.42 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.626 0.727 . . . . 0.0 111.185 -174.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -120.12 13.98 12.17 Favored 'General case' 0 C--N 1.312 -1.031 0 C-N-CA 124.54 1.136 . . . . 0.0 108.425 174.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.58 ' OG ' ' HD2' ' A' ' 71' ' ' PRO . 23.1 t -75.61 161.17 77.34 Favored Pre-proline 0 CA--C 1.596 2.732 0 CA-C-N 114.075 -1.42 . . . . 0.0 112.297 -172.001 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.58 ' HD2' ' OG ' ' A' ' 70' ' ' SER . 1.2 Cg_exo -36.1 8.69 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.967 1 C-N-CA 129.921 7.081 . . . . 0.0 121.931 177.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HB1' ' CG2' ' A' ' 75' ' ' VAL . . . 85.93 62.43 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.533 0 CA-C-O 124.987 2.327 . . . . 0.0 108.08 -164.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.736 ' HE2' ' HA ' ' A' ' 16' ' ' SER . 17.5 p80 -73.43 -30.06 62.97 Favored 'General case' 0 C--N 1.294 -1.827 0 CA-C-N 109.646 -3.434 . . . . 0.0 109.561 178.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.78 -29.07 64.08 Favored 'General case' 0 CA--C 1.51 -0.596 0 CA-C-O 122.287 1.042 . . . . 0.0 108.582 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.518 ' O ' HG12 ' A' ' 78' ' ' VAL . 57.4 t -75.25 -30.22 22.56 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.497 0 CA-C-N 113.752 -1.567 . . . . 0.0 108.254 176.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -73.65 -41.78 62.25 Favored 'General case' 0 C--O 1.211 -0.936 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 174.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.16 -47.48 75.1 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 122.826 0.45 . . . . 0.0 111.218 176.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.518 HG12 ' O ' ' A' ' 75' ' ' VAL . 1.1 p -67.55 -26.73 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.454 0 CA-C-O 121.381 0.61 . . . . 0.0 110.55 179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.58 -33.82 67.01 Favored 'General case' 0 C--N 1.316 -0.849 0 C-N-CA 124.206 1.003 . . . . 0.0 110.656 176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 20.1 m-80 -60.06 -76.55 0.05 OUTLIER 'General case' 0 CA--C 1.507 -0.711 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.658 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 84' ' ' TYR . . . 177.32 106.54 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.44 0 O-C-N 123.954 0.784 . . . . 0.0 110.489 179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.546 ' HB2' HG22 ' A' ' 94' ' ' VAL . 1.6 t70 -65.52 108.81 2.13 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 170.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.78 52.53 1.51 Allowed Glycine 0 N--CA 1.422 -2.298 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 -175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.484 ' HB3' ' HB3' ' A' ' 81' ' ' ALA . 41.8 p90 -97.72 133.13 42.66 Favored 'General case' 0 N--CA 1.439 -0.998 0 C-N-CA 120.157 -0.617 . . . . 0.0 110.199 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HD3' ' H ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -101.84 129.57 48.09 Favored 'General case' 0 C--N 1.296 -1.756 0 CA-C-N 115.342 -0.844 . . . . 0.0 112.987 -172.119 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 54.6 mt -86.21 -63.37 1.33 Allowed 'General case' 0 C--N 1.305 -1.337 0 CA-C-N 114.847 -1.069 . . . . 0.0 108.865 175.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -161.07 157.22 25.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.029 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 82.1 tttt 42.15 -92.33 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 126.262 1.825 . . . . 0.0 114.187 178.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -119.5 8.78 11.38 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.524 0.602 . . . . 0.0 111.825 -179.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.791 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 22.4 m170 -85.02 93.72 8.66 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -177.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.5 m -132.84 103.64 6.19 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.508 -177.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.9 m-85 -82.22 112.32 19.13 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -171.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.436 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 4.5 mpt_? -81.23 142.8 32.82 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 170.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.546 HG22 ' HB2' ' A' ' 82' ' ' ASP . 14.6 m -120.1 128.94 75.98 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.659 0 C-N-CA 120.19 -0.604 . . . . 0.0 111.878 -173.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.53 HD22 ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -151.61 167.8 26.97 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 170.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.424 HD21 ' O ' ' A' ' 10' ' ' GLU . 0.5 OUTLIER -108.64 -163.1 0.85 Allowed 'General case' 0 C--N 1.278 -2.503 0 C-N-CA 123.27 0.628 . . . . 0.0 111.216 177.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -91.75 6.31 46.46 Favored 'General case' 0 CA--C 1.485 -1.533 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.336 -178.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.627 ' HA ' ' CE1' ' A' ' 100' ' ' PHE . 83.5 m -78.64 67.46 4.39 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 122.94 1.353 . . . . 0.0 110.162 173.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -101.43 -9.96 20.63 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 113.289 -1.778 . . . . 0.0 107.566 178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.627 ' CE1' ' HA ' ' A' ' 98' ' ' THR 0.264 8.7 p90 -59.49 151.34 24.38 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 114.501 1.297 . . . . 0.0 114.501 177.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -49.72 -54.46 18.7 Favored 'General case' 0 C--N 1.321 -0.644 0 C-N-CA 125.511 1.524 . . . . 0.0 114.889 -170.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 2.7 mppt? -102.86 147.2 27.19 Favored 'General case' 0 CA--C 1.507 -0.696 0 C-N-CA 120.022 -0.671 . . . . 0.0 112.318 175.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -168.84 163.03 11.67 Favored 'General case' 0 N--CA 1.438 -1.067 0 C-N-CA 125.108 1.363 . . . . 0.0 107.513 177.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 15.0 tpt -72.22 121.91 20.16 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.382 0.61 . . . . 0.0 110.216 -179.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 11.0 m . . . . . 0 N--CA 1.413 -2.29 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -178.506 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.585 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -83.51 150.4 26.01 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.7 m -93.14 2.14 9.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -175.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.1 mp -96.53 -61.53 1.41 Allowed 'General case' 0 C--N 1.314 -0.973 0 C-N-CA 119.69 -0.804 . . . . 0.0 110.997 -177.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -103.46 -34.38 8.73 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.205 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 32.6 t70 57.7 65.79 1.26 Allowed 'General case' 0 CA--C 1.512 -0.512 0 O-C-N 124.532 1.145 . . . . 0.0 108.998 -175.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 88.6 mtt180 -146.75 159.27 44.31 Favored Pre-proline 0 C--N 1.304 -1.392 0 CA-C-N 114.137 -1.392 . . . . 0.0 108.681 -177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_endo -65.45 169.55 12.42 Favored 'Trans proline' 0 CA--C 1.534 0.503 0 C-N-CA 122.193 1.929 . . . . 0.0 107.73 166.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.5 tp60 -58.16 120.93 9.51 Favored 'General case' 0 C--O 1.243 0.732 0 CA-C-O 121.809 0.814 . . . . 0.0 109.584 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 40.8 mp0 -74.16 -16.72 60.98 Favored 'General case' 0 C--N 1.295 -1.789 0 C-N-CA 126.125 1.77 . . . . 0.0 113.943 -169.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -71.86 135.03 46.44 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -151.81 114.74 4.67 Favored 'General case' 0 C--N 1.309 -1.175 0 CA-C-O 121.551 0.691 . . . . 0.0 110.22 174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 82.22 -71.82 2.91 Favored Glycine 0 C--N 1.286 -2.209 0 CA-C-N 115.034 -0.985 . . . . 0.0 113.334 178.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 4.8 tp -126.08 124.51 66.13 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.331 0.586 . . . . 0.0 111.377 -177.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.611 ' OD1' ' HB2' ' A' ' 96' ' ' LEU . 35.6 t70 -151.22 62.37 0.9 Allowed 'General case' 0 N--CA 1.424 -1.746 0 CA-C-O 122.88 1.324 . . . . 0.0 108.104 172.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.545 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 42.8 m -116.37 14.36 15.69 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.694 179.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.526 ' HB ' ' CD1' ' A' ' 97' ' ' PHE . 61.5 t -138.04 131.83 42.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 O-C-N 121.77 -0.581 . . . . 0.0 110.312 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.447 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 9.7 mm -88.93 135.32 26.08 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.855 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.7 t -109.97 121.46 62.91 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.858 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 174.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.498 HG13 ' HB3' ' A' ' 92' ' ' PHE . 90.9 t -121.1 133.51 67.47 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 123.319 0.387 . . . . 0.0 111.816 -174.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.536 ' HB3' ' HB2' ' A' ' 93' ' ' ARG . 28.9 t70 -101.1 137.51 39.36 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 123.897 0.879 . . . . 0.0 109.52 175.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.424 0.2 OUTLIER 45.88 104.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 127.106 2.162 . . . . 0.0 116.397 -178.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.541 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 17.1 m -109.61 172.17 3.84 Favored Pre-proline 0 C--N 1.289 -2.063 0 CA-C-N 114.171 -1.377 . . . . 0.0 109.437 -179.105 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.575 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 80.9 Cg_exo -42.4 133.14 4.97 Favored 'Trans proline' 0 C--N 1.371 1.733 0 C-N-CA 123.292 2.661 . . . . 0.0 112.043 172.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.584 ' HB3' HE22 ' A' ' 89' ' ' GLN . 0.0 OUTLIER -74.39 155.63 37.9 Favored 'General case' 0 N--CA 1.417 -2.091 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.331 -177.449 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.431 HG11 ' HB2' ' A' ' 31' ' ' LEU . 2.3 t -123.05 165.68 18.88 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 C-N-CA 119.698 -0.801 . . . . 0.0 109.778 -167.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -166.26 -169.62 30.11 Favored Glycine 0 N--CA 1.406 -3.319 0 N-CA-C 104.086 -3.606 . . . . 0.0 104.086 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.53 124.69 16.68 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 CA-C-N 120.867 2.333 . . . . 0.0 111.99 -179.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 13.7 t70 58.62 17.87 5.38 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 126.3 1.84 . . . . 0.0 113.326 177.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.3 mtp85 -79.55 -26.98 41.26 Favored 'General case' 0 CA--C 1.5 -0.976 0 O-C-N 121.022 -1.049 . . . . 0.0 109.814 178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.589 ' O ' ' HG3' ' A' ' 35' ' ' LYS . 2.5 tm? -69.65 -27.48 65.07 Favored 'General case' 0 N--CA 1.435 -1.177 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.427 -177.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.29 -40.55 94.57 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 120.928 0.394 . . . . 0.0 111.053 -178.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.467 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -91.81 -13.84 30.78 Favored 'General case' 0 C--O 1.246 0.906 0 CA-C-O 121.244 0.545 . . . . 0.0 111.569 179.728 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.605 ' O ' HG12 ' A' ' 38' ' ' ILE . 7.2 tt -68.12 -37.61 81.3 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 107.84 -1.171 . . . . 0.0 107.84 177.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.589 ' HG3' ' O ' ' A' ' 31' ' ' LEU . 91.5 mttt -57.8 -25.62 60.82 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.132 178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.537 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 27.9 t-20 -81.71 -44.68 16.75 Favored 'General case' 0 CA--C 1.482 -1.641 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.153 -171.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.4 ' O ' HG12 ' A' ' 41' ' ' ILE . 14.7 p -67.68 -32.52 57.16 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 CA-C-N 115.923 -0.58 . . . . 0.0 109.793 -177.493 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.605 HG12 ' O ' ' A' ' 34' ' ' LEU . 33.7 mm -67.63 -52.53 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.465 177.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 34.3 t-80 -56.31 -38.46 71.32 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.583 -178.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 32.0 mmmt -67.08 -48.02 69.48 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 37' ' ' VAL . 47.3 mm -66.78 -43.98 89.53 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.068 0 CA-C-O 121.512 0.672 . . . . 0.0 110.573 -179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.494 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 73.2 m-85 -83.87 -9.86 58.43 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 114.705 1.372 . . . . 0.0 114.705 -171.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.0 m -72.4 -3.04 21.73 Favored 'General case' 0 C--N 1.312 -1.057 0 O-C-N 121.485 -0.759 . . . . 0.0 111.339 173.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -80.12 -21.72 42.9 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-O 121.174 0.511 . . . . 0.0 110.007 174.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -97.33 1.62 49.66 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.656 -176.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.31 -151.79 22.04 Favored Glycine 0 N--CA 1.427 -1.923 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 -179.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -104.88 128.01 52.92 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.546 HD12 HD12 ' A' ' 66' ' ' LEU . 47.3 mm -73.08 104.26 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.682 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 178.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 32.8 m -79.82 -41.33 26.62 Favored 'General case' 0 C--N 1.288 -2.102 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.177 -174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 49.5 t30 -156.14 161.14 40.38 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -142.66 144.69 32.87 Favored 'General case' 0 C--N 1.285 -2.223 0 CA-C-N 117.977 0.353 . . . . 0.0 110.321 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -130.23 100.44 5.39 Favored 'General case' 0 CA--C 1.492 -1.28 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.448 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -107.82 103.48 49.7 Favored Pre-proline 0 C--N 1.291 -1.947 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 176.347 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.72 170.49 15.55 Favored 'Trans proline' 0 C--O 1.208 -0.979 0 C-N-CA 121.659 1.572 . . . . 0.0 109.95 177.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 14.6 pt-20 -173.8 -175.87 1.14 Allowed 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 -178.256 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.707 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 5.9 mm-40 -144.21 135.42 25.49 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 177.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 50.73 26.69 2.65 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 124.638 1.175 . . . . 0.0 113.734 175.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 62.76 27.54 70.18 Favored Glycine 0 CA--C 1.532 1.154 0 C-N-CA 121.566 -0.349 . . . . 0.0 112.805 -177.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.707 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 62.7 pttt -117.35 -176.57 3.03 Favored 'General case' 0 N--CA 1.442 -0.827 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.472 HG23 ' HA ' ' A' ' 25' ' ' GLN . 48.2 m -43.8 119.29 1.66 Allowed 'General case' 0 N--CA 1.438 -1.057 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 -178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.523 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 49.1 mttm -74.0 169.37 17.62 Favored 'General case' 0 N--CA 1.438 -1.025 0 CA-C-N 113.8 -1.545 . . . . 0.0 109.07 171.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -123.29 -8.62 6.4 Favored Glycine 0 C--N 1.298 -1.58 0 C-N-CA 119.924 -1.131 . . . . 0.0 111.94 176.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -169.54 159.66 8.56 Favored 'General case' 0 C--O 1.239 0.524 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -175.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 41.7 pt -147.21 172.05 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.158 0 C-N-CA 122.968 0.507 . . . . 0.0 109.767 176.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.447 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.9 m-85 -136.26 137.09 40.4 Favored 'General case' 0 C--O 1.243 0.762 0 O-C-N 123.665 0.603 . . . . 0.0 109.975 178.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.546 HD12 HD12 ' A' ' 48' ' ' ILE . 3.6 mm? -111.94 116.48 30.68 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -99.44 124.03 44.23 Favored 'General case' 0 C--N 1.295 -1.777 0 CA-C-O 121.648 0.737 . . . . 0.0 110.668 -177.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 6.2 m-85 -123.13 -176.42 3.42 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.072 -1.084 . . . . 0.0 108.072 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.74 7.65 11.06 Favored 'General case' 0 C--N 1.293 -1.86 0 CA-C-N 115.331 -0.85 . . . . 0.0 108.867 175.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.663 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.6 m -79.66 154.57 76.06 Favored Pre-proline 0 CA--C 1.591 2.548 0 N-CA-C 117.116 2.265 . . . . 0.0 117.116 -165.461 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -39.16 6.61 0.0 OUTLIER 'Trans proline' 0 N--CA 1.518 2.96 2 C-N-CA 130.76 7.64 . . . . 0.0 123.16 178.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.481 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.23 65.25 0.01 OUTLIER 'General case' 0 C--N 1.367 1.329 0 CA-C-N 122.238 2.29 . . . . 0.0 108.86 -158.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.663 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 29.6 p80 -95.63 -24.67 16.47 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 109.36 -3.564 . . . . 0.0 107.738 177.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.413 ' O ' HG23 ' A' ' 78' ' ' VAL . . . -81.11 -33.86 32.99 Favored 'General case' 0 CA--C 1.493 -1.214 0 N-CA-C 107.687 -1.227 . . . . 0.0 107.687 -174.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.401 ' CG1' ' HB1' ' A' ' 72' ' ' ALA . 2.7 p -66.42 -26.88 38.79 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.24 0 CA-C-N 113.837 -1.529 . . . . 0.0 109.611 175.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.41 ' HB3' ' O ' ' A' ' 73' ' ' HIS . 15.8 t70 -69.5 -38.06 77.46 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.04 -42.76 94.0 Favored 'General case' 0 C--O 1.207 -1.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.291 177.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.421 HG21 ' HB3' ' A' ' 96' ' ' LEU . 92.8 t -57.84 -46.76 87.22 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 123.726 0.81 . . . . 0.0 112.245 -178.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -84.89 -15.58 44.06 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 112.558 0.577 . . . . 0.0 112.558 -176.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -109.89 -68.38 0.93 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -177.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -115.66 75.41 0.94 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 121.559 0.695 . . . . 0.0 111.759 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.551 ' HB2' HG22 ' A' ' 94' ' ' VAL . 6.0 t70 -111.42 134.91 52.67 Favored 'General case' 0 C--N 1.291 -1.961 0 CA-C-N 114.975 -1.011 . . . . 0.0 108.731 175.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 69.0 42.48 77.45 Favored Glycine 0 C--N 1.308 -0.993 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 31.0 p90 -92.33 130.97 37.88 Favored 'General case' 0 N--CA 1.432 -1.373 0 CA-C-O 121.097 0.475 . . . . 0.0 110.299 -178.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.47 ' O ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -98.6 126.61 44.24 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -175.518 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.7 mt -87.29 -61.6 1.69 Allowed 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -174.21 149.0 1.36 Allowed 'General case' 0 CA--C 1.511 -0.543 0 CA-C-N 114.767 -1.106 . . . . 0.0 109.381 -174.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 59.9 tttp 58.92 -81.61 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.057 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 170.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.584 HE22 ' HB3' ' A' ' 25' ' ' GLN . 41.2 tt0 -122.27 -9.52 8.59 Favored 'General case' 0 C--N 1.301 -1.511 0 C-N-CA 124.298 1.039 . . . . 0.0 110.148 -172.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.575 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 11.4 m170 -92.97 88.63 6.22 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.915 -167.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.4 m -132.95 98.19 4.22 Favored 'General case' 0 C--N 1.27 -2.871 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.046 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.498 ' HB3' HG13 ' A' ' 20' ' ' VAL . 53.2 m-85 -83.35 113.91 21.06 Favored 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.472 -169.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.536 ' HB2' ' HB3' ' A' ' 21' ' ' ASP . 2.9 mpt_? -89.05 136.85 32.79 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 105.971 -1.862 . . . . 0.0 105.971 174.075 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 82' ' ' ASP . 4.8 m -113.82 151.11 15.69 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.092 0 CA-C-O 121.619 0.723 . . . . 0.0 110.808 -172.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -141.9 152.73 43.85 Favored 'General case' 0 N--CA 1.401 -2.921 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.611 ' HB2' ' OD1' ' A' ' 15' ' ' ASP . 1.1 pt? -84.78 -172.11 4.0 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.942 0.776 . . . . 0.0 111.581 -174.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.526 ' CD1' ' HB ' ' A' ' 17' ' ' VAL . 6.2 t80 -108.97 2.64 21.48 Favored 'General case' 0 C--N 1.315 -0.895 0 C-N-CA 117.14 -1.824 . . . . 0.0 112.287 -176.127 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 58.0 m -78.39 82.48 4.67 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 171.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -77.61 -26.84 50.98 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.87 -1.513 . . . . 0.0 111.673 -176.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -84.66 110.21 18.58 Favored 'General case' 0 C--N 1.306 -1.321 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -101.71 79.61 1.95 Allowed 'General case' 0 C--N 1.297 -1.701 0 CA-C-O 122.057 0.932 . . . . 0.0 109.801 -173.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.97 152.8 35.09 Favored 'General case' 0 C--N 1.287 -2.114 0 CA-C-N 114.333 -1.303 . . . . 0.0 109.46 174.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -105.96 125.14 50.64 Favored 'General case' 0 C--N 1.284 -2.267 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 -178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 27.2 ttt -106.91 99.2 8.78 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.105 -176.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.0 m . . . . . 0 C--N 1.293 -1.881 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 174.835 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.788 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 6' ' ' ASP . 3.4 m-20 -85.5 150.29 24.79 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-O 120.757 0.313 . . . . 0.0 110.338 -178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 29.3 m -106.02 -25.43 3.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.263 178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 86.4 mt -103.98 -45.56 4.71 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.396 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 21.7 mtpp -71.32 -37.61 71.76 Favored 'General case' 0 C--O 1.239 0.521 0 CA-C-O 121.073 0.463 . . . . 0.0 111.632 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 2' ' ' ASP . 26.8 t70 -85.33 105.62 16.12 Favored 'General case' 0 CA--C 1.491 -1.294 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 177.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -142.25 138.73 16.91 Favored Pre-proline 0 C--N 1.278 -2.513 0 CA-C-N 114.525 -1.216 . . . . 0.0 112.338 -173.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -75.75 128.15 10.7 Favored 'Trans proline' 0 N--CA 1.436 -1.873 0 N-CA-C 104.69 -2.85 . . . . 0.0 104.69 162.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -102.45 157.04 17.2 Favored 'General case' 0 C--N 1.29 -1.986 0 C-N-CA 117.419 -1.712 . . . . 0.0 111.959 -172.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -74.87 19.6 0.14 Allowed 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 125.102 1.361 . . . . 0.0 113.291 -172.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.54 93.99 3.65 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 106.871 -1.529 . . . . 0.0 106.871 174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -118.93 119.68 35.04 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 114.952 -1.022 . . . . 0.0 110.775 -174.383 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 85.25 -49.82 4.27 Favored Glycine 0 C--N 1.294 -1.786 0 CA-C-N 114.962 -1.017 . . . . 0.0 112.931 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.438 HG21 ' HB3' ' A' ' 97' ' ' PHE . 8.1 tp -127.84 124.87 63.92 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-O 121.103 0.477 . . . . 0.0 111.295 -176.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.63 ' OD2' ' HA ' ' A' ' 72' ' ' ALA . 5.6 t70 -108.03 -17.19 14.11 Favored 'General case' 0 C--O 1.18 -2.585 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.437 175.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.575 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 16.3 m -85.1 -1.49 56.93 Favored 'General case' 0 C--N 1.273 -2.751 0 O-C-N 120.585 -1.322 . . . . 0.0 113.72 -172.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.492 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 60.7 t -117.67 128.48 74.86 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 C-N-CA 120.456 -0.498 . . . . 0.0 111.442 -175.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 18.6 mm -94.85 136.68 25.28 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.91 0 N-CA-C 106.195 -1.78 . . . . 0.0 106.195 175.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 39.3 t -136.01 119.34 23.28 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.204 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 -177.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.513 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 15.5 m -125.09 133.33 69.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 CA-C-O 120.817 0.341 . . . . 0.0 111.022 178.128 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -97.87 135.5 39.52 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.261 -0.882 . . . . 0.0 110.33 179.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.483 0.2 OUTLIER 48.34 85.64 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 127.675 2.39 . . . . 0.0 116.983 -178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.46 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 16.8 m -81.93 169.76 17.43 Favored Pre-proline 0 C--N 1.301 -1.528 0 CA-C-N 113.73 -1.577 . . . . 0.0 109.467 177.054 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 2.0 Cg_endo -44.35 138.05 7.55 Favored 'Trans proline' 0 C--N 1.372 1.778 0 C-N-CA 123.286 2.657 . . . . 0.0 112.312 173.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.565 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 3.8 pm0 -69.35 154.92 41.27 Favored 'General case' 0 N--CA 1.441 -0.913 0 N-CA-C 109.295 -0.631 . . . . 0.0 109.295 -176.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 3.5 t -124.23 147.64 28.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.485 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.032 -174.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -121.94 175.34 16.28 Favored Glycine 0 N--CA 1.419 -2.457 0 N-CA-C 106.941 -2.464 . . . . 0.0 106.941 174.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -55.73 126.88 23.91 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 122.023 1.815 . . . . 0.0 111.928 -178.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 68.17 17.41 9.39 Favored 'General case' 0 CA--C 1.502 -0.88 0 C-N-CA 125.002 1.321 . . . . 0.0 113.574 177.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.0 mtm105 -104.07 -6.18 21.37 Favored 'General case' 0 C--N 1.303 -1.448 0 C-N-CA 119.527 -0.869 . . . . 0.0 111.163 177.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.539 HD21 ' HE2' ' A' ' 61' ' ' LYS . 1.2 tm? -66.87 -31.5 72.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.122 178.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 66.1 mm-40 -61.31 -40.03 92.68 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.859 0.688 . . . . 0.0 112.859 -175.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -84.44 -13.46 52.03 Favored 'General case' 0 C--N 1.32 -0.674 0 C-N-CA 119.668 -0.813 . . . . 0.0 111.2 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.524 ' O ' HG12 ' A' ' 37' ' ' VAL . 8.6 tt -72.86 -28.35 62.46 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -65.21 -22.06 66.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.613 177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.629 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 25.4 t-20 -79.78 -43.67 22.07 Favored 'General case' 0 CA--C 1.499 -1.018 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.257 -175.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 34' ' ' LEU . 9.0 p -63.9 -24.6 36.17 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.369 -174.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.9 mm -55.61 -59.82 2.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.044 0.938 . . . . 0.0 110.408 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 27.2 p80 -73.08 -17.0 61.46 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -177.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.629 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 30.5 mmmt -71.39 -52.25 19.63 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 74.8 mt -80.03 -52.52 14.54 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.127 -177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.568 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 22.7 m-85 -73.49 -6.43 46.36 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -169.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.9 p -71.82 -18.3 62.09 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-O 121.84 0.829 . . . . 0.0 110.455 178.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.557 ' HA ' ' HE3' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -84.8 -3.84 58.81 Favored 'General case' 0 C--N 1.308 -1.205 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.21 179.78 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.526 ' HB3' ' HB2' ' A' ' 77' ' ' ALA . 76.5 m-85 -120.23 18.55 12.27 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.085 -178.194 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 139.14 -174.89 21.93 Favored Glycine 0 CA--C 1.499 -0.93 0 N-CA-C 110.229 -1.148 . . . . 0.0 110.229 179.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.6 tppt? -101.6 138.59 38.39 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 23.9 mm -75.68 88.96 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 -177.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 33.3 m -82.06 -55.37 4.61 Favored 'General case' 0 N--CA 1.427 -1.577 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.879 178.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.57 ' HB2' ' HB3' ' A' ' 67' ' ' GLU . 19.7 m120 -137.08 145.73 44.29 Favored 'General case' 0 C--N 1.309 -1.175 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -137.26 135.75 37.46 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -128.19 110.7 12.67 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.414 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.422 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 8.3 m-85 -106.05 106.29 56.44 Favored Pre-proline 0 N--CA 1.425 -1.685 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 178.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -80.59 173.67 12.0 Favored 'Trans proline' 0 N--CA 1.442 -1.544 0 C-N-CA 122.182 1.922 . . . . 0.0 109.885 176.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -148.45 170.01 18.97 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 -178.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 16.4 mm-40 -120.67 99.76 6.72 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 106.982 -1.488 . . . . 0.0 106.982 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.6 t70 39.66 56.21 2.35 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 125.028 1.331 . . . . 0.0 111.553 -177.139 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.3 -3.12 41.59 Favored Glycine 0 N--CA 1.466 0.68 0 CA-C-N 113.466 -1.697 . . . . 0.0 115.197 177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 35.4 mtmm -100.0 -177.46 3.55 Favored 'General case' 0 C--N 1.296 -1.736 0 O-C-N 122.337 -0.508 . . . . 0.0 111.056 -176.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 21.1 m -45.66 129.19 8.89 Favored 'General case' 0 N--CA 1.433 -1.315 0 C-N-CA 126.027 1.731 . . . . 0.0 111.611 177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.539 ' HE2' HD21 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -88.72 160.27 17.4 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.431 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -135.01 21.31 3.72 Favored Glycine 0 CA--C 1.489 -1.574 0 C-N-CA 119.817 -1.182 . . . . 0.0 111.066 -179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.513 ' HA ' ' O ' ' A' ' 20' ' ' VAL . 31.7 p90 -170.81 148.21 2.87 Favored 'General case' 0 C--N 1.315 -0.902 0 N-CA-C 108.404 -0.962 . . . . 0.0 108.404 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.498 HG12 ' CG2' ' A' ' 20' ' ' VAL . 21.5 pt -141.41 166.16 18.03 Favored 'Isoleucine or valine' 0 C--O 1.245 0.83 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 175.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.464 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 76.8 m-85 -136.41 134.34 37.65 Favored 'General case' 0 CA--C 1.499 -0.997 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.4 mp -120.6 145.32 47.49 Favored 'General case' 0 C--N 1.28 -2.455 0 N-CA-C 108.531 -0.914 . . . . 0.0 108.531 175.789 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.57 ' HB3' ' HB2' ' A' ' 50' ' ' ASN . 9.3 tp10 -124.28 116.12 22.13 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 -176.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.568 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 12.4 m-30 -118.31 171.6 8.02 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -118.78 14.26 13.37 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.6 0.715 . . . . 0.0 109.286 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.63 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 14.3 m -75.74 160.15 79.64 Favored Pre-proline 0 CA--C 1.608 3.187 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -170.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.402 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 24.1 Cg_exo -39.99 7.55 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.054 2 C-N-CA 129.972 7.115 . . . . 0.0 123.997 -179.016 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.63 ' HA ' ' OD2' ' A' ' 15' ' ' ASP . . . 87.36 66.77 0.01 OUTLIER 'General case' 0 CA--C 1.475 -1.932 0 CA-C-N 122.46 2.391 . . . . 0.0 106.579 -155.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.63 ' CD2' ' HB2' ' A' ' 70' ' ' SER . 26.6 p80 -97.02 -36.95 10.35 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 109.32 -3.582 . . . . 0.0 110.566 -175.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.602 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -80.88 -20.84 41.37 Favored 'General case' 0 CA--C 1.474 -1.955 0 C-N-CA 119.673 -0.811 . . . . 0.0 109.251 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.8 p -59.45 -30.07 43.6 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 172.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -83.53 -49.29 9.38 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 174.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.602 ' HB3' ' HA ' ' A' ' 74' ' ' ALA . . . -55.49 -42.58 74.62 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.395 -177.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.4 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 42.7 t -66.88 -22.85 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.79 0 C-N-CA 123.181 0.592 . . . . 0.0 111.556 -177.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -85.72 -47.52 9.69 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-O 122.153 0.978 . . . . 0.0 109.805 174.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 -86.52 -11.69 50.94 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 115.497 1.666 . . . . 0.0 115.497 -167.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -118.42 13.25 13.51 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-O 121.188 0.518 . . . . 0.0 110.278 177.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' A' ' 78' ' ' VAL . 9.3 t70 -78.93 106.37 10.91 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 -176.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.46 51.68 6.48 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-N 114.518 -1.219 . . . . 0.0 115.405 172.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.611 ' O ' ' HA ' ' A' ' 91' ' ' THR . 49.2 m-85 -101.5 106.18 17.25 Favored 'General case' 0 CA--C 1.491 -1.31 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -178.487 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.475 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 2.8 mptt -77.41 99.64 5.68 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 173.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 43.6 mt -59.57 -52.45 65.52 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-O 121.001 0.429 . . . . 0.0 110.544 -179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.525 ' OD2' ' HG2' ' A' ' 88' ' ' LYS . 27.4 t70 -151.54 -76.13 0.14 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.877 -177.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' HG2' ' OD2' ' A' ' 87' ' ' ASP . 0.0 OUTLIER -100.86 -101.21 0.25 Allowed 'General case' 0 N--CA 1.418 -2.074 0 CA-C-O 121.376 0.607 . . . . 0.0 112.596 178.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.565 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 0.0 OUTLIER -92.55 3.33 55.74 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.534 0.683 . . . . 0.0 111.701 -175.911 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 m-70 -86.99 96.54 10.31 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.611 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 39.5 m -133.41 123.98 26.31 Favored 'General case' 0 C--N 1.275 -2.671 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 -179.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -98.88 101.85 13.39 Favored 'General case' 0 CA--C 1.478 -1.791 0 C-N-CA 118.247 -1.381 . . . . 0.0 109.476 -176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -93.92 126.42 39.11 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 175.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 16.4 m -95.3 150.62 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.753 0 C-N-CA 119.615 -0.834 . . . . 0.0 109.31 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -155.81 175.05 14.44 Favored 'General case' 0 N--CA 1.397 -3.108 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -66.99 177.28 1.77 Allowed 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.438 ' HB3' HG21 ' A' ' 14' ' ' ILE . 84.8 t80 -131.56 -27.69 1.91 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 112.961 -1.927 . . . . 0.0 109.43 177.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -25.37 60.08 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.75 0.786 . . . . 0.0 112.25 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -109.73 -19.53 13.13 Favored 'General case' 0 C--N 1.282 -2.333 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.17 -176.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -113.22 153.45 28.33 Favored 'General case' 0 C--N 1.309 -1.193 0 N-CA-C 114.588 1.329 . . . . 0.0 114.588 -173.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.2 t70 166.69 125.47 0.01 OUTLIER 'General case' 0 CA--C 1.485 -1.556 0 C-N-CA 129.474 3.11 . . . . 0.0 103.002 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.16 145.23 3.29 Favored 'General case' 0 C--N 1.302 -1.486 0 CA-C-O 121.752 0.787 . . . . 0.0 113.097 178.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . 0.431 ' CE2' ' HB ' ' A' ' 105' ' ' THR . 41.4 t80 -90.57 97.87 11.44 Favored 'General case' 0 C--N 1.281 -2.382 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.986 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 10.6 tmm? -109.62 97.67 7.18 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 179.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.431 ' HB ' ' CE2' ' A' ' 103' ' ' TYR . 38.2 m . . . . . 0 C--N 1.294 -1.845 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 176.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.501 -0.831 0 N-CA-C 110.883 -0.887 . . . . 0.0 110.883 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -92.38 146.29 23.81 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 176.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 15.6 m -111.23 96.03 4.34 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 CA-C-O 121.883 0.849 . . . . 0.0 111.995 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 59.5 tp -84.19 -42.99 15.39 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.033 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.06 16.07 22.09 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.404 -176.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.6 t70 72.32 -49.18 0.69 Allowed 'General case' 0 N--CA 1.494 1.774 0 C-N-CA 125.236 1.414 . . . . 0.0 112.09 -178.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 94.3 mtt180 -69.47 124.71 91.07 Favored Pre-proline 0 C--N 1.299 -1.6 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.32 128.38 25.32 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 123.343 2.695 . . . . 0.0 112.809 -177.237 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 7.2 tm0? -76.44 131.89 39.33 Favored 'General case' 0 N--CA 1.423 -1.798 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.813 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 37.1 mt-10 -123.46 -21.58 5.26 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.189 168.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.35 98.41 0.24 Allowed 'General case' 0 C--O 1.236 0.344 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.325 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -90.72 126.93 36.14 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 -178.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -98.22 146.99 18.42 Favored Glycine 0 C--N 1.29 -1.975 0 C-N-CA 120.583 -0.818 . . . . 0.0 111.917 -176.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.542 HG23 ' HB3' ' A' ' 97' ' ' PHE . 4.4 tp -84.04 87.08 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.664 0 CA-C-O 123.096 1.427 . . . . 0.0 109.429 175.239 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -103.75 40.49 1.42 Allowed 'General case' 0 C--N 1.303 -1.438 0 CA-C-N 113.155 -1.839 . . . . 0.0 109.739 -175.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.563 ' HA ' ' NE2' ' A' ' 73' ' ' HIS . 21.4 m -107.28 6.2 28.31 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.785 177.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 47.3 t -139.27 135.72 41.26 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.203 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 -179.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 9.6 mm -101.04 130.34 50.59 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.073 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 175.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 32.2 t -103.09 110.55 29.99 Favored 'Isoleucine or valine' 0 C--N 1.262 -3.223 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 175.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.421 HG13 ' HB3' ' A' ' 92' ' ' PHE . 70.6 t -97.83 135.51 32.07 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 O-C-N 123.924 0.765 . . . . 0.0 111.763 -175.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -107.1 132.11 53.36 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 175.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.426 0.2 OUTLIER 47.79 100.27 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 126.846 2.058 . . . . 0.0 116.49 -178.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.554 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 22.5 m -91.57 173.77 5.01 Favored Pre-proline 0 C--N 1.303 -1.419 0 CA-C-N 114.391 -1.277 . . . . 0.0 110.668 -179.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HA ' ' CE1' ' A' ' 90' ' ' HIS . 98.8 Cg_exo -42.53 146.0 0.86 Allowed 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 123.195 2.596 . . . . 0.0 113.772 171.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -82.42 121.25 26.48 Favored 'General case' 0 N--CA 1.425 -1.698 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.407 -176.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.409 HG21 ' HB2' ' A' ' 31' ' ' LEU . 5.2 p -121.98 137.57 55.14 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.464 0 CA-C-N 114.964 -1.016 . . . . 0.0 111.8 -173.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -111.54 169.35 13.16 Favored Glycine 0 N--CA 1.405 -3.394 0 N-CA-C 107.431 -2.268 . . . . 0.0 107.431 172.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.27 127.67 22.88 Favored 'Trans proline' 0 C--O 1.253 1.253 0 C-N-CA 123.123 2.548 . . . . 0.0 112.775 -177.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 37.8 t70 73.66 21.15 2.88 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 124.998 1.319 . . . . 0.0 112.904 175.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 48.9 mtp180 -116.63 -1.58 12.12 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.538 -0.865 . . . . 0.0 111.095 175.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.409 ' HB2' HG21 ' A' ' 26' ' ' VAL . 3.3 tm? -67.53 -35.65 79.49 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 -173.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.444 ' O ' ' HG2' ' A' ' 35' ' ' LYS . 40.8 tt0 -63.27 -37.0 85.53 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 112.372 0.508 . . . . 0.0 112.372 -172.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 20.5 ptmt -78.05 -32.58 50.94 Favored 'General case' 0 C--N 1.313 -1.017 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.543 177.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.537 ' O ' HG12 ' A' ' 38' ' ' ILE . 9.4 mp -71.7 -26.02 62.32 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-N 116.16 -0.473 . . . . 0.0 112.162 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 32' ' ' GLU . 13.9 ptmm? -82.47 -18.22 42.46 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.628 0.728 . . . . 0.0 109.412 176.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -82.19 -37.79 25.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.232 -0.894 . . . . 0.0 109.201 -177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.438 ' O ' HG12 ' A' ' 41' ' ' ILE . 10.3 p -66.09 -32.12 56.71 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.854 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.941 177.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.537 HG12 ' O ' ' A' ' 34' ' ' LEU . 30.4 mm -58.36 -55.27 23.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.516 0 CA-C-O 121.374 0.607 . . . . 0.0 109.465 173.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 37.4 t-80 -55.14 -41.59 71.96 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 114.32 -1.309 . . . . 0.0 109.6 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -60.96 -57.44 12.61 Favored 'General case' 0 N--CA 1.431 -1.414 0 C-N-CA 123.599 0.76 . . . . 0.0 111.403 178.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.438 HG12 ' O ' ' A' ' 37' ' ' VAL . 41.2 mm -55.7 -51.06 63.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 121.656 0.741 . . . . 0.0 111.229 -178.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.564 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 65.8 m-85 -74.57 -6.17 47.03 Favored 'General case' 0 N--CA 1.415 -2.22 0 N-CA-C 114.42 1.267 . . . . 0.0 114.42 -173.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 63.3 m -70.57 -11.91 61.23 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.66 -0.65 . . . . 0.0 111.428 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -74.79 -14.92 60.76 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.447 0.642 . . . . 0.0 110.58 176.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.07 0.63 32.27 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.746 179.577 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 137.27 -166.18 25.04 Favored Glycine 0 N--CA 1.432 -1.623 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -91.94 129.22 37.95 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 179.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.479 HD12 HD12 ' A' ' 66' ' ' LEU . 26.3 mm -74.75 103.69 2.81 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 -179.061 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 27.4 m -71.55 -55.34 8.02 Favored 'General case' 0 N--CA 1.426 -1.661 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -145.22 169.31 18.46 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.604 ' HA ' ' O ' ' A' ' 65' ' ' PHE . 51.5 t0 -158.35 160.52 37.04 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 105.199 -2.148 . . . . 0.0 105.199 175.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.4 m-85 -136.63 103.26 5.17 Favored 'General case' 0 C--N 1.277 -2.561 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -171.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.449 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 21.7 m-85 -108.2 105.07 55.78 Favored Pre-proline 0 C--N 1.299 -1.621 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.591 -175.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.486 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 96.7 Cg_endo -89.26 164.13 5.6 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 121.402 1.402 . . . . 0.0 109.592 173.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -176.37 -175.51 0.68 Allowed 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.721 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 1.9 tm-20 -154.98 114.55 3.71 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 177.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 38.0 t70 64.89 26.47 12.84 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 124.932 1.293 . . . . 0.0 110.292 -178.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 64.61 24.42 69.55 Favored Glycine 0 CA--C 1.525 0.696 0 CA-C-N 115.074 -0.966 . . . . 0.0 114.702 178.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.721 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 15.4 pttm -92.47 -177.95 4.76 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 117.565 0.682 . . . . 0.0 110.278 176.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 18.7 m -71.61 108.09 4.8 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 114.552 1.316 . . . . 0.0 114.552 -171.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.486 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 3.4 pttm -69.97 160.33 32.11 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 114.184 -1.371 . . . . 0.0 109.192 165.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.69 14.77 12.87 Favored Glycine 0 N--CA 1.431 -1.642 0 C-N-CA 119.894 -1.146 . . . . 0.0 113.129 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.7 p90 -169.05 152.49 5.15 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 117.185 0.493 . . . . 0.0 110.986 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 32.5 pt -147.37 174.87 1.73 Allowed 'Isoleucine or valine' 0 C--O 1.262 1.736 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 177.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 51' ' ' ASP . 86.6 m-85 -141.56 113.94 8.2 Favored 'General case' 0 CA--C 1.497 -1.059 0 CA-C-N 118.313 0.506 . . . . 0.0 110.447 -177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.479 HD12 HD12 ' A' ' 48' ' ' ILE . 3.7 mm? -89.62 108.89 19.94 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 -177.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -101.32 123.54 45.58 Favored 'General case' 0 C--N 1.286 -2.192 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -178.33 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.564 ' OH ' ' HB3' ' A' ' 42' ' ' PHE . 22.2 m-85 -121.17 175.86 5.89 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -119.4 13.78 12.75 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 174.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.529 ' HB2' ' CD2' ' A' ' 73' ' ' HIS . 11.7 m -77.3 158.99 78.7 Favored Pre-proline 0 CA--C 1.581 2.159 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 -170.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 70' ' ' SER . 4.7 Cg_endo -39.88 7.63 0.0 OUTLIER 'Trans proline' 0 N--CA 1.511 2.515 1 C-N-CA 129.866 7.044 . . . . 0.0 121.743 179.167 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.615 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 84.41 65.45 0.01 OUTLIER 'General case' 0 CA--C 1.483 -1.611 0 CA-C-O 124.706 2.193 . . . . 0.0 107.534 -160.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.563 ' NE2' ' HA ' ' A' ' 16' ' ' SER . 27.2 p80 -82.6 -36.18 26.39 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 109.612 -3.449 . . . . 0.0 108.809 177.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -72.37 -28.44 63.01 Favored 'General case' 0 CA--C 1.49 -1.342 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.501 -176.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.615 HG12 ' O ' ' A' ' 72' ' ' ALA . 2.7 p -68.09 -24.41 30.12 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.305 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.571 178.446 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.539 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 26.8 t70 -83.78 -41.84 17.15 Favored 'General case' 0 C--N 1.34 0.174 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.83 175.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.79 -48.51 79.49 Favored 'General case' 0 C--O 1.245 0.865 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.365 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.458 HG12 HG23 ' A' ' 94' ' ' VAL . 34.4 m -66.03 -21.56 29.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.63 0 CA-C-O 121.439 0.638 . . . . 0.0 111.69 -179.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 27.3 ttpp -79.31 -43.6 23.28 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-O 121.785 0.803 . . . . 0.0 110.73 -179.04 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 91.6 m-20 -82.64 -56.09 4.06 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 114.821 -1.081 . . . . 0.0 113.344 -171.208 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.44 ' HB3' ' CE1' ' A' ' 84' ' ' TYR . . . -155.9 87.97 1.09 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 119.173 -1.011 . . . . 0.0 113.4 -176.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.474 ' CB ' HG22 ' A' ' 94' ' ' VAL . 2.7 t70 -77.42 109.83 11.67 Favored 'General case' 0 C--N 1.289 -2.043 0 N-CA-C 107.67 -1.233 . . . . 0.0 107.67 168.273 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 108.49 56.17 0.57 Allowed Glycine 0 N--CA 1.416 -2.641 0 N-CA-C 109.651 -1.38 . . . . 0.0 109.651 -174.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.494 ' O ' ' HA ' ' A' ' 91' ' ' THR . 78.7 m-85 -67.59 99.33 0.76 Allowed 'General case' 0 CA--C 1.502 -0.889 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.51 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -85.01 100.0 11.38 Favored 'General case' 0 N--CA 1.416 -2.168 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 176.052 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 mt -78.15 -50.84 11.21 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.208 179.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -150.22 174.53 12.71 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -176.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 7.9 tmtm? -30.97 -61.98 0.18 Allowed 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 126.767 2.027 . . . . 0.0 114.979 -173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 26.9 pt20 -105.1 12.71 31.79 Favored 'General case' 0 C--N 1.317 -0.838 0 C-N-CA 119.265 -0.974 . . . . 0.0 112.882 -172.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.724 ' CE1' ' HA ' ' A' ' 24' ' ' PRO . 20.0 m-70 -117.05 100.67 7.89 Favored 'General case' 0 C--N 1.312 -1.034 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.249 -177.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.494 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 9.0 m -133.02 101.1 5.1 Favored 'General case' 0 C--N 1.291 -1.947 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.005 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.421 ' HB3' HG13 ' A' ' 20' ' ' VAL . 10.2 m-85 -82.39 106.47 14.29 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 121.071 -0.252 . . . . 0.0 111.522 -171.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.9 mpt_? -78.88 137.4 37.65 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 173.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.474 HG22 ' CB ' ' A' ' 82' ' ' ASP . 6.4 m -114.66 149.3 16.95 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.899 0 O-C-N 123.697 0.623 . . . . 0.0 109.681 -170.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -159.69 159.54 33.09 Favored 'General case' 0 C--N 1.282 -2.326 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 171.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.548 HD23 ' H ' ' A' ' 96' ' ' LEU . 1.8 pt? -79.42 -167.54 1.24 Allowed 'General case' 0 C--N 1.31 -1.128 0 O-C-N 124.116 0.885 . . . . 0.0 111.294 -177.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . 0.542 ' HB3' HG23 ' A' ' 14' ' ' ILE . 28.6 t80 -82.93 -16.03 49.0 Favored 'General case' 0 C--N 1.307 -1.269 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.784 -176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.426 ' H ' ' HG ' ' A' ' 96' ' ' LEU . 4.5 m -86.09 70.05 10.55 Favored 'General case' 0 N--CA 1.439 -1.011 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 174.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -74.77 -21.45 59.33 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 115.352 -0.84 . . . . 0.0 111.418 -176.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 81.5 m-85 -93.13 26.55 2.81 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-O 121.82 0.819 . . . . 0.0 112.069 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 98' ' ' THR . 38.2 t70 -117.64 77.52 1.15 Allowed 'General case' 0 C--N 1.279 -2.499 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 28.1 mmmt -94.9 167.33 11.48 Favored 'General case' 0 C--N 1.295 -1.771 0 CA-C-N 113.765 -1.561 . . . . 0.0 108.523 -176.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 64.9 t80 -118.06 76.36 1.07 Allowed 'General case' 0 N--CA 1.419 -1.999 0 CA-C-O 122.152 0.977 . . . . 0.0 109.203 173.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 14.6 tmm? -95.57 -40.89 9.2 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 106.103 -1.814 . . . . 0.0 106.103 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 63.9 m . . . . . 0 N--CA 1.426 -1.669 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 173.939 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.491 -1.423 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . 0.559 ' O ' HG23 ' A' ' 3' ' ' VAL . 4.8 m-20 -91.33 111.61 23.17 Favored 'General case' 0 CA--C 1.486 -1.505 0 C-N-CA 120.127 -0.629 . . . . 0.0 111.339 178.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 2' ' ' ASP . 15.3 t 178.66 128.3 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 C-N-CA 130.466 3.506 . . . . 0.0 104.257 -178.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.7 mp -66.86 -26.07 66.72 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-O 121.153 0.501 . . . . 0.0 112.219 -175.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.429 ' HD2' ' N ' ' A' ' 5' ' ' LYS . 0.1 OUTLIER -85.62 -10.97 55.04 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.893 178.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 21.2 t0 -99.88 79.01 2.17 Favored 'General case' 0 CA--C 1.498 -1.054 0 CA-C-O 121.961 0.886 . . . . 0.0 108.692 -179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -112.94 161.74 25.16 Favored Pre-proline 0 C--N 1.297 -1.7 0 CA-C-N 114.376 -1.284 . . . . 0.0 108.878 -178.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_exo -65.47 149.39 87.91 Favored 'Trans proline' 0 C--O 1.246 0.903 0 C-N-CA 121.929 1.752 . . . . 0.0 109.706 173.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -73.63 133.29 43.43 Favored 'General case' 0 N--CA 1.422 -1.87 0 CA-C-O 122.609 1.195 . . . . 0.0 109.635 -178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -82.69 -21.72 34.8 Favored 'General case' 0 C--N 1.272 -2.781 0 CA-C-N 112.127 -2.306 . . . . 0.0 110.936 -171.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -76.07 153.09 36.62 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 176.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -102.8 174.06 6.05 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 101' ' ' ASP . . . -170.53 -139.75 2.83 Favored Glycine 0 CA--C 1.472 -2.633 0 C-N-CA 119.634 -1.27 . . . . 0.0 113.645 -173.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.813 HD13 ' H ' ' A' ' 16' ' ' SER . 1.4 pp -74.0 -172.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.393 -3.276 0 CA-C-O 122.899 1.333 . . . . 0.0 113.242 -177.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 18.2 p-10 -122.41 13.57 10.25 Favored 'General case' 0 C--N 1.26 -3.285 0 CA-C-N 112.905 -1.952 . . . . 0.0 107.889 -178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.813 ' H ' HD13 ' A' ' 14' ' ' ILE . 5.1 m -101.37 11.66 38.81 Favored 'General case' 0 N--CA 1.43 -1.472 0 N-CA-C 116.174 1.916 . . . . 0.0 116.174 -167.502 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 10.5 p -156.8 141.48 8.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.997 0 C-N-CA 118.47 -1.292 . . . . 0.0 111.909 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.481 ' CG1' ' HB2' ' A' ' 66' ' ' LEU . 32.5 mm -100.29 132.93 44.94 Favored 'Isoleucine or valine' 0 CA--C 1.486 -1.482 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 170.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.572 ' HB ' ' O ' ' A' ' 95' ' ' ASN . 67.9 t -135.88 109.37 9.53 Favored 'Isoleucine or valine' 0 C--N 1.257 -3.433 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 177.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 5.8 m -112.51 123.46 68.23 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.253 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.532 177.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -97.45 144.61 27.01 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.345 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 62' ' ' GLY 0.533 0.3 OUTLIER 42.93 80.5 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 116.787 2.143 . . . . 0.0 116.787 -176.694 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.512 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 19.4 m -91.57 168.09 14.09 Favored Pre-proline 0 N--CA 1.425 -1.719 0 CA-C-N 112.873 -1.967 . . . . 0.0 108.284 177.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.789 ' HA ' ' CD2' ' A' ' 90' ' ' HIS . 73.3 Cg_exo -45.58 129.05 11.1 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.597 2.865 . . . . 0.0 113.502 175.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -72.45 153.46 41.38 Favored 'General case' 0 N--CA 1.434 -1.229 0 CA-C-N 114.741 -1.118 . . . . 0.0 108.244 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.447 HG12 ' OG1' ' A' ' 60' ' ' THR . 10.7 p -92.71 134.6 30.16 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.362 0 C-N-CA 118.589 -1.245 . . . . 0.0 111.382 178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.412 ' H ' ' HB2' ' A' ' 30' ' ' ARG . . . -123.21 176.35 16.65 Favored Glycine 0 N--CA 1.414 -2.813 0 N-CA-C 105.765 -2.934 . . . . 0.0 105.765 171.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -50.97 127.05 20.35 Favored 'Trans proline' 0 C--N 1.322 -0.82 0 C-N-CA 122.557 2.171 . . . . 0.0 112.14 179.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 63.31 23.42 13.78 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.122 1.369 . . . . 0.0 112.85 177.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HB2' ' H ' ' A' ' 27' ' ' GLY . 58.9 mtp180 -105.2 -10.99 16.75 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.36 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.412 ' HB2' HG21 ' A' ' 26' ' ' VAL . 1.7 tm? -73.35 -42.05 62.72 Favored 'General case' 0 C--N 1.321 -0.643 0 C-N-CA 120.423 -0.511 . . . . 0.0 110.066 -175.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.0 tp10 -65.59 -37.91 88.0 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 116.658 -0.247 . . . . 0.0 111.046 -177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -81.25 -17.7 48.58 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 119.289 -0.964 . . . . 0.0 110.658 178.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.557 ' O ' HG12 ' A' ' 38' ' ' ILE . 62.6 tp -70.02 -39.7 75.65 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 174.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.6 -39.61 84.77 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 122.163 0.982 . . . . 0.0 109.816 176.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.46 ' OD1' ' HE2' ' A' ' 40' ' ' LYS . 41.6 t-20 -78.35 -37.5 44.23 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.644 -171.007 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 34' ' ' LEU . 5.1 p -65.28 -29.36 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.551 -177.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 34' ' ' LEU . 36.5 mm -64.94 -50.65 74.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 176.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -63.48 -20.12 65.32 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.317 -0.856 . . . . 0.0 112.724 -179.117 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.46 ' HE2' ' OD1' ' A' ' 36' ' ' ASN . 62.1 mttm -86.23 -60.1 2.1 Favored 'General case' 0 C--N 1.303 -1.451 0 C-N-CA 120.759 -0.376 . . . . 0.0 111.412 175.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.584 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 77.9 mt -66.22 -42.22 90.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -174.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CD2' HD11 ' A' ' 66' ' ' LEU . 3.3 m-85 -79.31 -23.57 43.41 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 112.704 0.631 . . . . 0.0 112.704 -170.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.565 ' HA ' ' O ' ' A' ' 46' ' ' GLY . 67.3 m -64.43 -8.17 12.49 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.584 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 21.7 ptmt -68.35 -33.04 73.57 Favored 'General case' 0 CA--C 1.508 -0.673 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 173.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.4 ' CE1' ' HA ' ' A' ' 77' ' ' ALA . 30.0 m-85 -83.33 -17.19 43.3 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.595 -176.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' O ' ' HA ' ' A' ' 43' ' ' SER . . . 153.16 -177.84 30.56 Favored Glycine 0 C--O 1.219 -0.81 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -76.86 131.93 38.88 Favored 'General case' 0 CA--C 1.508 -0.658 0 N-CA-C 109.447 -0.575 . . . . 0.0 109.447 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 44.5 mm -74.09 103.11 2.19 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 21.3 m -82.02 -60.68 2.14 Favored 'General case' 0 N--CA 1.427 -1.594 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.789 -178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.461 ' HB2' ' HB2' ' A' ' 67' ' ' GLU . 91.3 m-20 -126.91 122.97 36.11 Favored 'General case' 0 CA--C 1.478 -1.791 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -110.74 133.68 53.13 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -120.47 102.9 8.76 Favored 'General case' 0 C--N 1.277 -2.584 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.08 179.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.442 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 12.6 m-30 -101.0 104.72 34.07 Favored Pre-proline 0 N--CA 1.428 -1.564 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 175.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.466 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 91.9 Cg_endo -87.81 173.92 4.95 Favored 'Trans proline' 0 N--CA 1.436 -1.889 0 C-N-CA 122.008 1.805 . . . . 0.0 111.432 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -145.19 -175.66 4.79 Favored 'General case' 0 C--N 1.281 -2.371 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 175.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.575 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 37.6 tt0 -148.29 103.21 3.42 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 177.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 56.02 27.65 11.61 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.178 0.807 . . . . 0.0 113.178 177.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.09 7.31 73.9 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 114.541 0.576 . . . . 0.0 114.541 178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 15.6 ptpt -92.74 175.29 6.86 Favored 'General case' 0 C--O 1.25 1.088 0 CA-C-N 118.157 0.978 . . . . 0.0 108.866 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.447 ' OG1' HG12 ' A' ' 26' ' ' VAL . 13.5 t -72.16 137.56 47.04 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-O 121.381 0.61 . . . . 0.0 110.153 178.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 54' ' ' PRO . 13.6 pttm -79.35 163.94 24.46 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.493 174.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 22' ' ' ASN . . . -129.58 2.99 6.13 Favored Glycine 0 C--O 1.182 -3.133 0 C-N-CA 120.44 -0.886 . . . . 0.0 111.046 175.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 29.7 p90 -154.99 156.04 35.27 Favored 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.933 -0.745 . . . . 0.0 109.833 -175.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . . . . . . . . . 20.3 pt -141.27 167.33 17.02 Favored 'Isoleucine or valine' 0 C--O 1.245 0.851 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.41 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 87.5 m-85 -131.92 141.07 49.24 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.582 HD11 ' CD2' ' A' ' 42' ' ' PHE . 26.9 mt -127.87 149.35 50.33 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 110.596 -0.15 . . . . 0.0 110.596 179.225 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HB2' ' HB2' ' A' ' 50' ' ' ASN . 44.2 mt-10 -128.04 153.35 46.88 Favored 'General case' 0 C--O 1.255 1.388 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 173.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -124.37 159.89 29.36 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.1 -40.26 73.4 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.521 1.128 . . . . 0.0 111.212 179.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.443 ' O ' ' HD2' ' A' ' 73' ' ' HIS . 28.5 t -123.72 128.25 25.22 Favored Pre-proline 0 CA--C 1.461 -2.472 1 N-CA-C 97.14 -5.133 . . . . 0.0 97.14 173.101 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.496 ' HB3' ' HA ' ' A' ' 16' ' ' SER . 23.2 Cg_exo -62.49 -52.0 2.86 Favored 'Trans proline' 0 N--CA 1.438 -1.753 0 CA-C-N 121.813 1.683 . . . . 0.0 110.647 -165.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 26.52 5.79 0.0 OUTLIER 'General case' 0 N--CA 1.535 3.807 0 C-N-CA 131.551 3.94 . . . . 0.0 119.657 144.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.446 ' N ' ' O ' ' A' ' 71' ' ' PRO . 88.4 m-70 -127.24 -28.95 2.78 Favored 'General case' 1 C--N 1.225 -4.81 0 CA-C-O 121.214 0.53 . . . . 0.0 109.884 -170.22 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.471 ' HB3' ' O ' ' A' ' 15' ' ' ASP . . . -69.25 -26.77 64.95 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.048 175.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 p -67.65 -24.86 31.64 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.302 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -77.07 -45.1 28.2 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HA ' ' CE1' ' A' ' 45' ' ' PHE . . . -57.4 -47.14 82.5 Favored 'General case' 0 C--O 1.237 0.417 0 CA-C-N 115.31 -0.859 . . . . 0.0 111.911 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 31.6 m -72.38 -18.0 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.42 0 CA-C-O 121.109 0.48 . . . . 0.0 111.599 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 4.8 tppp? -84.2 -24.59 30.01 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.963 -0.755 . . . . 0.0 108.963 178.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -75.42 -84.18 0.05 Allowed 'General case' 0 CA--C 1.508 -0.638 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -177.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -153.89 109.45 3.21 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 121.253 0.549 . . . . 0.0 112.024 -173.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.72 ' HB2' HG22 ' A' ' 94' ' ' VAL . 1.2 t70 -95.46 120.22 35.33 Favored 'General case' 0 C--N 1.292 -1.919 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.86 173.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.05 53.8 2.29 Favored Glycine 0 C--N 1.3 -1.438 0 CA-C-N 115.457 -0.792 . . . . 0.0 113.576 176.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -106.42 119.14 38.48 Favored 'General case' 0 N--CA 1.436 -1.147 0 O-C-N 122.196 -0.591 . . . . 0.0 110.369 176.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.458 ' HG3' HG23 ' A' ' 91' ' ' THR . 0.0 OUTLIER -79.56 130.47 35.42 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-N 115.124 -0.944 . . . . 0.0 112.873 -175.671 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.2 mt -86.36 -63.3 1.34 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 167.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -172.15 169.63 5.44 Favored 'General case' 0 CA--C 1.506 -0.749 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 -179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' HG2' ' OE1' ' A' ' 89' ' ' GLN . 24.3 ttmm 51.79 -104.04 0.17 Allowed 'General case' 0 CA--C 1.555 1.143 0 C-N-CA 124.651 1.18 . . . . 0.0 112.44 173.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.457 ' OE1' ' HG2' ' A' ' 88' ' ' LYS . 5.7 pm0 -121.61 11.93 10.63 Favored 'General case' 0 CA--C 1.502 -0.882 0 CA-C-O 121.959 0.885 . . . . 0.0 109.217 176.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.789 ' CD2' ' HA ' ' A' ' 24' ' ' PRO . 7.4 m170 -90.33 88.48 7.22 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.918 -1.141 . . . . 0.0 107.918 -174.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.458 HG23 ' HG3' ' A' ' 85' ' ' LYS . 61.9 m -133.49 114.82 14.04 Favored 'General case' 0 C--N 1.257 -3.415 0 CA-C-N 114.123 -1.399 . . . . 0.0 107.452 -178.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -82.53 100.64 10.23 Favored 'General case' 0 C--N 1.294 -1.823 0 C-N-CA 118.488 -1.285 . . . . 0.0 110.79 -175.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -87.74 122.59 31.58 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 172.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.72 HG22 ' HB2' ' A' ' 82' ' ' ASP . 2.6 m -107.65 126.12 64.02 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.895 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 -172.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.572 ' O ' ' HB ' ' A' ' 19' ' ' VAL . 0.0 OUTLIER -159.11 176.22 12.51 Favored 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 119.348 -0.941 . . . . 0.0 108.96 179.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.3 pp -109.76 -173.78 2.34 Favored 'General case' 0 C--N 1.281 -2.382 0 C-N-CA 123.2 0.6 . . . . 0.0 109.406 171.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 42.9 p90 -123.43 -13.72 7.54 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 113.215 0.82 . . . . 0.0 113.215 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 1.5 m -60.76 154.22 22.29 Favored 'General case' 0 C--N 1.289 -2.052 0 C-N-CA 124.971 1.309 . . . . 0.0 111.189 -178.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -82.19 -42.96 18.3 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -172.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -133.09 164.31 27.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.513 ' HA ' ' HA2' ' A' ' 13' ' ' GLY . 5.7 p-10 -90.08 -0.13 57.43 Favored 'General case' 0 CA--C 1.499 -1.003 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.807 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . 0.27 18.2 mmmt -66.06 127.51 32.39 Favored 'General case' 0 N--CA 1.429 -1.486 0 C-N-CA 118.852 -1.139 . . . . 0.0 112.876 -172.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 27.8 t80 -134.31 161.43 34.97 Favored 'General case' 0 C--N 1.277 -2.555 0 CA-C-N 112.945 -1.934 . . . . 0.0 106.246 -169.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 13.6 tpt -71.02 102.97 2.56 Favored 'General case' 0 C--N 1.316 -0.856 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 176.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.413 -2.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.632 -178.447 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.577 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -78.56 150.13 32.89 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.23 0.538 . . . . 0.0 111.428 -179.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.6 m -91.46 3.96 6.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-O 121.493 0.664 . . . . 0.0 110.086 -179.564 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 96.4 mt -68.23 -20.1 64.8 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.765 -177.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 23.0 mtpp -75.84 -18.07 59.59 Favored 'General case' 0 N--CA 1.435 -1.221 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.825 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -92.01 82.12 5.1 Favored 'General case' 0 CA--C 1.496 -1.108 0 CA-C-O 121.084 0.469 . . . . 0.0 109.916 176.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 16.7 mmt85 -138.32 142.44 35.13 Favored Pre-proline 0 C--N 1.3 -1.578 0 CA-C-N 115.228 -0.896 . . . . 0.0 109.365 -178.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -73.99 128.54 12.4 Favored 'Trans proline' 0 N--CA 1.435 -1.919 0 N-CA-C 104.866 -2.782 . . . . 0.0 104.866 167.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 15.9 tp60 -67.09 119.5 12.13 Favored 'General case' 0 C--N 1.302 -1.465 0 C-N-CA 120.113 -0.635 . . . . 0.0 109.644 -174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -74.3 -20.36 60.15 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.515 0.674 . . . . 0.0 110.197 -176.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -97.41 86.82 3.96 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 173.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -127.8 161.3 29.32 Favored 'General case' 0 C--N 1.307 -1.272 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 83.53 -49.4 4.22 Favored Glycine 0 C--N 1.312 -0.793 0 O-C-N 123.317 0.385 . . . . 0.0 112.297 178.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 9.4 tp -75.03 132.52 33.2 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 CA-C-O 121.124 0.488 . . . . 0.0 109.884 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -129.2 -13.14 4.5 Favored 'General case' 0 C--N 1.304 -1.39 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.844 176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.426 ' HA ' ' HE1' ' A' ' 73' ' ' HIS . 38.5 m -106.48 -7.53 17.5 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 114.367 1.247 . . . . 0.0 114.367 -172.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 73.8 t -134.92 135.18 53.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 C-N-CA 120.757 -0.377 . . . . 0.0 110.231 -175.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . . . . . . . . . 12.3 mm -92.66 134.82 29.4 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.058 0 N-CA-C 106.343 -1.725 . . . . 0.0 106.343 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 35.4 t -123.89 112.9 34.71 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.869 0 N-CA-C 107.605 -1.257 . . . . 0.0 107.605 178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.41 HG23 HG12 ' A' ' 64' ' ' ILE . 1.8 m -121.98 118.42 55.5 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.962 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.446 -178.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -90.77 148.81 22.3 Favored 'General case' 0 C--N 1.309 -1.176 0 CA-C-N 114.661 -1.154 . . . . 0.0 108.263 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.442 0.1 OUTLIER 47.41 83.66 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 128.204 2.602 . . . . 0.0 114.776 -175.167 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.478 ' HB ' ' HD2' ' A' ' 24' ' ' PRO . 32.3 m -90.77 163.63 29.32 Favored Pre-proline 0 C--N 1.305 -1.353 0 CA-C-N 113.465 -1.698 . . . . 0.0 110.043 -178.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.478 ' HD2' ' HB ' ' A' ' 23' ' ' VAL . 0.9 OUTLIER -42.7 142.54 1.99 Allowed 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 124.531 3.487 . . . . 0.0 114.987 -179.856 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.485 ' HB3' ' NE2' ' A' ' 89' ' ' GLN . 0.1 OUTLIER -80.52 159.38 25.53 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-N 114.798 -1.092 . . . . 0.0 108.323 -178.263 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 27' ' ' GLY . 14.0 p -128.53 136.93 58.72 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 C-N-CA 119.44 -0.904 . . . . 0.0 111.957 -177.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.488 ' O ' HG22 ' A' ' 26' ' ' VAL . . . -101.51 168.09 19.42 Favored Glycine 0 N--CA 1.426 -2.03 0 N-CA-C 107.617 -2.193 . . . . 0.0 107.617 171.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.96 126.87 19.85 Favored 'Trans proline' 0 C--O 1.243 0.747 0 C-N-CA 122.834 2.356 . . . . 0.0 113.19 -177.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 66.15 24.08 10.88 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 125.096 1.359 . . . . 0.0 112.996 178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.408 ' HA ' ' HD3' ' A' ' 33' ' ' LYS . 20.0 mtp180 -107.3 -3.78 19.34 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 119.882 -0.727 . . . . 0.0 112.487 179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -68.51 -33.92 74.98 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 -176.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -51.54 -45.68 63.07 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.094 1.358 . . . . 0.0 111.449 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.474 ' HD2' ' H ' ' A' ' 33' ' ' LYS . 0.0 OUTLIER -85.08 -29.17 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.855 -0.738 . . . . 0.0 112.022 -179.081 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.601 ' O ' HG12 ' A' ' 38' ' ' ILE . 78.2 mt -64.51 -39.48 93.86 Favored 'General case' 0 C--O 1.208 -1.12 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 18.4 ptpt -71.56 -21.26 61.91 Favored 'General case' 0 C--N 1.32 -0.711 0 C-N-CA 120.008 -0.677 . . . . 0.0 111.479 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.432 ' O ' ' HG2' ' A' ' 40' ' ' LYS . 28.7 t-20 -84.38 -38.18 20.6 Favored 'General case' 0 C--N 1.31 -1.138 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.246 -176.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.8 p -67.05 -26.28 36.26 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.436 179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.601 HG12 ' O ' ' A' ' 34' ' ' LEU . 44.0 mm -57.69 -51.32 71.56 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.059 175.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 49.9 t-80 -62.88 -31.16 72.15 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.048 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 36' ' ' ASN . 34.4 mmtp -65.69 -47.8 74.18 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 47.5 mm -67.66 -47.86 78.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.63 179.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.539 ' HB3' ' OH ' ' A' ' 68' ' ' TYR . 68.4 m-85 -83.98 -11.76 56.32 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -170.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.5 p -69.31 -16.54 63.58 Favored 'General case' 0 C--N 1.318 -0.767 0 O-C-N 121.555 -0.715 . . . . 0.0 110.827 175.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.495 ' HE2' ' HA ' ' A' ' 44' ' ' LYS . 9.6 mmpt? -64.73 -24.75 67.66 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.347 176.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -96.23 -8.68 32.28 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.758 0.313 . . . . 0.0 111.39 -179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 146.95 -149.12 21.23 Favored Glycine 0 N--CA 1.428 -1.87 0 C-N-CA 119.878 -1.153 . . . . 0.0 112.35 179.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.6 tttp -103.18 118.29 36.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 -177.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 66' ' ' LEU . 23.0 mm -73.82 103.4 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 105.55 -2.019 . . . . 0.0 105.55 177.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 16.9 p -88.5 -23.74 23.14 Favored 'General case' 0 C--N 1.302 -1.496 0 CA-C-O 121.007 0.432 . . . . 0.0 111.411 -176.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -158.23 139.03 12.97 Favored 'General case' 0 N--CA 1.434 -1.24 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 -178.6 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.411 ' HB2' ' CE1' ' A' ' 53' ' ' TYR . 4.5 p30 -130.53 142.35 50.47 Favored 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.843 -0.536 . . . . 0.0 110.982 -177.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 65' ' ' PHE . 97.4 m-85 -128.23 98.97 5.26 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 178.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.411 ' CE1' ' HB2' ' A' ' 51' ' ' ASP . 7.4 m-30 -108.12 104.66 54.41 Favored Pre-proline 0 C--N 1.298 -1.633 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -81.35 163.07 19.67 Favored 'Trans proline' 0 N--CA 1.444 -1.441 0 C-N-CA 121.153 1.235 . . . . 0.0 109.863 175.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HB3' ' HG2' ' A' ' 61' ' ' LYS . 8.3 pt-20 -174.31 177.73 2.18 Favored 'General case' 0 C--N 1.293 -1.889 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 -175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 68.1 mm-40 -128.77 105.19 8.08 Favored 'General case' 0 C--N 1.295 -1.765 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 58.12 27.57 15.19 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.958 0.903 . . . . 0.0 111.979 -179.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.435 ' HA2' ' OE1' ' A' ' 55' ' ' GLU . . . 79.1 15.2 80.86 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.104 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 53.3 mtmt -92.03 -178.74 5.08 Favored 'General case' 0 C--O 1.245 0.832 0 O-C-N 122.537 -0.39 . . . . 0.0 110.521 179.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.415 ' HB ' ' H ' ' A' ' 26' ' ' VAL . 7.0 t -57.15 106.16 0.29 Allowed 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 113.95 1.093 . . . . 0.0 113.95 -174.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.472 ' HG2' ' HB3' ' A' ' 55' ' ' GLU . 42.2 mttm -57.38 168.39 0.79 Allowed 'General case' 0 C--O 1.245 0.82 0 C-N-CA 126.489 1.916 . . . . 0.0 110.883 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -117.51 -13.93 7.18 Favored Glycine 0 N--CA 1.431 -1.667 0 C-N-CA 120.167 -1.016 . . . . 0.0 111.669 177.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -170.47 159.45 6.93 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 -176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.41 HG12 HG23 ' A' ' 20' ' ' VAL . 25.7 pt -146.9 166.28 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.145 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 176.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 52' ' ' PHE . 63.7 m-85 -132.43 134.26 44.89 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.463 HD12 HD12 ' A' ' 48' ' ' ILE . 3.1 mm? -112.87 117.63 32.68 Favored 'General case' 0 C--N 1.294 -1.839 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 176.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -107.15 130.81 54.65 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 -179.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . 0.583 ' HB2' ' CE1' ' A' ' 73' ' ' HIS . 0.4 OUTLIER -127.38 177.62 6.6 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 179.869 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -117.72 13.51 14.21 Favored 'General case' 0 C--N 1.299 -1.591 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.448 ' HB2' ' ND1' ' A' ' 73' ' ' HIS . 29.6 m -79.11 151.0 75.37 Favored Pre-proline 0 CA--C 1.574 1.867 0 N-CA-C 114.244 1.201 . . . . 0.0 114.244 -172.401 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_endo -37.59 8.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.52 3.04 2 C-N-CA 130.593 7.529 . . . . 0.0 122.751 -175.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.501 ' O ' HG12 ' A' ' 75' ' ' VAL . . . 85.33 64.64 0.01 OUTLIER 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 124.576 2.131 . . . . 0.0 106.928 -160.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.583 ' CE1' ' HB2' ' A' ' 68' ' ' TYR . 53.4 p-80 -90.34 -36.35 14.7 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-N 109.129 -3.669 . . . . 0.0 107.662 179.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.67 -31.02 69.84 Favored 'General case' 0 CA--C 1.484 -1.567 0 CA-C-N 115.079 -0.964 . . . . 0.0 109.311 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.501 HG12 ' O ' ' A' ' 72' ' ' ALA . 4.0 p -65.92 -28.55 44.25 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.665 0 CA-C-N 114.111 -1.404 . . . . 0.0 109.153 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -81.5 -40.0 23.89 Favored 'General case' 0 CA--C 1.513 -0.447 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.854 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.43 75.14 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.626 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.2 t -63.58 -38.74 83.05 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.941 0 C-N-CA 124.439 1.096 . . . . 0.0 111.198 180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.424 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 0.4 OUTLIER -73.06 -20.91 60.87 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.422 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -93.59 -56.52 2.88 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.694 177.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . . . . . . . . . . . -136.62 97.85 3.66 Favored 'General case' 0 N--CA 1.431 -1.379 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 -171.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.466 ' CG ' HG22 ' A' ' 94' ' ' VAL . 5.5 t0 -112.0 122.69 48.45 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 169.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.47 42.39 9.25 Favored Glycine 0 C--N 1.3 -1.445 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.988 -177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 91' ' ' THR . 16.9 p90 -94.65 139.13 31.63 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.736 0.303 . . . . 0.0 110.939 -178.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.51 ' H ' ' HD2' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -103.36 123.84 47.56 Favored 'General case' 0 N--CA 1.436 -1.144 0 N-CA-C 112.897 0.703 . . . . 0.0 112.897 -175.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.1 mt -87.09 -50.59 6.53 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.812 175.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.406 ' HB3' ' CD2' ' A' ' 90' ' ' HIS . 9.8 t70 -155.18 -167.19 2.48 Favored 'General case' 0 C--N 1.311 -1.095 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -176.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -27.6 -75.41 0.02 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.932 2.093 . . . . 0.0 115.541 -170.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.485 ' NE2' ' HB3' ' A' ' 25' ' ' GLN . 5.1 pm0 -111.12 12.62 21.92 Favored 'General case' 0 C--N 1.321 -0.661 0 C-N-CA 119.051 -1.06 . . . . 0.0 112.27 -178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.417 ' ND1' ' HA ' ' A' ' 24' ' ' PRO . 3.7 m-70 -88.46 88.88 7.77 Favored 'General case' 0 CA--C 1.496 -1.103 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 84' ' ' TYR . 5.1 m -133.49 102.07 5.38 Favored 'General case' 0 C--N 1.266 -3.049 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 179.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -81.39 118.54 22.76 Favored 'General case' 0 C--N 1.304 -1.404 0 N-CA-C 112.2 0.444 . . . . 0.0 112.2 -167.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.1 mpt_? -88.34 125.19 34.57 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 175.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.466 HG22 ' CG ' ' A' ' 82' ' ' ASP . 4.1 m -94.56 147.78 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.067 -178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -157.14 167.94 28.93 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 -177.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.2 pp -69.48 -175.45 0.83 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 122.424 1.106 . . . . 0.0 112.554 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -123.21 -40.15 2.41 Favored 'General case' 0 C--N 1.282 -2.336 0 CA-C-N 114.306 -1.315 . . . . 0.0 109.299 -176.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.1 p -87.5 83.29 7.29 Favored 'General case' 0 N--CA 1.418 -2.042 0 CA-C-O 121.629 0.728 . . . . 0.0 111.162 -178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -70.08 -32.82 71.09 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.572 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 42.6 t80 -112.39 84.96 2.06 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-N 114.89 -1.05 . . . . 0.0 108.739 174.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -98.06 -7.69 29.25 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-O 122.408 1.099 . . . . 0.0 108.559 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 32.7 mmtp -73.02 164.03 27.3 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.162 -178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -139.11 155.16 48.1 Favored 'General case' 0 N--CA 1.422 -1.837 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 24.8 ttt -94.75 94.39 8.07 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.9 m . . . . . 0 C--N 1.29 -1.99 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 177.77 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.998 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -91.47 150.72 21.1 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.576 0.703 . . . . 0.0 110.161 179.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.5 p -134.34 8.71 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.277 -2.561 0 CA-C-N 114.401 -1.272 . . . . 0.0 109.695 -176.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -87.09 -24.79 24.45 Favored 'General case' 0 N--CA 1.435 -1.205 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 179.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.534 ' HA ' ' O ' ' A' ' 105' ' ' THR . 0.0 OUTLIER -76.05 -2.28 29.97 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 114.754 -1.112 . . . . 0.0 111.566 175.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -95.6 104.62 16.54 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 -177.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 54.0 mtt-85 -139.26 147.38 52.82 Favored Pre-proline 0 C--N 1.297 -1.689 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 -179.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -64.79 144.11 82.47 Favored 'Trans proline' 0 C--O 1.251 1.133 0 C-N-CA 121.56 1.507 . . . . 0.0 109.107 175.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -73.16 109.45 6.7 Favored 'General case' 0 CA--C 1.493 -1.234 0 CA-C-O 122.197 0.999 . . . . 0.0 113.301 -174.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -125.78 -22.13 4.27 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 113.4 -1.727 . . . . 0.0 107.229 167.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.46 103.0 13.23 Favored 'General case' 0 N--CA 1.441 -0.895 0 CA-C-N 114.406 -1.27 . . . . 0.0 111.935 -178.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.621 ' OD2' ' HB2' ' A' ' 96' ' ' LEU . 11.9 t70 -167.3 150.04 6.15 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 173.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -104.68 -6.46 40.71 Favored Glycine 0 C--N 1.302 -1.32 0 C-N-CA 120.109 -1.043 . . . . 0.0 113.734 -175.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . . . . . . . . . 5.2 tp -134.33 97.39 2.13 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.419 0 CA-C-O 122.55 1.167 . . . . 0.0 112.096 -175.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -96.02 18.34 13.62 Favored 'General case' 0 C--O 1.193 -1.911 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.376 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 8.0 t -109.04 -6.12 15.77 Favored 'General case' 0 C--N 1.296 -1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 111.108 -176.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 66' ' ' LEU . 48.7 t -111.84 118.47 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.079 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 -177.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 65' ' ' PHE . 35.5 mm -84.11 139.21 17.93 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 177.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.453 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 49.9 t -130.71 113.09 23.95 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.605 0 CA-C-N 114.654 -1.157 . . . . 0.0 108.103 -179.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.62 HG12 HG12 ' A' ' 94' ' ' VAL . 12.0 m -120.24 131.93 71.23 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.959 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.61 177.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -98.22 142.88 29.34 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-N 115.285 -0.87 . . . . 0.0 109.994 178.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . 0.484 0.2 OUTLIER 44.17 81.67 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 127.127 2.171 . . . . 0.0 115.815 -174.421 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 26.3 m -78.0 160.42 73.83 Favored Pre-proline 0 C--N 1.303 -1.45 0 CA-C-N 114.038 -1.437 . . . . 0.0 108.546 175.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.495 ' HA ' ' ND1' ' A' ' 90' ' ' HIS . 5.6 Cg_endo -46.64 132.94 16.78 Favored 'Trans proline' 0 CA--C 1.501 -1.138 0 C-N-CA 123.465 2.777 . . . . 0.0 114.28 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.7 138.05 42.69 Favored 'General case' 0 N--CA 1.416 -2.141 0 CA-C-N 113.416 -1.72 . . . . 0.0 109.311 175.374 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 4.9 t -103.11 138.42 27.47 Favored 'Isoleucine or valine' 0 C--N 1.271 -2.813 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.205 -174.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -104.4 -178.14 25.08 Favored Glycine 0 C--N 1.303 -1.278 0 N-CA-C 108.888 -1.685 . . . . 0.0 108.888 175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -59.6 125.79 18.83 Favored 'Trans proline' 0 C--O 1.237 0.453 0 C-N-CA 122.203 1.935 . . . . 0.0 112.299 -177.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.8 t70 51.71 22.53 1.68 Allowed 'General case' 0 N--CA 1.486 1.336 0 C-N-CA 126.519 1.928 . . . . 0.0 112.44 -178.21 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 52.9 mtp180 -86.91 -17.92 32.08 Favored 'General case' 0 C--N 1.315 -0.93 0 O-C-N 121.354 -0.841 . . . . 0.0 111.253 179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -54.17 -45.08 72.0 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 112.701 0.63 . . . . 0.0 112.701 -175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -56.9 -56.95 15.06 Favored 'General case' 0 C--N 1.315 -0.896 0 O-C-N 123.465 0.478 . . . . 0.0 110.99 -177.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 18.8 ptpt -68.38 -24.19 64.75 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 120.691 -0.404 . . . . 0.0 111.522 -179.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.61 ' O ' HG12 ' A' ' 38' ' ' ILE . 8.0 tt -70.69 -44.91 66.0 Favored 'General case' 0 N--CA 1.439 -0.986 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 23.4 pttp -73.57 -18.07 61.11 Favored 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 119.635 -0.826 . . . . 0.0 112.324 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . 0.491 ' O ' ' HG3' ' A' ' 40' ' ' LYS . 11.3 m120 -78.86 -41.73 29.17 Favored 'General case' 0 N--CA 1.417 -2.09 0 CA-C-N 115.831 -0.622 . . . . 0.0 109.591 179.371 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.461 HG12 ' O ' ' A' ' 34' ' ' LEU . 9.8 p -68.08 -32.62 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.525 0 CA-C-N 116.002 -0.545 . . . . 0.0 109.989 -179.344 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.61 HG12 ' O ' ' A' ' 34' ' ' LEU . 26.5 mm -61.09 -53.87 43.14 Favored 'Isoleucine or valine' 0 C--O 1.217 -0.637 0 C-N-CA 122.968 0.507 . . . . 0.0 109.661 176.097 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 12.0 t60 -53.34 -38.48 63.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 123.355 0.662 . . . . 0.0 109.916 179.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.491 ' HG3' ' O ' ' A' ' 36' ' ' ASN . 28.0 mtpp -73.92 -48.87 27.7 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.112 -0.495 . . . . 0.0 112.082 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.524 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 88.4 mt -62.01 -40.74 88.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 121.135 0.493 . . . . 0.0 110.326 -179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 38' ' ' ILE . 2.4 m-30 -74.26 -11.99 60.43 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.31 -176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 71.1 m -64.95 -16.43 63.32 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 178.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.524 ' HG2' ' O ' ' A' ' 41' ' ' ILE . 18.8 ptpt -67.32 -33.39 75.16 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.453 0.644 . . . . 0.0 110.523 177.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 81' ' ' ALA . 27.8 m-85 -79.79 -16.05 56.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.448 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.473 ' HA3' ' ND1' ' A' ' 73' ' ' HIS . . . 150.18 179.88 26.35 Favored Glycine 0 N--CA 1.423 -2.229 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.663 177.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -67.38 114.36 6.01 Favored 'General case' 0 C--N 1.306 -1.298 0 C-N-CA 124.301 1.04 . . . . 0.0 110.816 179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ILE . . . . . . . . . . . . . 24.3 mm -74.43 108.06 5.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 23.3 m -80.16 -45.2 18.52 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -154.03 153.15 31.41 Favored 'General case' 0 C--N 1.309 -1.195 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 177.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -131.62 150.69 52.06 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 123.037 0.535 . . . . 0.0 110.055 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -135.01 101.22 4.81 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -174.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . 0.507 ' HB3' ' HE3' ' A' ' 61' ' ' LYS . 34.8 m-85 -108.89 107.05 59.77 Favored Pre-proline 0 C--N 1.293 -1.857 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.194 177.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.431 ' O ' ' HD3' ' A' ' 61' ' ' LYS . 83.4 Cg_endo -95.44 173.22 1.16 Allowed 'Trans proline' 0 N--CA 1.444 -1.402 0 C-N-CA 121.864 1.709 . . . . 0.0 111.216 173.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -175.05 -175.49 0.86 Allowed 'General case' 0 C--N 1.301 -1.517 0 C-N-CA 125.7 1.6 . . . . 0.0 106.725 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' O ' ' HG2' ' A' ' 59' ' ' LYS . 7.6 pt-20 -128.41 128.36 44.32 Favored 'General case' 0 C--N 1.294 -1.809 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.8 t70 54.5 26.95 7.72 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 124.905 1.282 . . . . 0.0 111.282 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 69.53 21.38 76.15 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-N 115.18 -0.918 . . . . 0.0 114.047 179.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.516 ' HG2' ' O ' ' A' ' 56' ' ' GLU . 14.9 ptpt -92.75 -177.77 4.65 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.082 0.941 . . . . 0.0 109.198 -179.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 85.7 m -66.86 106.03 1.77 Allowed 'General case' 0 N--CA 1.429 -1.479 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 -178.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HE3' ' HB3' ' A' ' 53' ' ' TYR . 1.4 pttm -62.55 164.55 7.37 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.175 -0.92 . . . . 0.0 111.296 168.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -127.01 18.83 6.16 Favored Glycine 0 N--CA 1.431 -1.698 0 C-N-CA 120.532 -0.842 . . . . 0.0 111.993 177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -169.35 149.16 4.01 Favored 'General case' 0 C--O 1.243 0.749 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -179.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ILE . . . . . 0.5 HG12 ' CG2' ' A' ' 20' ' ' VAL . 19.8 pt -142.84 168.18 13.74 Favored 'Isoleucine or valine' 0 C--O 1.247 0.956 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 175.108 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.511 ' HA ' ' O ' ' A' ' 18' ' ' ILE . 77.4 m-85 -135.71 152.91 51.63 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.556 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 5.5 mp -135.0 154.48 51.72 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -130.24 128.17 41.09 Favored 'General case' 0 C--O 1.253 1.284 0 O-C-N 124.05 0.844 . . . . 0.0 109.273 -179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -104.75 176.59 5.11 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -81.98 -37.39 26.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.343 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.5 t -127.78 145.52 55.3 Favored Pre-proline 0 CA--C 1.466 -2.254 1 N-CA-C 99.534 -4.247 . . . . 0.0 99.534 176.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 73' ' ' HIS . 39.2 Cg_exo -63.64 -54.64 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.791 0 CA-C-N 122.193 1.819 . . . . 0.0 110.562 -171.162 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . 25.8 4.07 0.0 OUTLIER 'General case' 0 N--CA 1.532 3.654 1 C-N-CA 132.077 4.151 . . . . 0.0 119.824 148.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . 0.473 ' ND1' ' HA3' ' A' ' 46' ' ' GLY . 94.6 m-70 -129.32 -36.95 1.67 Allowed 'General case' 1 C--N 1.227 -4.754 0 C-N-CA 123.291 0.636 . . . . 0.0 110.045 -170.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.24 -26.86 64.04 Favored 'General case' 0 N--CA 1.428 -1.543 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.521 177.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.7 p -61.65 -31.9 52.14 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.033 0 CA-C-O 121.256 0.551 . . . . 0.0 110.45 177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -83.73 -40.16 19.2 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-O 121.195 0.522 . . . . 0.0 109.759 178.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -62.94 -46.8 86.05 Favored 'General case' 0 C--O 1.213 -0.863 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.639 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.572 ' HA ' HG21 ' A' ' 94' ' ' VAL . 53.2 t -65.59 -22.63 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-O 121.678 0.751 . . . . 0.0 111.16 -179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.0 tppt? -83.8 -38.3 21.45 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.927 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -110.06 -25.91 9.98 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -170.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ALA . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . . . -101.47 7.11 42.62 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 122.018 -0.427 . . . . 0.0 111.793 -174.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.613 ' HA ' HG22 ' A' ' 94' ' ' VAL . 14.4 t0 -76.63 103.35 6.56 Favored 'General case' 0 CA--C 1.489 -1.399 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -177.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.79 46.59 8.41 Favored Glycine 0 C--N 1.294 -1.775 0 CA-C-N 113.828 -1.533 . . . . 0.0 113.585 175.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -105.3 136.38 44.94 Favored 'General case' 0 N--CA 1.438 -1.028 0 C-N-CA 118.951 -1.1 . . . . 0.0 109.101 176.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.496 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.1 OUTLIER -106.72 129.33 54.62 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -172.662 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 83.5 mt -79.46 -62.45 1.69 Allowed 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 114.529 -1.214 . . . . 0.0 108.891 177.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -155.48 133.81 11.67 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.017 -1.105 . . . . 0.0 108.017 -179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm 53.1 -93.74 0.03 OUTLIER 'General case' 0 C--N 1.314 -0.965 0 C-N-CA 125.647 1.579 . . . . 0.0 114.792 175.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 8.7 pm0 -107.33 -4.1 18.97 Favored 'General case' 0 N--CA 1.444 -0.746 0 CA-C-O 120.661 0.267 . . . . 0.0 110.819 -175.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.495 ' ND1' ' HA ' ' A' ' 24' ' ' PRO . 6.9 m-70 -79.3 91.46 5.03 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -178.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.6 m -132.84 120.48 21.6 Favored 'General case' 0 C--N 1.276 -2.622 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 86.5 m-85 -83.86 104.6 14.08 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.786 -0.766 . . . . 0.0 111.114 -176.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -90.06 109.08 20.15 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 173.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.62 HG12 HG12 ' A' ' 20' ' ' VAL . 17.2 m -93.62 143.53 11.37 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -176.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -158.08 -172.0 3.73 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 119.064 -1.054 . . . . 0.0 110.066 176.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.621 ' HB2' ' OD2' ' A' ' 12' ' ' ASP . 2.0 pp -66.77 176.94 1.8 Allowed 'General case' 0 C--N 1.309 -1.159 0 C-N-CA 124.913 1.285 . . . . 0.0 112.181 -179.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -124.96 -14.03 6.73 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.042 -175.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 20.9 p -71.61 78.0 0.81 Allowed 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 122.623 1.201 . . . . 0.0 112.825 176.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -75.11 -13.89 60.52 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.159 -1.382 . . . . 0.0 109.054 177.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -64.33 154.87 34.04 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 113.892 -1.504 . . . . 0.0 107.684 175.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -87.44 79.68 8.33 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-O 121.936 0.874 . . . . 0.0 110.929 -174.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.7 151.37 37.69 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 168.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -64.35 103.5 0.65 Allowed 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -175.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' MET . . . . . . . . . . . . . 51.9 ttm -69.95 107.34 3.54 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 176.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.534 ' O ' ' HA ' ' A' ' 5' ' ' LYS . 6.1 m . . . . . 0 N--CA 1.414 -2.27 0 CA-C-O 117.953 -1.022 . . . . 0.0 108.889 -176.208 . . . . . . . . 1 1 . 1 stop_ save_